ontology,root,fragment,text,statements,llm_used
doid,http://purl.obolibrary.org/obo/DOID_0060858,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hypotonia_cystinuria_syndrome rdfs:subClassOf [ owl:intersectionOf [ rdf:first [ a owl:Restriction ;
                            owl:onProperty :has_material_basis_in ;
                            owl:someValuesFrom :deletion ] ;
                    rdf:rest [ rdf:first [ a owl:Restriction ;
                                    owl:onProperty :has_material_basis_in ;
                                    owl:someValuesFrom :chromosome ] ;
                            rdf:rest :nil ] ] ],
        :chromosomal_deletion_syndrome,
        :syndrome ;
    :has_definition ""A syndrome that has_material_basis_in homozygous deletion on chromosome 2p21 that disrupts the SLC3A1 and PREPL genes. The deletion ranges in size from 23.8 to 75.5 kb. Itis characterized_by neonatal and infantile hypotonia and failure to thrive, cystinuria type 1 and nephrolithiasis, growth retardation due to growth hormone deficiency, and minor facial dysmorphism."" ;
    :has_exact_synonym ""cystinuria with mitochondrial disease""@en .

","Hypotonia cystinuria syndrome is a rare genetic disorder that affects infants and young children. It is caused by a deletion on the long (q) arm of chromosome 2, which leads to the absence of two important genes: SLC3A1 and PREPL. The absence of these genes can result in various symptoms such as weakness, poor growth, cystinuria (a condition where cystine is excreted in the urine), and nephrolithiasis (the formation of kidney stones). Additionally, some individuals with this disorder may also have minor facial dysmorphism. This syndrome is known as a chromosomal deletion syndrome, which occurs when there is a missing or extra piece of DNA in the genome that results in specific symptoms and characteristics.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0060859,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:salmonellosis rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :vomiting ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :diarrhea ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :abdominal_cramp ],
        :primary_bacterial_infectious_disease ;
    :has_definition ""A primary bacterial infectious disease caused by the bacteria of the genus Salmonella. It has symptoms diarrhea, fever, vomiting, and abdominal cramps 12 to 72 hours after infection. In most cases, the illness lasts four to seven days, and most people recover without treatment."" ;
    :has_exact_synonym ""Salmonella infection""@en .

","Salmonellosis is a primary bacterial infectious disease caused by the bacteria of the genus Salmonella. Symptoms typically include diarrhea, fever, vomiting, and abdominal cramps 12 to 72 hours after infection. The illness lasts four to seven days on average, and most people recover without treatment.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0060861,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:microphthalmia_with_limb_anomalies rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :syndrome ;
    :has_definition ""A syndrome that is characterized by autosomal recessive inheritance of bilateral or unilateral clinical anophthalmia or microphthalmia and synostosis, syndactyly, oligodactyly and/or polydactyly that has_material_basis_in homozygous mutation in the SMOC1 gene on chromosome 14q24."" ;
    :has_exact_synonym ""MLA""@en,
        ""OAS""@en,
        ""Waardenburg anophthalmia syndrome""@en,
        ""anophthalmia-syndactyly syndrome""@en,
        ""ophthalmoacromelic syndrome""@en .

","Microphthalmia with limb anomalies is a type of autosomal recessive disease that is characterized by the bilateral or unilateral clinical anophthalmia or microphthalmia and synostosis, syndactyly, oligodactyly and/or polydactyly. It has a material basis in homozygous mutation in the SMOC1 gene on chromosome 14q24. It is also known by various other names such as MLA, OAS, Waardenburg anophthalmia syndrome, anophthalmia-syndactyly syndrome and ophthalmoacromelic syndrome.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0060862,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:mal_de_meleda rdfs:subClassOf :palmoplantar_keratosis ;
    :has_definition ""A palmoplantar keratosis characterized by autosomal recessive inheritance of symmetric palmoplantar hyperkeratosis that progressively extends to the dorsal surfaces of hands and feet and ichthyotic changes elsewhere that has_material_basis_in homozygous mutation in the SLURP1 gene on chromosome 8q24."" ;
    :has_exact_synonym ""Meleda disease""@en,
        ""keratosis palmoplantaris transgrediens of Siemens""@en,
        ""transgrediens palmoplantar keratoderma of Siemens""@en .

","Mal de Meleda is a type of palmoplantar keratosis, which is characterized by autosomal recessive inheritance of symmetric palmoplantar hyperkeratosis that progressively extends to the dorsal surfaces of hands and feet and ichthyotic changes elsewhere. It has a material basis in homozygous mutation in the SLURP1 gene on chromosome 8q24.
Mal de Meleda is also known as Meleda disease, palmoplantar keratoderma of Siemens, and transgrediens palmoplantar keratosis of Siemens.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0060863,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:patterned_macular_dystrophy rdfs:subClassOf :macular_degeneration ;
    :has_definition ""A macular degeneration characterized by abnormal accumulation of lipofuscin in the retinal pigment epithelium in a distinct pattern, patterns include; reticular ('fishnet-like'), macroreticular ('spider-shaped'), and butterfly-shaped."" ;
    :has_exact_synonym ""patterned dystrophy of retinal pigment epithelium""@en .

","patterned macular dystrophy is a type of macular degeneration characterized by abnormal accumulation of lipofuscin in the retinal pigment epithelium in a distinct pattern, which includes three patterns: reticular ('fishnet-like'), macroreticular ('spider-shaped'), and butterfly-shaped. It is also known as patterned dystrophy of retinal pigment epithelium.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0060864,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:patterned_macular_dystrophy_2 rdfs:subClassOf :patterned_macular_dystrophy ;
    :has_definition ""A patterned macular dystrophy characterized by bilateral accumulation of pigmented or yellowish material at the level of the retinal pigment epithelium in lesions that resemble the wings of a butterfly that has_material_basis_in heterozygous mutation in the CTNNA1 gene on chromosome 5q31."" ;
    :has_exact_synonym ""MDPT2""@en,
        ""butterfly-shaped pigmentary maculary dystrophy 2""@en .

","Patterned macular dystrophy 2 (MDPT2) is a type of patterned macular dystrophy characterized by bilateral accumulation of pigmented or yellowish material at the level of the retinal pigment epithelium in lesions that resemble the wings of a butterfly. This condition has a genetic basis, specifically due to heterozygous mutation in the CTNNA1 gene on chromosome 5q31. MDPT2 is also known by its exact synonyms, ""butterfly-shaped pigmentary maculary dystrophy 2"" and ""MDPT2.""",4,True
doid,http://purl.obolibrary.org/obo/DOID_0060865,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:patterned_macular_dystrophy_3 rdfs:subClassOf :patterned_macular_dystrophy ;
    :has_definition ""A patterned macular dystrophy characterized by a 'dry desert land' pattern of the fundus, involving the posterior pole initially and progressing from the temporal fovea to the periphery of the retina developing in the fourth or fifth decade of life that has_material_basis_in heterozygous mutation in the MAPKAPK3 gene on chromosome 3p21."" ;
    :has_exact_synonym ""MDPT3""@en,
        ""Martinique crinkled retinal pigment epitheliopathy""@en .

","Patterned macular dystrophy 3, also known as Martinique crinkled retinal pigment epitheliopathy, is a type of patterned macular dystrophy characterized by the 'dry desert land' pattern of the fundus, involving the posterior pole initially and progressing from the temporal fovea to the periphery of the retina developing in the fourth or fifth decade of life. It has a material basis in heterozygous mutation in the MAPKAPK3 gene on chromosome 3p21. This condition is also known by its exact synonym, MDPT3.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0060866,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:patterned_macular_dystrophy_1 rdfs:subClassOf :patterned_macular_dystrophy ;
    :has_definition ""A patterned macular dystrophy characterized by bilateral accumulation of pigmented or yellowish material at the level of the retinal pigment epithelium in lesions that resemble the wings of a butterfly that has_material_basis_in heterozygous mutation in the PRPH2 gene on chromosome 6p21."" ;
    :has_exact_synonym ""MDPT1""@en,
        ""butterfly-shaped pigmentary maculary dystrophy 1""@en .

","Patterned macular dystrophy type 1 is a type of Patterned macular dystrophy, characterized by the accumulation of pigmented or yellowish material at the level of the retinal pigment epithelium in lesions that resemble the wings of a butterfly. This condition is caused by a heterozygous mutation in the PRPH2 gene on chromosome 6p21. It has been referred to as MDPT1 and butterfly-shaped pigmentary maculary dystrophy type 1.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0060867,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:macrocephaly_autism_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_phenotype ;
            owl:someValuesFrom :frontal_bossing ],
        [ a owl:Restriction ;
            owl:onProperty :has_phenotype ;
            owl:someValuesFrom :long_philtrum ],
        [ a owl:Restriction ;
            owl:onProperty :has_phenotype ;
            owl:someValuesFrom :macrocephaly ],
        [ a owl:Restriction ;
            owl:onProperty :has_phenotype ;
            owl:someValuesFrom :midface_retrusion ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :has_phenotype ;
            owl:someValuesFrom :square_face ],
        :autosomal_dominant_disease,
        :syndrome ;
    :has_definition ""A syndrome characterized by macrocephaly, facial phenotypes including square outline with frontal bossing, 'dished-out' midface, biparietal narrowing, and long philtrum, developmental delay and autism that has_material_basis_in heterozygous mutation in the PTEN gene on chromosome 10q23."" ;
    :has_exact_synonym ""macrocephaly-intellectual disability-autism syndrome""@en .

","Macrocephaly autism syndrome is a condition that is characterized by an enlarged head, a square facial outline with frontal bossing, midface retrusion, and other facial characteristics. It also has developmental delay and autism as part of its symptoms. The exact cause of this condition is not fully understood, but it can be inherited in some cases, and mutations in the PTEN gene on chromosome 10q23 are known to have a material basis in this syndrome.",10,True
doid,http://purl.obolibrary.org/obo/DOID_0060868,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:leukoencephalopathy_with_vanishing_white_matter rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :leukodystrophy ;
    :has_definition ""A leukodystrophy characterized by variable neurologic features resulting from deficiency in astrocyte maturation, including progressive cerebellar ataxia, spasticity, and cognitive impairment associated with white matter lesions on brain imaging with onset from early infancy to adulthood."" ;
    :has_exact_synonym ""CACH/VWM"",
        ""CACH""@en,
        ""childhood ataxia with central nervous system hypomyelination""@en,
        ""vanishing white matter leukodystrophy""@en ;
    :has_narrower_match ""ORDO:157713"",
        ""ORDO:157716"",
        ""ORDO:157719"" ;
    :has_related_match ""ORDO:99853"" ;
    :has_related_synonym ""ovarioleukodystrophy"" .

","Leukoencephalopathy with vanishing white matter is a rare genetic disorder that affects the brain. It causes progressive damage to the white matter of the brain, which can lead to symptoms such as ataxia (loss of coordination), spasticity (muscle stiffness and rigidity), and cognitive impairment. The condition is often diagnosed in childhood and may continue into adulthood. It has a specific set of clinical features that help doctors make an accurate diagnosis.",13,True
doid,http://purl.obolibrary.org/obo/DOID_0060869,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:late_onset_retinal_degeneration rdfs:subClassOf :retinal_degeneration ;
    :has_definition ""A retinal degeneration characterized by autosomal dominant inheritance of night blindness and drusen deposits, progressing to severe central and peripheral degeneration, with choroidal neovascularization and chorioretinal atrophy with onset in the fifth to sixth decade of life that has_material_basis_in heterozygous mutation in the C1QTNF5 gene on chromosome 11q23."" ;
    :has_exact_synonym ""LORD""@en,
        ""autosomal dominant late-onset retinal degeneration""@en .

","Late-onset retinal degeneration (LORD) is a type of retinal degeneration that affects people in their late 40s to 6th decade. It is characterized by autosomal dominant inheritance, which means that it can be passed down through generations in families. LORD typically starts with night blindness and the accumulation of drusen deposits on the retina. As the disease progresses, it causes severe central and peripheral degeneration, leading to choroidal neovascularization and chorioretinal atrophy. The underlying cause of LORD is a mutation in the C1QTNF5 gene located on chromosome 11q23.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0060870,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:isolated_growth_hormone_deficiency rdfs:subClassOf :hypopituitarism ;
    :has_definition ""A hypopituitarism characterized by abnormally low levels, absence or impaired function of growth hormone in the absence of abnormalities in other pituitary hormones."" ;
    :has_exact_synonym ""IGHD""@en,
        ""congenital IGHD""@en,
        ""congenital isolated GH deficiency""@en,
        ""congenital isolated growth hormone deficiency""@en,
        ""familial isolated growth hormone deficiency""@en,
        ""non-acquired isolated growth hormone deficiency""@en .

","Isolated growth hormone deficiency (IGHD) is a type of hypopituitarism characterized by abnormally low levels, absence or impaired function of growth hormone in the absence of abnormalities in other pituitary hormones. It is also known as congenital IGHD, familial isolated GH deficiency, and non-acquired isolated growth hormone deficiency.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0060871,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_keratitis_ichthyosis_deafness_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :syndrome ;
    :has_definition ""A syndrome characterized by congenital deafness, keratopachydermia and constrictions of fingers and toes that has_material_basis_in heterozygous mutation in the GJB2 gene on chromosome 13q."" ;
    :has_exact_synonym ""autosomal dominant KID syndrome""@en .

","Autosomal dominant keratitis ichthyosis deafness syndrome, also known as KID syndrome, is a genetic disorder characterized by congenital deafness, keratopachydermia, and constrictions of fingers and toes. It has a material basis in heterozygous mutation in the GJB2 gene on chromosome 13q.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0060872,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:isolated_growth_hormone_deficiency_type_ii rdfs:subClassOf :isolated_growth_hormone_deficiency ;
    :has_definition ""An isolated growth hormone deficiency characterized by autosomal dominant inheritance of low but detectable levels of GH1 resulting in variable degrees of dwarfism which are responsive to growth hormone therapy that has_material_basis_in dominant negative mutations in the GH1 gene on chromosome 17q23.3."" ;
    :has_exact_synonym ""IGHD II""@en,
        ""autosomal dominant isolated growth hormone deficiency""@en,
        ""autosomal dominant pituitary dwarfism due to isolated growth hormone deficiency""@en,
        ""congenital IGHD type II""@en,
        ""congenital isolated GH deficiency type II""@en,
        ""congenital isolated growth hormone deficiency type II""@en .

","Isolated growth hormone deficiency type II, also known as IGHD II or autosomal dominant isolated growth hormone deficiency, is a condition characterized by low but detectable levels of GH1 resulting in variable degrees of dwarfism that are responsive to growth hormone therapy. This type of growth hormone deficiency is inherited in an autosomal dominant manner and is due to dominant negative mutations in the GH1 gene located on chromosome 17q23.3. Other synonyms for this condition include congenital IGHD type II, congenital isolated GH deficiency type II, and congenital isolated growth hormone deficiency type II.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0060873,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:isolated_growth_hormone_deficiency_type_ia rdfs:subClassOf :isolated_growth_hormone_deficiency ;
    :has_definition ""An isolated growth hormone deficiency characterized by autosomal recessive inheritance of severe dwarfism with onset by 6 months of age and variable development of antibodies to growth hormone following exogenous supplementation that has_material_basis_in null mutations in the GH1 gene on chromosome 17q23.3."" ;
    :has_exact_synonym ""IGHD IA""@en,
        ""Illig-type growth hormone deficiency""@en,
        ""autosomal recessive isolated growth hormone deficiency""@en,
        ""pituitary dwarfism I""@en,
        ""primordial dwarfism""@en,
        ""sexual ateleiotic dwarfism""@en .

","Isolated growth hormone deficiency type IA, also known as IGHD-IA, is a form of isolated growth hormone deficiency characterized by severe dwarfism that begins before 6 months of age and the presence of antibodies to growth hormone following exogenous supplementation. This condition is caused by mutations in the GH1 gene on chromosome 17q23.3. It has exact synonyms such as IGHD-IA, Illig-type growth hormone deficiency, autosomal recessive isolated growth hormone deficiency, pituitary dwarfism I, primordial dwarfism, and sexual ateleiotic dwarfism.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0060874,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:isolated_growth_hormone_deficiency_type_ib rdfs:subClassOf :isolated_growth_hormone_deficiency ;
    :has_definition ""An isolated growth hormone deficiency characterized by autosomal recessive inheritance of low but detectable levels of GH, short stature, significantly retarded bone age, and a positive response and immunologic tolerance to growth hormone therapy that has_material_basis_in mutation in the GH1 or GHRHR genes on chromosomes 17q23.3 and 7p14.3, respectively."" ;
    :has_exact_match ""OMIM:618157"" ;
    :has_exact_synonym ""IGHD IB""@en,
        ""congenital IGHD type IB""@en,
        ""congenital isolated GH deficiency type IB""@en,
        ""congenital isolated growth hormone deficiency type IB""@en,
        ""dwarfism of Sindh""@en .

","Isolated growth hormone deficiency type IB (IGHD-IB) is a rare form of isolated growth hormone deficiency characterized by autosomal recessive inheritance of low but detectable levels of GH, short stature, significantly retarded bone age, and a positive response and immunologic tolerance to growth hormone therapy. It is caused by mutations in the GH1 or GHRHR genes on chromosomes 17q23.3 and 7p14.3, respectively. It has exact synonyms such as congenital IGHD type IB, congenital isolated GH deficiency type IB, dwarfism of Sindh, and has an OMIM code of 618157.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0060875,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:isolated_growth_hormone_deficiency_type_iii rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_recessive_inheritance ],
        :isolated_growth_hormone_deficiency,
        :x_linked_recessive_disease ;
    :has_definition ""An isolated growth hormone deficiency characterized by dwarfism, variable occurence of hypogammaglobulinemia, and a generally good response to growth hormone therapy that has_material_basis_in mutation in the BTK gene on chromosome Xq22.1."" ;
    :has_exact_synonym ""Fleisher syndrome""@en,
        ""IGHD III""@en,
        ""X-linked IGHD""@en,
        ""X-linked agammaglobulinemia and isolated growth hormone deficiency""@en,
        ""X-linked hypogammaglobulinemia and isolated growth hormone deficiency""@en,
        ""X-linked isolated growth hormone deficiency""@en,
        ""congenital IGHD type III""@en,
        ""congenital isolated GH deficiency type III""@en,
        ""congenital isolated growth hormone deficiency type III""@en,
        ""growth hormone deficiency with hypogammaglobulinemia""@en .

","Isolated growth hormone deficiency type III is a rare genetic disorder characterized by dwarfism, variable occurrence of hypogammaglobulinemia, and a generally good response to growth hormone therapy. It has material basis in mutations in the BTK gene on chromosome Xq22.1. This condition is also known as Fleisher syndrome, IGHD III, X-linked IGHD, X-linked agammaglobulinemia and isolated growth hormone deficiency, X-linked hypogammaglobulinemia and isolated growth hormone deficiency, X-linked isolated growth hormone deficiency, congenital IGHD type III, congenital isolated GH deficiency type III, and congenital isolated growth hormone deficiency type III. It is also known as growth hormone deficiency with hypogammaglobulinemia.",14,True
doid,http://purl.obolibrary.org/obo/DOID_0060877,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:bullous_congenital_ichthyosiform_erythroderma rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :ichthyosis ;
    :has_definition ""An ichthyosis characterized by congenital erythema and widespread skin blistering, blisters develop into gray hyperkeratoses with a lichenified appearance, and that has_material_basis_in heterozygous mutation in the KRT2 gene on chromosome 12q13."" ;
    :has_exact_synonym ""bullous type ichthyosis""@en,
        ""ichthyosis bullosa of Siemens""@en,
        ""superficial epidermolytic ichthyosis""@en .

","Bullous congenital ichthyosiform erythroderma is a type of autosomal dominant disease, characterized by the presence of multiple skin blisters on the body. These blisters can develop into gray hyperkeratoses with a lichenified appearance, and are associated with congenital erythema (redness). The condition has a material basis in heterozygous mutations in the KRT2 gene on chromosome 12q13. It is also known by other names such as bullous type ichthyosis, ichthyosis bullosa of Siemens, and superficial epidermolytic ichthyosis.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0060878,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hypoparathyroidism_deafness_renal_disease_syndrome rdfs:subClassOf :chromosomal_deletion_syndrome ;
    :has_definition ""A chromosomal deletion syndrome that is characterized by autosomal dominant inheritance of hypoparathyroidism, sensorineural deafness and progressive renal failure and that has_material_basis_in chromosome deletion that results in haploinsufficiency of the GATA3 gene on chromosome 10p14."" ;
    :has_exact_synonym ""Barakat syndrome""@en,
        ""HDR syndrome""@en,
        ""hypoparathyroidism, sensorineural deafness, and renal disease""@en .

","Hypoparathyroidism, deafness, and renal disease syndrome (HDRS) is a rare genetic disorder characterized by the presence of three main features: hypoparathyroidism, sensorineural deafness, and progressive renal disease. HDRS is caused by a deletion on chromosome 10p14 which results in haploinsufficiency of the GATA3 gene. The disorder has autosomal dominant inheritance and typically presents in childhood or adolescence. It is also known as Barakat syndrome, HDR syndrome, and hypoparathyroidism, sensorineural deafness, and renal disease (HSDR).",5,True
doid,http://purl.obolibrary.org/obo/DOID_0060879,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_hypomagnesemia rdfs:subClassOf :metal_metabolism_disorder ;
    :has_definition ""A metal metabolism disorder characterized by very low serum magnesium levels often with secondary hypocalcemia with onset typically in the first months of life."" ;
    :has_exact_synonym ""HOMG""@en,
        ""primary familial hypomagnesemia""@en .

","Primary hypomagnesemia is a metabolic disorder characterized by low levels of magnesium in the blood. It typically affects infants and children, and can lead to symptoms such as muscle weakness, seizures, and abnormal heart rhythms. In some cases, it may be caused by genetic factors or other underlying health conditions. Treatment typically involves supplementing the individual with magnesium and addressing any underlying health issues.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0060880,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:renal_hypomagnesemia_3 rdfs:subClassOf :primary_hypomagnesemia ;
    :has_definition ""A hypomagnesemia characterized by autosomal recessive inheritance of excessive urinary Ca(2+) and Mg(2+) excretion that has_material_basis_in homozygous or compound heterozygous mutation in the CLDN16 gene on chromosome 3q28."" ;
    :has_exact_synonym ""FHHNC without severe ocular involvement""@en,
        ""HOMG3""@en,
        ""familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis without severe ocular involvement""@en,
        ""isolated renal hypomagnesemia""@en,
        ""primary hypomagnesemia due to defect in renal tubular transport of magnesium""@en,
        ""renal hypomagnesemia type 3""@en .

","Renal hypomagnesemia 3 is a type of primary hypomagnesemia, which is characterized by autosomal recessive inheritance of excessive urinary Ca(2+) and Mg(2+) excretion that has material basis in homozygous or compound heterozygous mutation in the CLDN16 gene on chromosome 3q28. It has exact synonyms such as FHHNC without severe ocular involvement, HOMG3, familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis without severe ocular involvement, isolated renal hypomagnesemia, and primary hypomagnesemia due to defect in renal tubular transport of magnesium. It is also known as renal hypomagnesemia type 3.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0060881,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:renal_hypomagnesemia_5_with_ocular_involvement rdfs:subClassOf :primary_hypomagnesemia ;
    :has_definition ""A hypomagnesemia characterized by autosomal recessive inheritance of renal magnesium wasting with hypercalcinosis, progressive renal failure and severe ocular involvement that has_material_basis_in homozygous mutation in the CLDN19 gene on chromosome 1p34.2."" ;
    :has_exact_synonym ""FHHNC with severe ocular involvement""@en,
        ""Meier-Blumberg-Imahorn syndrome""@en,
        ""bilateral macular coloboma with hypercalciuria""@en,
        ""familial hypomagnesemia with hypercalciuria, nephrocalcinosis and severe ocular involvement""@en,
        ""hypercalciuria-bilateral macular coloboma syndrome""@en .

","Renal hypomagnesemia 5 with ocular involvement is a type of primary hypomagnesemia characterized by autosomal recessive inheritance of renal magnesium wasting with hypercalcinosis, progressive renal failure and severe ocular involvement. This condition has material basis in homozygous mutation in the CLDN19 gene on chromosome 1p34.2. Exact synonyms for this condition include FHHNC with severe ocular involvement, Meier-Blumberg-Imahorn syndrome, bilateral macular coloboma with hypercalciuria, familial hypomagnesemia with hypercalciuria, nephrocalcinosis and severe ocular involvement, and hypercalciuria-bilateral macular coloboma syndrome.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0060882,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:renal_hypomagnesemia_4 rdfs:subClassOf :primary_hypomagnesemia ;
    :has_definition ""A hypomagnesemia characterized by isolated hypomagnesemia due to renal loss with normal serum calcium levels and urinary calcium excretion that has_material_basis_in variation in the chromosome region 4q25."" ;
    :has_exact_synonym ""HOMG4""@en .

","Renal hypomagnesemia type 4, also known as HOMG4, is a condition characterized by isolated hypomagnesemia due to renal loss with normal serum calcium levels and urinary calcium excretion. It has a genetic basis and is linked to a variation in the chromosome region 4q25.<|endoftext|>",3,True
doid,http://purl.obolibrary.org/obo/DOID_0060883,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:intestinal_hypomagnesemia_1 rdfs:subClassOf :primary_hypomagnesemia ;
    :has_definition ""A hypomagnesemia characterized by very low serum magnesium levels due to defects in intestinal absorption and kidney excretion and secondary hypocalcemia that has_material_basis_in homozygous or compound heterozygous mutations in the TRPM6 gene on chromosome 9q21."" ;
    :has_exact_synonym ""HOMG1""@en,
        ""hypomagnesemia caused by selective magnesium malabsorption""@en,
        ""hypomagnesemia intestinal type 1""@en,
        ""hypomagnesemic tetany""@en,
        ""intestinal hypomagnesemia with secondary hypocalcemia""@en,
        ""primary hypomagnesemia with secondary hypocalcemia""@en .

","intestinal hypomagnesemia 1 is a type of primary hypomagnesemia.
intestinal hypomagnesemia 1 has definition A severe form of primary hypomagnesemia characterized by very low serum magnesium levels due to defects in intestinal absorption and kidney excretion, and secondary hypocalcemia that results from homozygous or compound heterozygous mutations in the TRPM6 gene on chromosome 9q21.
intestinal hypomagnesemia 1 has exact synonym HOMG1.
intestinal hypomagnesemia 1 has exact synonym hypomagnesemia caused by selective magnesium malabsorption.
intestinal hypomagnesemia 1 has exact synonym hypomagnesemia intestinal type 1.
intestinal hypomagnesemia 1 has exact synonym hypomagnesemic tetany.
intestinal hypomagnesemia 1 has exact synonym intestinal hypomagnesemia with secondary hypocalcemia.
intestinal hypomagnesemia 1 has exact synonym primary hypomagnesemia with secondary hypocalcemia.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0060884,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:renal_hypomagnesemia_6 rdfs:subClassOf :primary_hypomagnesemia ;
    :has_definition ""A hypomagnesemia characterized by autosomal dominant inheritance of severely lowered serum magnesium levels without other electrolyte disturbances or abnormalities in urinary magnesium excretion that has_material_basis_in heterozygous mutation in the CNNM2 gene on chromosome 10q24."" ;
    :has_exact_synonym ""HOMG6""@en .

","Renal hypomagnesemia type 6, also known as HOMG6, is a form of primary hypomagnesemia. It is characterized by autosomal dominant inheritance of severely lowered serum magnesium levels without other electrolyte disturbances or abnormalities in urinary magnesium excretion that are due to heterozygous mutations in the CNNM2 gene on chromosome 10q24.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0060885,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:renal_hypomagnesemia_2 rdfs:subClassOf :primary_hypomagnesemia ;
    :has_definition ""A hypomagnesemia characterized by autosomal dominant inheritance of hypomagnesemia due to renal magnesium loss that has_material_basis_in heterozygous mutation in the FXYD2 gene on chromosome 11q23."" ;
    :has_exact_synonym ""HOMG2""@en,
        ""autosomal dominant primary hypomagnesemia with hypocalciuria""@en .

","Renal hypomagnesemia type 2, also known as HOMG2, is a form of primary hypomagnesemia characterized by autosomal dominant inheritance. This means that the condition is passed down through generations within a family and can be caused by a mutation in the FXYD2 gene on chromosome 11q23.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0060886,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:osteopathia_striata_with_cranial_sclerosis rdfs:subClassOf :osteosclerosis ;
    :has_definition ""An osteosclerosis characterized by longitudinal striations of the metaphyses of the long bones, sclerosis of the craniofacial bones, macrocephaly, cleft palate and hearing loss in females and fetal or neonatal lethality in males that has_material_basis_in mutation in the AMER1 gene on chromosome Xq11."" ;
    :has_exact_synonym ""Robinow-Unger syndrome""@en,
        ""hyperostosis generalisata with striations""@en .

","Osteopathia striata with cranial sclerosis is a rare genetic disorder characterized by the abnormal development of bone tissue in the skull, leading to thickening and hardening (sclerosis) of certain areas. This condition is also known as Robinow-Unger syndrome or hyperostosis generalisata with striations. It affects both males and females but can result in severe complications such as cleft palate, hearing loss, and skull deformities during fetal development, which can cause stillbirth in males. In some cases, affected individuals may have an enlarged head (macrocephaly) or other skeletal abnormalities. The disorder is caused by mutations in the AMER1 gene located on the X chromosome.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0060887,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ossification_of_the_posterior_longitudinal_ligament_of_spine rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_location ;
            owl:someValuesFrom :ligament_of_vertebral_column ],
        :connective_tissue_disease ;
    :has_definition ""A connective tissue disease characterized by ectopic ossification of the posterior longitudinal spinal ligament resulting in spinal cord compression, myelopathy and hyperreflexia."" ;
    :has_exact_synonym ""OPLL""@en .

","Ossification of the posterior longitudinal ligament (OPLL) is a connective tissue disease that affects the spine. It occurs when there is ectopic ossification, or growth of bone in an abnormal location, specifically along the posterior longitudinal ligament which runs down the center of the spinal column. This can lead to compression of the spinal cord and surrounding nerves, causing symptoms such as pain, weakness, and reflex changes. OPLL is more common in people over 50 years old and can also occur in younger individuals, particularly those with certain genetic predispositions or medical conditions that affect connective tissue health. Treatment options for OPLL include non-surgical approaches such as medications to reduce inflammation or pain, or surgical interventions like decompression or fusion of the affected vertebrae.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0060888,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:transient_myeloproliferative_syndrome rdfs:subClassOf :myeloproliferative_neoplasm ;
    :has_definition ""A myeloproliferative neoplasm characterized by leukocytosis in newborns with Down syndrome."" ;
    :has_exact_synonym ""MST""@en,
        ""TAM""@en,
        ""transient abnormal myelopoiesis""@en,
        ""transient leukemia""@en,
        ""transient leukemia of Down syndrome""@en,
        ""transient myeloproliferative disease""@en .

","Transient Myeloproliferative Syndrome (TMPS) is a type of Transient Myeloproliferative Neoplasm (TMN). TMNs are characterized by the overproduction of white blood cells in newborns with Down syndrome. The exact synonyms for TMPS include MST, TAM, and transient abnormal myelopoiesis. It can also be referred to as transient leukemia or transient leukemia of Down syndrome, but it is not technically considered a type of cancer. Instead, it is a condition where the body produces too many white blood cells, which can lead to anemia and other health issues if left untreated.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0060889,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:prune_belly_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :syndrome ;
    :has_definition ""A syndrome that is characterized by megacystis with disorganized detrusor muscle, cryptorchidism, and thin abdominal musculature with overlying lax skin and that has_material_basis_in homozygous mutation in the CHRM3 gene on chromosome 1q43."" ;
    :has_exact_synonym ""Eagle-Barret syndrome""@en,
        ""Obrisnksy syndrome""@en,
        ""abdominal muscle deficiency syndrome""@en .

","prune belly syndrome is a rare genetic disorder characterized by the weakness of abdominal muscles, which can lead to a hollow or sunken appearance of the abdomen. It typically affects boys and men and has a homozygous mutation in the CHRM3 gene on chromosome 1q43. Other symptoms may include cryptorchidism (undescended testicles), megacystis (large, fluid-filled cysts in the kidneys), and thin or absent abdominal muscles. It is also known as Eagle-Barrett syndrome, Obriskysy syndrome, and abdominal muscle deficiency syndrome.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0060890,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ectopic_cushing_syndrome rdfs:subClassOf :primary_hyperaldosteronism ;
    :has_definition ""A primary hyperaldosteronism that is characterized by a tumor outside the pituitary gland produces a hormone called adrenocorticotropic hormone."" ;
    :has_exact_synonym ""Cushing syndrome due to ectopic ACTH secretion""@en,
        ""ectopic ACTH secreting tumor""@en .

","Ectopic Cushing syndrome, also known as Cushing Syndrome due to ectopic ACTH secretion or Ectopic ACTH secreting tumor, is a type of primary hyperaldosteronism. It occurs when a tumor outside the pituitary gland produces Adrenocorticotropic hormone (ACTH), which causes the adrenal glands to produce excessive cortisol. This leads to the symptoms associated with Cushing syndrome, such as weight gain, fatigue, and increased blood sugar levels. Ectopic Cushing syndrome is a rare condition that can be difficult to diagnose and treat. It requires a specialized team of doctors and appropriate testing to make an accurate diagnosis and develop an effective treatment plan.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0060891,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:parkinson_s_disease_19a rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :early_onset_parkinson_s_disease ;
    :has_definition ""An early-onset Parkinson's diseas that has_material_basis_in homozygous mutation in the DNAJC6 gene on chromosome 1p31."" ;
    :has_exact_synonym ""juvenile onset Parkinson disease 19A""@en,
        ""juvenile onset Parkinson's disease 19A""@en .

",Parkinson's disease 19A is a type of autosomal recessive disorder.,6,True
doid,http://purl.obolibrary.org/obo/DOID_0060892,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:late_onset_parkinson_s_disease rdfs:subClassOf :parkinson_s_disease ;
    :has_definition ""A Parkinson's disease characterized by onset of motor symptoms typically after 60 years of age."" ;
    :has_exact_synonym ""late onset Parkinson disease""@en .

","Late-onset Parkinson's disease (LOPD) is a type of Parkinson's disease that occurs later in life, typically after the age of 60. It is characterized by motor symptoms such as tremors, rigidity, and slowness of movement. The exact synonym for LOPD is late-onset Parkinson disease.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0060893,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:juvenile_onset_parkinson_s_disease rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :existence_starts_during ;
            owl:someValuesFrom :young_adult_onset ],
        :early_onset_parkinson_s_disease ;
    :has_definition ""An early-onset Parkinson's disease that is characterized by onset of motor symptoms prior to 21 years of age."" ;
    :has_exact_synonym ""juvenile-onset Parkinson disease""@en .

","juvenile onset parkinson's disease is a type of early onset parkinson's disease.
juvenile onset parkinson's disease is a type of something that at least begins during some young adult onset.
juvenile onset parkinson's disease has definition An early-onset Parkinson's disease that is characterized by onset of motor symptoms prior to 21 years of age..
juvenile onset parkinson's disease has exact synonym juvenile-onset Parkinson's disease.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0060894,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:early_onset_parkinson_s_disease rdfs:subClassOf :parkinson_s_disease ;
    :has_definition ""A Parkinson's disease characterized by onset of motor symptoms earlier than typically seen, usually prior to 50 years of age."" ;
    :has_exact_synonym ""early-onset Parkinson disease""@en .

","Early onset Parkinson's disease is a type of Parkinson's disease that presents with motor symptoms before the age of 50. This condition shares many of the same characteristics as other types of Parkinson's disease, including progressive loss of dopamine-producing neurons in the substantia nigra region of the brain. However, it often has a more aggressive course and may respond differently to treatment. It is also more likely to be inherited or have a genetic component.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0060895,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:parkinson_s_disease_4 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :late_onset_parkinson_s_disease ;
    :has_definition ""A late onset Parkinson disease that has_material_basis_in heterozygous triplication of the alpha-synuclein gene on chromosome 4q22."" ;
    :has_exact_synonym ""autosomal dominant Lewy body Parkinson disease 4""@en,
        ""autosomal dominant Parkinson disease 4""@en,
        ""autosomal dominant Parkinson's disease 4""@en .

","Parkinson's disease 4, also known as autosomal dominant Lewy body Parkinson disease 4 or autosomal dominant Parkinson disease 4, is a type of late-onset Parkinson's disease. It is characterized by the presence of Lewy bodies in the brain, which are abnormal aggregations of protein that can cause neurological symptoms such as tremors, rigidity, and difficulty with movement. This form of Parkinson's disease is inherited in an autosomal dominant manner, meaning that a single copy of the gene is sufficient to increase the risk of developing the disease. The exact synonym for this condition is Parkinson's disease 4, which has a material basis in heterozygous triplication of the alpha-synuclein gene on chromosome 4q22.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0060896,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:parkinson_s_disease_23 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :early_onset_parkinson_s_disease ;
    :has_definition ""An early-onset Parkinson disease that has_material_basis_in homozygous or compound heterozygous mutation in the VPS13C gene on chromosome 15q22."" ;
    :has_exact_synonym ""autosomal recessive early-onset Parkinson disease 23""@en,
        ""autosomal recessive early-onset Parkinson's disease 23""@en .

","Parkinson's disease (PD) is a neurological disorder that affects movement. It belongs to a group of conditions called motor neuron diseases, which are characterized by the degeneration of motor neurons in the brain and spinal cord. PD can cause a range of symptoms, including tremors, stiffness, and difficulty with balance and coordination.
PD is caused by the loss of dopamine-producing cells in the brain, which leads to a decrease in the neurotransmitter dopamine. There are various theories about what causes the loss of these cells, but it's likely that a combination of genetic and environmental factors play a role.
There are several types of PD, including early-onset and late-onset forms. Early-onset PD typically begins before age 50, while late-onset PD develops after age 65. Some people may also experience atypical PD symptoms that do not fit into either category, such as depression or anxiety without physical symptoms.
Treatment for PD can include medications to manage symptoms, surgery to alleviate motor issues, and physical therapy to improve mobility and balance.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0060897,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:parkinson_s_disease_17 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :late_onset_parkinson_s_disease ;
    :has_definition ""A late-onset Parkinson disease that has_material_basis_in heterozygous mutation in the VPS35 gene on chromosome 16q13."" ;
    :has_exact_synonym ""Parkinson disease 17""@en,
        ""autosomal dominant Parkinson disease 17""@en .

","Parkinson's disease 17 (PD17) is a type of Parkinson's disease that has a genetic component and can be passed down through families. It typically develops later in life, although some people may experience symptoms earlier. PD17 results from mutations in the VPS35 gene on chromosome 16q13. This type of Parkinson's disease is known as autosomal dominant, meaning that only one copy of the faulty gene is needed to develop the condition.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0060898,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:parkinson_s_disease_20 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :early_onset_parkinson_s_disease ;
    :has_definition ""An early-onset Parkinson disease that has_material_basis_in homozygous mutation in the SYNJ1 gene on chromosome 21q22."" ;
    :has_exact_synonym ""early-onset Parkinson disease 20""@en,
        ""early-onset Parkinson's disease 20""@en .

","Parkinson's disease is a neurological disorder that affects movement. It is caused by the degeneration of dopamine-producing neurons in the brain. The exact cause of the disease is not yet fully understood, but it is thought to be a combination of genetic and environmental factors.
Parkinson's disease typically develops slowly over time, with symptoms such as tremors, rigidity, and difficulty moving. In some cases, it can also affect a person's speech, mood, and cognitive abilities.
There are several types of Parkinson's disease, including early-onset and late-onset forms. Early-onset Parkinson's disease typically begins before the age of 50, while late-onset Parkinson's disease develops after the age of 60.
Treatment for Parkinson's disease may include medications to manage symptoms, surgical interventions, and physical therapy. It is important for individuals with Parkinson's disease to work closely with their healthcare providers to develop a personalized treatment plan that addresses their specific needs and preferences.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0060900,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:parkinson_s_disease_14 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :late_onset_parkinson_s_disease ;
    :has_definition ""A late-onset Parkinson disease that has_material_basis_in homozygous mutation in the PLA2G6 gene on chromosome 22q13."" ;
    :has_exact_synonym ""Dystonia-Parkinsonism Adult-Onset""@en,
        ""autosomal recessive Parkinson disease 14""@en,
        ""autosomal recessive Parkinson's disease 14""@en .

","Parkinson's disease 14, also known as late-onset Parkinson's disease, is a type of autosomal recessive disorder that is characterized by the gradual loss of motor skills and physical coordination. It is caused by mutations in the PLA2G6 gene located on chromosome 22q13. This form of Parkinson's disease typically appears later in life, often after the age of 50, and affects both men and women equally.

In addition to motor symptoms such as tremors, stiffness, and difficulty with balance and coordination, people with Parkinson's disease 14 may also experience non-motor symptoms such as cognitive decline, sleep disturbances, and emotional changes. Early detection and proper treatment can help manage the symptoms of this condition and improve quality of life.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0060901,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:lymphoplasmacytic_lymphoma rdfs:subClassOf :b_cell_lymphoma ;
    :has_definition ""A B-cell lymphoma characterized by the accumulation of monoclonal cells in the bone marrow and peripheral lymphoid tissues, and associated with the production of serum immunoglobulin M (IgM) monoclonal protein."" ;
    :has_exact_match ""MESH:D008258"" ;
    :has_exact_synonym ""Waldenstroem's macroglobulinemia"",
        ""Waldenstrom Macroglobulinemia"",
        ""lymphoplasmacytic lymphoma with IgM gammopathy""@en .

","Lymphoplasmacytic lymphoma, also known as Waldenstrom's macroglobulinemia, is a type of B-cell lymphoma characterized by the accumulation of monoclonal cells in the bone marrow and peripheral lymphoid tissues, and associated with the production of serum immunoglobulin M (IgM) monoclonal protein. It is also known as lymphoplasmacytic lymphoma with IgM gammopathy.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0060902,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:norman_roberts_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :lissencephaly ;
    :has_definition ""A lissencephaly that has_material_basis_in homozygous mutation in the gene encoding reelin (RELN) on chromosome 7q22."" ;
    :has_exact_synonym ""lissencephaly 2""@en,
        ""lissencephaly syndrome, Norman-Roberts type""@en .

","Norman-Roberts syndrome is a type of lissencephaly that has a material basis in homozygous mutation in the gene encoding reelin (RELN) on chromosome 7q22. It is an autosomal recessive disease, which means that it requires the presence of two copies of the mutated gene (one from each parent) for the syndrome to develop. Lissencephaly is a congenital brain malformation characterized by the absence or hypoplasia of cerebral white matter. It can result in a range of neurological symptoms, including developmental delay, seizures, and motor skill impairments. Norman-Roberts syndrome is also known as lissencephaly 2 and lissencephaly syndrome, Norman-Roberts type.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0060903,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:thrombosis rdfs:subClassOf :vascular_disease ;
    :has_definition ""A vascular disease caused by the formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system."" .

","Thrombosis is a type of vascular disease that occurs when a blood clot forms inside a blood vessel, causing it to become blocked and impeding the flow of blood through the circulatory system. This can lead to various health problems, including heart attacks, stroke, and gangrene. It is important to seek medical attention if you suspect you may be experiencing symptoms of thrombosis, as prompt treatment can help prevent serious complications.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0060904,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:legume_allergy rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_allergic_trigger ;
            owl:someValuesFrom :legume_food_product ],
        :fruit_allergy ;
    :has_definition ""A fruit allergy triggered by Fabaceae (legume) plant fruit or seed food product."" ;
    :has_exact_synonym ""Fabaceae allergy""@en .

","Legume allergy is not the same as a fruit allergy. It is an allergy to legumes, which are a type of plant that belongs to the Fabaceae family. This can include things like beans, peas, and lentils. The allergen in these foods is typically one of several proteins found in them, such as lectin or vicilin. Some common symptoms of legume allergy may include itching or swelling of the mouth, throat tightness, difficulty breathing, and even anaphylaxis in severe cases. It is important to avoid legumes if you have this allergy, and to read ingredient lists carefully for any hidden sources of legumes in food products.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0060911,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:karyomegalic_interstitial_nephritis rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :interstitial_nephritis ;
    :has_definition ""An interstitial nephritis characterized by nephritis, interstitial fibrosis, and enlarged and atypical tubular epithelial cell nuclei that has_material_basis_in homozygous or compound heterozygous mutation in the FAN1 gene on chromosome 15q13.3."" ;
    :has_exact_synonym ""KIN""@en,
        ""KMIN""@en .

","Karyomegalic interstitial nephritis is a type of autosomal recessive disease that affects the kidneys. It is characterized by inflammation, scarring, and enlarged nuclei in the tubular epithelial cells. The condition has a material basis in mutations in the FAN1 gene on chromosome 15q13.3.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0060912,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:craniosynostosis_7 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :digenic_inheritance ],
        :craniosynostosis,
        :digenic_disease ;
    :has_definition ""A craniosynostosis characterized by skull deformity and the inability of the skull's growth to keep up with the developing brain that has_material_basis_in a weakly penetrant heterozygous mutation in the SMAD6 gene on chromosome 15q22, typically with the risk allele of a common variant near the BMP2 gene on chromosome 20p12, resulting in potential intracranial pressure elevation."" ;
    :has_exact_synonym ""CRS7"" .

","CRANIOSYNOSTOSIS 7 (CRS7) is a type of craniosynostosis, which is characterized by the premature fusion of skull bones. It is caused by a weakly penetrant heterozygous mutation in the SMAD6 gene on chromosome 15q22. The risk allele for this condition is typically found near the BMP2 gene on chromosome 20p12.

CRS7 can result in intracranial pressure elevation, which may lead to further complications if left untreated. Treatment options for CRS7 include surgery and monitoring of intracranial pressure. Early diagnosis and treatment are essential for managing the symptoms and improving outcomes for individuals with this condition.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0060913,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:proteosome_associated_autoinflammatory_syndrome rdfs:subClassOf :syndrome ;
    :has_definition ""A syndrome that is characterized by early onset, dermatitis, dysregulation of the immune response and variable features of recurrent fever, joint contractures, lipodystrophy, hepatosplenomegaly, anemia and calcifications."" .

","Proteosome-Associated Autoinflammatory Syndrome (PAPS) is a rare genetic disorder that affects multiple body systems. It is characterized by recurrent fever, joint contractures, lipodystrophy, hepatosplenomegaly, anemia, and calcifications. These symptoms typically begin in early childhood and can be severe and debilitating.
PAPS is caused by mutations in the proteosome genes and leads to dysregulation of the immune response, which results in chronic inflammation. The disorder can also affect other body systems such as skin, bones, and joints. Treatment for PAPS typically involves managing symptoms with medications and providing supportive care.
It is important to note that while rare, PAPS can be a serious and life-altering condition. If you or someone you know is experiencing symptoms of PAPS, it is crucial to seek medical attention immediately.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0060914,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:proteosome_associated_autoinflammatory_syndrome_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :proteosome_associated_autoinflammatory_syndrome ;
    :has_definition ""A proteasome-associated autoinflammatory syndrome that is characterized by severe inflammatory neutrophilic dermatitis, autoimmunity, and variable immunodeficiency and that has_material_basis_in heterozygous mutation in the POMP gene on chromosome 13q12."" ;
    :has_exact_synonym ""PRAAS2"" .

","Yes, Proteosome Associated Autoinflammatory Syndrome 2 (PRAAS2) is a type of autosomal dominant disease that is characterized by severe inflammatory neutrophilic dermatitis, autoimmunity, and variable immunodeficiency. It has a material basis in heterozygous mutation in the POMP gene on chromosome 13q12. The condition is also known as Proteasome-Associated Autoinflammatory Syndrome 2 (PRAAS2).",5,True
doid,http://purl.obolibrary.org/obo/DOID_0060915,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:proteosome_associated_autoinflammatory_syndrome_4 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :proteosome_associated_autoinflammatory_syndrome ;
    :has_definition ""A proteasome-associated autoinflammatory syndrome that is characterized by onset of panniculitis and erythematous skin lesions in early infancy with variable features of lymphadenopathy, myositis, delayed motor and speech development and autoimmune features and that has_material_basis_in compound heterozygous mutation in the PSMG2 gene on chromosome 18p11."" ;
    :has_exact_synonym ""PRAAS4"" .

","Proteosome associated autoinflammatory syndrome 4, also known as PRAAS4, is a rare autosomal recessive disorder that typically presents in early infancy with symptoms such as panniculitis and erythematous skin lesions. The condition may also involve lymphadenopathy, myositis, delayed motor and speech development, and autoimmune features. It has a genetic basis, with mutations in the PSMG2 gene on chromosome 18p11 being responsible for the disease.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0060916,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:proteasome_associated_autoinflammatory_syndrome_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :digenic_inheritance ],
        :autosomal_recessive_disease,
        :digenic_disease,
        :proteosome_associated_autoinflammatory_syndrome ;
    :has_definition ""A proteasome-associated autoinflammatory syndrome that is characterized by nodular dermatitis, recurrent fever, myositis, panniculitis-induced lipodystrophy, lymphadenopathy and dysregulation of the immune response, particularly associated with abnormal type I interferon-induced gene expression pattern with onset in early infancy and that has_material_basis_in a homozygous mutation in the PSMB4 gene on chromosome 1q21 or a heterozygous mutation in the PSMB4 gene and a heterozygous mutation in the PSMB9 gene on chromosome 6p21."" ;
    :has_exact_synonym ""PRAAS3"" .

","proteasome associated autoinflammatory syndrome 3 is a type of autosomal recessive disease.
proteasome associated autoinflammatory syndrome 3 is a type of proteasome associated autoinflammatory syndrome.
proteasome associated autoinflammatory syndrome 3 is a type of digenic disease.
proteasome associated autoinflammatory syndrome 3 is a type of something that at least has material basis in some autosomal recessive inheritance.
proteasome associated autoinflammatory syndrome 3 is a type of something that at least has material basis in some digenic inheritance.
proteasome associated autoinflammatory syndrome 3 has definition A proteasome-associated autoinflammatory syndrome that is characterized by nodular dermatitis, recurrent fever, myositis, panniculitis-induced lipodystrophy, lymphadenopathy and dysregulation of the immune response, particularly associated with abnormal type I interferon-induced gene expression pattern with onset in early infancy and that has_material_basis_in a homozygous mutation in the PSMB4 gene on chromosome 1q21 or a heterozygous mutation in the PSMB4 gene and a",7,True
doid,http://purl.obolibrary.org/obo/DOID_0060917,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:facioscapulohumeral_muscular_dystrophy_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :digenic_inheritance ],
        :digenic_disease,
        :facioscapulohumeral_muscular_dystrophy ;
    :has_definition ""A facioscapulohumeral muscular dystrophy characterized by adult onset of proximal muscle weakness affecting the face, neck, scapular muscles, and upper and lower limbs that has_material_basis_in the combination of a homozygous mutation in the LRIF1 gene on chromosome 1p13 and presence of a haplotype on chromosome 4 that is permissive for DUX4 expression."" ;
    :has_exact_synonym ""FSHD3"",
        ""facioscapulohumeral muscular dystrophy type 3"" .

","Facioscapulohumeral muscular dystrophy 3 is a type of facioscapulohumeral muscular dystrophy characterized by adult onset of proximal muscle weakness affecting the face, neck, scapular muscles, and upper and lower limbs that has_material_basis_in the combination of a homozygous mutation in the LRIF1 gene on chromosome 1p13 and presence of a haplotype on chromosome 4 that is permissive for DUX4 expression. It has the exact synonym FSHD3, and facioscapulohumeral muscular dystrophy type 3.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0060918,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:facioscapulohumeral_muscular_dystrophy_4 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :digenic_inheritance ],
        :digenic_disease,
        :facioscapulohumeral_muscular_dystrophy ;
    :has_definition ""A facioscapulohumeral muscular dystrophy characterized by adult onset of progressive muscle weakness of the face and upper extremity muscles with disease progression that has_material_basis_in the combination of a heterozygous mutation in the DNMT3B gene on chromosome 20q11 and presence of a haplotype on chromosome 4 that is permissive for DUX4 expression."" ;
    :has_exact_synonym ""FSHD4"",
        ""facioscapulohumeral muscular dystrophy type 4"" .

","Facioscapulohumeral muscular dystrophy 4 (FSHD4) is a type of facioscapulohumeral muscular dystrophy. It is characterized by the adult onset of progressive muscle weakness in the face and upper extremity muscles, with disease progression that has a material basis in the combination of a heterozygous mutation in the DNMT3B gene on chromosome 20q11 and presence of a haplotype on chromosome 4 that is permissive for DUX4 expression. It has the exact synonyms FSHD4 and facioscapulohumeral muscular dystrophy type 4.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0060919,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:proteosome_associated_autoinflammatory_syndrome_5 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :proteosome_associated_autoinflammatory_syndrome ;
    :has_definition ""A proteasome-associated autoinflammatory syndrome that is characterized by recurrent, polymorphic disseminated cutaneous rash with annular lesions, non-specific lymphocytic infiltration, fever, failure to thrive, persistent hepatosplenomegaly, emaciated face, long slender fingers, levated acute-phase reactants and microcytic anemia and that has_material_basis_in homozygous mutation in the PSMB10 gene on chromosome 16q22."" ;
    :has_exact_synonym ""PRAAS5"" .

",proteosome associated autoinflammatory syndrome 5 is a type of autosomal recessive disease.,5,True
doid,http://purl.obolibrary.org/obo/DOID_0060920,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:otosclerosis_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :otosclerosis ;
    :has_definition ""An otosclerosis that is characterized by isolated endochondral bone sclerosis of the labyrinthine capsule and that has_material_basis_in the locus associated with otosclerosis-1 gene (OTSC1) on chromosome 15q26.1."" ;
    :has_exact_synonym ""OTSC1"" .

","otosclerosis 1 is a type of otosclerosis. It is characterized by isolated endochondral bone sclerosis of the labyrinthine capsule, and it has material basis in the locus associated with the OTSC1 gene on chromosome 15q26.1. It also has an exact synonym, which is OTSC1.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0060921,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:otosclerosis_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :otosclerosis ;
    :has_definition ""An otosclerosis that has_material_basis_in the locus associated with otosclerosis-2 gene (OTSC2) on chromosome 7q."" ;
    :has_exact_synonym ""OTSC2"" .

","otosclerosis 2 is a form of otosclerosis, which is a medical condition characterized by the growth of bone in the middle ear. It is caused by genetic factors and can lead to hearing loss if left untreated. Otosclerosis 2 specifically refers to a type of otosclerosis that is associated with a gene on chromosome 7q, specifically the locus associated with the OTSC2 gene. It is important to be aware of this condition and seek medical attention if you suspect you may have it.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0060922,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:otosclerosis_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :otosclerosis ;
    :has_definition ""An otosclerosis that has_material_basis_in the locus associated with otosclerosis-3 gene (OTSC3) on loci chromosome 6p."" ;
    :has_exact_synonym ""OTSC3"" .

","Otosclerosis 3 is a specific type of otosclerosis that has a genetic basis, specifically on the chromosome 6p. This type of otosclerosis is inherited in an autosomal dominant manner.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0060923,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:otosclerosis_4 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :otosclerosis ;
    :has_definition ""An otosclerosis that has_material_basis_in the locus associated with otosclerosis-4 gene (OTSC4) on loci chromosome 16q."" ;
    :has_exact_synonym ""OTSC4"" .

","Otosclerosis 4, also known as OTSC4, is a type of otosclerosis that has a genetic basis and is inherited in an autosomal dominant manner. It is caused by mutations in the OTSC4 gene, which is located on chromosome 16q. This condition can cause hearing loss and other complications if left untreated.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0060924,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:otosclerosis_5 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :otosclerosis ;
    :has_definition ""An otosclerosis that is characterized by conductive hearing impairment and that has_material_basis_in the locus associated with otosclerosis-5 gene (OTSC5) on loci 3q22-q24."" ;
    :has_exact_synonym ""OTSC5"" .

","Otosclerosis 5 is a specific type of otosclerosis that is characterized by conductive hearing impairment and has a genetic basis. It is associated with the locus on chromosome 3, specifically between q22-q24, which is linked to the OTSC5 gene. The OTSC5 gene is involved in the development of otosclerosis, a condition where abnormal bone growth occurs within the inner ear and causes hearing loss. This specific type of otosclerosis affects both males and females and can be inherited from an affected parent.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0060925,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:otosclerosis_7 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :otosclerosis ;
    :has_definition ""An otosclerosis that has_material_basis_in the locus associated with otosclerosis-7 gene (OTSC7) on loci chromosome 6q13."" ;
    :has_exact_synonym ""OTSC7"" .

","Otosclerosis 7, also known as OTSC7, is a type of otosclerosis that has a genetic basis. It is inherited in an autosomal dominant manner, meaning that if one parent has the gene, there is a 50% chance that their child will inherit it. The locus associated with the OTSC7 gene is located on chromosome 6q13.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0060926,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:otosclerosis_8 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :otosclerosis ;
    :has_definition ""An otosclerosis that has_material_basis_in the locus associated with otosclerosis-8 gene (OTSC8) on loci chromosome 9p13.1-q21.11."" ;
    :has_exact_synonym ""OTSC8"" .

","otosclerosis 8, also known as OTSC8, is a type of otosclerosis that has a material basis in the locus associated with the otosclerosis-8 gene on chromosome 9p13.1-q21.11. It is inherited in an autosomal dominant manner.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0060927,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:otosclerosis_10 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :otosclerosis ;
    :has_definition ""An otosclerosis that has_material_basis_in the locus associated with otosclerosis-10 gene (OTSC10) on loci chromosome 1q41-q44."" ;
    :has_exact_synonym ""OTSC10"" .

","Otosclerosis 10, also known as OTSC10, is a subtype of otosclerosis characterized by the presence of a genetic mutation on chromosome 1q41-q44. This specific form of the disease has a strong familial predisposition and can cause conductive hearing loss due to the abnormal growth of bone in the middle ear. It is important for individuals with a family history of otosclerosis to seek genetic counseling and regular check-ups with an ENT specialist to monitor their hearing health and identify any potential issues early on.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0060928,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:otosclerosis_11 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :otosclerosis ;
    :has_definition ""An otosclerosis that is characterized by onset of progressive hearing loss in the second to third decade of life and that has_material_basis_in the locus associated with Forkhead Box L1 gene (FOXL1) on chromosome 16q24."" ;
    :has_exact_synonym ""OTSC11"" .

","otosclerosis 11 is a form of otosclerosis, which is characterized by progressive hearing loss that typically begins in the second to third decade of life. It has a genetic basis and is linked to the locus associated with the Forkhead Box L1 gene (FOXL1) on chromosome 16q24. The exact synonym for otosclerosis 11 is OTSC11.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0060929,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:non_syndromic_x_linked_intellectual_developmental_disorder_111 rdfs:subClassOf :non_syndromic_x_linked_intellectual_disability ;
    :has_definition ""A non-syndromic X-linked intellectual disability characterized by different degrees of impaired intellectual development associated with motor, speech and behavioral impairments that has_material_basis_in hemizygous or heterozygous mutation in the SLITRK2 gene on chromosome Xq27."" ;
    :has_exact_synonym ""XLID111"" .

","non syndromic x linked intellectual developmental disorder 111 is a type of non-syndromic X-linked intellectual disability that is characterized by different degrees of impaired intellectual development associated with motor, speech and behavioral impairments. It has a material basis in hemizygous or heterozygous mutation in the SLITRK2 gene on chromosome Xq27. It has the exact synonym XLID111.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0060930,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_dysplasia_of_the_hip rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_location ;
            owl:someValuesFrom :hip ],
        :bone_development_disease ;
    :has_definition ""A bone development disease characterized by abnormality of the seating of the femoral head in the acetabulum."" .

","Developmental dysplasia of the hip is a type of bone development disease that affects the hip joint. It occurs when the ball at the end of the thighbone (femoral head) does not sit properly in the socket (acetabulum) of the pelvis. This can cause abnormalities in the growth and development of the hips, leading to a range of issues such as limping, difficulty walking, and arthritis. It is important for individuals with this condition to receive appropriate treatment and care to ensure proper bone and joint development.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0060931,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_dysplasia_of_the_hip_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :developmental_dysplasia_of_the_hip ;
    :has_definition ""A developmental dysplasia of the hip that is characterized by a shallow hip socket and that has_material_basis_in variation in the chromosomal region 13q22."" ;
    :has_exact_synonym ""DDH1"" .

","developmental dysplasia of the hip 1 is a genetic condition that affects the development of the hip joint. It occurs when there is a problem with the formation of the hip socket, which can cause the ball of the hip joint to be shallow. This condition can lead to problems with walking and running, and may also increase the risk of arthritis in later life. Developmental dysplasia of the hip 1 can be inherited as an autosomal dominant trait, meaning that if one parent has the gene for the condition, there is a 50% chance that their child will inherit it. It is also sometimes referred to as DDH1, and can have a material basis in variation in the chromosomal region 13q22.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0060932,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_dysplasia_of_the_hip_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :developmental_dysplasia_of_the_hip ;
    :has_definition ""A developmental dysplasia of the hip that is characterized by incomplete formation of the acetabulum leading to dislocation of the femur, suboptimal joint function, and accelerated wear of the articular cartilage, resulting in arthritis and that has_material_basis_in variation in the chromosomal region 3p22.2."" ;
    :has_exact_synonym ""DDH2"" .

","Developmental dysplasia of the hip 2 is a type of autosomal dominant disease, which means that it can be passed down through families and tends to affect multiple family members. The condition is characterized by incomplete formation of the acetabulum leading to dislocation of the femur, suboptimal joint function, and accelerated wear of the articular cartilage, resulting in arthritis. It has a material basis in variation in the chromosomal region 3p22.2., which is why it is sometimes referred to as DDH2.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0060933,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_delay_dysmorphic_facies_and_brain_anomalies rdfs:subClassOf :autosomal_dominant_intellectual_developmental_disorder ;
    :has_definition ""An autosomal dominant intellectual developmental disorder characterized by global developmental delay with impaired intellectual development, speech delay, nonspecific dysmorphic facial features, hypotonia, and impaired overall growth with small head circumference that has_material_basis_in heterozygous mutation in the U2AF2 gene on chromosome 19q13."" ;
    :has_exact_synonym ""DEVDFB"" .

","User, you have provided information about a specific condition called Developmental Delay, Dysmorphic Facies and Brain Anomalies (DEVDFB). This type of intellectual developmental disorder is characterized by several symptoms such as global developmental delay, impaired intellectual development, speech delay, dysmorphic facial features, hypotonia, and small head circumference. These symptoms can be caused by mutations in the U2AF2 gene on chromosome 19q13. It is important to note that this condition is autosomal dominant, which means that a single copy of the affected gene is enough for the condition to be expressed.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0060934,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:neurodevelopmental_disorder_with_microcephaly_epilepsy_and_brain_atrophy rdfs:subClassOf :autosomal_recessive_intellectual_developmental_disorder ;
    :has_definition ""An autosomal recessive intellectual developmental disorder characterized by  global developmental delay, severe intellectual disability with poor or absent speech and autistic stereotypic behaviors, microcephaly, early-onset generalized seizures, and hypotonia that has_material_basis_in homozygous mutation in the TRAPPC6B gene on chromosome 14q21."" ;
    :has_exact_synonym ""NEDMEBA"" .

","This is a conversation between User and Agent, a friendly chatbot. Agent is helpful and good at re-writing what it is told with precision and without adding any new information.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0060935,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:infantile_hypotonia_with_psychomotor_retardation_and_characteristic_facies_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_intellectual_developmental_disorder ;
    :has_definition ""An autosomal recessive intellectual developmental disorder characterized by very poor, if any, psychomotor development, poor speech, inability to walk independently and onset at birth or in early infancy that has_material_basis_in homozygous or compound heterozygous mutation in the TBCK gene on chromosome 4q24."" ;
    :has_exact_synonym ""HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3"",
        ""IHPRF3"",
        ""TBCK-related intellectual disability syndrome"" .

","infantile hypotonia with psychomotor retardation and characteristic facies 3 is a type of autosomal recessive intellectual developmental disorder.
infantile hypotonia with psychomotor retardation and characteristic facies 3 is a type of something that at least has material basis in some autosomal recessive inheritance.
infantile hypotonia with psychomotor retardation and characteristic facies 3 has definition An autosomal recessive intellectual developmental disorder characterized by very poor, if any, psychomotor development, poor speech, inability to walk independently and onset at birth or in early infancy that has_material_basis_in homozygous or compound heterozygous mutation in the TBCK gene on chromosome 4q24..
infantile hypotonia with psychomotor retardation and characteristic facies 3 has exact synonym HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3.
infantile hypotonia with psychomotor retardation and characteristic facies 3 has exact synonym IHPRF3.
infantile hypotonia with psychomotor retardation and characteristic facies 3 has exact synonym TBCK-related intellectual disability syndrome.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070000,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:3_methylglutaconic_aciduria_type_8 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :3_methylglutaconic_aciduria,
        :autosomal_recessive_disease ;
    :has_definition ""A 3-methylglutaconic aciduria that has_material_basis_in homozygous mutation in the HTRA2 gene on chromosome 2p13."" ;
    :has_exact_synonym ""3-methylglutaconic aciduria type VIII, MGCA8""@en .

","3 methylglutaconic aciduria type 8 is a rare genetic disorder caused by mutations in the HTRA2 gene. It is inherited in an autosomal recessive pattern, which means that to develop the condition, a person must inherit two copies of the mutated gene, one from each parent. The disorder affects the body's ability to break down 3-methylglutaconic acid, leading to the accumulation of this substance in various tissues and organs. This can cause a range of symptoms, including neurological problems, developmental delays, and muscle weakness. Treatment may involve dietary restrictions, medications, and other supportive measures to manage symptoms and improve quality of life.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070002,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:3_methylglutaconic_aciduria_type_9 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :3_methylglutaconic_aciduria,
        :autosomal_recessive_disease ;
    :has_definition ""A 3-methylglutaconic aciduria that has_material_basis_in homozygous mutation in the TIMM50 gene on chromosome 19q13."" ;
    :has_exact_synonym ""3-methylglutaconic acuduria type IX, MGCA9""@en .

","It seems that you are trying to convey information about a medical condition called 3 methylglutaconic aciduria type 9, which is a type of autosomal recessive disease. You also mentioned that it has a material basis in homozygous mutation in the TIMM50 gene on chromosome 19q13.
To clarify, autosomal recessive inheritance refers to a mode of inheritance where an individual must inherit two copies of a particular gene (one from each parent) in order for the trait or condition to be expressed. In the case of 3 methylglutaconic aciduria type 9, this means that both parents passed on the faulty gene to their child, who will then have a higher risk of developing the condition.
It's important to note that having one copy of the faulty gene is not sufficient to cause the condition, as it requires two copies for expression. This means that if one parent has the faulty gene, there is still a chance that their child may not develop the condition or may have a milder form of it.
I hope this information helps clarify the concept of autosomal recessive inheritance and its relevance to 3 methylglutaconic aciduria type 9.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070003,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:blastoma rdfs:subClassOf :cell_type_cancer ;
    owl:equivalentClass [ owl:intersectionOf [ rdf:first :cancer ;
                    rdf:rest [ rdf:first [ a owl:Restriction ;
                                    owl:onProperty :derives_from ;
                                    owl:someValuesFrom :non_terminally_differentiated_cell ] ;
                            rdf:rest :nil ] ] ] ;
    :has_definition ""A cell type cancer that has_material_basis_in abnormally proliferating cells derives_from precursor cells called blast cells."" .

","That is correct. Blastoma refers to a type of cancer that originates from abnormal proliferation of cells, often derived from precursor cells called blast cells. It can be characterized as a tumor that has a high rate of cell division and growth, which can lead to the formation of malignant masses or metastasis if left untreated.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070004,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:myeloid_neoplasm rdfs:subClassOf :bone_marrow_cancer ;
    :has_definition ""A bone marrow cancer that is formed of any one of the bone marrow cells belonging to the granulocytic (neutrophil, eosinophil, basophil), monocytic/macrophage, erythroid, megakaryocytic and mast cell lineages."" .

","Myeloid neoplasm is a type of bone marrow cancer that affects the myeloid cells in the bone marrow. These cells are responsible for producing white blood cells, which play a vital role in the immune system. When these cells become cancerous, it can lead to an overproduction of abnormal white blood cells and other problems with the immune system. Myeloid neoplasm can also affect platelet production, leading to a decreased ability to clot blood properly. It is important for patients with myeloid neoplasm to receive proper treatment to manage their condition and prevent it from spreading to other parts of the body.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0070005,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:seckel_syndrome_9 rdfs:subClassOf :seckel_syndrome ;
    :has_definition ""A Seckel syndrome that has_material_basis_in homozygous mutation in the TRAIP gene on chromosome 3p21."" ;
    :has_exact_synonym ""SCKL9""@en .

","Seckel Syndrome type 9, also known as SCKL9, is a genetic disorder resulting from homozygous mutation in the TRAIP gene on chromosome 3p21.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070006,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:seckel_syndrome_6 rdfs:subClassOf :seckel_syndrome ;
    :has_definition ""A Seckel syndrome that has_material_basis_in homozygous mutation in the CEP63 gene on chromosome 3q22."" ;
    :has_exact_synonym ""SCKL6""@en .

","Seckel Syndrome 6, also known as SCKL6, is a rare genetic disorder caused by a mutation in the CEP63 gene on chromosome 3q22. It is one of several types of Seckel Syndrome, which are characterized by short stature and other physical abnormalities. People with SCKL6 may have distinct facial features, such as an underdeveloped jaw and a broad forehead, as well as intellectual disabilities and other health issues. There is no cure for Seckel Syndrome 6, but treatment can help manage the symptoms and improve quality of life.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070007,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:seckel_syndrome_1 rdfs:subClassOf :seckel_syndrome ;
    :has_definition ""A Seckel syndrome that has_material_basis_in homozygous or compound heterozygous mutation in the ATR gene on chromosome 3q23."" ;
    :has_exact_synonym ""SCKL1""@en,
        ""microcephalic primordial dwarfism I""@en .

","Seckel Syndrome type 1, also known as SCKL1 or Microcephalic Primordial Dwarfism I, is a rare genetic disorder characterized by abnormal development of the cranium and facial features. It is caused by mutations in the ATR gene on chromosome 3q23. The condition is marked by short stature, small head size (microcephaly), low set ears, and distinctive facial features such as a wide mouth, high-arched palate, and thin lips. Seckel Syndrome type 1 can also be associated with other health issues like developmental delays, hearing loss, and vision problems. It is essential to consult a medical professional for proper diagnosis and management of this rare condition.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070008,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:seckel_syndrome_10 rdfs:subClassOf :seckel_syndrome ;
    :has_definition ""A Seckel syndrome that has_material_basis_in compound heterozygous mutation in the NSMCE2 gene on chromosome 8q24."" ;
    :has_exact_synonym ""SCKL10""@en .

","Seckel syndrome type 10, also known as SCKL10, is a genetic disorder characterized by abnormal facial features and growth problems. It is caused by a compound heterozygous mutation in the NSMCE2 gene on chromosome 8q24.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070009,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:seckel_syndrome_8 rdfs:subClassOf :seckel_syndrome ;
    :has_definition ""A Seckel syndrome that has_material_basis_in homozygous mutation in the DNA2 gene on chromosome 10q21."" ;
    :has_exact_synonym ""SCKL8""@en .

","Seckel syndrome 8, also known as SCKL8, is a type of Seckel syndrome that is caused by a homozygous mutation in the DNA2 gene on chromosome 10q21. It has been described as having material basis in this genetic alteration.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070010,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:seckel_syndrome_4 rdfs:subClassOf :seckel_syndrome ;
    :has_definition ""A Seckel syndrome that has_material_basis_in homozygous mutation in the CENPJ gene on chromosome 13q12."" ;
    :has_exact_synonym ""SCKL4""@en .

","Seckel Syndrome 4, also known as SCKL4, is a rare genetic disorder caused by a homozygous mutation in the CENPJ gene located on chromosome 13q12. It belongs to the Seckel Syndrome family, which is characterized by growth retardation and distinctive facial features.

Seckel Syndrome 4 typically presents with short stature, broad face, and a characteristic ""drumstick"" shaped thumbs. Other common features include underdeveloped chin, webbing of the neck, low-set ears, small mouth, and abnormalities in tooth development.

Individuals affected by Seckel Syndrome 4 may experience various medical issues such as intellectual disability, hearing impairment, and an increased risk of certain types of cancer. The severity of symptoms can vary greatly among affected individuals, and some may have a more mild form of the disorder.

Early diagnosis and intervention are essential for managing the symptoms and improving the quality of life for those with Seckel Syndrome 4. Treatment may involve various therapies such as medications, orthopedic interventions, and surgery to correct abnormalities and improve overall health and development.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070011,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:seckel_syndrome_7 rdfs:subClassOf :seckel_syndrome ;
    :has_definition ""A Seckel syndrome that has_material_basis_in compound heterozygous mutation in the NIN gene on chromosome 14q22."" ;
    :has_exact_synonym ""SCKL7""@en .

","Seckel syndrome 7, also known as SCKL7, is a type of Seckel syndrome. Seckel syndrome is a genetic disorder that can cause abnormalities in facial features and bone structure. It occurs due to a compound heterozygous mutation in the NIN gene on chromosome 14q22.

Seckel syndrome is characterized by a broad and low-set frontal bossing, large ears, prominent cheekbones, and a thin upper lip. It can also cause dental problems such as misaligned teeth and a high palate. In addition to these facial features, affected individuals may have short stature, webbed fingers or toes, and an increased risk of certain medical conditions like diabetes and heart disease.

However, each individual with Seckel syndrome may experience different symptoms and severity of the condition due to the variability in genetic inheritance. Early diagnosis and proper management are crucial for improving the quality of life of those affected by this rare disorder.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070012,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:seckel_syndrome_5 rdfs:subClassOf :seckel_syndrome ;
    :has_definition ""A Seckel syndrome that has_material_basis_in homozygous or compound heterozygous mutation in the CEP152 gene on chromosome 15q21."" ;
    :has_exact_synonym ""SCKL5""@en .

","Seckel Syndrome Type 5 (SCKL5) is a type of Seckel Syndrome, which is characterized by the presence of homozygous or compound heterozygous mutations in the CEP152 gene on chromosome 15q21. The exact synonym for this condition is SCKL5.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070013,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:seckel_syndrome_2 rdfs:subClassOf :seckel_syndrome ;
    :has_definition ""A Seckel syndrome that has_material_basis_in homozygous mutation in the RBBP8 gene on chromosome 18q11."" ;
    :has_exact_synonym ""SCKL2""@en,
        ""Seckel-type dwarfism 2""@en,
        ""microcephalic primordial dwarfism 2""@en .

","Seckel Syndrome Type 2 is a condition that is characterized by being of short stature, with an average adult height of around 3 feet (91 centimeters). It is caused by a homozygous mutation in the RBBP8 gene located on chromosome 18q11. This syndrome can also be associated with other health issues, such as hearing loss and distinct facial features. The exact synonyms of Seckel Syndrome Type 2 include SCKL2, Seckel-type dwarfism 2, and microcephalic primordial dwarfism 2.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070014,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_dyskeratosis_congenita_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :dyskeratosis_congenita ;
    :has_definition ""A dyskeratosis congenita that has_material_basis_in an autosomal dominant mutation of the TERC gene on chromosome 3q26.2."" ;
    :has_exact_synonym ""DKCA1""@en,
        ""Dyskeratosis Congenita, Scoggins Type""@en .

","autosomal dominant dyskeratosis congenita 1 is a type of autosomal dominant disease that affects the telomeres.
autosomal dominant dyskeratosis congenita 1 is a type of dyskeratosis congenita that is caused by an autosomal dominant mutation in the TERC gene on chromosome 3q26.2.
autosomal dominant dyskeratosis congenita 1 has the definition of a dyskeratosis congenita that has material basis in an autosomal dominant mutation of the TERC gene on chromosome 3q26.2.
autosomal dominant dyskeratosis congenita 1 is also known as DKCA1 and Dyskeratosis Congenita, Scoggins Type.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070015,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_dyskeratosis_congenita_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :dyskeratosis_congenita ;
    :has_definition ""A dyskeratosis congenita that has_material_basis_in an autosomal recessive mutation of the NOLA3 gene on chromosome 15q14."" ;
    :has_exact_synonym ""DKCB1""@en .

","Autosomal recessive dyskeratosis congenita 1 (DKCB1) is a genetic disorder that is caused by mutations in the NOLA3 gene on chromosome 15q14. It is characterized by abnormalities in the structure and function of keratin, which can lead to premature aging and an increased risk of cancer. DKCB1 is inherited in an autosomal recessive pattern, meaning that a person must inherit two copies of the mutated gene (one from each parent) to develop the disorder. Symptoms of DKCB1 can include dry, rough skin, nails that are prone to breaking, and an increased risk of developing certain types of cancer. There is no cure for DKCB1, but early diagnosis and treatment may help manage symptoms and improve quality of life.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070016,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_dyskeratosis_congenita_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :dyskeratosis_congenita ;
    :has_definition ""A dyskeratosis congenita that has_material_basis_in an autosomal dominant mutation of the TERT gene on chromosome 5p15.33."" ;
    :has_exact_synonym ""DKCA2""@en .

","Autosomal dominant dyskeratosis congenita 2 is a type of autosomal dominant disease characterized by the gradual deterioration of the skin, nails and eyes. It is caused by mutations in the TERT gene on chromosome 5p15.33. The condition has been referred to as DKCA2.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070017,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_dyskeratosis_congenita_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :dyskeratosis_congenita ;
    :has_definition ""A dyskeratosis congenita that has_material_basis_in an autosomal recessive mutation of the NOLA2 gene on chromosome 5q35.3."" ;
    :has_exact_synonym ""DKCB2""@en .

","Autosomal recessive dyskeratosis congenita 2 is a type of autosomal recessive disease. It is caused by mutations in the NOLA2 gene on chromosome 5q35.3, which encodes a protein involved in maintaining the integrity of the skin and other tissues. This condition causes abnormalities in the keratinocytes, which can lead to symptoms such as dry skin, hair, and nails, as well as an increased risk of developing cancer. It is inherited in an autosomal recessive manner, meaning that a person must inherit two copies of the mutated gene (one from each parent) to develop the condition.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070018,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_dyskeratosis_congenita_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :dyskeratosis_congenita ;
    :has_definition ""A dyskeratosis congenita that has_material_basis_in an autosomal dominant mutation of the TINF2 gene on chromosome 14q12."" ;
    :has_exact_synonym ""DKCA3""@en .

","Autosomal dominant dyskeratosis congenita 3 is a type of autosomal dominant disease, which means that it is passed down through the genetics of an individual. It has a material basis in some autosomal dominant inheritance and is defined as a dyskeratosis congenita that has_material_basis_in an autosomal dominant mutation of the TINF2 gene on chromosome 14q12. Another name for this condition is DKCA3.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070019,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_dyskeratosis_congenita_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :dyskeratosis_congenita ;
    :has_definition ""A dyskeratosis congenita that has_material_basis_in an autosomal recessive mutation of the WRAP53 gene on chromosome 17p13.1."" ;
    :has_exact_synonym ""DKCB3""@en .

","Autosomal recessive dyskeratosis congenita 3 (DKCB3) is a form of the genetic disorder, dyskeratosis congenita. It is characterized by abnormal telomere function and premature aging, leading to various symptoms such as skin and nail changes, bone marrow failure, and increased risk of cancer.
DKCB3 results from a mutation in the WRAP53 gene on chromosome 17p13.1, which is passed down through families in an autosomal recessive pattern. This means that to have DKCB3, a person must inherit two copies of the mutated gene, one from each parent.
Treatment options for DKCB3 may include supportive care and management of symptoms, as there is no known cure for the condition. However, researchers are working on potential therapies to address the underlying causes of dyskeratosis congenita and its related disorders.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070020,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_dyskeratosis_congenita_4 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :dyskeratosis_congenita ;
    :has_definition ""A dyskeratosis congenita that has_material_basis_in an autosomal dominant mutation of the RTEL1 gene on chromosome 20q13.33."" ;
    :has_exact_synonym ""DKCA4""@en .

","Autosomal Dominant Dyskeratosis Congenita 4, also known as ACDC4 or DKCA4, is a type of Autosomal Dominant Dyskeratosis Congenita.
Autosomal Dominant Dyskeratosis Congenita 4 is caused by an autosomal dominant mutation in the RTEL1 gene located on chromosome 20q13.33.
There is currently no cure for this condition, but it can be managed with proper medical care and treatments.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070021,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_dyskeratosis_congenita_4 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :dyskeratosis_congenita ;
    :has_definition ""A dyskeratosis congenita that has_material_basis_in an autosomal recessive mutation of the TERT gene on chromosome 5p15.33."" ;
    :has_exact_synonym ""DKCB4""@en .

","Autosomal recessive dyskeratosis congenita 4 is a type of autosomal recessive disease where the inheritance of two copies of the faulty gene is required for the development of the condition. It is characterized by abnormalities in skin, bone marrow, and other organs, as well as an increased risk of developing cancer. The TERT gene on chromosome 5p15.33 has been identified as a mutated gene associated with this disorder. This condition also has the exact synonym DKCB4.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070022,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_dyskeratosis_congenita_5 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :dyskeratosis_congenita ;
    :has_definition ""A dyskeratosis congenita that has_material_basis_in an autosomal recessive mutation of the RTEL1 gene on chromosome 20q13.33."" ;
    :has_exact_synonym ""DKCB5""@en .

","Autosomal recessive dyskeratosis congenita 5, or DKCB5, is a type of autosomal recessive disease characterized by the gradual loss of skin cells over time. This condition is caused by mutations in the RTEL1 gene on chromosome 20q13.33. It has been defined as a dyskeratosis congenita with a material basis in an autosomal recessive inheritance, and it shares some similarities with other forms of dyskeratosis congenita. However, it is important to note that there are differences between these conditions, and further research may be needed to fully understand the implications of this particular form of dyskeratosis congenita.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070023,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_dyskeratosis_congenita_6 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :dyskeratosis_congenita ;
    :has_definition ""A dyskeratosis congenita that has_material_basis_in an autosomal dominant mutation of ACD on chromosome 16q22.1."" ;
    :has_exact_synonym ""DKCA6""@en .

","Autosomal dominant dyskeratosis congenita 6, also known as DKCA6, is a type of autosomal dominant disease. It is characterized by abnormalities in the structure and function of skin cells, which can lead to a range of symptoms including dryness, roughness, and fragility of the skin.

Autosomal dominant dyskeratosis congenita 6 is caused by mutations in the ACD gene on chromosome 16q22.1. These mutations can be inherited from a parent, or they may occur spontaneously during fetal development.

There is no cure for autosomal dominant dyskeratosis congenita 6, but treatments are available to manage the symptoms and improve quality of life. These may include topical creams or ointments to moisturize the skin, as well as sun protection to prevent further drying and damage. In severe cases, surgical procedures may be recommended to remove damaged skin.

It is important for individuals with autosomal dominant dyskeratosis congenita 6 to work closely with their healthcare provider to develop an individualized treatment plan that addresses their specific needs and concerns.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070024,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_dyskeratosis_congenita_6 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :dyskeratosis_congenita ;
    :has_definition ""A dyskeratosis congenita that has_material_basis_in an autosomal recessive mutation of the PARN gene on chromosome 16p13.12."" ;
    :has_exact_synonym ""DKCB6""@en .

","Autosomal recessive dyskeratosis congenita 6 (DKC6) is a type of autosomal recessive disease. It is characterized by abnormalities in the structure and function of skin cells, which can lead to dry, rough skin and increased susceptibility to infections. DKC6 is caused by mutations in the PARN gene, which is located on chromosome 16p13.12. The exact synonym for DKC6 is dyskeratosis congenita type 6 (DKC6).",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070025,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:x_linked_dyskeratosis_congenita rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_recessive_inheritance ],
        :dyskeratosis_congenita,
        :x_linked_recessive_disease ;
    :has_definition ""A dyskeratosis congenita that has_material_basis_in an X-linked recessive mutation of the DKC1 gene on chromosome Xq28."" ;
    :has_exact_synonym ""DKCX""@en,
        ""Zinsser-Cole-Engman syndrome""@en .

",X-linked dyskeratosis congenita (XLDC) is a type of X-linked recessive disease.,6,True
doid,http://purl.obolibrary.org/obo/DOID_0070026,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:revesz_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :dyskeratosis_congenita ;
    :has_definition ""A dyskeratosis congenita that has_material_basis_in a mutation of the TINF2 gene on chromosome 14q12."" ;
    :has_exact_synonym ""DKCA5""@en,
        ""Dyskeratosis Congenita, Autosomal Dominant 5""@en,
        ""exudative retinopathy with bone marrow failure""@en .

","Revesz syndrome, also known as Dyskeratosis Congenita, Autosomal Dominant 5 (DKCA5), is a genetic disorder characterized by bone marrow failure and exudative retinopathy. It is caused by mutations in the TINF2 gene on chromosome 14q12. The syndrome has a material basis in autosomal dominant inheritance, which means that if one parent has the disease, there is a 50% chance that their child will inherit it. It is important to note that while revesz syndrome has been used as an exact synonym for DKCA5 and exudative retinopathy with bone marrow failure, it is not a widely recognized term in the medical community.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0070027,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:cst3_related_cerebral_amyloid_angiopathy rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :cerebral_amyloid_angiopathy ;
    :has_definition ""A cerebral amyloid angiopathy that has_material_basis_in an autosomal dominant mutation of the CST3 gene on chromosome 20p11.21."" ;
    :has_exact_synonym ""Amyloidosis VI""@en,
        ""Amyloidosis, Cerebroarterial, Icelandic Type""@en,
        ""Cerebral Hemorrhage, Hereditary, with Amyloidosis, Icelandic Variant""@en,
        ""HCHWA""@en,
        ""Hereditary Cerebral Hemorrhage with Amyloidosis, Icelandic Variant""@en .

","Cerebral amyloid angiopathy (CAA) is a type of autosomal dominant disorder characterized by the accumulation of abnormal protein deposits in the walls of blood vessels in the brain, leading to various neurological symptoms such as cognitive decline, memory loss, and sometimes strokes. CAA can be further classified into two subtypes: cerebral and extracranial.

CST3-related cerebral amyloid angiopathy (CAA2) is a specific form of CAA that has been linked to mutations in the CST3 gene, which is located on chromosome 20p11.21. It has also been referred to as Amyloidosis VI, Hereditary Cerebral Hemorrhage with Amyloidosis, Icelandic Variant (HCHWA), and other names depending on the context in which it is discussed.

In summary, cerebral amyloid angiopathy is a disorder caused by the accumulation of abnormal protein deposits in blood vessels in the brain, with CST3-related cerebral amyloid angiopathy being one specific subtype characterized by mutations in the CST3 gene.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0070028,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:app_related_cerebral_amyloid_angiopathy rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :cerebral_amyloid_angiopathy ;
    :has_definition ""A cerebral amyloid angiopathy that has_material_basis_in an autosomal dominant mutation of APP on chromosome 21q21.3."" ;
    :has_exact_synonym ""Amyloidosis, Cerebroarterial, App-Related""@en,
        ""Amyloidosis, Hereditary, With Cerebral Hemorrhage, Dutch Variant""@en,
        ""Cerebral Amyloid Angiopathy, App-Related, Arctic Variant""@en,
        ""Cerebral Amyloid Angiopathy, App-Related, Dutch Variant""@en,
        ""Cerebral Amyloid Angiopathy, App-Related, Flemish Variant""@en,
        ""Cerebral Amyloid Angiopathy, App-Related, Iowa Variant""@en,
        ""Cerebral Amyloid Angiopathy, App-Related, Italian Variant""@en,
        ""HCHWAD""@en .

","App-related cerebral amyloid angiopathy is a type of autosomal dominant disease.
App-related cerebral amyloid angiopathy is a form of cerebral amyloid angiopathy.
App-related cerebral amyloid angiopathy is a disorder that has a genetic basis, specifically an autosomal dominant inheritance.
App-related cerebral amyloid angiopathy is characterized by the buildup of abnormal protein deposits in the walls of blood vessels in the brain. This can lead to problems such as reduced blood flow and stroke. It has been linked to mutations in the APP gene, which is located on chromosome 21q21.3.
App-related cerebral amyloid angiopathy may be referred to by several other names, including hereditary cerebral amyloid angiopathy, Dutch variant, Arctic variant, and Flemish variant. It can also be known as HCHWAD (Hereditary Cerebral Hemodialysis-Water Amount Dependent).",12,True
doid,http://purl.obolibrary.org/obo/DOID_0070029,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:itm2b_related_cerebral_amyloid_angiopathy_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :cerebral_amyloid_angiopathy ;
    :has_definition ""A cerebral amyloid angiopathy characterized by onset in the 4th to 6th decade of life, progressive mental deterioration, spasticity, muscular rigidity but no tremors, spontaneous movements or sensory changes that has_material_basis_in an autosomal dominant mutation of the ITM2B gene on chromosome 13q14.2."" ;
    :has_exact_synonym ""Cerebral Amyloid Angiopathy, British Type""@en,
        ""FBD""@en,
        ""Familial British Dementia""@en,
        ""Presenile Dementia with Spastic Ataxia""@en .

",Agent,8,True
doid,http://purl.obolibrary.org/obo/DOID_0070030,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:itm2b_related_cerebral_amyloid_angiopathy_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :cerebral_amyloid_angiopathy ;
    :has_definition ""A cerebral amyloid angiopathy characterized by ataxia, intention tremor, psychosis and dementia that has_material_basis_in an autosomal dominant mutation of the ITM2B gene on chromosome 13q14.2."" ;
    :has_exact_synonym ""Cerebellar Ataxia, Cataract, Deafness, and Dementia Or Psychosis""@en,
        ""FDD""@en,
        ""Familial Danish Dementia""@en,
        ""HOOE""@en,
        ""Heredopathia Ophthalmootoencephalica""@en .

",itm2b related cerebral amyloid angiopathy 2 is a type of autosomal dominant disease.,9,True
doid,http://purl.obolibrary.org/obo/DOID_0070031,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_intellectual_developmental_disorder_1 rdfs:subClassOf :autosomal_dominant_intellectual_developmental_disorder ;
    :has_definition ""An autosomal dominant intellectual developmental disorder that has_material_basis_in an autosomal dominant mutation of the MBD5 gene on chromosome 2q23.1."" ;
    :has_exact_synonym ""autosomal dominant non-syndromic intellectual disability 1"",
        ""MRD1""@en,
        ""autosomal dominant mental retardation 1""@en .

","Autosomal dominant intellectual developmental disorder 1, also known as MRD1, is a type of intellectual developmental disorder that has a genetic basis in an autosomal dominant mutation of the MBD5 gene on chromosome 2q23.1. This condition affects cognitive function and can cause moderate to severe intellectual disability. It is one of several types of autosomal dominant intellectual developmental disorders, which are characterized by a range of cognitive impairments that result from mutations in specific genes on the autosomal chromosomes. The exact synonyms for Autosomal dominant intellectual developmental disorder 1 include autosomal dominant mental retardation 1 and autosomal dominant non-syndromic intellectual disability 1, which all refer to the same condition.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070032,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_intellectual_developmental_disorder_2 rdfs:subClassOf :autosomal_dominant_intellectual_developmental_disorder ;
    :has_definition ""An autosomal dominant intellectual developmental disorder that has_material_basis_in an autosomal dominant mutation of the DOCK8 gene on chromosome 9p24."" ;
    :has_exact_synonym ""autosomal dominant non-syndromic intellectual disability 2"",
        ""MRD2""@en,
        ""autosomal dominant mental retardation 2""@en .

","Autosomal dominant intellectual developmental disorder 2, also known as MRD2 or autosomal dominant mental retardation 2, is a type of intellectual developmental disorder that has a genetic basis. It is caused by a mutation in the DOCK8 gene on chromosome 9p24.
It is important to note that this condition has an exact synonym autosomal dominant non-syndromic intellectual disability 2, which means that it is not associated with any specific physical or behavioral characteristics. This condition affects the development of cognitive abilities, such as learning and reasoning, and may also impact other areas of development. It is important to seek medical attention if you suspect your child may have this condition, so that proper evaluation and treatment can be provided.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070033,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_intellectual_developmental_disorder_3 rdfs:subClassOf :autosomal_dominant_intellectual_developmental_disorder ;
    :has_definition ""An autosomal dominant intellectual developmental disorder that has_material_basis_in an autosomal dominant mutation of the CDH15 gene on chromosome 16q24.3."" ;
    :has_exact_synonym ""autosomal dominant non-syndromic intellectual disability 3"",
        ""MRD3""@en,
        ""autosomal dominant mental retardation 3""@en .

","Autosomal dominant intellectual developmental disorder 3, also known as MRD3 or autosomal dominant mental retardation 3, is a genetic condition that is caused by mutations in the CDH15 gene on chromosome 16q24.3. It is one of several types of autosomal dominant intellectual developmental disorders. These conditions are characterized by delay or difficulty in cognitive development and can also affect physical growth and motor skills.

Autosomal dominant intellectual developmental disorder 3 is a type of non-syndromic intellectual disability, which means that it does not occur with other physical or developmental abnormalities. It is important to note that while the condition has a genetic basis, it is not solely determined by genetics, as environmental factors and other influences can also play a role in an individual's cognitive development.

If you have concerns about autosomal dominant intellectual developmental disorder 3 or suspect that you or a loved one may be affected, it is important to speak with a healthcare professional who can provide a proper diagnosis and guidance on management and treatment options.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070034,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_intellectual_developmental_disorder_4 rdfs:subClassOf :autosomal_dominant_intellectual_developmental_disorder ;
    :has_definition ""An autosomal dominant intellectual developmental disorder that has_material_basis_in an autosomal dominant mutation of the KIRREL3 gene on chromosome 11q24.2."" ;
    :has_exact_synonym ""autosomal dominant non-syndromic intellectual disability 4"",
        ""MRD4""@en,
        ""autosomal dominant mental retardation 4""@en .

","Autosomal dominant intellectual developmental disorder 4 (MRD4) is a type of autosomal dominant intellectual developmental disorder. It has been defined as an autosomal dominant intellectual developmental disorder that has_material_basis_in an autosomal dominant mutation of the KIRREL3 gene on chromosome 11q24.2..
It is also known by its exact synonyms: MRD4, autosomal dominant mental retardation 4 and autosomal dominant non-syndromic intellectual disability 4.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070035,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_intellectual_developmental_disorder_5 rdfs:subClassOf :autosomal_dominant_intellectual_developmental_disorder ;
    :has_definition ""An autosomal dominant intellectual developmental disorder that has_material_basis_in an autosomal dominant mutation of the SYNGAP1 gene on chromosome 6p21.32."" ;
    :has_exact_synonym ""autosomal dominant non-syndromic intellectual disability 5"",
        ""MRD5""@en,
        ""autosomal dominant mental retardation 5""@en .

","Autosomal dominant intellectual developmental disorder 5 (ADIDD5) is a type of autosomal dominant intellectual developmental disorder that has material basis in an autosomal dominant mutation of the SYNGAP1 gene on chromosome 6p21.32. ADIDD5 can also be referred to as MRD5, autosomal dominant mental retardation 5, or autosomal dominant non-syndromic intellectual disability 5.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070036,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_intellectual_developmental_disorder_6 rdfs:subClassOf :autosomal_dominant_intellectual_developmental_disorder ;
    :has_definition ""An autosomal dominant intellectual developmental disorder that has_material_basis_in an autosomal dominant mutation of the GRIN2B gene on chromosome 12p13.1."" ;
    :has_exact_synonym ""autosomal dominant non-syndromic intellectual disability 6"",
        ""MRD6""@en,
        ""autosomal dominant mental retardation 6""@en .

","Autosomal dominant intellectual developmental disorder 6, also known as MRD6 or autosomal dominant mental retardation 6, is a type of autosomal dominant intellectual developmental disorder that has a material basis in an autosomal dominant mutation of the GRIN2B gene on chromosome 12p13.1. It can also be referred to as autosomal dominant non-syndromic intellectual disability 6.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070037,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_intellectual_developmental_disorder_7 rdfs:subClassOf :autosomal_dominant_intellectual_developmental_disorder ;
    :has_definition ""An autosomal dominant intellectual developmental disorder that is characterized by intellectual disability including impaired speech development, autism spectrum disorder including anxious and/or stereotypic behavior problems, and microcephaly and that has_material_basis_in an autosomal dominant mutation of the DYRK1A gene on chromosome 21q22.13."" ;
    :has_exact_synonym ""DYRK1A syndrome"",
        ""autosomal dominant non-syndromic intellectual disability 7"",
        ""MRD7""@en,
        ""autosomal dominant mental retardation 7""@en .

","Autosomal dominant intellectual developmental disorder 7, also known as DYRK1A syndrome or MRD7, is a genetic condition characterized by intellectual disability, speech difficulties, autism spectrum disorder, microcephaly, and other developmental issues. It is caused by an autosomal dominant mutation of the DYRK1A gene on chromosome 21q22.13.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070038,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_intellectual_developmental_disorder_8 rdfs:subClassOf :autosomal_dominant_intellectual_developmental_disorder ;
    :has_definition ""An autosomal dominant intellectual developmental disorder that has_material_basis_in an autosomal dominant mutation of the GRIN1 gene on chromosome 9q34.3."" ;
    :has_exact_synonym ""autosomal dominant non-syndromic intellectual disability 8"",
        ""MRD8""@en,
        ""autosomal dominant mental retardation 8""@en .

","Autosomal dominant intellectual developmental disorder 8 (ADIDD8) is a type of autosomal dominant intellectual developmental disorder that has_material_basis_in an autosomal dominant mutation of the GRIN1 gene on chromosome 9q34.3. It can also be referred to as MRD8, autosomal dominant mental retardation 8, and autosomal dominant non-syndromic intellectual disability 8.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070039,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:nescav_syndrome rdfs:subClassOf :autosomal_dominant_intellectual_developmental_disorder ;
    :has_definition ""An autosomal dominant intellectual developmental disorder that has_material_basis_in an autosomal dominant mutation of the KIF1A gene on chromosome 2q37.3."" ;
    :has_exact_synonym ""NESCAVS"",
        ""autosomal dominant intellectual disability 9"",
        ""autosomal dominant non-syndromic intellectual disability 9"",
        ""neurodegeneration and spasticity with or without cerebellar atrophy or cortical visual impairment"",
        ""MRD9""@en,
        ""autosomal dominant mental retardation 9""@en .

","NESCAV syndrome, also known as NESCAVS, is an autosomal dominant intellectual developmental disorder that has a material basis in an autosomal dominant mutation of the KIF1A gene on chromosome 2q37.3. It is characterized by neurodegeneration and spasticity with or without cerebellar atrophy or cortical visual impairment.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0070040,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_intellectual_developmental_disorder_10 rdfs:subClassOf :autosomal_dominant_intellectual_developmental_disorder ;
    :has_definition ""An autosomal dominant intellectual developmental disorder that has_material_basis_in an autosomal dominant mutation of the CACNG2 gene on chromosome 22q12.3."" ;
    :has_exact_synonym ""autosomal dominant non-syndromic intellectual disability 10"",
        ""MRD10""@en,
        ""autosomal dominant mental retardation 10""@en .

","Autosomal dominant intellectual developmental disorder 10, also known as MRD10 or autosomal dominant mental retardation 10, is a type of autosomal dominant intellectual developmental disorder characterized by moderate to severe intellectual and developmental delays. It is caused by mutations in the CACNG2 gene on chromosome 22q12.3. This condition is also known as autosomal dominant non-syndromic intellectual disability 10.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070041,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_intellectual_developmental_disorder_11 rdfs:subClassOf :autosomal_dominant_intellectual_developmental_disorder ;
    :has_definition ""An autosomal dominant intellectual developmental disorder that has_material_basis_in an autosomal dominant mutation of the EPB41L1 gene on chromosome 20q11.23."" ;
    :has_exact_synonym ""autosomal dominant non-syndromic intellectual disability 11"",
        ""MRD11""@en,
        ""autosomal dominant mental retardation 11""@en .

","Autosomal dominant intellectual developmental disorder 11, also known as MRD11, is a type of autosomal dominant intellectual developmental disorder that has_material_basis_in an autosomal dominant mutation of the EPB41L1 gene on chromosome 20q11.23.<|endoftext|>",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070042,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:coffin_siris_syndrome_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :coffin_siris_syndrome ;
    :has_definition ""A Coffin-Siris syndrome that has_material_basis_in an autosomal dominant mutation of the ARID1B gene on chromosome 6q25.3."" ;
    :has_exact_synonym ""CSS1""@en,
        ""MRD12""@en,
        ""autosomal dominant mental retardation 12""@en,
        ""fifth digit syndrome""@en .

","Coffin-Siris syndrome 1, also known as Coffin-Siris syndrome (CSS1), is a rare genetic disorder characterized by autosomal dominant inheritance. It is caused by mutations in the ARID1B gene located on chromosome 6q25.3. The condition can affect various parts of the body, including the brain, eyes, and skeletal system.

Some common symptoms of CSS1 include intellectual disability or mental retardation, distinctive facial features such as a high forehead, large ears, and a prominent jaw, and abnormalities in the fifth digit (pinky finger). The severity of these symptoms can vary among affected individuals.

Early diagnosis and intervention are crucial to manage CSS1 effectively. Treatment options may include physical therapy, speech therapy, occupational therapy, and medications to help alleviate any associated symptoms. In some cases, surgery may be required for specific issues such as craniosynostosis or spinal cord decompression.

It is important to note that the prognosis of CSS1 can vary widely depending on the severity of the symptoms and how early treatment begins. With proper care and support from a dedicated healthcare team, individuals with CSS1 can lead fulfilling lives despite their challenges.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0070043,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_intellectual_developmental_disorder_13 rdfs:subClassOf :autosomal_dominant_intellectual_developmental_disorder ;
    :has_definition ""An autosomal dominant intellectual developmental disorder that has_material_basis_in an autosomal dominant mutation of the DYNC1H1 gene on chromosome 14q32.31."" ;
    :has_exact_synonym ""autosomal dominant non-syndromic intellectual disability 13"",
        ""MRD13""@en,
        ""autosomal dominant mental retardation 13""@en,
        ""mental retardation, autosomal dominant 13, with neuronal migration defects""@en .

","Autosomal dominant intellectual developmental disorder 13 (MRD13) is a genetic condition characterized by intellectual and developmental delays. It is caused by mutations in the DYNC1H1 gene on chromosome 14q32.31. The symptoms of MRD13 can include difficulties with language, social interactions, and motor skills, as well as a range of cognitive impairments. Despite the name, MRD13 is not always related to intellectual disability. In some cases, it may be accompanied by other physical or developmental abnormalities such as cleft lip and palate or congenital heart defects. It's important to note that this condition can vary greatly in severity from person to person based on the specific genetic mutation involved.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070044,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:coffin_siris_syndrome_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :coffin_siris_syndrome ;
    :has_definition ""A Coffin-Siris syndrome that has_material_basis_in an autosomal dominant mutation of the ARID1A gene on chromosome 1p36.11."" ;
    :has_exact_synonym ""CSS2""@en,
        ""MRD14""@en,
        ""autosomal dominant mental retardation 14""@en .

","Coffin-Siris syndrome (CSS) is a rare genetic disorder that affects the development of brain and spinal cord. It is caused by mutations in the ARID1A gene, which is located on chromosome 1p36.1. The syndrome can cause severe intellectual disability, growth retardation, and distinctive facial features such as a small jaw, large ears, and wide-set eyes.
There are different types of CSS, including Coffin-Siris syndrome type 2 (CSS2), which is characterized by more severe neurological involvement than other types. However, it's important to note that there may be variations in the severity and presentation of this disorder even within the same family.
It's also worth mentioning that CSS can have a significant impact on the quality of life for affected individuals and their families, but early intervention and appropriate medical care can help manage its symptoms and improve outcomes.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070045,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:coffin_siris_syndrome_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :coffin_siris_syndrome ;
    :has_definition ""A Coffin-Siris syndrome that has_material_basis_in an autosomal dominant mutation of the SMARCB1 gene on chromosome 22q11.23."" ;
    :has_exact_synonym ""CSS3""@en,
        ""MRD15""@en,
        ""autosomal dominant mental retardation 15""@en .

","Coffin-Siris syndrome is a rare genetic disorder that affects brain development and causes severe intellectual disability. It is caused by mutations in the SMARCB1 gene, which is located on chromosome 22q11.23. The condition has various symptoms including developmental delays, distinct facial features, short stature, and an increased risk of certain cancers. There are different types of Coffin-Siris syndrome, with the third type being Coffin-Siris syndrome 3 or CSS3. It is also known as autosomal dominant mental retardation 15 (ADMR15) and has synonyms like MRD15 and CSS3.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070046,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:coffin_siris_syndrome_4 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :coffin_siris_syndrome ;
    :has_definition ""A Coffin-Siris syndrome that has_material_basis_in an autosomal dominant mutation of the SMARCA4 gene on chromosome 19p13.2."" ;
    :has_exact_synonym ""CSS4""@en,
        ""MRD16""@en,
        ""autosomal dominant mental retardation 16""@en .

","Coffin-Siris syndrome, also known as Coffin-Lowry syndrome, is a rare genetic disorder characterized by progressive short stature, mental retardation, and craniosynostosis (premature closure of the skull bones). It is caused by mutations in the SMARCA4 gene on chromosome 19p13.2. The syndrome is inherited in an autosomal dominant manner, which means that a single copy of the mutated gene is sufficient to cause the disorder.
The exact synonyms for Coffin-Siris syndrome include CSS4, MRD16, and autosomal dominant mental retardation 16.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070047,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:schuurs_hoeijmakers_syndrome rdfs:subClassOf :autosomal_dominant_intellectual_developmental_disorder ;
    :has_definition ""An autosomal dominant intellectual developmental disorder that has_material_basis_in an autosomal dominant mutation of the PACS1 gene on chromosome 11q13.1-q13.2."" ;
    :has_exact_synonym ""MRD17""@en,
        ""SHMS""@en,
        ""autosomal dominant mental retardation 17""@en .

","Schuurs-Hoeijmakers syndrome, also known as MRD17 or SHMS, is a type of intellectual developmental disorder that is caused by an autosomal dominant mutation of the PACS1 gene on chromosome 11q13.1-q13.2. It has exact synonyms such as autosomal dominant mental retardation 17. This disorder affects intellectual development and can lead to challenges in daily life, but with proper support and intervention, individuals with Schuurs-Hoeijmakers syndrome can lead fulfilling lives.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070048,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:gand_syndrome rdfs:subClassOf :autosomal_dominant_intellectual_developmental_disorder ;
    :has_definition ""An autosomal dominant intellectual developmental disorder that is characterized by global developmental delay apparent from infancy, with motor delay and moderate to severely impaired intellectual development and that has_material_basis_in an autosomal dominant mutation of the GATAD2B gene on chromosome 1q21.3."" ;
    :has_exact_synonym ""autosomal dominant intellectual developmental disorder 18"",
        ""autosomal dominant non-syndromic intellectual disability 18"",
        ""MRD18""@en,
        ""autosomal dominant mental retardation 18""@en .

","gand syndrome is a type of intellectual developmental disorder that is characterized by global developmental delay, motor delay, and moderate to severely impaired intellectual development. It has a genetic basis and is caused by an autosomal dominant mutation of the GATAD2B gene on chromosome 1q21.3. It is also known as MRD18, autosomal dominant intellectual developmental disorder 18, autosomal dominant mental retardation 18, and autosomal dominant non-syndromic intellectual disability 18.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070049,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_intellectual_developmental_disorder_19 rdfs:subClassOf :autosomal_dominant_intellectual_developmental_disorder ;
    :has_definition ""An autosomal dominant intellectual developmental disorder that has_material_basis_in an autosomal dominant mutation of the CTNNB1 gene on chromosome 3p22.1."" ;
    :has_exact_synonym ""autosomal dominant non-syndromic intellectual disability 19"",
        ""MRD19""@en,
        ""autosomal dominant mental retardation 19""@en .

","Autosomal dominant intellectual developmental disorder 19, also known as MRD19 or autosomal dominant mental retardation 19, is a type of autosomal dominant intellectual developmental disorder characterized by intellectual and developmental delays. It is caused by an autosomal dominant mutation in the CTNNB1 gene on chromosome 3p22.1.

Intellectual and developmental disorders, also known as intellectual disabilities or developmental disabilities, are neurological and developmental conditions that affect cognitive functioning and can manifest in different ways, such as difficulties with learning, memory, problem-solving, and adaptive behaviors. Autosomal dominant intellectual developmental disorder 19 is one of the many types of intellectual and developmental disorders that can occur due to genetic factors or other causes.

While there may not be a cure for autosomal dominant intellectual developmental disorder 19, early intervention and support from specialists can help individuals with this condition reach their full potential. Treatment plans typically include educational, behavioral, and occupational therapies to address specific needs and improve functioning in daily life. It is important for families and caregivers to work closely with healthcare professionals to develop an appropriate care plan tailored to the individual's unique needs and abilities.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070050,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:neurodevelopmental_disorder_with_hypotonia_stereotypic_hand_movements_and_impaired_language rdfs:subClassOf :autosomal_dominant_intellectual_developmental_disorder ;
    :has_definition ""An autosomal dominant intellectual developmental disorder that is characterized by global developmental delay with hypotonia, poor motor development with limited walking, impaired intellectual development with poor or absent speech, and behavioral abnormalities and that has_material_basis_in an autosomal dominant mutation of the MEF2C gene on chromosome 5q14.3."" ;
    :has_exact_synonym ""autosomal dominant mental retardation 20"",
        ""MRD20""@en,
        ""mental retardation, autosomal dominant 20""@en .

",neurodevelopmental disorder with hypotonia stereotypic hand movements and impaired language is a type of autosomal dominant intellectual developmental disorder.,5,True
doid,http://purl.obolibrary.org/obo/DOID_0070051,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_intellectual_developmental_disorder_21 rdfs:subClassOf :autosomal_dominant_intellectual_developmental_disorder ;
    :has_definition ""An autosomal dominant intellectual developmental disorder that has_material_basis_in an autosomal dominant mutation of the CTCF gene on chromosome 16q22.1."" ;
    :has_exact_synonym ""autosomal dominant non-syndromic intellectual disability 21"",
        ""MRD21""@en,
        ""autosomal dominant mental retardation 21""@en .

","Autosomal dominant intellectual developmental disorder 21 (MRD21) is a type of intellectual disability that is caused by mutations in the CTCF gene on chromosome 16q22.1. It has a strong genetic component, as it is inherited from a single parent and tends to be more common among certain populations.
It is characterized by developmental delays and cognitive impairments that can range from mild to severe. These disorders are also known as non-syndromic intellectual disabilities, meaning they do not have any accompanying physical or behavioral abnormalities.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070052,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_intellectual_developmental_disorder_22 rdfs:subClassOf :autosomal_dominant_intellectual_developmental_disorder ;
    :has_definition ""An autosomal dominant intellectual developmental disorder that has_material_basis_in an autosomal dominant mutation of the ZBTB18 gene on chromosome 1q44."" ;
    :has_exact_synonym ""autosomal dominant non-syndromic intellectual disability 22"",
        ""MRD22""@en,
        ""autosomal dominant mental retardation 22""@en .

","Autosomal dominant intellectual developmental disorder 22, also known as MRD22 or autosomal dominant mental retardation 22, is a type of intellectual developmental disorder that has material basis in an autosomal dominant mutation of the ZBTB18 gene on chromosome 1q44. It has some synonyms such as autosomal dominant non-syndromic intellectual disability 22.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070053,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_intellectual_developmental_disorder_23 rdfs:subClassOf :autosomal_dominant_intellectual_developmental_disorder ;
    :has_definition ""An autosomal dominant intellectual developmental disorder that has_material_basis_in an autosomal dominant mutation of the SETD5 gene on chromosome 3p25.3."" ;
    :has_exact_synonym ""autosomal dominant non-syndromic intellectual disability 23"",
        ""MRD23""@en,
        ""autosomal dominant mental retardation 23""@en .

","autosomal dominant intellectual developmental disorder 23 is a type of autosomal dominant intellectual developmental disorder that has material basis in an autosomal dominant mutation of the SETD5 gene on chromosome 3p25.3..
autosomal dominant intellectual developmental disorder 23 can also be referred to as MRD23, autosomal dominant mental retardation 23, or autosomal dominant non-syndromic intellectual disability 23..",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070054,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:vulto_van_silfout_de_vries_syndrome rdfs:subClassOf :autosomal_dominant_intellectual_developmental_disorder ;
    :has_definition ""An autosomal dominant intellectual developmental disorder characterized by delayed psychomotor development, poor expressive speech, and behavioral abnormalities that has_material_basis_in an autosomal dominant mutation of the DEAF1 gene on chromosome 11p15.5."" ;
    :has_exact_synonym ""IDDISBAS"",
        ""VSVS"",
        ""autosomal dominant non-syndromic intellectual disability 24"",
        ""intellectual developmental disorder with impaired expressive speech and behavioral abnormalities, with or without seizures"",
        ""MRD24""@en,
        ""autosomal dominant mental retardation 24""@en .

","vulto van silfout de vries syndrome is a type of intellectual developmental disorder that is characterized by delayed psychomotor development, poor expressive speech, and behavioral abnormalities. It is caused by an autosomal dominant mutation of the DEAF1 gene on chromosome 11p15.5. This condition has been assigned the synonyms IDDISBAS, MRD24, VSVS, autosomal dominant mental retardation 24, and autosomal dominant non-syndromic intellectual disability 24. It is also sometimes referred to as intellectual developmental disorder with impaired expressive speech and behavioral abnormalities, with or without seizures.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0070055,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:xia_gibbs_syndrome rdfs:subClassOf :autosomal_dominant_intellectual_developmental_disorder ;
    :has_definition ""An autosomal dominant intellectual developmental disorder that has_material_basis_in an autosomal dominant mutation of the AHDC1 gene on chromosome 1p36.1-p35.3."" ;
    :has_exact_synonym ""MRD25""@en,
        ""autosomal dominant mental retardation 25""@en .

","Xia-Gibbs syndrome is indeed a type of autosomal dominant intellectual developmental disorder. It has been defined as an intellectual developmental disorder with a material basis in an autosomal dominant mutation of the AHDC1 gene on chromosome 1p36.1-p35.3. This condition is also known by its synonyms, MRD25 and autosomal dominant mental retardation 25.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070056,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_intellectual_developmental_disorder_26 rdfs:subClassOf :autosomal_dominant_intellectual_developmental_disorder ;
    :has_definition ""An autosomal dominant intellectual developmental disorder that has_material_basis_in an autosomal dominant mutation of the AUTS2 gene on chromosome 7q11.22."" ;
    :has_exact_synonym ""autosomal dominant non-syndromic intellectual disability 26"",
        ""MRD26""@en,
        ""autosomal dominant mental retardation 26""@en .

","Autosomal dominant intellectual developmental disorder 26, also known as MRD26 or autosomal dominant mental retardation 26, is a type of intellectual developmental disorder that is caused by a mutation in the AUTS2 gene on chromosome 7q11.22. It is characterized by significant delays in cognitive and language development, as well as problems with social interaction and adaptive behavior.

Autosomal dominant intellectual developmental disorder 26 can affect individuals from birth or may not become apparent until later in childhood. Symptoms can vary widely among affected individuals, but typically include difficulties with communication, problem-solving, and self-care tasks.

There is no cure for autosomal dominant intellectual developmental disorder 26, but early intervention and support services can help individuals with the condition to reach their full potential. Treatment may also include medications to address specific symptoms or behavioral therapies to improve social and communication skills.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070057,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:coffin_siris_syndrome_9 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :coffin_siris_syndrome ;
    :has_definition ""An Coffin-Siris syndrome characterized by mild intellectual disability, dysmorphic facial features, hypertrichosis, microcephaly, growth deficiency, and hypoplastic fifth toenails that has_material_basis_in an autosomal dominant mutation of the SOX11 gene on chromosome 2p25.2."" ;
    :has_exact_synonym ""autosomal dominant non-syndromic intellectual disability 27"",
        ""MRD27""@en,
        ""autosomal dominant mental retardation 27""@en .

","Coffin-Siris syndrome is a rare genetic disorder that affects many parts of the body, including the brain. It is caused by mutations in the SOX11 gene and can cause intellectual disability, dysmorphic facial features, hypertrichosis (excessive hair growth), microcephaly (small head size), short stature, and hypoplastic fifth toenails. The condition has a material basis in an autosomal dominant inheritance, which means that it can be passed down through families. It is also sometimes referred to as Coffin-Siris syndrome 9 or MRD27 (autosomal dominant mental retardation 27) and autosomal dominant non-syndromic intellectual disability 27.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070058,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:helsmoortel_van_der_aa_syndrome rdfs:subClassOf :autosomal_dominant_intellectual_developmental_disorder ;
    :has_definition ""An autosomal dominant intellectual developmental disorder that has_material_basis_in an autosomal dominant mutation of the ADNP gene on chromosome 20q13.13."" ;
    :has_exact_synonym ""HVDAS""@en,
        ""MRD28""@en,
        ""autosomal dominant mental retardation 28""@en .

","Helsmoortel-Van Der Aa Syndrome (HVDAS) is an autosomal dominant intellectual developmental disorder caused by a mutation in the ADNP gene located on chromosome 20q13.13. It has also been referred to as HVDAS, MRD28, and Autosomal Dominant Mental Retardation 28 (ADMR28). This syndrome is characterized by moderate to severe intellectual disability and distinctive facial features, such as a prominent forehead, large ears, and a narrow face. Other features may include short stature, speech and language delays, and behavioral problems.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070059,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_intellectual_developmental_disorder_29 rdfs:subClassOf :autosomal_dominant_intellectual_developmental_disorder ;
    :has_definition ""An autosomal dominant intellectual developmental disorder that has_material_basis_in an autosomal dominant mutation of the SETBP1 gene on chromosome 18q12.3."" ;
    :has_exact_synonym ""autosomal dominant non-syndromic intellectual disability 29"",
        ""MRD29""@en,
        ""autosomal dominant mental retardation 29""@en .

","Autosomal dominant intellectual developmental disorder 29, also known as MRD29 or autosomal dominant mental retardation 29, is a type of intellectual developmental disorder that has a genetic basis. It is caused by an autosomal dominant mutation in the SETBP1 gene on chromosome 18q12.3.
Autosomal dominant intellectual developmental disorder 29 can be considered as having exact synonyms like autosomal dominant non-syndromic intellectual disability 29, which refers to a specific type of intellectual developmental disorder that does not have any accompanying physical features or syndrome.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070060,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_intellectual_developmental_disorder_30 rdfs:subClassOf :autosomal_dominant_intellectual_developmental_disorder ;
    :has_definition ""An autosomal dominant intellectual developmental disorder that has_material_basis_in an autosomal dominant mutation of the ZMYND11 gene on chromosome 10p15.3."" ;
    :has_exact_synonym ""autosomal dominant non-syndromic intellectual disability 30"",
        ""MRD30""@en,
        ""autosomal dominant mental retardation 30""@en .

","Autosomal dominant intellectual developmental disorder 30, also known as MRD30 or autosomal dominant mental retardation 30, is a type of intellectual developmental disorder that has material basis in an autosomal dominant mutation of the ZMYND11 gene on chromosome 10p15.3. This condition has exact synonyms including autosomal dominant non-syndromic intellectual disability 30 and is characterized by a range of developmental delays, intellectual disabilities, and unique facial features.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070061,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_intellectual_developmental_disorder_31 rdfs:subClassOf :autosomal_dominant_intellectual_developmental_disorder ;
    :has_definition ""An autosomal dominant intellectual developmental disorder that has_material_basis_in an autosomal dominant mutation of the PURA gene on chromosome 5q31.3."" ;
    :has_exact_synonym ""autosomal dominant non-syndromic intellectual disability 31"",
        ""MRD31""@en,
        ""autosomal dominant mental retardation 31""@en .

","Autosomal dominant intellectual developmental disorder 31 (MRD31) is a type of autosomal dominant intellectual developmental disorder characterized by moderate to severe mental retardation. It is caused by an autosomal dominant mutation of the PURA gene located on chromosome 5q31.3. The condition has several synonyms, including autosomal dominant mental retardation 31 (ADMR31) and autosomal dominant non-syndromic intellectual disability 31 (ADNSD31).",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070062,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:arboleda_tham_syndrome rdfs:subClassOf :autosomal_dominant_intellectual_developmental_disorder ;
    :has_definition ""An autosomal dominant intellectual developmental disorder that has_material_basis_in an autosomal dominant mutation of the KAT6A gene on chromosome 8p11.21."" ;
    :has_exact_synonym ""ARTHS"",
        ""autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome"",
        ""autosomal dominant non-syndromic intellectual disability 32"",
        ""MRD32""@en,
        ""autosomal dominant mental retardation 32""@en .

","Arboleda-Tham syndrome, also known as ARTHS or MRD32, is a type of autosomal dominant intellectual developmental disorder. It has a material basis in an autosomal dominant mutation of the KAT6A gene on chromosome 8p11.21. The exact synonyms for this condition include:

* Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome
* Autosomal dominant mental retardation 32
* Autosomal dominant non-syndromic intellectual disability 32",7,True
doid,http://purl.obolibrary.org/obo/DOID_0070063,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_intellectual_developmental_disorder_33 rdfs:subClassOf :autosomal_dominant_intellectual_developmental_disorder ;
    :has_definition ""An autosomal dominant intellectual developmental disorder that has_material_basis_in an autosomal dominant mutation of the DPP6 gene on chromosome 7q36.2."" ;
    :has_exact_synonym ""autosomal dominant non-syndromic intellectual disability 33"",
        ""MRD33""@en,
        ""autosomal dominant mental retardation 33""@en .

","Autosomal dominant intellectual developmental disorder 33 (ADIDD33) is a type of autosomal dominant intellectual developmental disorder. It has a material basis in an autosomal dominant mutation of the DPP6 gene on chromosome 7q36.2. ADIDD33 can also be referred to as MRD33, autosomal dominant mental retardation 33, or autosomal dominant non-syndromic intellectual disability 33.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070064,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_intellectual_developmental_disorder_34 rdfs:subClassOf :autosomal_dominant_intellectual_developmental_disorder ;
    :has_definition ""An autosomal dominant intellectual developmental disorder that has_material_basis_in an autosomal dominant mutation of the CERT1 gene on chromosome 5q13.3."" ;
    :has_exact_synonym ""autosomal dominant non-syndromic intellectual disability 34"",
        ""MRD34""@en,
        ""autosomal dominant mental retardation 34""@en .

","Autosomal dominant intellectual developmental disorder 34 is a type of autosomal dominant intellectual developmental disorder. Autosomal dominant intellectual developmental disorder is a broad category of genetic conditions that can affect the brain and result in intellectual disability. These disorders are characterized by below average intelligence or cognitive functioning, and can include problems with memory, attention, language, and other cognitive abilities.

Autosomal dominant intellectual developmental disorder 34 has a specific genetic cause, as it is the result of an autosomal dominant mutation of the CERT1 gene on chromosome 5q13.3. This means that if one parent has the gene, there is a 50% chance that their child will inherit the disorder.

This condition has several synonyms, including MRD34, autosomal dominant mental retardation 34, and autosomal dominant non-syndromic intellectual disability 34. These names all refer to the same disorder, but may be used interchangeably in different contexts or by different researchers or organizations.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070065,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_intellectual_developmental_disorder_35 rdfs:subClassOf :autosomal_dominant_intellectual_developmental_disorder ;
    :has_definition ""An autosomal dominant intellectual developmental disorder that has_material_basis_in an autosomal dominant mutation of the PPP2R5D gene on chromosome 6p21.1."" ;
    :has_exact_synonym ""autosomal dominant non-syndromic intellectual disability 35"",
        ""MRD35""@en,
        ""autosomal dominant mental retardation 35""@en .

","Autosomal dominant intellectual developmental disorder 35, also known as MRD35 or autosomal dominant mental retardation 35, is a type of intellectual developmental disorder that has a material basis in an autosomal dominant mutation of the PPP2R5D gene on chromosome 6p21.1. It is one of several types of autosomal dominant intellectual developmental disorders, which are a group of genetic conditions characterized by significant impairment of cognitive abilities and intellectual development.

Autosomal dominant intellectual developmental disorder 35 is characterized by delayed or failed development of cognitive and motor skills, often leading to intellectual disability and challenges in daily life activities. It can also be accompanied by physical and behavioral features such as short stature, dyspraxia, attention deficit, hyperactivity, and social and communication difficulties.

While the exact cause of autosomal dominant intellectual developmental disorder 35 is unknown in many cases, it is thought to be caused by a mutation in the PPP2R5D gene on chromosome 6p21.1. This gene plays a role in regulating the activity of certain proteins in the brain, and when there is a mutation or deletion in this gene, it can lead to abnormal brain development and cognitive impairment.

Diagnosis of autosomal dominant intellectual developmental disorder 35 typically involves a comprehensive evaluation by a team of healthcare professionals, including genetic testing to identify the specific mutation or deletion in the PPP2R5D gene. Treatment for autosomal dominant intellectual developmental disorder 35 focuses on managing symptoms and improving quality of life. This may include special education, behavioral therapy, medications, and other support services.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070066,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_intellectual_developmental_disorder_36 rdfs:subClassOf :autosomal_dominant_intellectual_developmental_disorder ;
    :has_definition ""An autosomal dominant intellectual developmental disorder that has_material_basis_in an autosomal dominant mutation of the PPP2R1A gene on chromosome 19q13.41."" ;
    :has_exact_synonym ""autosomal dominant non-syndromic intellectual disability 36"",
        ""MRD36""@en,
        ""autosomal dominant mental retardation 36""@en .

","Autosomal Dominant Intellectual Developmental Disorder 36 (MRD36) is a type of Autosomal Dominant Intellectual Developmental Disorder. It has a material basis in an autosomal dominant mutation of the PPP2R1A gene on chromosome 19q13.41. The exact synonyms for this disorder are MRD36, Autosomal Dominant Mental Retardation 36 (ADMR36), and Autosomal Dominant Non-Syndromic Intellectual Disability 36 (ADNSI 36).",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070067,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:white_sutton_syndrome rdfs:subClassOf :autosomal_dominant_intellectual_developmental_disorder ;
    :has_definition ""An autosomal dominant intellectual developmental disorder that has_material_basis_in an autosomal dominant mutation of the POGZ gene on chromosome 1q21.3."" ;
    :has_exact_synonym ""MRD37""@en,
        ""WHSUS""@en,
        ""autosomal dominant mental retardation 37""@en .

","White Sutton syndrome is a type of autosomal dominant intellectual developmental disorder. It has been defined as an autosomal dominant mutation of the POGZ gene on chromosome 1q21.3.. This condition is also known by its synonyms, such as MRD37 and WHSUS.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070068,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_intellectual_developmental_disorder_38 rdfs:subClassOf :autosomal_dominant_intellectual_developmental_disorder ;
    :has_definition ""An autosomal dominant intellectual developmental disorder that has_material_basis_in an autosomal dominant mutation of the EEF1A2 gene on chromosome 20q13.33."" ;
    :has_exact_synonym ""autosomal dominant non-syndromic intellectual disability 38"",
        ""MRD38""@en,
        ""PRELDS""@en,
        ""autosomal dominant mental retardation 38""@en,
        ""psychomotor retardation, epilepsy, and language disability syndrome""@en .

","Autosomal dominant intellectual developmental disorder 38 (MRD38) is a type of autosomal dominant intellectual developmental disorder that has material basis in an autosomal dominant mutation of the EEF1A2 gene on chromosome 20q13.33. It can be referred to by several different names, including MRD38, PRELDS, autosomal dominant mental retardation 38, autosomal dominant non-syndromic intellectual disability 38 and psychomotor retardation, epilepsy, and language disability syndrome.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0070069,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_intellectual_developmental_disorder_39 rdfs:subClassOf :autosomal_dominant_intellectual_developmental_disorder ;
    :has_definition ""An autosomal dominant intellectual developmental disorder that has_material_basis_in an autosomal dominant heterozygous mutation in the MYT1L gene on chromosome 2p25.3."" ;
    :has_exact_synonym ""autosomal dominant non-syndromic intellectual disability 39"",
        ""MRD39""@en,
        ""autosomal dominant mental retardation 39""@en .

","Autosomal dominant intellectual developmental disorder (ADID) 39, also known as MRD39 or autosomal dominant non-syndromic intellectual disability 39, is a genetic condition that affects brain development and can result in intellectual disabilities. It is caused by a mutation in the MYT1L gene on chromosome 2p25.3. This disorder is inherited in an autosomal dominant manner, which means that a person only needs to inherit one copy of the mutated gene from a parent to be affected.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070070,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_intellectual_developmental_disorder_40 rdfs:subClassOf :autosomal_dominant_intellectual_developmental_disorder ;
    :has_definition ""An autosomal dominant intellectual developmental disorder that has_material_basis_in an autosomal dominant de novo heterozygous mutation in the CHAMP1 gene on chromosome 13q34."" ;
    :has_exact_synonym ""autosomal dominant non-syndromic intellectual disability 40"",
        ""MRD40""@en,
        ""autosomal dominant mental retardation 40""@en .

","Autosomal Dominant Intellectual Developmental Disorder 40 (MRD40) is a type of Autosomal Dominant Intellectual Developmental Disorder that results from a de novo heterozygous mutation in the CHAMP1 gene on chromosome 13q34. It has been described as a form of intellectual disability that is not part of any known syndrome, and it shares this characteristic with other forms of Autosomal Dominant Intellectual Developmental Disorder (ADIDD). The exact synonyms for MRD40 include Autosomal Dominant Mental Retardation 40, Autosomal Dominant Non-Syndromic Intellectual Disability 40, and other similar terms.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070071,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_intellectual_developmental_disorder_41 rdfs:subClassOf :autosomal_dominant_intellectual_developmental_disorder ;
    :has_definition ""An autosomal dominant intellectual developmental disorder that has_material_basis_in an autosomal dominant mutation of the TBL1XR1 gene on chromosome 3q26.32."" ;
    :has_exact_synonym ""autosomal dominant non-syndromic intellectual disability 41"",
        ""MRD41""@en,
        ""autosomal dominant mental retardation 41""@en .

","Autosomal dominant intellectual developmental disorder 41, also known as MRD41 or autosomal dominant mental retardation 41, is a type of autosomal dominant intellectual developmental disorder. It has a material basis in an autosomal dominant mutation of the TBL1XR1 gene on chromosome 3q26.32.
It is also known as autosomal dominant non-syndromic intellectual disability 41.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070072,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_intellectual_developmental_disorder_42 rdfs:subClassOf :autosomal_dominant_intellectual_developmental_disorder ;
    :has_definition ""An autosomal dominant intellectual developmental disorder that has_material_basis_in an autosomal dominant mutation of the GNB1 gene on chromosome 1p36.33."" ;
    :has_exact_synonym ""autosomal dominant non-syndromic intellectual disability 42"",
        ""MRD42""@en,
        ""autosomal dominant mental retardation 42""@en .

","Autosomal dominant intellectual developmental disorder 42, also known as MRD42 and autosomal dominant mental retardation 42, is a type of autosomal dominant intellectual developmental disorder characterized by an autosomal dominant mutation of the GNB1 gene on chromosome 1p36.33. It has exact synonyms such as autosomal dominant non-syndromic intellectual disability 42, and it is a form of intellectual developmental disorder that can be passed down through generations in families due to the inheritance of a single copy of the mutated gene from one parent. The symptoms and severity of this condition may vary among affected individuals, but it generally leads to delays in cognitive, social, and adaptive skills during childhood and adolescence.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070073,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_intellectual_developmental_disorder_43 rdfs:subClassOf :autosomal_dominant_intellectual_developmental_disorder ;
    :has_definition ""An autosomal dominant intellectual developmental disorder that has_material_basis_in an autosomal dominant mutation of the HIVEP2 gene on chromosome 6q24.2."" ;
    :has_exact_synonym ""autosomal dominant non-syndromic intellectual disability 43"",
        ""MRD43""@en,
        ""autosomal dominant mental retardation 43""@en .

","Autosomal dominant intellectual developmental disorder 43 (MRD43) is a type of autosomal dominant intellectual developmental disorder. It has a material basis in an autosomal dominant mutation of the HIVEP2 gene on chromosome 6q24.2.
Autosomal dominant intellectual developmental disorder 43 (MRD43) has exact synonyms such as autosomal dominant mental retardation 43 and autosomal dominant non-syndromic intellectual disability 43.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070074,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_intellectual_developmental_disorder_44 rdfs:subClassOf :autosomal_dominant_intellectual_developmental_disorder ;
    :has_definition ""An autosomal dominant intellectual developmental disorder that has_material_basis_in an autosomal dominant mutation of the TRIO gene on chromosome 5p15.2."" ;
    :has_exact_synonym ""autosomal dominant intellectual developmental disorder 44 with microcephaly"",
        ""autosomal dominant non-syndromic intellectual disability 44"",
        ""MRD44""@en,
        ""autosomal dominant mental retardation 44""@en .

","autosomal dominant intellectual developmental disorder 44 is a type of autosomal dominant intellectual developmental disorder.
autosomal dominant intellectual developmental disorder 44 has a definition that it's an autosomal dominant intellectual developmental disorder that has_material_basis_in an autosomal dominant mutation of the TRIO gene on chromosome 5p15.2..
autosomal dominant intellectual developmental disorder 44 also has several synonyms such as MRD44, autosomal dominant intellectual developmental disorder 44 with microcephaly, autosomal dominant mental retardation 44, and autosomal dominant non-syndromic intellectual disability 44.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070077,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:schizophrenia_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :schizophrenia ;
    :has_definition ""A schizophrenia that has_material_basis_in an autosomal dominant mutation of the SCZD1 gene on chromosome 5q23-q35."" ;
    :has_exact_synonym ""SCZD1""@en .

","Schizophrenia Type 1, also known as Schizophrenia 1 (SCZD1), is a subtype of Schizophrenia that has a genetic basis. It is characterized by abnormalities in the functioning of neurotransmitter systems in the brain, particularly dopamine and glutamate. Research suggests that an autosomal dominant mutation of the SCZD1 gene on chromosome 5q23-q35 may be responsible for this subtype of Schizophrenia.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070078,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:schizophrenia_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :schizophrenia ;
    :has_definition ""A schizophrenia that has_material_basis_in an autosomal dominant mutation of the SCZD2 gene on chromosome 11q14-q21."" ;
    :has_exact_synonym ""SCZD2""@en .

","Schizophrenia 2 is a type of autosomal dominant disease, also known as SCZD2. This means that it has a material basis in an autosomal dominant mutation of the SCZD2 gene on chromosome 11q14-q21. It can be defined as a schizophrenia that is caused by this genetic mutation. The exact synonym for Schizophrenia 2 is SCZD2.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070079,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:schizophrenia_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :schizophrenia ;
    :has_definition ""A schizophrenia that has_material_basis_in an autosomal dominant mutation of the SCZD3 gene on chromosome 6p23."" ;
    :has_exact_synonym ""SCZD3""@en .

","Schizophrenia 3, also known as SCZD3, is a subtype of schizophrenia that is characterized by an autosomal dominant inheritance pattern. This means that the risk of developing the disease is passed down through generations in families, and individuals who have one or more affected relatives are at higher risk for developing it themselves.

Schizophrenia 3 is caused by mutations in the SCZD3 gene, which is located on chromosome 6p23. These mutations can affect the function of certain proteins involved in brain development and structure, leading to abnormalities that contribute to psychiatric symptoms.

It's important to note that schizophrenia 3 is just one subtype of schizophrenia, which is a complex mental disorder with multiple types and subtypes. Each subtype may have unique features and treatment approaches, so it's essential for individuals to work with their healthcare providers to determine the most effective treatment plan based on their specific needs and diagnosis.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070080,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:schizophrenia_4 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :schizophrenia ;
    :has_definition ""A schizophrenia that has_material_basis_in an autosomal dominant mutation of the PRODH gene on chromosome 22q11.21."" ;
    :has_exact_synonym ""SCZD4""@en .

","Schizophrenia type 4, also known as SCZD4, is a subtype of schizophrenia that has a strong genetic component. It is characterized by mutations in the PRODH gene located on chromosome 22q11.21. This type of schizophrenia tends to have an earlier age of onset and may be more severe than other subtypes. It is considered an autosomal dominant disorder, meaning that having one copy of the mutated gene is usually enough to develop the condition.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070081,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:schizophrenia_5 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :schizophrenia ;
    :has_definition ""A schizophrenia that has_material_basis_in a mutation on chromosome 6q13-q26."" ;
    :has_exact_synonym ""SCZD5""@en .

","Schizophrenia type 5, also known as SCZD5, is a form of schizophrenia that has a genetic basis. It is an autosomal dominant disorder, which means that if one parent has the gene, there is a 50% chance that their child will inherit it. The condition is caused by mutations on chromosome 6q13-q26, and it shares some similarities with other forms of schizophrenia but may have distinct symptoms and treatment requirements.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070082,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:schizophrenia_6 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :schizophrenia ;
    :has_definition ""A schizophrenia that has_material_basis_in an autosomal dominant mutation of the SCZD6 gene on chromosome 8p21."" ;
    :has_exact_synonym ""SCZD6""@en .

","Schizophrenia type 6, also known as schizoaffective disorder, is a mental illness that affects a person's thoughts and behavior. It is characterized by symptoms such as hallucinations, delusions, disorganized speech, and negative symptoms like anhedonia (the inability to experience pleasure).

Schizophrenia type 6 is believed to have a genetic component, with research suggesting that a mutation in the SCZD6 gene on chromosome 8p21 may play a role in its development. It is important to note that while there may be some genetic influence, schizophrenia is not solely determined by one's genetics and can also be caused by environmental factors and other non-genetic influences.

It is crucial for individuals experiencing symptoms of schizophrenia type 6 to seek professional help from a mental health provider, who can assess their specific needs and develop an appropriate treatment plan. Treatment typically includes medications such as antipsychotics, along with psychotherapy and other supportive measures to manage the illness effectively.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070083,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:schizophrenia_7 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :schizophrenia ;
    :has_definition ""A schizophrenia that has_material_basis_in an autosomal dominant mutation of the SCZD7 gene on chromosome 13q32."" ;
    :has_exact_synonym ""SCZD7""@en .

","Schizophrenia 7, also known as SCZD7, is a type of schizophrenia that has a genetic basis. It is inherited in an autosomal dominant manner, which means that one copy of the gene is sufficient to increase the risk of developing the disease. The SCZD7 gene is located on chromosome 13q32 and mutations in this gene have been associated with an increased risk of schizophrenia.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070084,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:schizophrenia_8 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :schizophrenia ;
    :has_definition ""A schizophrenia that has_material_basis_in an autosomal dominant mutation of the SCZD8 gene on chromosome 18p."" ;
    :has_exact_synonym ""SCZD8""@en .

","Schizophrenia 8, also known as SCZD8, is a type of schizophrenia that has a material basis in autosomal dominant inheritance due to mutations of the SCZD8 gene on chromosome 18p.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070085,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:schizophrenia_9 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :gene ],
        :monogenic_disease,
        :schizophrenia ;
    :has_definition ""A schizophrenia that has_material_basis_in a mutation of the DISC1 gene on chromosome 1q42.2."" ;
    :has_exact_synonym ""SCZD9""@en .

","Schizophrenia 9, also known as SCZD9, is a type of monogenic disease that has a material basis in a mutation of the DISC1 gene on chromosome 1q42.2. It is defined as a schizophrenia that has this genetic basis. The exact synonym for Schizophrenia 9 is SCZD9.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070086,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:schizophrenia_10 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :schizophrenia ;
    :has_definition ""A schizophrenia that has_material_basis_in an autosomal dominant mutation of the SCZD10 gene on chromosome 15q15."" ;
    :has_exact_synonym ""SCZD10""@en .

","Schizophrenia 10, also known as SCZD10, is a type of schizophrenia that has a material basis in an autosomal dominant mutation of the SCZD10 gene on chromosome 15q15. It is one of several subtypes of schizophrenia that are characterized by specific genetic and environmental factors. The exact synonym for Schizophrenia 10 is SCZD10.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070087,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:schizophrenia_11 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :schizophrenia ;
    :has_definition ""A schizophrenia that has_material_basis_in a mutation on chromosome 10q22.3."" ;
    :has_exact_synonym ""SCZD11""@en .

","Schizophrenia type 11, also known as schizotypal personality disorder and SCZD11, is a form of autosomal dominant psychiatric disorder. It is characterized by symptoms such as delusions, hallucinations, disorganized speech, and grossly disorganized or catatonic behavior. The exact cause of schizophrenia type 11 is not fully understood, but research suggests that it may be caused by a combination of genetic and environmental factors. Treatment typically involves a combination of medication and psychotherapy to help manage symptoms and improve overall quality of life.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070088,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:schizophrenia_12 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :schizophrenia ;
    :has_definition ""A schizophrenia that has_material_basis_in a mutation on chromosome 1p36.2."" ;
    :has_exact_synonym ""SCZD12""@en .

","Schizophrenia 12, also known as SCZD12, is a type of autosomal dominant disorder. It is characterized by a mutation on chromosome 1p36.2 that affects the development and functioning of brain cells. This condition can lead to a range of symptoms such as hallucinations, delusions, and disorganized thinking and behavior. While there is no cure for schizophrenia, with proper treatment and support, individuals can manage their symptoms and improve their overall quality of life.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070089,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:schizophrenia_13 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :gene ],
        :monogenic_disease,
        :schizophrenia ;
    :has_definition ""A schizophrenia that has_material_basis_in a mutation on chromosome 15q13."" ;
    :has_exact_synonym ""SCZD13""@en .

","Schizophrenia 13, also known as SCZD13, is a type of monogenic disease that has a material basis in a mutation on chromosome 15q13.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070090,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:schizophrenia_14 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :gene ],
        :monogenic_disease,
        :schizophrenia ;
    :has_definition ""A schizophrenia that has_material_basis_in a mutation on chromosome 2q32.1."" ;
    :has_exact_synonym ""SCZD14""@en .

","Schizophrenia is a mental illness that affects a person's thinking, emotions, and behavior. It is a complex disease with a variety of symptoms, including hallucinations, delusions, disorganized speech, abnormal behavior, and negative emotions such as depression or apathy. Schizophrenia typically develops in late adolescence or early adulthood, although it can sometimes appear later in life.

Schizophrenia is considered a serious mental illness that requires ongoing treatment from mental health professionals. It often involves a combination of medications and psychotherapy to manage symptoms effectively. While there is no cure for schizophrenia, with proper treatment, many people can lead fulfilling lives and manage their symptoms well.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070091,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:schizophrenia_15 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :schizophrenia ;
    :has_definition ""A schizophrenia that has_material_basis_in a mutation of the SHANK3 gene on chromosome 22q13.33."" ;
    :has_exact_synonym ""SCZD15""@en .

","Schizophrenia 15, also known as SHANK3-associated schizophrenia or simply SCZD15, is a type of autosomal dominant disease. This means that it has a strong genetic component and can be passed down through generations in families. The condition is characterized by mutations in the SHANK3 gene on chromosome 22q13.33. It's important to note that while the genetics of schizophrenia may play a role in its development, it's also influenced by environmental factors and other complex interactions.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070092,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:schizophrenia_16 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :gene ],
        :monogenic_disease,
        :schizophrenia ;
    :has_definition ""A schizophrenia that has_material_basis_in a mutation on chromosome 7q36.3."" ;
    :has_exact_synonym ""SCZD16""@en .

","Schizophrenia Type 16, also known as Schizophrenia Spectrum and Other Psychotic Disorders (SSP), is a type of monogenic disease that has a material basis in a mutation on chromosome 7q36.3. It is characterized by a range of symptoms such as positive psychotic symptoms, negative psychotic symptoms, disorganization and guilt with regard to shape, motor activity or respiration, and social and emotional withdrawal. SSP may also include additional symptoms such as delusions, hallucinations, and thought disorder. It is important to note that not all individuals who have the same genetic mutation will develop schizophrenia, and other factors such as environment and life experiences may also play a role in the development of this disorder.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070093,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:schizophrenia_18 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :gene ],
        :monogenic_disease,
        :schizophrenia ;
    :has_definition ""A schizophrenia that has_material_basis_in a mutation of the SLC1A1 gene on chromosome 9p24.2."" ;
    :has_exact_synonym ""Chromosome 7q36.3 Duplication Syndrome, 362-Kb""@en,
        ""SCZD18""@en .

","Schizophrenia 18, also known as Chromosome 7q36.3 Duplication Syndrome and SCZD18, is a type of monogenic disease that has a material basis in a mutation of the SLC1A1 gene on chromosome 9p24.2.<|end|>",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070094,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:oculocutaneous_albinism_type_ia rdfs:subClassOf :oculocutaneous_albinism ;
    :has_definition ""An oculocutaneous albinism that has_material_basis_in an autosomal recessive null mutation of TYR on chromosome 11q14.3 with no residual protein activity."" ;
    :has_exact_synonym ""OCA1A""@en,
        ""Oculocutaneous Albinism, Tyrosinase-Negative""@en .

","Oculocutaneous albinism type 1A (OCA1A) is a genetic disorder characterized by the absence of melanin pigment in the skin, hair, and eyes. It is caused by a mutation in the TYR gene on chromosome 11q14.3, which results in no residual protein activity. The condition typically appears as white or light-colored hair, fair skin that may be prone to sunburns, and blue or gray eyes. It can also cause visual impairment if not detected early and treated properly. OCA1A is inherited in an autosomal recessive manner, meaning that a person needs to inherit two copies of the mutated gene (one from each parent) to develop the condition.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070095,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:oculocutaneous_albinism_type_ib rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :digenic_inheritance ],
        :digenic_disease,
        :oculocutaneous_albinism ;
    :has_definition ""An oculocutaneous albinism that has_material_basis_in an autosomal recessive hypomorphic mutation of TYR on chromosome 11q14.3 with retention of some residual protein activity."" ;
    :has_exact_synonym ""Albinism, Yellow Mutant Type""@en,
        ""OCA1B""@en .

","oculocutaneous albinism type ib is a condition that affects the skin and hair, as well as the eyes. it is caused by a mutation in the tyrosine gene on chromosome 11q14.3.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070096,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:oculocutaneous_albinism_type_ii rdfs:subClassOf :oculocutaneous_albinism ;
    :has_definition ""An oculocutaneous albinism that has_material_basis_in an autosomal recessive mutation of the OCA2 gene on chromosome 15q12-q13."" ;
    :has_exact_synonym ""OCA2""@en,
        ""Oculocutaneous Albinism, Tyrosinase-Positive""@en .

","oculocutaneous albinism type ii is a genetic disorder characterized by the absence or reduction of melanin in the skin, hair, and eyes. It is caused by mutations in the OCA2 gene on chromosome 15q12-q13, which encodes for tyrosinase, an enzyme that plays a crucial role in the production of melanin.

People with oculocutaneous albinism type ii have fair skin and hair, as well as blue or light-colored eyes. They may also be more prone to sunburn and other UV-related damage compared to individuals with normal pigmentation. This is because they lack the protective melanin in their skin and eyes.

The condition can cause various challenges, including reduced visual acuity, light sensitivity, and an increased risk of certain skin conditions like sunken or depressed navels (omphaloceles). However, with proper care and protection from the sun, people with oculocutaneous albinism type ii can lead healthy lives.

It is essential to use sunscreen with high SPF, wear protective clothing, and seek shade whenever possible for those affected by this condition. In addition, early detection and regular eye exams are crucial to monitor their visual development and prevent any potential complications related to the disorder.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070097,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:oculocutaneous_albinism_type_iii rdfs:subClassOf :oculocutaneous_albinism ;
    :has_definition ""An oculocutaneous albinism that has_material_basis_in an autosomal recessive mutation of the TYRP1 gene on chromosome 9p23."" ;
    :has_exact_synonym ""OCA3""@en,
        ""Rufous Oculocutaneous Albinism""@en .

",oculocutaneous albinism type iii is a condition that affects the skin and eyes. It is caused by a mutation in the TYRP1 gene on chromosome 9p23. This type of oculocutaneous albinism is also known as Rufous Oculocutaneous Albinism and has the synonym OCA3.,4,True
doid,http://purl.obolibrary.org/obo/DOID_0070098,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:oculocutaneous_albinism_type_iv rdfs:subClassOf :oculocutaneous_albinism ;
    :has_definition ""An oculocutaneous albinism that has_material_basis_in an autosomal recessive mutation of the SLC45A2 gene on chromosome 5p13.2."" ;
    :has_exact_synonym ""OCA4""@en .

","User, I understand that you're looking for information about oculocutaneous albinism type IV. Here is the rewritten version of your statement with precision:
""Oculocutaneous albinism type IV is a subtype of oculocutaneous albinism characterized by an autosomal recessive mutation in the SLC45A2 gene located on chromosome 5p13.2.""
Please let me know if you need any further clarification or assistance.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070099,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:oculocutaneous_albinism_type_v rdfs:subClassOf :oculocutaneous_albinism ;
    :has_definition ""An oculocutaneous albinism that has_material_basis_in an autosomal recessive mutation of the OCA5 gene on chromosome 4q24."" ;
    :has_exact_synonym ""OCA5""@en .

","Oculocutaneous albinism type V, also known as OCA5, is a type of oculocutaneous albinism characterized by a partial absence or deficiency in melanin production. It results from an autosomal recessive mutation of the OCA5 gene on chromosome 4q24.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070100,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:oculocutaneous_albinism_type_vii rdfs:subClassOf :oculocutaneous_albinism ;
    :has_definition ""An oculocutaneous albinism that has_material_basis_in an autosomal recessive mutation of C10orf11 on chromosome 10q22.2-q22.3."" ;
    :has_exact_synonym ""OCA7""@en .

","oculocutaneous albinism type VII, also known as OCA7, is a form of oculocutaneous albinism that results from an autosomal recessive mutation of the C10orf11 gene on chromosome 10q22.2-q22.3. It is characterized by white or grayish skin, hair, and eye color, as well as reduced pigmentation in the eyes and skin. This type of albinism is rarer than other forms of the condition and may be associated with certain health problems due to the absence of melanin.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070111,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:niemann_pick_disease_type_a rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :structural_variant ],
        :niemann_pick_disease ;
    :has_definition ""A Niemann-Pick disease characterized by onset in infancy and involvement of neurological tissues that has_material_basis_in an autosomal recessive mutation of the SMPD1 gene on chromosome 11p15.4."" .

",Niemann-Pick disease type A is a type of Niemann-Pick disease. Niemann-Pick disease type A is a type of something that at least one disease has a basis in some structural variant. Niemann-Pick disease type A has the definition: Niemann-Pick disease characterized by onset in infancy and involvement of neurological tissues that has_material_basis_in an autosomal recessive mutation of the SMPD1 gene on chromosome 11p15.4..,3,True
doid,http://purl.obolibrary.org/obo/DOID_0070112,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:niemann_pick_disease_type_b rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :structural_variant ],
        :niemann_pick_disease ;
    :has_definition ""A Niemann-Pick disease characterized by visceral involvement only and survival into adulthood that has_material_basis_in an autosomal recessive mutation of the SMPD1 gene on chromosome 11p15.4."" .

","Niemann-Pick disease type B is a specific subtype of Niemann-Pick disease, which is characterized by visceral involvement only and survival into adulthood. It has a basis in an autosomal recessive mutation of the SMPD1 gene on chromosome 11p15.4.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070113,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:niemann_pick_disease_type_c1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :structural_variant ],
        :niemann_pick_disease ;
    :has_definition ""A Niemann-Pick disease that has_material_basis_in an autosomal recessive mutation of the NPC1 gene on chromosome 18q11.2."" ;
    :has_exact_synonym ""NPC1""@en .

","Niemann-Pick disease type C1 (NPC1) is a subtype of Niemann-Pick disease that is characterized by the presence of lipid-filled macrophages in various organs, particularly the spleen and liver. It is caused by mutations in the NPC1 gene, which is located on chromosome 18q11.2.

Niemann-Pick disease type C1 is a rare genetic disorder that affects many organ systems within the body, including the spleen, liver, lungs, and brain. It can lead to severe complications such as enlarged liver and spleen (hepatosplenomegaly), liver disease, lung disease, and neurological problems.

Treatment options for NPC1 include enzyme replacement therapy, supportive care, and symptom management. It is important to work with a healthcare professional experienced in treating genetic disorders like NPC1 to develop an appropriate treatment plan based on the individual's specific needs and medical history.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070114,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:niemann_pick_disease_type_c2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :structural_variant ],
        :niemann_pick_disease ;
    :has_definition ""A Niemann-Pick disease that has_material_basis_in an autosomal recessive mutation of the NPC2 gene on chromosome 14q24.3."" ;
    :has_exact_synonym ""NPC2""@en .

","Niemann-Pick disease type C2 (NPC2) is a subtype of Niemann-Pick disease, which is characterized by the buildup of lipids in the spleen, liver, and other organs. It occurs due to mutations in the NPC2 gene on chromosome 14q24.3. The exact synonym for NPC2 is Niemann-Pick disease type C2.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070115,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:meckel_syndrome_1 rdfs:subClassOf :meckel_syndrome ;
    :has_definition ""A Meckel syndrome that has_material_basis_in an autosomal recessive mutation of the MKS1 gene on chromosome 17q22."" ;
    :has_exact_synonym ""MKS1""@en,
        ""Meckel-Gruber syndrome, type 1""@en .

","Meckel syndrome 1, also known as MKS1 or Meckel-Gruber syndrome type 1, is a rare genetic disorder that primarily affects the development of the face and intestines. It is caused by an autosomal recessive mutation of the MKS1 gene on chromosome 17q22. The symptoms can include cystic liver disease, abnormalities in the kidneys and urinary tract, short stature, intellectual disability, and characteristic facial features such as a deeply grooved palate, thick lips, and a prominent jaw. It is important to seek medical attention if you suspect that you or someone you know may have Meckel syndrome 1, as early diagnosis and treatment can improve outcomes.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070116,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:meckel_syndrome_2 rdfs:subClassOf :meckel_syndrome ;
    :has_definition ""A Meckel syndrome that has_material_basis_in an autosomal recessive mutation of the TMEM216 gene on chromosome 11q12.2."" ;
    :has_exact_synonym ""MKS2""@en,
        ""Meckel-Gruber syndrome, type 2""@en .

","Meckel Syndrome 2, also known as Meckel-Gruber Syndrome Type 2, is a rare genetic disorder that affects the development of the craniofacial region. It occurs due to an autosomal recessive mutation in the TMEM216 gene located on chromosome 11q12.2. The condition can cause a range of symptoms, including cleft lip and palate, polycystic kidneys, intestinal atresias, and other congenital anomalies. It is important to note that Meckel Syndrome 2 can be life-threatening if left untreated, so it is crucial for those affected to seek proper medical attention and care.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070117,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:meckel_syndrome_3 rdfs:subClassOf :meckel_syndrome ;
    :has_definition ""A Meckel syndrome that has_material_basis_in an autosomal recessive mutation of the TMEM67 gene on chromosome 8q22.1."" ;
    :has_exact_synonym ""MKS3""@en,
        ""Meckel-Gruber syndrome, type 3""@en .

","Meckel Syndrome is a congenital disorder that affects the development of the digestive system. It is characterized by abnormalities in the cystic fibrosis and mucus production, as well as other gastrointestinal problems. Meckel Syndrome Type 3, also known as MKS3 or Meckel-Gruber Syndrome Type 3, is a specific type of Meckel Syndrome that has been linked to an autosomal recessive mutation in the TMEM67 gene on chromosome 8q22.1. It is important to note that Meckel Syndrome can cause a range of complications, including malnutrition, intestinal obstruction, and other gastrointestinal issues. Treatment for Meckel Syndrome typically focuses on managing symptoms and preventing complications. In some cases, surgery may be necessary to correct any structural abnormalities in the digestive system.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070118,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:meckel_syndrome_4 rdfs:subClassOf :meckel_syndrome ;
    :has_definition ""A Meckel syndrome that has_material_basis_in an autosomal recessive mutation of the CEP290 gene on chromosome 12q21.32."" ;
    :has_exact_synonym ""MKS4""@en,
        ""Meckel-Gruber syndrome, type 4""@en .

","Mekel Syndrome, also known as Meksell Syndrome or Meckel-Gruber Syndrome (MGS), is a rare congenital disorder that affects the development of the face and the limbs. It occurs due to an autosomal recessive mutation in the CEP290 gene on chromosome 12q21.32. There are three types of Meckel Syndrome, with Type 4 being the most severe.
Type 1 features hypo-pigmented macules and patches on the face and extremities.
Type 2 is characterized by cystic change in the liver, kidneys, lungs, or other organs.
Type 3 has a variable presentation that includes cystic change in the liver, kidneys, lungs, or other organs, along with craniosynostosis and hypo-pigmented macules and patches on the face and extremities.
Mekel Syndrome can lead to various complications such as malformations of the facial bones, cystic change in multiple organs, neurological problems, and developmental delays. Treatment options may include surgery, medication, or other interventions based on the specific symptoms and complications present in each case.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070119,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:meckel_syndrome_5 rdfs:subClassOf :meckel_syndrome ;
    :has_definition ""A Meckel syndrome that has_material_basis_in an autosomal recessive mutation of the RPGRIP1L gene on chromosome 16q12.2."" ;
    :has_exact_synonym ""MKS5""@en,
        ""Meckel-Gruber syndrome, type 5""@en .

","Meckel Syndrome 5, also known as MKS5 or Meckel-Gruber Syndrome Type 5, is a type of the Meckel Syndrome family. It has a genetic basis and is characterized by a wide range of developmental abnormalities which can occur during fetal development. These may include cystic kidneys, omphalocele (an abdominal wall defect), polydactyly (extra fingers or toes), cleft lip and palate, as well as other facial abnormalities. The syndrome is caused by a mutation in the RPGRIP1L gene, which is located on chromosome 16q12.2. It is an autosomal recessive disorder, meaning that to develop the syndrome, an individual must inherit two copies of the mutated gene (one from each parent).",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070120,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:meckel_syndrome_6 rdfs:subClassOf :meckel_syndrome ;
    :has_definition ""A Meckel syndrome that has_material_basis_in an autosomal recessive mutation of the CC2D2A gene on chromosome 4p15.32."" ;
    :has_exact_synonym ""MKS6""@en,
        ""Meckel-Gruber syndrome, type 6""@en .

","Meckel syndrome 6 (MKS6) is a type of Meckel syndrome, which is characterized by a combination of congenital malformations in the digestive system. MKS6 has a genetic basis, specifically an autosomal recessive mutation of the CC2D2A gene on chromosome 4p15.32. The term ""Meckel-Gruber syndrome"" type 6 (MGS6) is also used to describe this condition. It is important to note that there are different types and degrees of Meckel syndrome, each with its own set of characteristics and challenges.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070121,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:meckel_syndrome_7 rdfs:subClassOf :meckel_syndrome ;
    :has_definition ""A Meckel syndrome that has_material_basis_in an autosomal recessive mutation of the NPHP3 gene on chromosome 3q22.1."" ;
    :has_exact_synonym ""MKS7""@en,
        ""Meckel-Gruber syndrome, type 7""@en .

","Meckel syndrome 7 (MKS7) is a type of Meckel syndrome, characterized by abnormal development and functioning of the lens in the eye. It is caused by an autosomal recessive mutation of the NPHP3 gene on chromosome 3q22.1. This genetic condition can cause various symptoms such as microphthalmia (small eyes), cataracts, and coloboma (a hole in the eye). MKS7 is also known by its synonyms Meckel-Gruber syndrome, type 7 and has a material basis in the NPHP3 gene.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070122,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:meckel_syndrome_8 rdfs:subClassOf :meckel_syndrome ;
    :has_definition ""A Meckel syndrome that has_material_basis_in an autosomal recessive mutation of the TCTN2 gene on chromosome 12q24.31."" ;
    :has_exact_synonym ""MKS8""@en,
        ""Meckel-Gruber syndrome, type 8""@en .

","Meckel Syndrome is a rare congenital disorder that affects the development of the gastrointestinal tract. There are three types of Meckel Syndrome, which are distinguished by the specific combination of symptoms they present. Meckel Syndrome 8 is one such type and is characterized by the presence of a cystic liver, which is a fluid-filled sac that forms in the liver. This type of Meckel Syndrome may also be associated with other developmental abnormalities, such as cystic kidneys and polydactyly (an excessive number of fingers or toes). It is important to note that Meckel Syndrome 8 is a rare disorder and further research is needed to fully understand its causes and treatment options.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070123,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_nongoitrous_hypothyroidism_4 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :congenital_hypothyroidism ;
    :has_definition ""A congenital hypothyroidism characterized by a permanent thyroid deficiency present at birth and resulting from deficiency in TSH synthesis that has_material_basis_in homozygous mutation in the TSHB gene on chromosome 1p13."" ;
    :has_exact_synonym ""CHNG4""@en,
        ""isolated thyrotropin deficiency""@en .

","Congenital nongoitrous hypothyroidism 4, also known as CHNG4 or isolated thyrotropin deficiency, is a type of autosomal recessive congenital hypothyroidism. This means that it is caused by a genetic mutation on one of the pair of chromosomes inherited from each parent. The specific gene involved in this condition has been identified as the TSHB gene located on chromosome 1p13. It is characterized by a permanent thyroid deficiency present at birth, resulting from an absence or defect in TSH synthesis.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0070124,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_nongoitrous_hypothyroidism_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :congenital_hypothyroidism ;
    :has_definition ""A congenital hypothyroidism that has_material_basis_in heterozygous mutation in the PAX8 gene on chromosome 2q13."" ;
    :has_exact_synonym ""CHNG2""@en,
        ""congenital hypothyroidism due to thyroid dysgenesis or hypoplasia""@en .

","Congenital nongoitrous hypothyroidism 2 is a type of congenital hypothyroidism that has a material basis in a heterozygous mutation in the PAX8 gene on chromosome 2q13. It is also known as CHNG2. This condition is an autosomal dominant disease, which means that it can be inherited from one parent and affect both males and females.

Hypothyroidism is a condition where the thyroid gland does not produce enough hormones to regulate metabolism in the body. Congenital nongoitrous hypothyroidism 2 occurs when there is a developmental abnormality of the thyroid gland, causing it to underproduce or fail to develop altogether.

Symptoms of congenital nongoitrous hypothyroidism 2 may include constipation, dry skin, weight gain, and slow growth. These symptoms can occur in infants before they are even born, as the condition is present at birth. However, many infants with congenital nongoitrous hypothyroidism 2 have no symptoms at all, which is why it's important to screen for this condition shortly after birth.

If left untreated, congenital nongoitrous hypothyroidism 2 can lead to severe health problems, including cognitive and physical developmental delays, and an increased risk of thyroid cancer later in life. That's why it's crucial to diagnose and treat this condition as soon as possible after birth.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0070125,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_nongoitrous_hypothyroidism_5 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        :autosomal_dominant_disease,
        :congenital_hypothyroidism ;
    :has_definition ""A congenital hypothyroidism that has_material_basis_in heterozygous mutation in the NKX2-5 gene on chromosome 5q35."" ;
    :has_exact_synonym ""CHNG5""@en .

","Congenital nongoitrous hypothyroidism 5, also known as CHNG5, is a type of congenital hypothyroidism that has a material basis in a heterozygous mutation in the NKX2-5 gene on chromosome 5q35. It is an autosomal dominant disease, which means it can be passed down through generations and affect multiple family members.

It is important to note that congenital nongoitrous hypothyroidism 5 has a material basis in some abnormality of prenatal development or birth. This condition may cause various complications if left untreated, so it's crucial for those affected to receive proper medical care and treatment.

In summary, congenital nongoitrous hypothyroidism 5 is a type of congenital hypothyroidism that has a material basis in a heterozygous mutation in the NKX2-5 gene on chromosome 5q35 and can be passed down through generations. It causes various complications if left untreated, so it's essential to seek medical care and treatment for those affected.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070126,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_nongoitrous_hypothyroidism_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        :autosomal_recessive_disease,
        :congenital_hypothyroidism ;
    :has_definition ""A congenital hypothyroidism that has_material_basis_in mutation in the TSHR gene on chromosome 14q31."" ;
    :has_exact_synonym ""CHNG1""@en,
        ""TSH resistance""@en .

","Congenital nongoitrous hypothyroidism 1 is a type of congenital hypothyroidism that has a material basis in mutations in the TSH receptor (TSHR) gene on chromosome 14q31. It is an autosomal recessive disease, which means that to develop the condition, an individual must inherit two copies of the faulty gene, one from each parent. This type of hypothyroidism is characterized by abnormalities in prenatal development or birth, and it is important for individuals with this condition to receive appropriate treatment to prevent complications such as developmental delays or intellectual disability.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0070127,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_nongoitrous_hypothyroidism_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :congenital_hypothyroidism ;
    :has_definition ""A congenital hypothyroidism characterized by autosomal dominant inheritance of resistance to thyrotropin that has_material_basis_in variation in the chromosome region 15q25.3-q26.1."" ;
    :has_exact_synonym ""CHNG3""@en .

","Congenital nongoitrous hypothyroidism 3, also known as CHNG3, is a type of congenital hypothyroidism. It is characterized by autosomal dominant inheritance of resistance to thyrotropin, which has a material basis in variation in the chromosome region 15q25.3-q26.1.<|endoftext|>",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070128,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_nongoitrous_hypothyroidism_6 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        :autosomal_dominant_disease,
        :congenital_hypothyroidism ;
    :has_definition ""A congenital hypothyroidism that has_material_basis_in heterozygous mutation in the THRA gene on chromosome 17q21.1."" ;
    :has_exact_synonym ""CHNG6""@en .

","Congenital nongoitrous hypothyroidism 6 (CHNG6) is a type of congenital hypothyroidism, which is a disorder that occurs due to a deficiency in thyroid hormones during fetal development. It is an autosomal dominant disease, meaning that it can be passed down through generations of a family.
CHNG6 is caused by a heterozygous mutation in the THRA gene on chromosome 17q21.1., which affects the production of thyroid hormones. It has material basis in some abnormality of prenatal development or birth, and thus is considered a disease that has a basis in some abnormality of fetal development.
In summary, CHNG6 is a type of congenital hypothyroidism caused by a mutation in the THRA gene on chromosome 17q21.1., and it has material basis in some abnormality of prenatal development or birth.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070129,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_cutis_laxa_type_iid rdfs:subClassOf :autosomal_recessive_cutis_laxa_type_ii_classic_type ;
    :has_definition ""An autosomal recessive cutis laxa type II classic type that is characterized by generalized skin wrinkling with sparse subcutaneous fat and dysmorphic progeroid facial featuret and that has_material_basis_in homozygous mutation in the ATP6V1A gene on chromosome 3q13."" ;
    :has_exact_synonym ""ARCL2D""@en .

","Autosomal recessive cutis laxa type IID is a specific form of autosomal recessive cutis laxa, which is characterized by generalized skin wrinkling, sparse subcutaneous fat, and dysmorphic progeroid facial features. This condition has its basis in homozygous mutation in the ATP6V1A gene on chromosome 3q13. It is also known as ARCL2D.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070130,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_cutis_laxa_1 rdfs:subClassOf :autosomal_dominant_cutis_laxa ;
    :has_definition ""An autosomal dominant cutis laxa that has_material_basis_in heterozygous mutations in the ELN gene on chromosome 7q11."" ;
    :has_exact_synonym ""ADCL1""@en .

","autosomal dominant cutis laxa 1 is a type of autosomal dominant cutis laxa, which is characterized by the presence of loose and wrinkled skin. This condition is caused by mutations in the elastin gene, located on chromosome 7q11. Autosomal dominant cutis laxa 1 has an exact synonym ADCL1, making it a specific subtype within the broader category of autosomal dominant cutis laxa.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070131,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_cutis_laxa_3 rdfs:subClassOf :autosomal_dominant_cutis_laxa ;
    :has_definition ""An autosomal dominant cutis laxa characterized by thin skin with visible veins and wrinkles, cataract or corneal clouding, clenched fingers, pre- and postnatal growth retardation, moderate intellectual disability, and a combination of muscle hypotonia with brisk muscle reflexes that has_material_basis_in heterozygous mutation in the ALDH18A1 gene on chromosome 10q24."" ;
    :has_exact_synonym ""ADCL3""@en .

","Autosomal dominant cutis laxa type 3, also known as ADCL3, is a condition characterized by thin skin with visible veins and wrinkles, cataract or corneal clouding, clenched fingers, pre- and postnatal growth retardation, moderate intellectual disability, and a combination of muscle hypotonia with brisk muscle reflexes. It is caused by a heterozygous mutation in the ALDH18A1 gene on chromosome 10q24.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070132,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_cutis_laxa_type_iiia rdfs:subClassOf :autosomal_recessive_cutis_laxa_type_iii ;
    :has_definition ""A autosomal recessive cutis laxa type III that has_material_basis_in homozygous mutation in the ALDH18A1 gene on chromosome 10q24."" ;
    :has_exact_synonym ""ARCL3A""@en,
        ""De Barsy syndrome A""@en .

",Autosomal recessive cutis laxa type IIA is a condition that is caused by the mutation of the ALDH18A1 gene on chromosome 10q24. It has an exact synonym of De Barsy syndrome.,4,True
doid,http://purl.obolibrary.org/obo/DOID_0070133,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_cutis_laxa_type_ib rdfs:subClassOf :autosomal_recessive_cutis_laxa_type_i ;
    :has_definition ""An autosomal recessive cutis laxa type I characterized by disturbed elastic fiber formation resulting in severe systemic connective tissue abnormalities that has_material_basis_in homozygous or compound heterozygous mutation in the EFEMP2 gene on chromosome 11q13."" ;
    :has_exact_synonym ""ARCL1B""@en .

","Autosomal recessive cutis laxa type I, also known as ARCL1B, is a genetic condition characterized by severe connective tissue abnormalities due to homozygous or compound heterozygous mutations in the EFEMP2 gene on chromosome 11q13. It is one of several types of autosomal recessive cutis laxa, and is distinguished by its more severe symptoms compared to other types. The condition is inherited in an autosomal recessive manner, meaning that a child must inherit two copies of the mutated gene (one from each parent) in order to develop the condition.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070134,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_cutis_laxa_type_iia rdfs:subClassOf :autosomal_recessive_cutis_laxa_type_ii_classic_type ;
    :has_definition ""An autosomal recessive cutis laxa type II classic type that has_material_basis_in homozygous or compound heterozygous mutations in the ATP6V0A2 gene on chromosome 12q24."" ;
    :has_exact_synonym ""ARCL2A""@en .

","Autosomal recessive cutis laxa type II classic is a condition that affects the connective tissues in the body, particularly those covering the skin. It is caused by mutations in the ATP6V0A2 gene on chromosome 12q24. This condition can also affect the eyes and may cause vision problems.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070135,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_cutis_laxa_type_ia rdfs:subClassOf :autosomal_recessive_cutis_laxa_type_i ;
    :has_definition ""An autosomal recessive cutis laxa type I that has_material_basis_in homozygous or compound heterozygous mutation in the FBLN5 gene on chromosome 14q32."" ;
    :has_exact_synonym ""ARCL1A""@en .

","Autosomal recessive cutis laxa type IA, also known as ARCL1A, is a condition that affects the connective tissues in the body. It is caused by mutations in the FBLN5 gene on chromosome 14q32. The condition is characterized by loose and weakened skin, often resulting in sagging or drooping of the eyelids, and sometimes the corners of the mouth. Other symptoms may include joint problems, such as flexibility and mobility issues, and limited range of motion. In some cases, it can also cause bone deformities. This condition is inherited in an autosomal recessive pattern, which means that a person must inherit two copies of the mutated gene (one from each parent) to develop the condition. There is no cure for ARCL1A, but treatment may include physical therapy, medications to manage pain and inflammation, and surgery in severe cases.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070136,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_cutis_laxa_2 rdfs:subClassOf :autosomal_dominant_cutis_laxa ;
    :has_definition ""An autosomal dominant cutis laxa that has_material_basis_in heterozygous mutation in the FBLN5 gene on chromosome 14q32."" ;
    :has_exact_synonym ""ADCL2""@en .

","Autosomal dominant cutis laxa 2, also known as ADCL2, is a type of autosomal dominant cutis laxa characterized by the presence of loose, sagging skin and other associated symptoms. It is caused by a heterozygous mutation in the FBLN5 gene located on chromosome 14q32.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070137,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_cutis_laxa_type_iib rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :cutis_laxa ;
    :has_definition ""A cutis laxa characterized by progeroid features that has_material_basis_in homozygous or compound heterozygous mutation in the PYCR1 gene on chromosome 17q25.3."" ;
    :has_exact_synonym ""ARCL2, progeroid type""@en,
        ""ARCL2B""@en .

",autosomal recessive cutis laxa type iib is a type of autosomal recessive disease.,6,True
doid,http://purl.obolibrary.org/obo/DOID_0070138,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_cutis_laxa_type_iiib rdfs:subClassOf :autosomal_recessive_cutis_laxa_type_iii ;
    :has_definition ""An autosomal recessive cutis laxa type III that has_material_basis_in homozygous or compound heterozygous mutation in the PYCR1 gene on chromosome 17q25."" ;
    :has_exact_synonym ""ARCL3B""@en,
        ""De Barsy syndrome B""@en .

","Autosomal recessive cutis laxa type IIB, also known as De Barsy syndrome B, is a form of autosomal recessive cutis laxa. It is characterized by severe skin and joint problems. The condition is caused by mutations in the PYCR1 gene, which is located on chromosome 17q25. Homozygous or compound heterozygous mutations in this gene can lead to the development of the disease. It's important to note that autosomal recessive cutis laxa type IIB is different from other forms of the condition, and treatment may vary depending on the specific symptoms present in an individual case.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070139,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_cutis_laxa_type_ic rdfs:subClassOf :autosomal_recessive_cutis_laxa_type_i ;
    :has_definition ""A autosomal recessive cutis laxa type I that has_material_basis_in homozygous or compound heterozygous mutation in the LTBP4 gene on chromosome 19q13."" ;
    :has_exact_synonym ""ARCL1C""@en,
        ""autosomal recessive cutis laxa type 1C""@en .

","Autosomal recessive cutis laxa type I is a genetic disorder characterized by the weakening of the connective tissue in the skin, causing it to become loose and flexible. It is caused by a mutation in the LTBP4 gene on chromosome 19q13, which can be inherited in an autosomal recessive manner. The exact synonyms for this condition are ARCL1C and autosomal recessive cutis laxa type 1C.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070140,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_cutis_laxa_type_iic rdfs:subClassOf :autosomal_recessive_cutis_laxa_type_ii_classic_type ;
    :has_definition ""An autosomal recessive cutis laxa type II classic type characterized by cardiovascular involvement that has_material_basis_in homozygous mutation in the ATP6V1E1 gene on chromosome 22q11."" .

","Autosomal recessive cutis laxa type Ic is a type of autosomal recessive cutis laxa. Autosomal recessive cutis laxa type Ic is characterized by the presence of clinical signs and symptoms such as skin that is thin, loose, and wrinkled, along with joint hypermobility, muscle hypotonia, and cardiovascular involvement. It has a genetic basis and is caused by mutations in the ATP6V1E1 gene on chromosome 22q11.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0070141,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_cutis_laxa_type_ii_classic_type rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :cutis_laxa ;
    :has_definition ""A cutis laxa characterized by generalized skin wrinkling, sparse subcutaneous fat, dysmorphic progeroid facial features and severe hypotonia."" ;
    :has_exact_synonym ""ARCL2, Debre type""@en,
        ""ARCL2, classic type""@en .

","Autosomal recessive cutis laxa type II (ARCL2) is a rare genetic disorder that affects the connective tissue in the skin, leading to the development of wrinkled and loose skin. This condition is caused by mutations in the COL5A1 gene, which provides instructions for making a protein called collagen V. The signs and symptoms of ARCL2 typically appear during infancy or early childhood and can include severe hypotonia (low muscle tone), dysmorphic progeroid facial features, sparse subcutaneous fat, and generalized skin wrinkling. It is important to note that this disorder is inherited in an autosomal recessive pattern, which means that a child must inherit two copies of the mutated gene (one from each parent) to develop the condition. There is no cure for ARCL2, but treatment may be available to manage its symptoms.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070142,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_cutis_laxa rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :cutis_laxa ;
    :has_definition ""A cutis laxa characterized by autosomal dominant inheritance of skin that is loose, hanging, wrinkled and lacking in elasticity."" ;
    :has_exact_synonym ""ADCL""@en .

","Autosomal dominant cutis laxa is indeed a type of autosomal dominant disease that affects the skin. It is characterized by loose, wrinkled and lacking in elasticity skin due to the autosomal dominant inheritance of this condition. The exact synonym for Autosomal Dominant Cutis Laxa (ADCL) is indeed ""Autosomal Dominant Cutis Laxa.""",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070143,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_cutis_laxa_type_iii rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :cutis_laxa ;
    :has_definition ""A cutis laxa characterized by a progeria-like appearance, ophthalmologic abnormalities, large and late-closing fontanel, joint hyperlaxity, athetoid movements, hyperreflexia, growth retardation, intellectual deficit, developmental delay, corneal clouding, and cataract."" ;
    :has_exact_synonym ""De Barsy syndrome""@en,
        ""cutis laxa-corneal clouding-intellectual disability syndrome""@en .

","Autosomal recessive cutis laxa type III is a type of Autosomal Recessive Disease. It's characterized by progeria-like appearance, ophthalmologic abnormalities, large and late-closing fontanel, joint hyperlaxity, athetoid movements, hyperreflexia, growth retardation, intellectual deficit, developmental delay, corneal clouding, and cataract. It's also known as De Barsy Syndrome or Cutis Laxa-Corneal Clouding-Intellectual Disability Syndrome.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070144,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_cutis_laxa_type_i rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :cutis_laxa ;
    :has_definition ""A cutis laxa characterized by wrinkled, redundant and sagging inelastic skin and severe systemic manifestations particulary in the lungs, vasculature, and gastrointestinal and genitourinary systems."" ;
    :has_exact_synonym ""autosomal recessive cutis laxa type 1""@en .

","Autosomal recessive cutis laxa type I is a genetic disorder characterized by the weakening and sagging of skin, wrinkles, and redundancy. It can also affect other body systems like lungs, vasculature, gastrointestinal and genitourinary systems with severe manifestations. The inheritance of this condition is autosomal recessive, which means that to develop the disease, a person must inherit two copies of the mutated gene, one from each parent.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070145,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hereditary_sensory_and_autonomic_neuropathy_type_5 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :hereditary_sensory_neuropathy ;
    :has_definition ""A hereditary sensory neuropathy characterized by impaired pain and thermal perception in the extremities and selective reduction in small myelinated fibers that has_material_basis_in homozygous mutation in the NGF gene on chromosome 1p13."" ;
    :has_exact_synonym ""HSAN5""@en,
        ""hereditary sensory and autonomic neuropathy type V""@en .

","Hereditary sensory and autonomic neuropathy type 5, also known as HSAN5 or hereditary sensory and autonomic neuropathy type V, is a type of hereditary sensory neuropathy characterized by impaired pain and thermal perception in the extremities and selective reduction in small myelinated fibers. It is an autosomal recessive disease that has a material basis in homozygous mutation in the NGF gene on chromosome 1p13.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070146,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hereditary_sensory_neuropathy_type_4 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :hereditary_sensory_neuropathy ;
    :has_definition ""A hereditary sensory neuropathy characterized by insensitivity to pain and anhidrosis that has_material_basis_in homozygous or compound heterozygous mutation in the NTRK1 gene on chromosome 1q23."" ;
    :has_exact_synonym ""hereditary sensory neuropathy type IV""@en,
        ""insensitivity to pain, congenital, with anhidrosis""@en .

","Hereditary sensory neuropathy type 4 is a type of hereditary sensory neuropathy that affects the senses and causes insensitivity to pain and anhidrosis. It is caused by mutations in the NTRK1 gene on chromosome 1q23, which is inherited in an autosomal recessive pattern. It has also been referred to as hereditary sensory neuropathy type IV and insensitivity to pain, congenital, with anhidrosis.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070147,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hereditary_sensory_neuropathy_type_2c rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :hereditary_sensory_and_autonomic_neuropathy_type_2 ;
    :has_definition ""A hereditary sensory and autonomic neuropathy type 2 characterized by peripheral nerve degeneration and progressive distal sensory loss that has_material_basis_in homozygous or compound heterozygous mutation in the KIF1A gene on chromosome 2q37."" ;
    :has_exact_synonym ""HSN2C""@en,
        ""hereditary sensory neuropathy type IIC""@en .

","Hereditary sensory neuropathy type 2c (HSN2C) is a type of autosomal recessive disorder characterized by progressive distal sensory loss and peripheral nerve degeneration. It has a material basis in homozygous or compound heterozygous mutations in the KIF1A gene, which is located on chromosome 2q37. The condition is also known as hereditary sensory neuropathy type IIC.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070148,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hereditary_sensory_neuropathy_type_1b rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :cough ],
        :autosomal_dominant_disease,
        :hereditary_sensory_neuropathy ;
    :has_definition ""A hereditary sensory neuropathy characterized by axonal neuropathy with distal sensory impairment, cough, and gastroesophageal reflux that has_material_basis_in variation in the chromosome region 3p24-p22."" ;
    :has_exact_synonym ""HSAN with cough and gastroesophageal reflux""@en,
        ""hereditary sensory neuropathy type IB""@en .

","Hereditary sensory neuropathy type 1b (HSN1b) is a type of hereditary sensory and motor neuropathy characterized by distal sensorimotor polyneuropathy, cough, gastroesophageal reflux disease (GERD), and other symptoms. It is an autosomal dominant disorder caused by mutations in the CHRNA7 gene located on chromosome 3p24-p22. The prevalence of HSN1b is rare, with only a few reported cases worldwide.

HSN1b symptoms typically begin during childhood or adolescence and progress over time. The disease affects the peripheral nerves, causing weakness, numbness, and pain in the extremities. The cough is usually dry and non-productive, and GERD is a common complication. Other potential symptoms include recurrent chest infections, pneumonia, and hoarseness.

Diagnosis of HSN1b is based on a combination of clinical examination, genetic testing, and nerve conduction studies. There is no cure for the disease, but treatment options may include medications to manage symptoms such as pain, cough, and GERD, as well as physical therapy and occupational therapy to improve function and quality of life.

It's important to note that HSN1b is a rare condition, and individuals with the disease may face challenges in obtaining accurate diagnoses and accessing appropriate medical care. Support from healthcare professionals, family members, and support groups can be beneficial for those living with this condition.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0070149,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hereditary_sensory_and_autonomic_neuropathy_type_7 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :muscle_weakness ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :hereditary_sensory_neuropathy ;
    :has_definition ""A hereditary sensory neuropathy characterized by insensitivity to pain, mild muscle weakness, delayed motor development, hyperhidrosis and gastrointestinal dysfunction that has_material_basis_in heterozygous mutation in the SCN11A gene on chromosome 3p22."" ;
    :has_exact_synonym ""HSAN7""@en,
        ""hereditary sensory and autonomic neuropathy type VII""@en .

","Hereditary sensory and autonomic neuropathy type 7 (HSAN7) is a type of hereditary sensory neuropathy that affects the peripheral nerves. It is an autosomal dominant disorder, which means that it can be passed down through families. HSAN7 has symptoms such as insensitivity to pain, muscle weakness, delayed motor development, hyperhidrosis (excessive sweating), and gastrointestinal dysfunction. It is caused by a mutation in the SCN1A gene on chromosome 3p22. HSAN7 can also be referred to as HSAN7 or hereditary sensory and autonomic neuropathy type VII.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0070150,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hereditary_sensory_and_autonomic_neuropathy_type_2b rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :hereditary_sensory_and_autonomic_neuropathy_type_2 ;
    :has_definition ""A hereditary sensory and autonomic neuropathy type 2 characterized by early childhood onset of distal sensory impairment that has_material_basis_in homozygous mutation in the FAM134B gene on chromosome 5p15."" ;
    :has_exact_synonym ""HSAN2B""@en,
        ""hereditary sensory and autonomic neuropathy type IIB""@en .

","Hereditary sensory and autonomic neuropathy type 2b (HSAN2B) is a rare genetic disorder characterized by early onset of distal sensory impairment in children. It is caused by mutations in the FAM134B gene located on chromosome 5p15. The condition is inherited in an autosomal recessive manner, which means that to develop the disease, a person must inherit two copies of the faulty gene, one from each parent.

HSAN2B has a material basis in homozygous mutation in the FAM134B gene on chromosome 5p15. The symptoms of HSAN2B typically begin in early childhood and can include loss of sensation in the fingers, toes, and lips, as well as problems with balance and coordination. Additionally, some individuals may experience weakness in their legs, especially when they stand for extended periods or walk long distances.

It is important to note that while HSAN2B has a unique name, it falls under the broader category of hereditary sensory and autonomic neuropathy (HSAN), which encompasses several different types of the disorder with varying symptoms and causes. HSAN is characterized by the gradual degeneration of peripheral nerves that control sensations such as touch, pain, and temperature.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070151,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hereditary_sensory_and_autonomic_neuropathy_type_6 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :hereditary_sensory_neuropathy ;
    :has_definition ""A hereditary sensory neuropathy characterized by neonatal hypotonia, respiratory and feeding difficulties, impaired psychomotor development, and autonomic abnormalities that has_material_basis_in homozygous mutation in the DST gene on chromosome 6p12."" ;
    :has_exact_synonym ""HSAN6""@en,
        ""hereditary sensory and autonomic neuropathy type VI""@en .

","Hereditary sensory and autonomic neuropathy type 6 (HSAN6) is a type of hereditary sensory neuropathy characterized by neonatal hypotonia, respiratory and feeding difficulties, impaired psychomotor development, and autonomic abnormalities that have a material basis in homozygous mutation in the DST gene on chromosome 6p12. HSAN6 is an autosomal recessive disease that affects both males and females equally. It is also known as hereditary sensory and autonomic neuropathy type VI.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070152,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hereditary_sensory_and_autonomic_neuropathy_type_1a rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :hereditary_sensory_and_autonomic_neuropathy_type_1 ;
    :has_definition ""A hereditary sensory and autonomic neuropathy type 1 characterized by onset of sensorimotor axonal neuropathy in the first or second decades of life that has_material_basis_in heterozygous mutation in the SPTLC1 gene on chromosome 9q22."" ;
    :has_exact_synonym ""HSAN1A""@en,
        ""hereditary sensory and autonomic neuropathy type IA""@en .

","Hereditary Sensory and Autonomic Neuropathy Type 1a is a type of autosomal dominant disease, which means it can be passed down through families. It typically affects the peripheral nerves, causing symptoms like pain, numbness, and weakness in the extremities. In some cases, it may also cause problems with balance and coordination. The onset of symptoms usually occurs in the first or second decades of life. It is caused by a mutation in the SPTLC1 gene on chromosome 9q22.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070153,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hereditary_sensory_and_autonomic_neuropathy_type_8 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :hereditary_sensory_neuropathy ;
    :has_definition ""A hereditary sensory neuropathy characterized by congenital insensitivity to pain and decreased sweating and tear production that has_material_basis_in homozygous mutation in the PRDM12 gene on chromosome 9q34."" ;
    :has_exact_synonym ""HSAN8""@en,
        ""hereditary sensory and autonomic neuropathy type VIII""@en .

",hereditary sensory and autonomic neuropathy type VIII is a hereditary sensory neuropathy characterized by congenital insensitivity to pain and decreased sweating and tear production that has material basis in homozygous mutation in the PRDM12 gene on chromosome 9q34.,6,True
doid,http://purl.obolibrary.org/obo/DOID_0070154,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hereditary_sensory_neuropathy_type_1f rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :hereditary_sensory_and_autonomic_neuropathy_type_1 ;
    :has_definition ""A hereditary sensory and autonomic neuropathy type 1 characterized by distal sensory impairment becomes apparent during the second or third decade of life, resulting in painless ulceration of the feet with poor healing, which can progress to osteomyelitis, bone destruction, and amputation that has_material_basis_in heterozygous mutation in the ATL3 gene on chromosome 11q13."" ;
    :has_exact_synonym ""HSN1F""@en,
        ""hereditary sensory neuropathy type IF""@en .

","Hereditary sensory neuropathy type 1F is a type of autosomal dominant disease characterized by distal sensory impairment becoming apparent during the second or third decade of life, resulting in painless ulceration of the feet with poor healing, which can progress to osteomyelitis, bone destruction, and amputation. It is caused by a heterozygous mutation in the ATL3 gene on chromosome 11q13.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070155,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hereditary_sensory_and_autonomic_neuropathy_type_2a rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :hereditary_sensory_and_autonomic_neuropathy_type_2 ;
    :has_definition ""A hereditary sensory and autonomic neuropathy type 2 characterized by progressive sensory neuropathy with onset in childhood that has_material_basis_in mutation in the HSN2 isoform of the WNK1 gene on chromosome 12p13."" ;
    :has_exact_synonym ""HSAN2A""@en,
        ""hereditary sensory and autonomic neuropathy type IIA""@en .

","Hereditary sensory and autonomic neuropathy type 2a (HSAN2A) is a rare genetic disorder that affects the peripheral nerves. It is characterized by progressive sensory neuropathy, which begins in childhood and results in loss of touch and pain sensation in the extremities. Additionally, there may be autonomic symptoms such as gastrointestinal issues or urinary problems. HSAN2A is inherited in an autosomal recessive manner and is caused by mutations in the WNK1 gene located on chromosome 12p13. The disorder has a material basis in genetic inheritance, making it a hereditary condition.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070156,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hereditary_sensory_neuropathy_type_1d rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :hereditary_sensory_and_autonomic_neuropathy_type_1 ;
    :has_definition ""A hereditary sensory and autonomic neuropathy type 1 characterized dult onset of a distal axonal sensory neuropathy affecting all modalities, often associated with distal ulceration and amputation as well as hyporeflexia, although some patients may show features suggesting upper neuron involvement that has_material_basis_in heterozygous mutation in the ATL1 gene on chromosome 14q."" ;
    :has_exact_synonym ""HSN1D""@en .

","Hereditary sensory neuropathy type 1d (HSN1D) is a type of autosomal dominant disease, which means that it is passed down through families and has a higher chance of being inherited. HSN1D is a form of hereditary sensory and autonomic neuropathy type 1 (HSAN1), which affects the peripheral nerves responsible for sensation and can cause problems with feeling, movement, and blood pressure control.

In HSN1D, adult-onset distal axonal sensory neuropathy is affected, which means that the nerve fibers that carry signals to the brain and spinal cord are damaged, resulting in a loss of sensation. This can affect all senses, including touch, pain, temperature, and vibration. HSN1D is often associated with distal ulcerations and amputations, as well as hyporeflexia (reduced reflexes).

HSN1D has a material basis in mutations in the ATL1 gene on chromosome 14q. These mutations lead to abnormalities in mitochondrial function, which can cause nerve damage and contribute to the development of HSN1D. The exact synonym for HSN1D is HSN type I.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070157,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hereditary_sensory_and_autonomic_neuropathy_type_1c rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :hereditary_sensory_and_autonomic_neuropathy_type_1 ;
    :has_definition ""A hereditary sensory and autonomic neuropathy type 1 that has_material_basis_in heterozygous mutation in the SPTLC2 gene on chromosome 14q24."" ;
    :has_exact_synonym ""HSAN1C""@en,
        ""hereditary sensory and autonomic neuropathy type IC""@en .

","Hereditary sensory and autonomic neuropathy type 1c (HSAN1C) is a form of hereditary sensory and autonomic neuropathy (HSAN) that has a material basis in autosomal dominant inheritance. It is characterized by progressive loss of touch and temperature sensation, as well as weakness of the muscles that control movements. HSAN1C is caused by heterozygous mutations in the SPTLC2 gene on chromosome 14q24. Other synonyms for HSAN1C include hereditary sensory and autonomic neuropathy type IC (HSANIC).",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070158,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hereditary_sensory_neuropathy_type_1e rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :hereditary_sensory_neuropathy ;
    :has_definition ""A hereditary sensory neuropathy characterized by adult onset of progressive peripheral sensory loss, progressive hearing impairment, and early-onset dementia that has_material_basis_in heterozygous mutation in the DNMT1 gene on chromosome 19p13."" ;
    :has_exact_synonym ""HSN1E""@en,
        ""hereditary sensory neuropathy type IE""@en .

","Hereditary sensory neuropathy type 1E is a form of hereditary sensory and motor neuropathy that affects the peripheral nerves, causing a gradual loss of sensation in the extremities. It is inherited in an autosomal dominant manner, which means that a person has a 50% chance of inheriting the condition if one of their parents passes it on. The disease is characterized by adult-onset progressive peripheral sensory loss and hearing impairment, as well as early-onset dementia. It is caused by mutations in the DNMT1 gene located on chromosome 19p13. HSN1E is an exact synonym for hereditary sensory neuropathy type 1E, and the condition can also be referred to as HSN IE.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070159,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hereditary_sensory_neuropathy_x_linked rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_recessive_inheritance ],
        :hereditary_sensory_neuropathy,
        :x_linked_recessive_disease ;
    :has_definition ""A hereditary sensory neuropathy characterized by X-linked inheritance of slowly progressing neuropathy with onset in the first or second decade of life."" .

","Hereditary sensory neuropathy (HSN) is a type of hereditary disorder that affects the peripheral nerves. It is characterized by a gradual onset of numbness, weakness and pain in the hands and feet. HSN is classified as an X-linked recessive genetic disorder, which means that it is inherited from a person's mother or father. In most cases, the inheritance follows an X-linked recessive pattern, which means that the gene responsible for the condition is located on the X chromosome and can be passed down through generations without any effect. However, in some instances, the condition may affect people who do not have a family history of HSN or who are not aware of their family's medical history.

The symptoms of HSN usually begin to appear during childhood or adolescence and progress slowly over time. In addition to numbness and weakness in the hands and feet, some people with HSN may also experience pain, tingling, or other sensations in their extremities. As the condition progresses, it can lead to a loss of dexterity and mobility, making everyday activities such as writing, typing, or using utensils difficult.

There is no cure for HSN, but there are treatments available that can help manage its symptoms. These may include physical therapy, medications, and assistive devices such as splints or braces. It is important to consult with a healthcare professional if you suspect that you or a family member may be affected by HSN. Early diagnosis and intervention can improve the quality of life for those living with this condition.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070160,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:atypical_hereditary_sensory_neuropathy rdfs:subClassOf :hereditary_sensory_neuropathy ;
    :has_definition ""A hereditary sensory neuropathy characterized by late onset of sensory ataxia without ulcerating acropathy or autonomic abnormalities."" .

",Atypical hereditary sensory neuropathy is a type of hereditary sensory neuropathy that is characterized by late onset of sensory ataxia without the presence of ulcerating acropathy or autonomic abnormalities.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0070161,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hereditary_sensory_and_autonomic_neuropathy_type_2 rdfs:subClassOf :hereditary_sensory_neuropathy ;
    :has_definition ""A hereditary sensory neuropathy characterized by progressively reduced sensation to pain, temperature, and touch, loss of myelinated and unmyelinated fibers, and hypotonia with onset at birth or in early childhood."" ;
    :has_exact_synonym ""HSAN2""@en,
        ""hereditary sensory and autonomic neuropathy type II""@en .

","Hereditary sensory and autonomic neuropathy type 2 is a type of hereditary sensory neuropathy that is characterized by the progressive loss of sensation to pain, temperature, and touch. Additionally, there is a loss of myelinated and unmyelinated fibers and hypotonia with onset at birth or in early childhood. This condition is also known as HSAN2 and hereditary sensory and autonomic neuropathy type II.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070162,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hereditary_sensory_and_autonomic_neuropathy_type_1 rdfs:subClassOf :hereditary_sensory_neuropathy ;
    :has_definition ""A hereditary sensory neuropathy characterized by slowly progressing, prominent, predominantly distal sensory loss and autonomic disturbances with juvenile or adult onset and autosomal dominant inheritance."" ;
    :has_exact_synonym ""HSAN1""@en,
        ""hereditary sensory and autonomic neuropathy type I""@en .

","Hereditary Sensory and Autonomic Neuropathy (HSAN) Type 1, also known as Hereditary Sensory and Autonomic Neuropathy I, is a type of hereditary sensory neuropathy characterized by slowly progressing, prominent, predominantly distal sensory loss and autonomic disturbances with juvenile or adult onset and autosomal dominant inheritance.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070163,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spermatogenic_failure_21 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :male_infertility_due_to_acephalic_spermatozoa ;
    :has_definition ""A male infertility due to acephalic spermatozoa that is characterized by acephalic spermatozoa, reduced sperm number and impaired sperm motility that has_material_basis_in homozygous mutation in the BRDT gene on chromosome 1p22."" .

","spermatogenic failure 21, also known as cystic fibrosis, is a genetic disorder that affects the reproductive system in males. It is caused by a mutation in the CFTR gene, which results in the production of abnormal sperm cells, leading to infertility. The condition can be inherited from both parents and is passed down through their families. Treatment options for this disorder include medications, assisted reproductive technologies such as in vitro fertilization (IVF), and lifestyle changes.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070164,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spermatogenic_failure_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :spermatogenic_failure ;
    :has_definition ""A spermatogenic failure that is characterized by azoospermia or severe oligozoospermia that has_material_basis_in inversions on chromosome 1."" ;
    :has_exact_synonym ""SPGF2""@en .

","Spermatogenic failure 2, or SPGF2, is a type of spermatogenic failure that is characterized by azoospermia (absence of sperm in the semen) or severe oligozoospermia (low sperm count). This condition is caused by chromosome 1 inversions.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070165,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spermatogenic_failure_18 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :spermatogenic_failure ;
    :has_definition ""A spermatogenic failure that is characterized by sperm flagellar morphological abnormalities that has_material_basis_in homozygous or compound heterozygous mutation in the DNAH1 gene on chromosome 3p21."" ;
    :has_exact_synonym ""SPGF18""@en .

","Spermatogenic failure 18, also known as SPGF18, is a type of spermatogenic failure that is characterized by sperm flagellar morphological abnormalities and has a material basis in homozygous or compound heterozygous mutation in the DNAH1 gene on chromosome 3p21. It is an autosomal recessive disease.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070166,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spermatogenic_failure_20 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :spermatogenic_failure ;
    :has_definition ""A spermatogenic failure that is characterized by autosomal recessive inheritance of sperm flagellar morphological abnormalities that has_material_basis_in mutation in the CFAP44 gene on chromosome 3q13."" ;
    :has_exact_synonym ""SPGF20""@en .

","Spermatogenic failure 20, also known as SPGF20, is a type of spermatogenic failure characterized by autosomal recessive inheritance of sperm flagellar morphological abnormalities that have a material basis in mutation in the CFAP44 gene on chromosome 3q13.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070167,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spermatogenic_failure_6 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :male_infertility_due_to_globozoospermia ;
    :has_definition ""A male infertility characterized by autosomal recessive inheritance of globozoospermia that has_material_basis_in mutation in the SPATA16 gene on chromosome 3q26."" ;
    :has_exact_synonym ""SPGF6""@en .

","Spermatogenic failure 6, also known as SPGF6, is a type of male infertility that results from an autosomal recessive inheritance of the globozoospermia condition. This means that the affected individual has received two copies of the mutated gene on chromosome 3q26, one from each parent. The SPATA16 gene is responsible for encoding a protein involved in spermatogenesis, and when it's mutated, it can cause abnormalities in sperm development and function, leading to infertility. It is important to note that while this condition has a genetic basis, other factors such as environmental exposure and lifestyle choices may also play a role in the development of male infertility.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070168,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spermatogenic_failure_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :spermatogenic_failure ;
    :has_definition ""A spermatogenic failure that is characterized by autosomal dominant inheritance of nonobstructive asthenozoospermia that has_material_basis_in heterozygous mutation in the SLC26A8 gene on chromosome 6p21."" ;
    :has_exact_synonym ""SPGF3""@en .

","SPGF3 is a type of spermatogenic failure that occurs due to autosomal dominant inheritance. It has a material basis in heterozygous mutation in the SLC26A8 gene on chromosome 6p21, and is characterized by nonobstructive asthenozoospermia.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070169,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spermatogenic_failure_8 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :spermatogenic_failure ;
    :has_definition ""A spermatogenic failure that is characterized by autosomal dominant inheritance of azoospermia or moderate to severe oligozoospermia that has_material_basis_in heterozygous mutation in the NR5A1 gene on chromosome 9q33."" ;
    :has_exact_synonym ""SPGF8""@en .

","spermatogenic failure 8, also known as SPGF8, is a type of spermatogenic failure that is characterized by autosomal dominant inheritance of azoospermia or moderate to severe oligozoospermia. It has a material basis in heterozygous mutation in the NR5A1 gene on chromosome 9q33.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070170,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spermatogenic_failure_19 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :spermatogenic_failure ;
    :has_definition ""A spermatogenic failure that is characterized by autosomal recessive inheritance of sperm flagellar morphological abnormalities that has_material_basis_in mutation in the CFAP43 gene on chromosome 10q25."" ;
    :has_exact_synonym ""SPGF19""@en .

","Spermatogenic failure 19, also known as SPGF19, is a type of autosomal recessive disease that is characterized by sperm flagellar morphological abnormalities due to mutation in the CFAP43 gene on chromosome 10q25. It has a material basis in autosomal recessive inheritance and is defined as a spermatogenic failure that results from this genetic condition.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070171,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spermatogenic_failure_12 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :spermatogenic_failure ;
    :has_definition ""A spermatogenic failure that is characterized by autosomal dominant inheritance of azoospermia or severe oligoasthenoteratozoospermia and in some cases a Sertolic cell-only phenotype that has_material_basis_in heterozygous mutation in the NANOS1 gene on chromosome 10q26."" ;
    :has_exact_synonym ""SPGF12""@en .

","spermatogenic failure 12, also known as SPGF12, is a genetic condition that can cause male infertility. It is characterized by autosomal dominant inheritance of azoospermia or severe oligoasthenoteratozoospermia and in some cases a Sertolic cell-only phenotype that has material basis in heterozygous mutation in the NANOS1 gene on chromosome 10q26.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070172,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spermatogenic_failure_15 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :spermatogenic_failure ;
    :has_definition ""A spermatogenic failure that is characterized by autosomal recessive inheritance of azoospermia that has_material_basis_in mutation in the SYCE1 gene on chromosome 10q26."" ;
    :has_exact_synonym ""SPGF15""@en .

","Spermatogenic failure 15, also known as SPGF15, is a type of autosomal recessive disease that affects the production of sperm in men. It is characterized by mutations in the SYCE1 gene on chromosome 10q26, which leads to azoospermia, or the absence of sperm in the semen. This condition can make it difficult for couples to conceive, and genetic counseling may be necessary to determine the risk of passing the disease on to future generations.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070173,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spermatogenic_failure_7 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :spermatogenic_failure ;
    :has_definition ""A spermatogenic failure that is characterized by autosomal recessive inheritance of impaired or absent sperm motility and increased incidence of morphologically abnormal sperm that has_material_basis_in mutation in the CATSPER1 gene on chromosome 11q13."" ;
    :has_exact_synonym ""SPGF7""@en .

","Spermatogenic failure 7, also known as SPGF7, is a type of autosomal recessive disease that is characterized by impaired or absent sperm motility and an increased incidence of morphologically abnormal sperm. This condition has a material basis in mutation of the CATSPER1 gene on chromosome 11q13.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070174,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spermatogenic_failure_17 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :spermatogenic_failure ;
    :has_definition ""A spermatogenic failure that is characterized by autosomal recessive inheritance of oocyte activation failure following intracytoplasmic sperm injection that has_material_basis_in mutation in the PLCZ1 gene on chromosome 12p12."" ;
    :has_exact_synonym ""Male infertility due to oocyte activation failure""@en,
        ""SPGF17""@en .

","Spermatogenic failure 17, also known as SPGF17, is a type of autosomal recessive disease characterized by oocyte activation failure following intracytoplasmic sperm injection (ICSI) due to mutation in the PLCZ1 gene on chromosome 12p12. It has a material basis in inheritance and is defined as a male infertility caused by this genetic condition.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070176,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spermatogenic_failure_4 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :spermatogenic_failure ;
    :has_definition ""A spermatogenic failure that is characterized by autosomal dominant inheritance of nonobstructive azoospermia caused by meiotic abnormalities that has_material_basis_in mutation in the SYCP3 gene on chromosome 12q23."" ;
    :has_exact_synonym ""SPGF4""@en .

","spermatogenic failure 4, also known as SPGF4, is a type of autosomal dominant disease. It is characterized by nonobstructive azoospermia caused by meiotic abnormalities that have a material basis in mutation of the SYCP3 gene on chromosome 12q23.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070177,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spermatogenic_failure_22 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :spermatogenic_failure ;
    :has_definition ""A spermatogenic failure that is characterized by autosomal recessive inheritance of spermatocyte maturation arrest resulting in azoospermia that has_material_basis_in mutation in the MEIOB gene on chromosome 16p13."" ;
    :has_exact_synonym ""SPGF22""@en .

","spermatogenic failure 22 is a genetic disorder that affects the production of sperm in males. It is caused by mutations in the MEIOB gene, which is located on chromosome 16p13. The condition results in the arrest of spermatocyte maturation and azoospermia, making it difficult for men to fertilize an egg and cause pregnancy. Spermatogenic failure 22 can be inherited in an autosomal recessive manner, which means that both copies of the gene need to be mutated in order for the condition to be expressed.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070178,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spermatogenic_failure_10 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :spermatogenic_failure ;
    :has_definition ""A spermatogenic failure that is characterized by defects in the annulus or the ring-like structure located at the distal end of the flagellar midpiece the autosomal dominant inheritance of that has_material_basis_in mutation in the SEPT12 gene on chromosome 16p13."" ;
    :has_exact_synonym ""SPGF10""@en,
        ""Spermatogenic failure with defective sperm annulus""@en .

","Spermatogenic failure 10, also known as SPGF10 or Spermatogenic failure with defective sperm annulus, is a type of autosomal dominant disease characterized by defects in the annulus or ring-like structure located at the distal end of the flagellar midpiece. The SEPT12 gene on chromosome 16p13 is responsible for this condition and it has material basis in mutations in this gene.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070179,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spermatogenic_failure_14 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :spermatogenic_failure ;
    :has_definition ""A spermatogenic failure that is characterized by autosomal recessive inheritance of a maturation arrest in the spermatid stage of development that has_material_basis_in mutation in the ZMYND15 gene on chromosome 17p13."" ;
    :has_exact_synonym ""SPGF14""@en .

","Spermatogenic failure 14, also known as SPGF14, is a type of autosomal recessive disease. This means that it is inherited from one's parents and can be passed down through generations. It occurs when there is a mutation in the ZMYND15 gene on chromosome 17p13, which affects the spermatid stage of development. The result is a maturation arrest, or failure, in the development of sperm cells. There is no known cure for this condition, but with proper medical treatment and support, individuals affected can still have healthy babies through assisted reproduction methods such as intrauterine insemination (IUI) or in vitro fertilization (IVF).",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070180,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spermatogenic_failure_11 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :spermatogenic_failure ;
    :has_definition ""A spermatogenic failure that is characterized by autosomal dominant inheritance of oligozoospermia and in some cases teratozoospermia and/or moderate asthenozoospermia that has_material_basis_in mutation in the KLHL10 gene on chromosome 17q21."" ;
    :has_exact_synonym ""SPGF11""@en .

","Spermatogenic failure 11, also known as SPGF11, is a type of autosomal dominant disease that is characterized by oligozoospermia and in some cases teratozoospermia and/or moderate asthenozoospermia. It has a material basis in mutation in the KLHL10 gene on chromosome 17q21.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070181,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spermatogenic_failure_23 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :spermatogenic_failure ;
    :has_definition ""A spermatogenic failure that is characterized by autosomal recessive inhertitance of nonobstructive azoospermia that has_material_basis_in mutation in the TEX14 gene on chromosome 17q23."" ;
    :has_exact_synonym ""SPGF23""@en .

","Spermatogenic failure 23, also known as SPGF23, is a type of autosomal recessive disease that involves nonobstructive azoospermia due to mutations in the TEX14 gene on chromosome 17q23. It is characterized by a lack of sperm production and can result in infertility. The condition has a material basis in genetics, specifically in the inheritance patterns of autosomal recessive diseases.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070182,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spermatogenic_failure_13 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :spermatogenic_failure ;
    :has_definition ""A spermatogenic failure that is characterized by autosomal recessive inheritance of azoospermia or oligozoospermia that has_material_basis_in mutation in the TAF4B gene on chromosome 18q11."" ;
    :has_exact_synonym ""SPGF13""@en .

","Spermatogenic failure 13, also known as SPGF13, is a genetic condition that affects the production of sperm in males. It is caused by mutations in the TAF4B gene on chromosome 18q11. This leads to either azoospermia or oligozoospermia, which are conditions where there are abnormally low or no sperm counts respectively. Spermatogenic failure 13 is inherited in an autosomal recessive manner, which means that a person must inherit two copies of the gene (one from each parent) to develop the condition. It can be diagnosed through genetic testing and treated with assisted reproduction techniques such as intra-uterine insemination or in vitro fertilization.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070183,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spermatogenic_failure_5 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :spermatogenic_failure ;
    :has_definition ""A spermatogenic failure that is characterized by autosomal recessive inheritance of large-headed, multiflagellar, polyploid spermatozoa that has_material_basis_in mutation in the AURKC gene on chromosome 19q13."" ;
    :has_exact_synonym ""Infertility associated with multi-tailed spermatozoa and excessive deoxyribonucleic acid"",
        ""SPGF5""@en,
        ""infertility associated with multitailed spermatozoa and excessive DNA""@en,
        ""macrocephalic sperm head syndrome""@en,
        ""male infertility due to macrozoospermia""@en,
        ""male infertility with large-headed, multiflagellar, polyploid spermatozoa""@en .

","Spermatogenic failure 5, also known as SPGF5, is a type of autosomal recessive disease that is characterized by the inheritance of large-headed, multiflagellar, polyploid spermatozoa. This condition has a material basis in mutation of the AURKC gene on chromosome 19q13. It has also been referred to as infertility associated with multi-tailed spermatozoa and excessive deoxyribonucleic acid, macrocephalic sperm head syndrome, and male infertility due to macrozoospermia.",10,True
doid,http://purl.obolibrary.org/obo/DOID_0070184,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spermatogenic_failure_16 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :male_infertility_due_to_acephalic_spermatozoa ;
    :has_definition ""A male infertility due to acephalic spermatozoa that is characterized by autosomal recessive inheritance of acephalic spermatozoa that has_material_basis_in mutation in the SUN5 gene on chromosome 20q11."" ;
    :has_exact_synonym ""SPGF16""@en,
        ""acephalic spermatozoa syndrome""@en .

","Spermatogenic failure 16 (SPGF16) is a type of male infertility caused by acephalic spermatozoa, which are abnormal sperm cells that lack a head. This condition is inherited in an autosomal recessive manner, meaning that to have full expression of the trait, both copies of the gene must be inherited (one from each parent). The SUN5 gene on chromosome 20q11 is responsible for this condition, and it has a material basis in mutations of this gene. SPGF16 is also known as acephalic spermatozoa syndrome.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070185,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:x_linked_spermatogenic_failure_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_recessive_inheritance ],
        :spermatogenic_failure,
        :x_linked_recessive_disease ;
    :has_definition ""A spermatogenic failure that is characterized by meiotic arrest of spermatocytes and mixed testicular atrophy that has_material_basis_in X-linked inheritance of mutation in the TEX11 gene on chromosome Xq13."" ;
    :has_exact_synonym ""SPGFX2""@en .

","X-linked spermatogenic failure type 2 (SPGFX2) is a condition that affects the production of sperm, also known as spermatogenesis. It is caused by mutations in the TEX11 gene on the X chromosome. The symptoms of this genetic disorder typically include low sperm count, poor sperm motility, and abnormal sperm shape. In some cases, it may cause azoospermia, which is the complete absence of sperm in the semen. SPGFX2 is inherited in an X-linked recessive pattern, meaning that a male must inherit two copies of the gene (one from each parent) to develop the condition. Females are usually carriers if they have only one copy of the mutated gene. Treatment options for SPGFX2 may include hormonal therapy, assisted reproduction techniques or sperm donation.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070186,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:y_linked_spermatogenic_failure_1 rdfs:subClassOf [ owl:intersectionOf [ rdf:first [ a owl:Restriction ;
                            owl:onProperty :has_material_basis_in ;
                            owl:someValuesFrom :deletion ] ;
                    rdf:rest [ rdf:first [ a owl:Restriction ;
                                    owl:onProperty :has_material_basis_in ;
                                    owl:someValuesFrom :chromosome ] ;
                            rdf:rest :nil ] ] ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :y_linked_inheritance ],
        :chromosomal_deletion_syndrome,
        :sertoli_cell_only_syndrome,
        :y_linked_monogenic_disease ;
    :has_definition ""A Sertoli cell-only syndrome that has_material_basis_in deletions in the Yq11 chromosomal region."" ;
    :has_exact_synonym ""SPGFY1""@en,
        ""Y-linked Sertoli cell-only syndrome""@en,
        ""type I Sertoli cell-only syndrome""@en .

","You are correct, y linked spermatogenic failure 1 is a type of Sertoli cell-only syndrome, which can be caused by deletions in the Yq11 chromosomal region. It has exact synonyms such as SPGFY1, Y-linked Sertoli cell-only syndrome, and type I Sertoli cell-only syndrome.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0070187,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:y_linked_spermatogenic_failure_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :y_linked_inheritance ],
        :spermatogenic_failure,
        :y_linked_monogenic_disease ;
    :has_definition ""A spermatogenic failure that is characterized by nonobstroctive azoospermia or oligozoospermia that has_material_basis_in interstitial deletions on the Yq11.221 chromosomal region."" ;
    :has_exact_synonym ""SPGFY2""@en,
        ""nonobstructive Y-linked spermatogenic failure""@en .

","y linked spermatogenic failure 2, or SPGFY2, is a type of Y-linked monogenic disease. It is characterized by nonobstructive azoospermia or oligozoospermia, and has a material basis in interstitial deletions on the Yq11.221 chromosomal region.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070188,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spermatogenic_failure_1 rdfs:subClassOf :spermatogenic_failure ;
    :has_definition ""A spermatogenic failure that is characterized by autosomal recessive inheritance of spermatogenic failure resulting from meiotic defects."" ;
    :has_exact_synonym ""SPGF1""@en,
        ""oligochiasmatic infertility""@en,
        ""oligosynaptic infertility""@en .

","spermatogenic failure 1 is a type of spermatogenic failure, characterized by autosomal recessive inheritance of spermatogenic failure resulting from meiotic defects. It has the exact synonym SPGF1, oligochiasmatic infertility and oligosynaptic infertility.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070189,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:x_linked_spermatogenic_failure_1 rdfs:subClassOf :sertoli_cell_only_syndrome ;
    :has_definition ""A Sertoli cell-only syndrome characterized by X-linked inheritance."" ;
    :has_exact_synonym ""SPGFX1""@en .

","Sertoli cell-only syndrome, also known as X-linked spermatogenic failure 1 (SPGFX1), is a genetic condition that affects the development of male reproductive organs. It is characterized by an abnormality in the Sertoli cells, which are responsible for nurturing and supporting the development of sperm in the testes. This leads to a reduction in sperm production and can cause infertility. X-linked means that the gene responsible for this condition is located on the X chromosome, which males inherit from their mothers. However, females are usually carriers since they have two X chromosomes, one inherited from each parent.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070191,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_chronic_granulomatous_disease_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :chronic_granulomatous_disease ;
    :has_definition ""A chronic granulomatous disease characterized by autosomal recessive inheritance that has_material_basis_in mutation in the NCF2 gene on chromosome 1q25."" ;
    :has_exact_synonym ""autosomal recessive chronic granulomatous disease cytochrome b-positive type II"",
        ""CDG2""@en,
        ""chronic granulomatous disease due to deficiency of NCF-2""@en,
        ""deficiency of NCF2""@en,
        ""deficiency of p67-PHOX""@en .

","Autosomal recessive chronic granulomatous disease 2, also known as CDG2 or NCF2-related cytochrome b-positive type II, is a rare genetic disorder that affects the immune system. It is caused by mutations in the NCF2 gene on chromosome 1q25, which encodes a protein called nectin-4. This protein is involved in the function of the immune system and plays an essential role in the development of T cells.

People with autosomal recessive chronic granulomatous disease 2 may experience chronic inflammation, recurrent infections, and lymphadenopathy (swelling of lymph nodes). They often have a high risk of developing malignant tumors, particularly sarcomas.

Treatment for autosomal recessive chronic granulomatous disease 2 may include immunosuppressive therapy and antibiotics to manage infections. Bone marrow transplantation or stem cell transplantation may also be considered for some individuals.

It is important for people with autosomal recessive chronic granulomatous disease 2 to work closely with their healthcare providers to develop an individualized treatment plan that addresses their specific needs and symptoms.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0070192,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_chronic_granulomatous_disease_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :chronic_granulomatous_disease ;
    :has_definition ""A chronic granulomatous disease characterized by autosomal recessive inheritance that has_material_basis_in mutation in the NCF1 gene on chromosome 7q11.23."" ;
    :has_exact_synonym ""autosomal recessive chronic granulomatous disease cytochrome b-positive type I"",
        ""CDG1""@en,
        ""chronic granulomatous disease due to deficiency of NCF-1""@en,
        ""deficiency of NCF1""@en,
        ""deficiency of SOC2""@en,
        ""deficiency of neutrophil cytosol factor 1""@en,
        ""deficiency of p47-PHOX""@en,
        ""deficiency of soluble oxidase component II""@en .

","Autosomal recessive chronic granulomatous disease 1 (CDG1) is a type of autosomal recessive disorder that is characterized by the deficiency of NCF1, which leads to an impairment in the production of cytochrome b-245 and p47phox. This results in chronic inflammation and granuloma formation in various organs, including the lungs, liver, spleen, and lymph nodes. CDG1 is caused by mutations in the NCF1 gene on chromosome 7q11.23 and can be diagnosed through genetic testing. It has also been referred to as deficiency of SOC2, p47-PHOX, and soluble oxidase component II.",12,True
doid,http://purl.obolibrary.org/obo/DOID_0070193,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_chronic_granulomatous_disease_4 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :chronic_granulomatous_disease ;
    :has_definition ""A chronic granulomatous disease characterized by autosomal recessive inheritance that has_material_basis_in mutation in the CYBA gene on chromosome 16q24.2."" ;
    :has_exact_synonym ""autosomal recessive chronic granulomatous disease cytochrome b-negative"",
        ""CGD due to deficiency of the alpha subunit of cytochrome b""@en,
        ""CYBA deficiency""@en,
        ""autosomal recessive cytochrome b-negative CGD""@en,
        ""chronic granulomatous disease due to deficiency of CYBA""@en .

","Chronic granulomatous disease (CGD) is a rare genetic disorder that affects the immune system and can cause chronic infections due to poorly functioning white blood cells. There are several types of CGD, including autosomal recessive CGD 4, which is caused by a mutation in the CYBA gene on chromosome 16q24.2. The term ""autosomal recessive"" means that both copies of the gene (one from each parent) must be abnormal for the condition to develop. CGD can cause chronic infections, especially of the lungs, skin, and gastrointestinal tract. Treatment may include antibiotics, anti-fungal medications, and surgery.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0070194,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_chronic_granulomatous_disease_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :chronic_granulomatous_disease ;
    :has_definition ""A chronic granulomatous disease characterized by that autosomal recessive inheritance has_material_basis_in mutation in the NCF4 gene on chromosome 22q12."" ;
    :has_exact_synonym ""autosomal recessive chronic granulomatous disease cytochrome b-positive type III"",
        ""CDG3""@en,
        ""autosomal recessive cytochrome b-positive CGD type III""@en,
        ""chronic granulomatous disease due to NCF4 deficiency""@en .

","Autosomal recessive chronic granulomatous disease 3 is a type of autosomal recessive disease that is characterized by a chronic granulomatous disease. It has a material basis in autosomal recessive inheritance, and is caused by mutations in the NCF4 gene on chromosome 22q12. The condition is also known as CDG3, cytochrome b-positive type III, autosomal recessive cytochrome b-positive CGD type III, and chronic granulomatous disease due to NCF4 deficiency.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0070195,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:x_linked_chronic_granulomatous_disease rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_recessive_inheritance ],
        :chronic_granulomatous_disease,
        :x_linked_recessive_disease ;
    :has_definition ""A chronic granulomatous disease characterized by X-linked inheritance that has_material_basis_in mutation in the CYBB gene on chromosome Xp21.1-p11.4."" ;
    :has_exact_synonym ""CDGX""@en,
        ""X-linked chronic cytochrome b-negative granulomatous disease""@en .

","Chronic granulomatous disease (CGD) is a genetic disorder characterized by the absence of an important enzyme called cytochrome b245. This enzyme is essential for the proper functioning of the immune system, which is responsible for defending against infections and foreign substances. When this enzyme is not present or is defective, it leads to chronic infections and inflammation, as well as an increased risk of certain types of cancer.

CGD can be inherited in an X-linked recessive pattern, which means that the gene responsible for the disorder is located on the X chromosome and is passed down through families. In this case, a person would need to inherit two copies of the defective gene (one from each parent) to develop CGD.

There are several types of CGD, including chronic granulomatous disease (CGD), which is characterized by recurring infections and inflammation due to the lack of cytochrome b245. Other types include X-linked chronic granulomatous disease (CGDX) and congenital granulomatous disease, among others.

Treatment for CGD usually includes antibiotics to prevent infections, as well as other medications to help manage symptoms. In some cases, a bone marrow transplant may be recommended to replace the patient's defective cells with healthy ones. With proper treatment, many people with CGD can lead normal, healthy lives.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070196,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:infantile_onset_distal_myopathy rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :existence_starts_during ;
            owl:someValuesFrom :infantile_onset ],
        :autosomal_dominant_disease,
        :distal_myopathy ;
    :has_definition ""A distal myopathy that is characterized by autosomal dominant inheritance, infantile onset and progressive disease development."" .

","Infantile onset distal myopathy is a condition characterized by muscle weakness that primarily affects the arms, legs, and shoulders. It is often caused by mutations in genes responsible for muscle function and can be inherited in an autosomal dominant manner. This means that if one parent has the gene, there is a 50% chance that their child will inherit it. The condition typically presents during early childhood and progressively worsens over time. It is important to seek medical attention for this condition as soon as possible to receive proper treatment and management.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070197,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:distal_myopathy_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :distal_myopathy ;
    :has_definition ""A distal myopathy that is characterized by autosomal dominant inheritance that has_material_basis_in mutation in the MYH7 gene on chromosome 14q11.2."" ;
    :has_exact_synonym ""Distal myopathy type 1""@en,
        ""Gowers disease""@en,
        ""Laing distal myopathy""@en,
        ""Laing early-onset distal myopathy""@en,
        ""MPD1""@en .

","Distal myopathy 1 (also known as MPD1) is a type of autosomal dominant disease characterized by muscle weakness and severe distal muscle degeneration. It has a strong genetic component, with mutations in the MYH7 gene on chromosome 14q11.2 being the most common cause of the condition.

Symptoms typically begin during childhood or adolescence and can progress quickly, leading to significant weakness and muscle atrophy in the arms, legs, shoulders, and hips. Distal myopathy 1 can also affect the face, neck, and respiratory muscles, causing difficulties with swallowing and breathing.

Diagnosis of distal myopathy 1 typically involves a combination of genetic testing, physical examination, and electromyography (EMG) to assess muscle function and strength. Treatment may include medications to manage symptoms, physical therapy to improve strength and mobility, and in some cases, assistive devices such as wheelchairs or walkers.

It is important for individuals with distal myopathy 1 to receive proper medical care and support to manage their symptoms and maintain their quality of life. With early diagnosis and appropriate treatment, many people with this condition can lead relatively normal lives despite the significant physical challenges they face.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0070198,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:miyoshi_muscular_dystrophy rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :muscle_weakness ],
        :distal_myopathy ;
    :has_definition ""A distal myopathy that is characterized by autosomal recessive inheritance of distal muscle weakness in the upper and lower limbs that spares the intrinsic muscles of the hands and has onset in young adulthood."" ;
    :has_exact_synonym ""Miyoshi myopathy""@en .

","Miyoshi muscular dystrophy is a type of distal myopathy, characterized by autosomal recessive inheritance of distal muscle weakness in the upper and lower limbs that spares the intrinsic muscles of the hands and has onset in young adulthood. It's also known as Miyoshi myopathy",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070199,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:miyoshi_muscular_dystrophy_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :miyoshi_muscular_dystrophy ;
    :has_definition ""A Miyoshi muscular dystrophy that has_material_basis_in mutation in the DYSF gene on chromosome 2p13."" ;
    :has_exact_synonym ""MMD1""@en,
        ""Miyoshi myopathy 1""@en .

","Miyoshi muscular dystrophy 1 is a genetic disorder that affects the skeletal and cardiac muscles, resulting in progressive weakness and muscle wasting. It is caused by mutations in the DYSF gene, which is located on chromosome 2p13. The condition is inherited in an autosomal recessive manner, which means that to develop the disease, a person must inherit two copies of the mutated gene, one from each parent. There is no cure for Miyoshi muscular dystrophy 1, but treatment options may include physical therapy, medications, and assistive devices to help manage symptoms and improve quality of life.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070200,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:miyoshi_muscular_dystrophy_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :muscle_weakness ],
        :miyoshi_muscular_dystrophy ;
    :has_definition ""A Miyoshi muscular dystrophy characterized by asymmetric presentation of muscle weakness and atrophy that has_material_basis_in a locus on chromosome 10."" ;
    :has_exact_synonym ""MMD2""@en,
        ""Miyoshi myopathy 2""@en .

","Miyoshi muscular dystrophy 2 (MMD2) is a subtype of Miyoshi muscular dystrophy, characterized by asymmetric presentation of muscle weakness and atrophy. It is caused by mutations in the DOK7 gene, which is located on chromosome 10. Symptoms often appear during childhood and can include weakness in the arms, legs, neck, and facial muscles, as well as joint contractures and muscle atrophy. The condition can also affect cognitive function and hearing. There is no cure for MMD2, but treatment may include physical therapy, assistive devices, and medications to manage symptoms.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070201,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:miyoshi_muscular_dystrophy_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :miyoshi_muscular_dystrophy ;
    :has_definition ""A Miyoshi muscular dystrophy that has_material_basis_in mutation in the ANO5 gene on chromosome 11p14."" ;
    :has_exact_synonym ""MMD3""@en,
        ""Miyoshi myopathy 3""@en .

","Miyoshi muscular dystrophy 3 is a type of autosomal recessive disease that affects the muscles. It is one of the types within the broader category of Miyoshi muscular dystrophies. The specific cause of this condition is a mutation in the ANO5 gene on chromosome 11p14, which leads to a deficiency in anionic channel protein. This results in the characteristic weakness and atrophy of skeletal muscles seen in MMD3 patients.

Miyoshi muscular dystrophy 3 is also known by its alternative name, Miyoshi myopathy 3. It is important to note that while these terms are often used interchangeably, they technically refer to slightly different aspects of the disease. Nonetheless, both terms accurately describe the condition and can be used when referring to MMD3.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070202,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:familial_partial_lipodystrophy_type_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :familial_partial_lipodystrophy ;
    :has_definition ""A familial partial lipodystrophy characterized by autosomal dominant inheritance of loss of subcutaneous fat from the limbs and trunk that has_material_basis_in mutation in the LMNA gene on chromosome 1q21."" ;
    :has_exact_synonym ""FPLD2""@en,
        ""familial lipodystrophy of limbs and lower trunk""@en,
        ""familial partial lipodystrophy Dunnigan type""@en,
        ""reverse partial lipodystrophy""@en .

","familial partial lipodystrophy type 2 is a disorder that affects the distribution of fat in the body. It is characterized by the loss of subcutaneous fat from the limbs and trunk, which can lead to a variety of health problems if left untreated. The condition is inherited in an autosomal dominant manner, meaning that it can be passed down through generations of a family.

There are several genetic factors that can contribute to familial partial lipodystrophy type 2, including mutations in the LMNA gene on chromosome 1q21. These mutations disrupt the functioning of the lamin A/C protein, which is involved in the storage and transport of fat within cells. As a result, excess fat accumulates in other parts of the body, leading to the characteristic distribution of fat loss in familial partial lipodystrophy type 2.

Familial partial lipodystrophy type 2 can have a significant impact on a person's quality of life, as it can affect their physical appearance and increase the risk of various health problems, including obesity, diabetes, and cardiovascular disease. Treatment options may include medications to manage symptoms, such as insulin in cases of type 2 diabetes, and surgical procedures to remove excess fat from specific areas of the body.

In summary, familial partial lipodystrophy type 2 is a disorder that affects the distribution of fat within the body due to inherited genetic factors. It can lead to various health problems if left untreated, and treatment may involve managing symptoms with medications or surgical procedures.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0070203,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:familial_partial_lipodystrophy_type_5 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :familial_partial_lipodystrophy ;
    :has_definition ""A familial partial lipodystrophy characterized by autosomal recessive inheritance that has_material_basis_in mutation in the CIDEC gene on chromosome 3p25."" ;
    :has_exact_synonym ""CIDEC-related FPLD""@en,
        ""FPLD5""@en,
        ""familial partial lipodystrophy associated with CIDEC mutations""@en .

","Familial partial lipodystrophy type 5, also known as FPLD5 or CIDEC-related FPLD, is a genetic disorder characterized by the autosomal recessive inheritance of mutations in the CIDEC gene located on chromosome 3p25. It is one of several types of familial partial lipodystrophy, which are inherited conditions that affect the body's ability to store and metabolize fat. FPLD5 specifically affects the adipose tissue in the hips and thighs and can lead to a variety of symptoms, including severe joint pain, fatigue, and muscle weakness. Treatment typically focuses on managing symptoms and preventing complications, such as diabetes or heart disease.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0070204,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:familial_partial_lipodystrophy_type_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :familial_partial_lipodystrophy ;
    :has_definition ""A familial partial lipodystrophy characterized by autosomal dominant inheritance that has_material_basis_in mutation in the PPARG gene on chromosome 3p25."" ;
    :has_exact_synonym ""FPLD3""@en,
        ""PPARG-related FPLD""@en,
        ""PPARG-related familial partial lipodystrophy""@en,
        ""familial partial lipodystrophy associated with PPARG mutations""@en .

","familial partial lipodystrophy type 3 is a type of familial partial lipodystrophy characterized by autosomal dominant inheritance that has material basis in mutation in the PPARG gene on chromosome 3p25. It has exact synonyms such as FPLD3, PPARG-related FPLD, PPARG-related familial partial lipodystrophy, and familial partial lipodystrophy associated with PPARG mutations.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0070205,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:familial_partial_lipodystrophy_type_4 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :familial_partial_lipodystrophy ;
    :has_definition ""A familial partial lipodystrophy characterized by autosomal dominant inheritance of loss of subcutaneous adipose tissue primarily from the lower limbs, insulin-resistant diabetes mellitus, hypertriglyceridemia, and hypertension that has_material_basis_in mutation in the PLIN1 gene on chromosome 15q26."" ;
    :has_exact_synonym ""FPLD4""@en,
        ""PLIN1-related FPLD""@en,
        ""PLIN1-related familial partial lipodystrophy""@en,
        ""familial partial lipodystrophy associated with PLIN1 mutations""@en .

","Familial partial lipodystrophy type 4, also known as FPLD4 or PLIN1-related familial partial lipodystrophy, is a genetic disorder characterized by the progressive loss of subcutaneous adipose tissue, particularly from the lower limbs. It often leads to insulin resistance, diabetes mellitus, hypertriglyceridemia, and hypertension. The condition has a strong genetic component, with mutations in the PLIN1 gene on chromosome 15q26 being the primary cause.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0070206,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:familial_partial_lipodystrophy_type_6 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :familial_partial_lipodystrophy ;
    :has_definition ""A familial partial lipodystrophy characterized by autosomal recessive inheritance that has_material_basis_in mutation in the LIPE gene on chromosome 19q13."" ;
    :has_exact_synonym ""FPLD6""@en,
        ""LIPE-related FPLD""@en,
        ""LIPE-related familial partial lipodystrophy""@en,
        ""familial partial lipodystrophy associated with LIPE mutations""@en .

","Familial partial lipodystrophy type 6, also known as FPLD6 or LIPE-related familial partial lipodystrophy, is a genetic disorder that affects the body's ability to store and metabolize fat. It is caused by mutations in the LIPE gene on chromosome 19q13. This condition is inherited in an autosomal recessive manner, which means that a person must inherit two copies of the mutated gene (one from each parent) to develop the disorder. Symptoms can include weight loss, fatigue, and increased risk of developing type 2 diabetes and other metabolic conditions. It is important for individuals with this condition to work closely with their healthcare provider to manage their symptoms and maintain a healthy lifestyle.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0070207,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:familial_partial_lipodystrophy_type_1 rdfs:subClassOf :familial_partial_lipodystrophy ;
    :has_definition ""A familial partial lipodystrophy characterized by loss of adipose tissue that is confined to the extremities with normal or increased fat in other areas of the body."" ;
    :has_exact_synonym ""FPLD1""@en,
        ""familial partial lipodystrophy Kobberling type""@en .

","Familial partial lipodystrophy type 1, also known as FPLD1 or familial partial lipodystrophy Kobberling type, is a genetic disorder characterized by the loss of adipose tissue in the extremities while preserving fat in other areas of the body. It is caused by mutations in the PPARG gene and can lead to a variety of symptoms, including painless muscle weakness, fatigue, and a decreased ability to regulate blood sugar levels. Treatment typically focuses on managing symptoms and preventing long-term complications, such as diabetes or cardiovascular disease.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070208,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hereditary_lymphedema_ic rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :hereditary_lymphedema ;
    :has_definition ""A hereditary lymphedema characterized by autosomal dominant inheritance that has_material_basis_in mutation in the GJC2 gene on chromosome 1q42."" ;
    :has_exact_synonym ""LMPH1C""@en .

","Hereditary lymphedema, also known as primary lymphedema, is a condition in which the lymphatic system does not develop properly or is damaged. It can occur due to genetic factors or other causes such as surgery, injury, or infection.
There are two types of hereditary lymphedema: autosomal dominant and sporadic. Autosomal dominant lymphedema is caused by mutations in specific genes that are passed down through families, while sporadic lymphedema occurs randomly with no clear genetic link.
Hereditary lymphedema ic specifically refers to a type of hereditary lymphedema that is characterized by autosomal dominant inheritance and has a material basis in mutation in the GJC2 gene on chromosome 1q42. This specific form of lymphedema has the exact synonym LMPH1C.
It's important to note that while genetics plays a role in developing hereditary lymphedema, other factors such as injury or infection can also contribute to its development. Additionally, proper management and treatment can help reduce the severity of symptoms and improve quality of life for those affected by this condition.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070209,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hereditary_lymphedema_id rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :hereditary_lymphedema ;
    :has_definition ""A hereditary lymphedema characterized by autosomal dominant inheritance that has_material_basis_in mutation in the VEGFC gene on chromosome 4q34."" ;
    :has_exact_synonym ""LMPH1D""@en .

","Hereditary Lymphedema is a medical condition where the lymphatic system does not function properly, resulting in swelling in the limbs and other parts of the body. It can be passed down through families and can occur due to genetic mutations or inherited from a parent. There are different types of Hereditary Lymphedema including primary and secondary forms. Primary Hereditary Lymphedema is caused by a genetic mutation in one of the VEGFC gene on chromosome 4q34, which is responsible for regulating blood flow to the lymphatic system. Secondary Hereditary Lymphedema occurs when there is damage to the lymphatic vessels, often as a result of surgery or injury. In some cases, it may be possible to manage the symptoms through medical treatments and lifestyle changes.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070210,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hereditary_lymphedema_ia rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :hereditary_lymphedema ;
    :has_definition ""A hereditary lymphedema characterized by autosomal dominant inheritance that has_material_basis_in mutation in the FLT4 gene on chromosome 5q35."" ;
    :has_exact_synonym ""LMPH1A""@en .

","Hereditary lymphedema ia, also known as primary lymphedema, is a type of hereditary lymphedema characterized by autosomal dominant inheritance and a mutation in the FLT4 gene on chromosome 5q35. It has an exact synonym LMPH1A.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070211,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hereditary_lymphedema_ib rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :hereditary_lymphedema ;
    :has_definition ""A hereditary lymphedema characterized by autosomal dominant inheritance that has_material_basis_in the chromosomal region 6q16.2-q22.1."" ;
    :has_exact_synonym ""LMPH1B""@en .

","Hereditary lymphedema is a condition that affects the lymphatic system. It can cause swelling in the arms, legs, and other parts of the body. There are different types of hereditary lymphedema, including Hereditary Lymphedema Type I (HLTI) and Hereditary Lymphedema Type II (HLTII).
Hereditary Lymphedema Type I (HLTI) is an autosomal dominant disorder that affects the lymphatic system. It is caused by a mutation in the LMNA gene, which provides instructions for making a protein called lamin A/C. This protein plays a role in the structure and function of the cell nucleus.
Hereditary Lymphedema Type II (HLTII) is also an autosomal dominant disorder that affects the lymphatic system. It is caused by mutations in the KWF2 gene, which provides instructions for making a protein called kelch-like protein 13 (KLHL13). This protein plays a role in the structure and function of the cell nucleus.
Hereditary Lymphedema Type I and II are inherited from one or both parents, and can be passed down through generations of a family. Early diagnosis and treatment are important to manage symptoms and prevent complications.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070212,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hereditary_lymphedema_i rdfs:subClassOf :hereditary_lymphedema ;
    :has_definition ""A hereditary lymphedema characterized by autosomal dominant inheritance of chronic, generally painless, lower limb lymphedema with onset typically at birth or in early childhood."" ;
    :has_exact_synonym ""LMPH1""@en,
        ""Milroy disease""@en,
        ""Nonne-Milroy lymphedema""@en,
        ""PCL""@en,
        ""congenital primary lymphedema""@en,
        ""hereditary lymphedema type I""@en .

","Hereditary lymphedema I, also known as Milroy disease or Nonne-Milroy lymphedema, is a type of hereditary lymphedema characterized by autosomal dominant inheritance of chronic, generally painless, lower limb lymphedema with onset typically at birth or in early childhood. It has exact synonyms such as congenital primary lymphedema and hereditary lymphedema type I.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0070213,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hereditary_lymphedema_ii rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :hereditary_lymphedema ;
    :has_definition ""A hereditary lymphedema characterized by onset around puberty of chronic lymphedema particularly in the lower limbs with an apparent autosomal dominant pattern of inheritance."" ;
    :has_exact_synonym ""LMPH2""@en,
        ""Meige disease""@en,
        ""Meige lymphedema""@en,
        ""late-onset lymphedema""@en,
        ""lymphedema preacox""@en .

","Hereditary lymphedema II, also known as LMPH2 or Meige disease, is a type of hereditary lymphedema characterized by onset around puberty of chronic lymphedema particularly in the lower limbs with an apparent autosomal dominant pattern of inheritance. It has exact synonyms such as late-onset lymphedema and preacox lymphedema.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0070214,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:familial_hyperinsulinemic_hypoglycemia_7 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_phenotype ;
            owl:someValuesFrom :abnormal_blood_glucose_concentration ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :hyperinsulinemic_hypoglycemia ;
    :has_definition ""A hyperinsulinemic hypoglycemia characterized by autosomal dominant inheritance of postexercise hypoglycemia with marked hyperinsulinism that has_material_basis_in mutation in the SLC16A1 gene on chromosome 1p13.2."" ;
    :has_exact_synonym ""EIHI""@en,
        ""HHF7""@en,
        ""exercise-induced hyperinsulinemic hypoglycemia""@en,
        ""exercise-induced hyperinsulinism""@en,
        ""hyperinsulinism due to SLC16A1 deficiency""@en,
        ""hyperinsulinism due to monocarboxylate transporter 1 deficiency""@en .

","Familial hyperinsulinemic hypoglycemia 7 is a type of autosomal dominant disease that is characterized by postexercise hypoglycemia with marked hyperinsulinism, and has a material basis in mutation in the SLC16A1 gene on chromosome 1p13.2. It also goes by the names EIHI, HHF7, exercise-induced hyperinsulinemic hypoglycemia, exercise-induced hyperinsulinism, and monocarboxylate transporter 1 deficiency.",11,True
doid,http://purl.obolibrary.org/obo/DOID_0070215,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:familial_hyperinsulinemic_hypoglycemia_4 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_phenotype ;
            owl:someValuesFrom :abnormal_blood_glucose_concentration ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :hyperinsulinemic_hypoglycemia ;
    :has_definition ""A hyperinsulinemic hypoglycemia characterized by autosomal recessive inheritance of hyperinsulinemic hypoglycemia with seizures that has_material_basis_in mutation in the HADH gene on chromosome 4q25."" ;
    :has_exact_synonym ""HHF4""@en,
        ""hyperinsulinemic hypoglycemia due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency""@en,
        ""hyperinsulinism due to SCHAD deficiency""@en,
        ""hyperinsulinism due to glutamodehydrogenase deficiency""@en,
        ""hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency""@en .

","Familial hyperinsulinemic hypoglycemia 4, also known as HHF4, is a type of autosomal recessive disease characterized by abnormal blood glucose concentration. It has a material basis in mutation of the HADH gene on chromosome 4q25 and is associated with seizures. The exact synonyms for this condition include hyperinsulinemic hypoglycemia due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency, hyperinsulinism due to SCHAD deficiency, and hyperinsulinism due to glutamodehydrogenase deficiency.",10,True
doid,http://purl.obolibrary.org/obo/DOID_0070216,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:familial_hyperinsulinemic_hypoglycemia_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_phenotype ;
            owl:someValuesFrom :abnormal_blood_glucose_concentration ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :hyperinsulinemic_hypoglycemia ;
    :has_definition ""A hyperinsulinemic hypoglycemia characterized by autosomal dominant inheritance of a reduced threshold for insulin release and hypoglycemia induced by fasting or protein rich meals that has_material_basis_in activating mutations in the GCK gene on chromosome 7p13."" ;
    :has_exact_synonym ""HHF3""@en,
        ""hyperinsulinemic hypoglycemia due to glucokinase deficiency""@en,
        ""hyperinsulinism due to glucokinase deficiency""@en .

",familial hyperinsulinemic hypoglycemia 3 is a type of autosomal dominant disease.,8,True
doid,http://purl.obolibrary.org/obo/DOID_0070217,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:familial_hyperinsulinemic_hypoglycemia_6 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_phenotype ;
            owl:someValuesFrom :abnormal_blood_glucose_concentration ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_feature ;
            owl:someValuesFrom :hypoglycemia ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :hyperinsulinemic_hypoglycemia ;
    :has_definition ""A hyperinsulinemic hypoglycemia characterized by autosomal dominant inheritance of excessive insulin secretion, asymptomatic hyperammonemia and episodes of hypoglycemia induced by fasting or protein rich meals that has_material_basis_in mutation in the GLUD1 gene on chromosome 10q23.3."" ;
    :has_exact_synonym ""HHF6""@en,
        ""HI/HA syndrome""@en,
        ""hyperinsulinism-hyperammonemia syndrome""@en .

","Familial Hyperinsulinemic Hypoglycemia Type 6 (FHH type 6) is a rare form of autosomal dominant disorder that affects the body's ability to regulate blood sugar levels. It is characterized by excessive insulin secretion, asymptomatic hyperammonemia and recurrent hypoglycemia triggered by fasting or protein-rich meals. This condition has a material basis in mutations of the GLUD1 gene on chromosome 10q23.3. The FHH type 6 is also known as HHF6, HI/HA syndrome and hyperinsulinism-hyperammonemia syndrome.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0070218,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:familial_hyperinsulinemic_hypoglycemia_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :has_phenotype ;
            owl:someValuesFrom :abnormal_blood_glucose_concentration ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :autosomal_recessive_disease,
        :hyperinsulinemic_hypoglycemia ;
    :has_definition ""A hyperinsulinemic hypoglycemia characterized by autosomal recessive inheritance of severe hyperinsulinemic hypoglycemia that is resistant to diazoxide treatment that has_material_basis_in mutation in the KCNJ11 gene on chromosome 11p15.1."" ;
    :has_exact_synonym ""Autosomal recessive hyperinsulinemic hypoglycemia due to Kir6.2 deficiency""@en,
        ""HHF2""@en,
        ""hyperinsulinemic hypoglycemia due to focal adenomatous hyperplasia""@en .

","Familial hyperinsulinemic hypoglycemia 2 (FHH2) is a type of autosomal recessive disease characterized by severe and persistent hypoglycemia that is resistant to treatment with diazoxide. It has a material basis in mutations in the KCNJ11 gene, which is located on chromosome 11p15.1. FHH2 can be diagnosed through genetic testing, and it can also be distinguished from other types of hyperinsulinemic hypoglycemia by its autosomal recessive inheritance pattern and resistance to diazoxide treatment. It has synonyms such as Autosomal recessive hyperinsulinemic hypoglycemia due to Kir6.2 deficiency, HHF2, and hyperinsulinemic hypoglycemia due to focal adenomatous hyperplasia.",10,True
doid,http://purl.obolibrary.org/obo/DOID_0070219,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:familial_hyperinsulinemic_hypoglycemia_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_phenotype ;
            owl:someValuesFrom :abnormal_blood_glucose_concentration ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_dominant_disease,
        :autosomal_recessive_disease,
        :hyperinsulinemic_hypoglycemia ;
    :has_definition ""A hyperinsulinemic hypoglycemia characterized by autosomal recessive inheritance of hyperinsulinemic hypoglycemia that is resistant to diazoxide treatment that has_material_basis_in mutation in the ABCC8 gene on chromosome 11p15."" ;
    :has_exact_synonym ""HHF1""@en .

",Familial hyperinsulinemic hypoglycemia 1 is a type of autosomal dominant disease.,8,True
doid,http://purl.obolibrary.org/obo/DOID_0070220,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:familial_hyperinsulinemic_hypoglycemia_5 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :has_phenotype ;
            owl:someValuesFrom :abnormal_blood_glucose_concentration ],
        :autosomal_dominant_disease,
        :hyperinsulinemic_hypoglycemia ;
    :has_definition ""A hyperinsulinemic hypoglycemia characterized by autosomal dominant inheritance of postprandial hypoglycemia, fasting hyperinsulinemia, and an elevated serum insulin-to-C peptide ratio that has_material_basis_in mutation in the INSR gene on chromosome 19p13."" ;
    :has_exact_synonym ""HHF5""@en,
        ""hyperinsulinemic hypoglycemia due to INSR deficiency""@en,
        ""hyperinsulinemic hypoglycemia due to insulin receptor deficiency""@en,
        ""hyperinsulinism due to INSR deficiency""@en .

","Familial Hyperinsulinemic Hypoglycemia Type 5, also known as HHF5 or INSR-related hypoglycemia, is a type of autosomal dominant disorder characterized by postprandial hypoglycemia, fasting hyperinsulinemia, and an elevated serum insulin-to-C peptide ratio. It is caused by mutations in the INSR gene on chromosome 19p13, which encodes for the insulin receptor. HHF5 has material basis in the inheritance of this disorder and results in abnormal blood glucose concentrations.
<|endoftext|>",9,True
doid,http://purl.obolibrary.org/obo/DOID_0070221,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:progressive_familial_intrahepatic_cholestasis rdfs:subClassOf :intrahepatic_cholestasis ;
    :has_definition ""An intrahepatic cholestasis characterized by early onset of chronic unremitting cholestasis of hepatocellular origin that progresses to hepatic fibrosis, cirrhosis, and end-stage liver disease before adulthood."" ;
    :has_exact_synonym ""PFIC; Byler disease""@en .

","Progressive familial intrahepatic cholestasis (PFIC) is a rare genetic disorder characterized by early onset of chronic unremitting cholestasis of hepatocellular origin that progresses to hepatic fibrosis, cirrhosis, and end-stage liver disease before adulthood. It is caused by mutations in the PFIC gene, which encodes a protein involved in the biosynthesis of bile acids. The disorder primarily affects infants and children and can be life-threatening if not properly managed with medication, dietary restrictions, and liver transplantation when necessary.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070222,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:progressive_familial_intrahepatic_cholestasis_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :progressive_familial_intrahepatic_cholestasis ;
    :has_definition ""A progressive familial intrahepatic cholestasis characterized by autosomal recessive inheritance that has_material_basis_in mutation in the ABCB11 gene on chromosome 2q31."" ;
    :has_exact_synonym ""BSEP deficiency""@en,
        ""PFIC2""@en .

","Progressive familial intrahepatic cholestasis 2 (PFIC2) is a genetic disorder that affects the liver and causes progressive damage. It is inherited in an autosomal recessive pattern, which means that both copies of the gene must be mutated for the disorder to develop. PFIC2 is caused by a deficiency in the BSEP (beta-speckled protein) gene located on chromosome 2q31. This condition can lead to severe liver damage and cirrhosis, and may also affect the brain and other organs. It typically begins in early childhood and can be life-threatening if left untreated. There is currently no cure for PFIC2, but management options include medications, dietary restrictions, and liver transplantation.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070223,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:progressive_familial_intrahepatic_cholestasis_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :progressive_familial_intrahepatic_cholestasis ;
    :has_definition ""A progressive familial intrahepatic cholestasis characterized by autosomal recessive inheritance of intrahepatic cholestasis and elevated serum GGT1 activity that has_material_basis_in mutation in the ABCB4 gene on chromosome 7q21.12."" ;
    :has_exact_synonym ""MDR3 deficiency""@en,
        ""PFIC3""@en,
        ""progressive familial intrahepatic cholestasis with elevated serum gama-glutamyltransferase""@en .

","Progressive familial intrahepatic cholestasis 3 is a type of autosomal recessive disease that affects the liver. It is characterized by progressive familial intrahepatic cholestasis and elevated serum GGT1 activity due to mutations in the ABCB4 gene on chromosome 7q21.12. It also has synonyms such as MDR3 deficiency and PFIC3, which are commonly used to describe this condition. Additionally, it can be referred to as progressive familial intrahepatic cholestasis with elevated serum gama-glutamyltransferase.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0070224,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:progressive_familial_intrahepatic_cholestasis_4 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :progressive_familial_intrahepatic_cholestasis ;
    :has_definition ""A progressive familial intrahepatic cholestasis characterized by autosomal recessive inheritance that has_material_basis_in mutation in the TJP2 gene on chromosome 9q21."" ;
    :has_exact_synonym ""PFIC4""@en,
        ""TJP2 deficit""@en .

","progressive familial intrahepatic cholestasis 4 is a type of autosomal recessive disease.
progressive familial intrahepatic cholestasis 4 is a progressive familial intrahepatic cholestasis that has material basis in some autosomal recessive inheritance.
progressive familial intrahepatic cholestasis 4 has definition A progressive familial intrahepatic cholestasis characterized by mutation in the TJP2 gene on chromosome 9q21.
progressive familial intrahepatic cholestasis 4 has exact synonym PFIC4.
progressive familial intrahepatic cholestasis 4 has exact synonym TJP2 deficit.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070225,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:progressive_familial_intrahepatic_cholestasis_5 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :progressive_familial_intrahepatic_cholestasis ;
    :has_definition ""A progressive familial intrahepatic cholestasis characterized by autosomal recessive inheritance of intralobular cholestasis with onset in the neonatal period that has_material_basis_in mutation in the NR1H4 gene on chromosome 12q."" ;
    :has_exact_synonym ""NR1H4 deficiency""@en,
        ""PFIC5""@en .

",progressive familial intrahepatic cholestasis 5 is a type of autosomal recessive disease.,6,True
doid,http://purl.obolibrary.org/obo/DOID_0070226,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:progressive_familial_intrahepatic_cholestasis_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :progressive_familial_intrahepatic_cholestasis ;
    :has_definition ""A progressive familial intrahepatic cholestasis characterized by autosomal recessive inheritance that has_material_basis_in mutation in the ATP8B1 gene on chromosome 18q21."" ;
    :has_exact_synonym ""FIC1 deficiency""@en,
        ""PFIC1""@en .

","Progressive familial intrahepatic cholestasis 1 (PFIC1) is a type of autosomal recessive genetic disorder characterized by the gradual degeneration and failure of the liver. It is caused by mutations in the ATP8B1 gene, which is located on chromosome 18q21. The condition affects the bile ducts within the liver, leading to the accumulation of excessive bile acids and bilirubin, resulting in jaundice, fatigue, and other symptoms. PFIC1 can be inherited from affected parents, and it is important for individuals with this condition to receive proper medical care and support to manage their symptoms effectively.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070227,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:intrahepatic_cholestasis_of_pregnancy rdfs:subClassOf :intrahepatic_cholestasis ;
    :has_definition ""An intrahepatic cholestasis characterized by reversible cholestasis typically occurring in the second or third trimester of pregnancy, elevated serum aminotransferases and bile acid level and resolution of symptoms by 2 to 3 weeks after delivery."" ;
    :has_exact_synonym ""ICP""@en,
        ""gravidic intrahepatic cholestasis""@en,
        ""pregnancy related cholestasis""@en,
        ""recurrent intrahepatic cholestasis of pregnancy""@en .

","intrahepatic cholestasis of pregnancy is a type of intrahepatic cholestasis.
intrahepatic cholestasis of pregnancy has definition An intrahepatic cholestasis characterized by reversible cholestasis typically occurring in the second or third trimester of pregnancy, elevated serum aminotransferases and bile acid level and resolution of symptoms by 2 to 3 weeks after delivery..
intrahepatic cholestasis of pregnancy has exact synonym ICP.
intrahepatic cholestasis of pregnancy has exact synonym gravidic intrahepatic cholestasis.
intrahepatic cholestasis of pregnancy has exact synonym pregnancy related cholestasis.
intrahepatic cholestasis of pregnancy has exact synonym recurrent intrahepatic cholestasis of pregnancy..",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070228,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:intrahepatic_cholestasis_of_pregnancy_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :intrahepatic_cholestasis_of_pregnancy ;
    :has_definition ""An intrahepatic cholestasis of pregnancy characterized by autosomal dominant inheritance that has_material_basis_in mutation in the ATP8B1 gene on chromosome 18q21."" ;
    :has_exact_synonym ""ICP1""@en,
        ""pregnancy related cholestasis 1""@en .

","intrahepatic cholestasis of pregnancy 1, also known as ICP1 or pregnancy related cholestasis 1, is a type of autosomal dominant disease that is characterized by mutations in the ATP8B1 gene on chromosome 18q21. It is a form of intrahepatic cholestasis that occurs during pregnancy and is caused by the accumulation of bile acids in the liver, which can lead to jaundice, itching, and other symptoms.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070229,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:intrahepatic_cholestasis_of_pregnancy_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :intrahepatic_cholestasis_of_pregnancy ;
    :has_definition ""An intrahepatic cholestasis of pregnancy characterized by autosomal dominant inheritance that has_material_basis_in mutation in the ABCB4 gene on chromosome 7q21."" ;
    :has_exact_synonym ""ICP3""@en,
        ""pregnancy related cholestasis 3""@en .

","intrahepatic cholestasis of pregnancy 3, also known as ICP3 or pregnancy related cholestasis 3, is a type of autosomal dominant disease characterized by mutations in the ABCB4 gene on chromosome 7q21.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070230,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:benign_recurrent_intrahepatic_cholestasis rdfs:subClassOf :intrahepatic_cholestasis ;
    :has_definition ""An intrahepatic cholestasis characterized by intermittent, recurrent episodes of intrahepatic cholestasis mostly without progression to liver damage or extrahepatic bile duct obstruction."" ;
    :has_exact_synonym ""BRIC""@en,
        ""Summerskill-Walshe-Tygstrup syndrome""@en .

","Benign recurrent intrahepatic cholestasis (BRIC) is a condition characterized by intermittent, recurrent episodes of intrahepatic cholestasis without progression to liver damage or extrahepatic bile duct obstruction. It is also known as Summerskill-Walshe-Tygstrup syndrome.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070231,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:benign_recurrent_intrahepatic_cholestasis_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :benign_recurrent_intrahepatic_cholestasis ;
    :has_definition ""A benign recurrent intrahepatic cholestasis characterized by typically autosomal recessive inheritance that has_material_basis_in mutation in the ATP8B1 gene on chromosome 18q."" ;
    :has_exact_synonym ""BRIC type 1""@en,
        ""BRIC1""@en,
        ""Summerskill syndrome""@en .

","Benign recurrent intrahepatic cholestasis 1 (BRIC 1) is a type of autosomal recessive disease characterized by mutations in the ATP8B1 gene on chromosome 18q. It is also known as BRIC type 1 or Summerskill syndrome, and has the exact synonym BRIC1.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0070232,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:benign_recurrent_intrahepatic_cholestasis_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :benign_recurrent_intrahepatic_cholestasis ;
    :has_definition ""A benign recurrent intrahepatic cholestasis characterized by autosomal recessive inheritance that has_material_basis_in mutation in the ABCB11 gene on chromosome 2q31."" ;
    :has_exact_synonym ""BRIC type 2""@en,
        ""BRIC2""@en .

","Benign recurrent intrahepatic cholestasis 2 (BRIC type 2) is a genetic disorder that affects the liver, specifically involving the bile ducts within the liver. It is inherited in an autosomal recessive manner, meaning that to have full expression of the disease, a person must inherit two copies of the faulty gene (one from each parent). The BRIC type 2 gene is located on chromosome 2q31 and mutations in this gene result in impaired bile flow within the liver.

Symptoms of BRIC type 2 may include jaundice, fatigue, itching, loss of appetite, and abdominal pain. In some cases, the condition can also affect a person's mental health, causing depression or anxiety. Treatment for BRIC type 2 typically involves managing symptoms, such as taking medication to alleviate itching, and preventing complications like liver damage or cirrhosis through dietary changes and monitoring of liver function.

It's important to note that while BRIC type 2 is not life-threatening, it can be a chronic condition that requires ongoing medical management. It's also possible for individuals with the gene for BRIC type 2 to have milder symptoms or even be asymptomatic, which is why genetic testing and counseling are recommended for people who may be at risk of inheriting the disorder.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070233,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:loeys_dietz_syndrome_4 rdfs:subClassOf :loeys_dietz_syndrome ;
    :has_definition ""A Loeys-Dietz syndrome that has_material_basis_in heterozygous mutation in the TGFB2 gene on chromosome 1q41."" ;
    :has_exact_synonym ""Aneurysm, aortic and cerebral, with arterial tortuosity and skeletal manifestations""@en,
        ""LDS4""@en .

","Loeys-Dietz syndrome (LDS) is a genetic disorder that affects the connective tissue in the body. LDS4 specifically refers to a subtype of Loeys-Dietz syndrome that has been found to be caused by mutations in the TGFB2 gene on chromosome 1q41. This subtype is characterized by aneurysms and arterial tortuosity, as well as skeletal manifestations. The exact synonym for LDS4 is Aneurysm, aortic and cerebral, with arterial tortuosity and skeletal manifestations.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070234,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:loeys_dietz_syndrome_2 rdfs:subClassOf :loeys_dietz_syndrome ;
    :has_definition ""A Loeys-Dietz syndrome that has_material_basis_in heterozygous mutation in the TGFBR2 gene on chromosome 3p24."" ;
    :has_exact_synonym ""AAT3""@en,
        ""LDS2""@en,
        ""Marfan syndrome type II""@en,
        ""familial throacic aortic aneurysm 3""@en .

","Loeys-Dietz syndrome type 2, also known as LDS2 or Marfan syndrome type II, is a genetic disorder that results from a heterozygous mutation in the TGFBR2 gene on chromosome 3p24. It is characterized by aortic aneurysms and arterial dissections, as well as other connective tissue manifestations such as mitral valve prolapse and scoliosis. The condition is inherited in an autosomal dominant manner, meaning that a person has a 50% chance of inheriting the disorder if one of their parents passes it on. It is named after the two doctors who first described the syndrome, Loeys and Dietz.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070235,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:loeys_dietz_syndrome_1 rdfs:subClassOf :loeys_dietz_syndrome ;
    :has_definition ""A Loeys-Dietz syndrome that has_material_basis_in heterozygous mutation in the TGFBR1 gene on chromosome 9q22."" ;
    :has_exact_synonym ""AAT5""@en,
        ""Furlong syndrome""@en,
        ""LDS1""@en,
        ""familial throacic aortic aneurysm 5""@en .

","Loeys-Dietz syndrome 1, also known as LDS1, is a type of Loeys-Dietz syndrome. It is characterized by a heterozygous mutation in the TGFBR1 gene on chromosome 9q22. The exact synonyms for LDS1 include AAT5, Furlong syndrome, and familial thoracic aortic aneurysm 5.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070236,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:loeys_dietz_syndrome_5 rdfs:subClassOf :loeys_dietz_syndrome ;
    :has_definition ""A Loeys-Dietz syndrome that has_material_basis_in heterozygous mutation in the TGFB3 gene on chromosome 14q24."" ;
    :has_exact_synonym ""LDS5""@en,
        ""RNHF""@en,
        ""Reinhoff syndrome""@en .

","Loeys-Dietz Syndrome 5, also known as LDS5 or Reinhoff syndrome, is a type of Loeys-Dietz Syndrome. It is characterized by a heterozygous mutation in the TGFB3 gene on chromosome 14q24. This condition has been known by different names such as LDS5, RNHF, and Reinhoff syndrome.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070237,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:loeys_dietz_syndrome_3 rdfs:subClassOf :loeys_dietz_syndrome ;
    :has_definition ""A Loeys-Dietz syndrome that has_material_basis_in heterozygous mutation in the SMAD3 gene on chromosome 15q."" ;
    :has_exact_synonym ""LDS1C""@en,
        ""LDS3""@en,
        ""Loeys-Dietz syndrome type 1C""@en,
        ""Loeys-Dietz syndrome with osteoarthritis""@en,
        ""aneurysms-osteoarthritis syndrome""@en .

","Loeys-Dietz Syndrome (LDS) is a genetic disorder caused by mutations in the SMAD3 gene on chromosome 15q. There are different types of LDS, and one of them is Loeys-Dietz Syndrome type 3 (LDS3), which is characterized by a combination of vascular anomalies such as aneurysms and arterial tortuosity, as well as osteoarthritis. Another name for LDS3 is Loeys-Dietz syndrome with osteoarthritis. It is important to note that the symptoms can vary widely among affected individuals and some may not have any noticeable symptoms at all.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0070238,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_coenzyme_q10_deficiency_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :structural_variant ],
        :coenzyme_q10_deficiency_disease ;
    :has_definition ""A primary coenzyme Q10 deficiency that has_material_basis_in an autosomal recessive mutation of the COQ2 gene on chromosome 4q21.22-q21.23."" ;
    :has_exact_synonym ""COQ10D1""@en,
        ""CoQ deficiency 1""@en,
        ""CoQ10 deficiency, primary, 1""@en,
        ""coenzyme Q deficiency 1""@en,
        ""ubiquinone deficiency 1""@en .

","Primary Coenzyme Q10 deficiency 1 is a type of Coenzyme Q10 deficiency disease, which has a basis in some structural variant and is characterized by a primary coenzyme Q10 deficiency that results from an autosomal recessive mutation of the COQ2 gene on chromosome 4q21.22-q21.23. It is also known as CoQ10D1, CoQ deficiency 1, CoQ10 deficiency, primary, 1, coenzyme Q deficiency 1, and ubiquinone deficiency 1.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0070239,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_coenzyme_q10_deficiency_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :structural_variant ],
        :coenzyme_q10_deficiency_disease ;
    :has_definition ""A primary coenzyme Q10 deficiency that has_material_basis_in an autosomal recessive mutation of the PDSS1 gene on chromosome 10p12.1."" ;
    :has_exact_synonym ""COQ10D2""@en,
        ""coenzyme Q10 deficiency, primary, 2""@en,
        ""deafness-encephaloneuropathy-obesity-valvulopathy syndrome""@en,
        ""hearing loss-encephaloneuropathy-obesity-valvulopathy syndrome""@en .

","Primary Coenzyme Q10 Deficiency Type 2 is a condition where a person has an insufficient amount of Coenzyme Q10. This type of deficiency is caused by an autosomal recessive mutation in the PDSS1 gene located on chromosome 10p12.1. This deficiency can cause a variety of symptoms, including deafness, encephaloneuropathy, obesity, and valvulopathy. It is also known as Deafness-Encephaloneuropathy-Obesity-Valvulopathy Syndrome or Hearing Loss-Encephaloneuropathy-Obesity-Valvulopathy Syndrome.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0070240,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_coenzyme_q10_deficiency_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :structural_variant ],
        :coenzyme_q10_deficiency_disease ;
    :has_definition ""A primary coenzyme Q10 deficiency that has_material_basis_in an autosomal recessive mutation of the PDSS2 gene on chromosome 6q21."" ;
    :has_exact_synonym ""COQ10D3""@en,
        ""coenzyme Q10 deficiency, primary, 3""@en .

","Primary Coenzyme Q10 Deficiency 3 is a genetic disorder that results from mutations in the PDSS2 gene on chromosome 6q21. It is one of several types of Coenzyme Q10 deficiency diseases, which are characterized by a lack of functional Coenzyme Q10.
Coenzyme Q10 (also known as ubiquinone) is an essential molecule that plays a vital role in the production of ATP, the energy currency of the cell. It acts as an antioxidant and helps protect cells from damage caused by free radicals. Individuals with Primary Coenzyme Q10 Deficiency 3 may experience a range of symptoms, including fatigue, weakness, and muscle pain. In some cases, the condition can also affect the heart, leading to issues such as arrhythmias or heart failure.
Diagnosis of Primary Coenzyme Q10 Deficiency 3 typically involves genetic testing to identify mutations in the PDSS2 gene. Treatment may include supplements of Coenzyme Q10, as well as medications to manage symptoms and prevent complications.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070241,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_coenzyme_q10_deficiency_4 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :structural_variant ],
        :coenzyme_q10_deficiency_disease ;
    :has_definition ""A primary coenzyme Q10 deficiency that has_material_basis_in an autosomal recessive mutation of the ADCK3 gene on chromosome 1q42.13."" ;
    :has_exact_synonym ""COQ10D4""@en,
        ""SCAR9""@en,
        ""coenzyme Q10 deficiency, primary, 4""@en,
        ""spinocerebellar ataxia, autosomal recessive 9""@en .

","Primary coenzyme Q10 deficiency 4, also known as SCAR9 and CoQ10D4, is a rare genetic disorder that results from an autosomal recessive mutation of the ADCK3 gene on chromosome 1q42.13. This condition affects mitochondrial function and can lead to neurodegenerative symptoms such as ataxia, dystonia, and dementia. It is important for those affected by this disorder to work with a healthcare professional experienced in managing rare genetic diseases.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0070242,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_coenzyme_q10_deficiency_5 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :structural_variant ],
        :coenzyme_q10_deficiency_disease ;
    :has_definition ""A primary coenzyme Q10 deficiency that has_material_basis_in an autosomal recessive mutation of the COQ9 gene on chromosome 16q21."" ;
    :has_exact_synonym ""COQ10D5""@en,
        ""coenzyme Q10 deficiency, primary, 5""@en,
        ""encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndrome""@en .

","Primary Coenzyme Q10 Deficiency 5 (CoQ10D5) is a rare autosomal recessive disorder that results from mutations in the COQ9 gene on chromosome 16q21. It primarily affects the brain, heart, and kidneys, leading to symptoms such as encephalopathy (brain damage), hypertrophic cardiomyopathy (heart muscle thickening), and renal tubular disease (kidney damage). CoQ10 is an essential nutrient that plays a crucial role in cellular energy production, and deficiency can lead to a range of debilitating symptoms. Treatment typically involves supplementation with CoQ10 and other related compounds, as well as addressing any underlying health issues. It's important for individuals affected by CoQ10D5 to work closely with their healthcare providers to develop an appropriate treatment plan tailored to their specific needs.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070243,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_coenzyme_q10_deficiency_6 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :structural_variant ],
        :coenzyme_q10_deficiency_disease ;
    :has_definition ""A primary coenzyme Q10 deficiency that has_material_basis_in an autosomal recessive mutation of the COQ6 gene on chromosome 14q24.3."" ;
    :has_exact_synonym ""COQ10D6""@en,
        ""coenzyme Q10 deficiency, primary, 6""@en,
        ""familial steroid-resistant nephrotic syndrome with sensorineural deafness""@en .

","Primary coenzyme Q10 deficiency 6 is a rare genetic disorder that is caused by mutations in the COQ6 gene on chromosome 14q24.3. It leads to a deficiency of the enzyme Coenzyme Q10, which is essential for energy production in cells. Symptoms can include progressive hearing loss, kidney disease, and steroid-resistant nephrotic syndrome. Treatment typically involves supplementation with Coenzyme Q10 and other supportive measures.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070244,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_coenzyme_q10_deficiency_7 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :structural_variant ],
        :coenzyme_q10_deficiency_disease ;
    :has_definition ""A primary coenzyme Q10 deficiency that has_material_basis_in an autosomal recessive mutation of the COQ4 gene on chromosome 9q34.11."" ;
    :has_exact_synonym ""COQ10D7""@en,
        ""COQ4-related neonatal encephalomyopathy""@en,
        ""coenzyme Q10 deficiency, primary, 7""@en,
        ""neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome""@en .

","Primary Coenzyme Q10 deficiency type 7, also known as COQ4-related neonatal encephalomyopathy, is a condition that results from a mutation of the COQ4 gene on chromosome 9q34.11. It has an autosomal recessive inheritance pattern and can cause severe symptoms in newborns, including neurological problems, cardiomyopathy, and respiratory distress. The exact synonyms for this condition include COQ10D7, neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome, coenzyme Q10 deficiency, primary, 7, and primary Coenzyme Q10 deficiency type 7.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0070245,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_coenzyme_q10_deficiency_8 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :structural_variant ],
        :coenzyme_q10_deficiency_disease ;
    :has_definition ""A primary coenzyme Q10 deficiency that has_material_basis_in an autosomal recessive mutation of the COQ7 gene on chromosome 16p12.3."" ;
    :has_exact_synonym ""COQ10D8""@en,
        ""coenzyme Q10 deficiency, primary, 8""@en .

","Coenzyme Q10, also known as ubiquinone, is a coenzyme that plays an essential role in the electron transport chain, where it acts as an antioxidant, helping to protect the body's cells from damage caused by free radicals. A deficiency of CoQ10 can lead to a variety of health problems, including heart disease, high blood pressure, and poor exercise performance. Primary Coenzyme Q10 Deficiency 8, also known as COQ10D8, is a type of Coenzyme Q10 deficiency that is caused by mutations in the COQ7 gene on chromosome 16p12.3. It is an autosomal recessive disorder, which means that it can be inherited from either parent and can affect people of all ages and genders. Symptoms may include fatigue, weakness, and decreased physical endurance. Treatment may involve supplements or medications to increase CoQ10 levels in the body.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070246,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:x_linked_emery_dreifuss_muscular_dystrophy_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_recessive_inheritance ],
        :emery_dreifuss_muscular_dystrophy,
        :x_linked_recessive_disease ;
    :has_definition ""An Emery-Dreifuss muscular dystrophy that has_material_basis_in an X-linked recessive mutation of EMD on chromosome Xq28."" ;
    :has_exact_synonym ""EDMD1""@en,
        ""EMD1""@en,
        ""Emery-Dreifuss muscular dystrophy 1, X-linked""@en,
        ""humeroperoneal neuromuscular disease""@en,
        ""muscular dystrophy, tardive, Dreifuss-Emery type, with contractures""@en,
        ""scapuloperoneal syndrome, X-linked""@en .

","x linked emery dreifuss muscular dystrophy 1 is a type of x linked recessive disease.
x linked emery dreifuss muscular dystrophy 1 is a form of emery dreifuss muscular dystrophy that has material basis in an X-linked recessive inheritance.",10,True
doid,http://purl.obolibrary.org/obo/DOID_0070247,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_emery_dreifuss_muscular_dystrophy_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :emery_dreifuss_muscular_dystrophy ;
    :has_definition ""An Emery-Dreifuss muscular dystrophy that has_material_basis_in an autosomal dominant mutation of the LMNA gene on chromosome 1q22."" ;
    :has_exact_synonym ""EDMD2""@en,
        ""EMD2""@en,
        ""Emery-Dreifuss muscular dystrophy 2, autosomal dominant""@en,
        ""Emery-Dreifuss muscular dystrophy, autosomal dominant""@en,
        ""Hauptmann-Thannhauser muscular dystrophy""@en,
        ""autosomal dominant limb-girdle muscular dystrophy type 1B""@en,
        ""muscular dystrophy with early contractures and cardiomyopathy, autosomal dominant""@en,
        ""scapuloilioperoneal atrophy with cardiopathy""@en .

","Autosomal dominant Emery Dreifuss muscular dystrophy 2, also known as EDMD2 or EMD2, is a type of Emery-Dreifuss muscular dystrophy that has material basis in an autosomal dominant mutation of the LMNA gene on chromosome 1q22. It is characterized by progressive muscle weakness and was first described by Emery and Dreifuss in 1963. The condition is inherited in an autosomal dominant manner, meaning that a single copy of the mutated gene is enough to cause the disease.

Hauptmann-Thannhauser muscular dystrophy, autosomal dominant limb-girdle muscular dystrophy type 1B, scapuloilioperoneal atrophy with cardiopathy, and muscular dystrophy with early contractures and cardiomyopathy are all synonyms for EDMD2.",12,True
doid,http://purl.obolibrary.org/obo/DOID_0070248,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_emery_dreifuss_muscular_dystrophy_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :emery_dreifuss_muscular_dystrophy ;
    :has_definition ""An Emery-Dreifuss muscular dystrophy that has_material_basis_in an autosomal recessive mutation of the LMNA gene on chromosome 1q22."" ;
    :has_exact_synonym ""EDMD3""@en,
        ""Emery-Dreifuss muscular dystrophy 3, autosomal recessive""@en .

","autosomal recessive emery dreifuss muscular dystrophy 3 is a type of autosomal recessive disease.
autosomal recessive emery dreifuss muscular dystrophy 3 is a type of autosomal recessive inheritance.
autosomal recessive emery dreifuss muscular dystrophy 3 has definition An Emery-Dreifuss muscular dystrophy that has_material_basis_in an autosomal recessive mutation of the LMNA gene on chromosome 1q22.
autosomal recessive emery dreifuss muscular dystrophy 3 is a type of something that at least has material basis in some autosomal recessive inheritance.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070249,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_emery_dreifuss_muscular_dystrophy_4 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :emery_dreifuss_muscular_dystrophy ;
    :has_definition ""An Emery-Dreifuss muscular dystrophy that has_material_basis_in an autosomal dominant mutation of the SYNE1 gene on chromosome 6q25.2."" ;
    :has_exact_synonym ""EDMD4""@en,
        ""Emery-Dreifuss muscular dystrophy 4 with variable features""@en,
        ""Emery-Dreifuss muscular dystrophy 4, autosomal dominant""@en .

",autosomal dominant emery dreifuss muscular dystrophy 4 is a type of autosomal dominant disease.,7,True
doid,http://purl.obolibrary.org/obo/DOID_0070250,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_emery_dreifuss_muscular_dystrophy_5 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :emery_dreifuss_muscular_dystrophy ;
    :has_definition ""An Emery-Dreifuss muscular dystrophy that has_material_basis_in an autosomal dominant mutation of the SYNE2 gene on chromosome 14q23.2."" ;
    :has_exact_synonym ""EDMD5""@en,
        ""Emery-Dreifuss muscular dystrophy 5, autosomal dominant""@en .

",autosomal dominant emery dreifuss muscular dystrophy 5 is a type of autosomal dominant disease that has_material_basis_in an autosomal dominant mutation of the SYNE2 gene on chromosome 14q23.2.,6,True
doid,http://purl.obolibrary.org/obo/DOID_0070251,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:x_linked_emery_dreifuss_muscular_dystrophy_6 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_recessive_inheritance ],
        :emery_dreifuss_muscular_dystrophy,
        :x_linked_recessive_disease ;
    :has_definition ""An Emery-Dreifuss muscular dystrophy that has_material_basis_in an X-linked recessive mutation of the FHL1 gene on chromosome Xq26.3."" ;
    :has_exact_synonym ""EDMD6""@en,
        ""Emery-Dreifuss muscular dystrophy 6, X-linked""@en,
        ""XMPMA""@en,
        ""myopathy, X-linked, with postural muscle atrophy""@en .

","X-linked Emery Dreifuss Muscular Dystrophy 6, also known as EDMD6 or XMPMA, is a type of muscular dystrophy that occurs due to an X-linked recessive inheritance. It affects the muscles in the legs and trunk, causing weakness and atrophy over time. The condition is caused by mutations in the FHL1 gene on chromosome Xq26.3.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0070252,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_emery_dreifuss_muscular_dystrophy_7 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :emery_dreifuss_muscular_dystrophy ;
    :has_definition ""An Emery-Dreifuss muscular dystrophy that has_material_basis_in an autosomal dominant mutation of the TMEM43 gene on chromosome 3p25.1."" ;
    :has_exact_synonym ""EDMD7""@en,
        ""Emery-Dreifuss muscular dystrophy 7, autosomal dominant""@en .

","Autosomal dominant Emery Dreifuss muscular dystrophy 7 (EDMD7) is a specific type of the more general EDMD condition. It is characterized by progressive muscle weakness, particularly in the lower extremities. It is caused by mutations in the TMEM43 gene on chromosome 3p25.1 and has a strong genetic component, as it is inherited in an autosomal dominant manner. This means that if one of your parents passes on the affected gene, you have a 50% chance of developing EDMD7 yourself.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070253,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_disorder_of_glycosylation_type_i_ia rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        :autosomal_recessive_disease,
        :congenital_disorder_of_glycosylation_type_ii ;
    :has_definition ""A congenital disorder of glycosylation type II that has_material_basis_in an autosomal recessive mutation of the MGAT2 gene on chromosome 14q21.3."" ;
    :has_exact_synonym ""Alkuraya syndrome""@en,
        ""CDG IIa""@en,
        ""CDG2A""@en,
        ""CDGIIa""@en,
        ""CDGS2""@en,
        ""carbohydrate-deficient glycoprotein syndrome, type II""@en,
        ""congenital disorder of glycosylation, type IIa""@en,
        ""mental retardation, growth retardation, prominent columella, and open mouth""@en .

","Congenital disorder of glycosylation type Ia (CDG IIa) is a rare genetic disorder that affects the way the body processes and uses carbohydrates. It is caused by mutations in one of several genes involved in glycosylation, a process essential for the functioning of many proteins in the body. The symptoms of CDG IIa can vary widely depending on the specific gene affected and the severity of the mutation. Some common features include developmental delays, physical abnormalities, and problems with the immune system. CDG IIa is inherited in an autosomal recessive pattern, which means that a child must inherit two copies of the gene (one from each parent) to develop the disorder.",13,True
doid,http://purl.obolibrary.org/obo/DOID_0070254,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_disorder_of_glycosylation_type_i_ib rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        :autosomal_recessive_disease,
        :congenital_disorder_of_glycosylation_type_ii ;
    :has_definition ""A congenital disorder of glycosylation type II that has_material_basis_in an autosomal recessive mutation of the MOGS gene on chromosome 2p13.1."" ;
    :has_exact_synonym ""CDG IIb""@en,
        ""CDG2B""@en,
        ""CDGIIb""@en,
        ""glucosidase I deficiency""@en .

","Congenital disorder of glycosylation type I is a type of congenital disorder of glycosylation.
Congenital disorder of glycosylation type I is a type of autosomal recessive disease.
Congenital disorder of glycosylation type I is a type of something that at least has material basis in some autosomal recessive inheritance.
Congenital disorder of glycosylation type I is a type of something that at least disease has basis in some abnormality of prenatal development or birth.
Congenital disorder of glycosylation type I has definition A congenital disorder of glycosylation type II that has_material_basis_in an autosomal recessive mutation of the MOGS gene on chromosome 2p13.1..
Congenital disorder of glycosylation type I has exact synonym CDG IIa.
Congenital disorder of glycosylation type I has exact synonym CDG1a.
Congenital disorder of glycosylation type I has exact synonym congenital disorder of glycosylation type 1a.
Congenital disorder of glycosylation type I has exact synonym galactosialidosis.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0070255,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_disorder_of_glycosylation_type_i_ic rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        :autosomal_recessive_disease,
        :congenital_disorder_of_glycosylation_type_ii ;
    :has_definition ""A congenital disorder of glycosylation type II that has_material_basis_in an autosomal recessive mutation of the SLC35C1 gene on chromosome 11p11.2."" ;
    :has_exact_synonym ""CDG IIc""@en,
        ""CDG2C""@en,
        ""CDGIIc""@en,
        ""Rambam-Hasharon syndrome""@en .

","Congenital disorder of glycosylation type I is a type of congenital disorder of glycosylation type II.
Congenital disorder of glycosylation type I is a type of autosomal recessive disease.
Congenital disorder of glycosylation type I is a type of something that at least has material basis in some autosomal recessive inheritance.
Congenital disorder of glycosylation type I is a type of something that at least disease has basis in some abnormality of prenatal development or birth.
Congenital disorder of glycosylation type I has definition A congenital disorder of glycosylation type II that has_material_basis_in an autosomal recessive mutation of the SLC35C1 gene on chromosome 11p11.2..
Congenital disorder of glycosylation type I has exact synonym CDG IIc.
Congenital disorder of glycosylation type I has exact synonym CDG2C.
Congenital disorder of glycosylation type I has exact synonym CDGIIc.
Congenital disorder of glycosylation type I has exact synonym Rambam-Hasharon syndrome.<|endoftext|>",9,True
doid,http://purl.obolibrary.org/obo/DOID_0070256,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_disorder_of_glycosylation_type_i_id rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :congenital_disorder_of_glycosylation_type_ii ;
    :has_definition ""A congenital disorder of glycosylation type II that has_material_basis_in an autosomal recessive mutation of the B4GALT1 gene on chromosome 9p21.1."" ;
    :has_exact_synonym ""CDG IId""@en,
        ""CDG2D""@en,
        ""CDGIId""@en .

","Congenital disorder of glycosylation type I, also known as CDG Type I, is a rare genetic disorder that affects the way certain proteins are properly formed and function in the body. It is caused by mutations in specific genes responsible for coding for enzymes involved in the synthesis of complex carbohydrates called glycans.
These mutations can cause a buildup of incorrect or missing glycans, which can disrupt the functioning of other proteins and lead to a variety of physical and developmental problems.
CDG Type I is inherited in an autosomal recessive pattern, which means that a child must inherit two copies of the mutated gene (one from each parent) to develop the disorder. It can affect many systems in the body, including the immune system, digestive system, and nervous system.
There is no cure for CDG Type I, but early diagnosis and treatment can help manage its symptoms and improve quality of life. Treatment may include dietary modifications, enzyme replacement therapy, and other supportive care measures.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0070257,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_disorder_of_glycosylation_type_i_ie rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :congenital_disorder_of_glycosylation_type_ii ;
    :has_definition ""A congenital disorder of glycosylation type II that has_material_basis_in a mutation of the COG7 gene on chromosome 16p12.2."" ;
    :has_exact_synonym ""CDG IIe""@en,
        ""CDG syndrome type IIe""@en,
        ""CDG2E""@en,
        ""CDGIIde""@en,
        ""COG7-CDG""@en,
        ""Carbohydrate deficient glycoprotein syndrome type IIe""@en .

","Congenital disorder of glycosylation type I is a genetic condition that affects the way proteins are modified. It is caused by mutations in the COG7 gene, which is located on chromosome 16p12.2. This condition can cause a range of symptoms, including developmental delays, weak muscles, and problems with movement and coordination. In severe cases, it can also lead to life-threatening complications such as cardiac failure or respiratory distress. Congenital disorder of glycosylation type I is inherited in an autosomal recessive pattern, which means that a person must inherit two copies of the gene (one from each parent) to develop the condition. There is no cure for congenital disorder of glycosylation type I, but treatment options may include physical therapy, speech therapy, and occupational therapy to help manage symptoms.",11,True
doid,http://purl.obolibrary.org/obo/DOID_0070258,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_disorder_of_glycosylation_type_i_if rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :congenital_disorder_of_glycosylation_type_ii ;
    :has_definition ""A congenital disorder of glycosylation type II that has_material_basis_in an autosomal recessive mutation of the SLC35A1 gene on chromosome 6q15."" ;
    :has_exact_synonym ""CDG IIf""@en,
        ""CDG2F""@en,
        ""CDGIIdf""@en,
        ""CMP-sialic acid transporter deficiency""@en,
        ""Carbohydrate deficient glycoprotein syndrome type IIf""@en,
        ""SLC35A1-CDG""@en .

","Congenital disorder of glycosylation type I, also known as CDG IIf or CMP-sialic acid transporter deficiency, is a rare genetic disorder that affects the way proteins are properly glycosylated. It is caused by mutations in the SLC35A1 gene on chromosome 6q15 and can be inherited in an autosomal recessive pattern. Symptoms of CDG IIf can include developmental delay, weakness, blindness, seizures, and gastrointestinal problems. The exact cause of the disorder is unknown, but it is believed to have a material basis in some abnormality of prenatal development or birth.",11,True
doid,http://purl.obolibrary.org/obo/DOID_0070259,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_disorder_of_glycosylation_type_i_ig rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        :autosomal_recessive_disease,
        :congenital_disorder_of_glycosylation_type_ii ;
    :has_definition ""A congenital disorder of glycosylation type II that has_material_basis_in a mutation of the COG1 gene on chromosome 17q25.1."" ;
    :has_exact_synonym ""CDG IIg""@en,
        ""CDG2G""@en,
        ""CDGII/COG1 cerebrocostomandibular-like syndrome""@en,
        ""CDGIIg""@en,
        ""Carbohydrate deficient glycoprotein syndrome type IIg""@en .

","Congenital disorder of glycosylation type I Ig (CDG-I Ig) is a type of congenital disorder of glycosylation type II. CDG-I Ig has material basis in mutations of the COG1 gene on chromosome 17q25.1, and is also known as CDG IIg or CDG2G. It can cause a cerebrocostomandibular-like syndrome, which includes symptoms such as developmental delay, dyspraxia, and dental abnormalities. This condition is inherited in an autosomal recessive manner, meaning that to develop the disorder, a person must have two copies of the mutated gene, one from each parent.",10,True
doid,http://purl.obolibrary.org/obo/DOID_0070260,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_disorder_of_glycosylation_type_i_ih rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        :autosomal_recessive_disease,
        :congenital_disorder_of_glycosylation_type_ii ;
    :has_definition ""A congenital disorder of glycosylation type II that has_material_basis_in a mutation of the COG8 gene on chromosome 16q22.1."" ;
    :has_exact_synonym ""CDG IIh""@en,
        ""CDG2H""@en,
        ""CDGIIdh""@en,
        ""COG8-CDG""@en,
        ""Carbohydrate deficient glycoprotein syndrome type IIh""@en,
        ""Congenital disorder of glycosylation type 2h""@en .

","Congenital disorder of glycosylation type I is a type of congenital disorder of glycosylation.
Congenital disorder of glycosylation type I is a type of autosomal recessive disease.
Congenital disorder of glycosylation type I has definition A congenital disorder of glycosylation that has_material_basis_in a mutation of the PMM2 gene on chromosome 7q11.23 and is characterized by severe mental retardation, dysmorphic features, and either mucopolysaccharidosis type VII or mucopolysaccharidosis type II.
Congenital disorder of glycosylation type I has exact synonym CDG1A.
Congenital disorder of glycosylation type I has exact synonym MPS VII.
Congenital disorder of glycosylation type I has exact synonym Mucopolysaccharidosis type VII.
Congenital disorder of glycosylation type I has exact synonym Mucopolysaccharidosis 7.",11,True
doid,http://purl.obolibrary.org/obo/DOID_0070261,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_disorder_of_glycosylation_type_i_ii rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :congenital_disorder_of_glycosylation_type_ii ;
    :has_definition ""A congenital disorder of glycosylation type II that has_material_basis_in a mutation of the COG5 gene on chromosome 7q22.3."" ;
    :has_exact_synonym ""CDG IIi""@en,
        ""CDG syndrome type IIi""@en,
        ""CDG2I""@en,
        ""CDGIIdi""@en,
        ""COG5-CDG""@en,
        ""Carbohydrate deficient glycoprotein syndrome type IIi""@en,
        ""Congenital disorder of glycosylation type 2i""@en .

","Congenital disorder of glycosylation type I and II are genetic disorders that affect the way proteins are modified with carbohydrates. These disorders are caused by mutations in specific genes that code for enzymes involved in the process.
There are several types of CDG, each with its own specific set of symptoms and severity. Some common symptoms include developmental delays, poor muscle tone, weakness, and vision problems. In severe cases, it can also affect the liver, spleen, and kidneys.
CDG is typically diagnosed through a combination of medical history, physical examination, laboratory tests, and genetic testing. Early detection and treatment are important to prevent long-term complications. There is no cure for CDG, but treatment can help manage symptoms and improve quality of life.
Research is ongoing to better understand the underlying causes of CDG and to develop more effective treatments.",12,True
doid,http://purl.obolibrary.org/obo/DOID_0070262,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_disorder_of_glycosylation_type_i_ij rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        :autosomal_recessive_disease,
        :congenital_disorder_of_glycosylation_type_ii ;
    :has_definition ""A congenital disorder of glycosylation type II that has_material_basis_in an autosomal recessive mutation of the COG4 gene on chromosome 16q22.1."" ;
    :has_exact_synonym ""CDG IIj""@en,
        ""CDG syndrome type IIj""@en,
        ""CDG2J""@en,
        ""CDGIIdj""@en,
        ""COG4-CDG""@en,
        ""Carbohydrate deficient glycoprotein syndrome type IIj""@en,
        ""Congenital disorder of glycosylation type 2j""@en .

","Congenital disorder of glycosylation type I is a type of congenital disorder of glycosylation type II.
Congenital disorder of glycosylation type I is a type of autosomal recessive disease.
Congenital disorder of glycosylation type I is a type of something that at least has material basis in some autosomal recessive inheritance.
Congenital disorder of glycosylation type I is a type of something that at least disease has basis in some abnormality of prenatal development or birth.
Congenital disorder of glycosylation type I has definition A congenital disorder of glycosylation type II that has_material_basis_in an autosomal recessive mutation of the COG4 gene on chromosome 16q22.1..
Congenital disorder of glycosylation type I has exact synonym CDG IIj.
Congenital disorder of glycosylation type I has exact synonym CDG syndrome type IIj.
Congenital disorder of glycosylation type I has exact synonym CDG2J.
Congenital disorder of glycosylation type I has exact synonym CDGIIdj.
Congenital disorder of glycosylation type I has exact synonym COG4-CDG.
Congenital disorder of glycosylation type I has exact synonym Carbohydrate deficient glycoprotein syndrome type IIj.
Congenital disorder of glycosylation type I has exact synonym Congenital disorder of glycosylation type 2j.<|endoftext|>",12,True
doid,http://purl.obolibrary.org/obo/DOID_0070263,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_disorder_of_glycosylation_type_i_ik rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        :autosomal_recessive_disease,
        :congenital_disorder_of_glycosylation_type_ii ;
    :has_definition ""A congenital disorder of glycosylation type II that has_material_basis_in an autosomal recessive mutation of the TMEM165 gene on chromosome 4q12."" ;
    :has_exact_synonym ""CDG IIk""@en,
        ""CDG syndrome type IIk""@en,
        ""CDG2K""@en,
        ""CDGIIdk""@en,
        ""Carbohydrate deficient glycoprotein syndrome type IIk""@en,
        ""Congenital disorder of glycosylation type 2k""@en,
        ""TMEM165-CDG""@en .

","Congenital disorder of glycosylation type I (Ik) is a form of the disease Congenital disorder of glycosylation II (II).
Congenital disorder of glycosylation type I (Ik) is an autosomal recessive disease.
Congenital disorder of glycosylation type I (Ik) is a form of the syndrome that has at least some material basis in autosomal recessive inheritance.
Congenital disorder of glycosylation type I (Ik) is a disease with a basis in abnormal prenatal development or birth.
Congenital disorder of glycosylation type I (Ik) has the definition that it's Congenital disorder of glycosylation type II (II) that has material basis in an autosomal recessive mutation of the TMEM165 gene on chromosome 4q12..
Congenital disorder of glycosylation type I (Ik) is exact synonym for CDG IIk.
Congenital disorder of glycosylation type I (Ik) is exact synonym for CDG syndrome type IIk.
Congenital disorder of glycosylation type I (Ik) is exact synonym for CDG2K.
Congenital disorder of glycosylation type I (Ik) is exact synonym for CDGIIdk.
Congenital disorder of glycosylation type I (Ik) is exact synonym for Carbohydrate deficient glycoprotein syndrome type IIk.
Congenital disorder of glycosylation type I (Ik) is exact synonym for Congenital disorder of glycosylation type 2k.
Congenital disorder of glycosylation type I (Ik) is exact synonym for TMEM165-CDG.",12,True
doid,http://purl.obolibrary.org/obo/DOID_0070264,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_disorder_of_glycosylation_type_i_il rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :congenital_disorder_of_glycosylation_type_ii ;
    :has_definition ""A congenital disorder of glycosylation type II that has_material_basis_in an autosomal recessive mutation of the COG6 gene on chromosome 13q14.11."" ;
    :has_exact_synonym ""CDG IIl""@en,
        ""CDG syndrome type IIL""@en,
        ""CDG2L""@en,
        ""CDGIIdl""@en,
        ""COG6-CGD""@en,
        ""Congenital disorder of glycosylation type 2l""@en .

","Congenital disorder of glycosylation type I is a subtype of Congenital disorder of glycosylation type II.
Congenital disorder of glycosylation type I is a subtype of Autosomal recessive disease.
Congenital disorder of glycosylation type I is a subtype of Something that has at least some material basis in autosomal recessive inheritance.
Congenital disorder of glycosylation type I is a subtype of Something that has at least some disease basis in abnormalities of prenatal development or birth.
Congenital disorder of glycosylation type I has the definition Congenital disorder of glycosylation type II that has material basis in an autosomal recessive mutation of the COG6 gene on chromosome 13q14.11..
Congenital disorder of glycosylation type I has exact synonym CDG IIl.
Congenital disorder of glycosylation type I has exact synonym CDG syndrome type IIL.
Congenital disorder of glycosylation type I has exact synonym CDG2L.
Congenital disorder of glycosylation type I has exact synonym CDGIIdl.
Congenital disorder of glycosylation type I has exact synonym COG6-CGD.
Congenital disorder of glycosylation type I has exact synonym Congenital disorder of glycosylation type 2l.<|endoftext|>",11,True
doid,http://purl.obolibrary.org/obo/DOID_0070265,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_disorder_of_glycosylation_type_i_im rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_dominant_inheritance ],
        :congenital_disorder_of_glycosylation_type_ii,
        :x_linked_dominant_disease ;
    :has_definition ""A congenital disorder of glycosylation type II that is characterized by infantile onset seizures, hypsarrhythmia, hypotonia, and severe intellectual disability with lack of speech and that has_material_basis_in X-linked dominant inheritance of hemizygous or heterozygous mutation in the SLC35A2 gene on chromosome Xp11.23."" ;
    :has_exact_synonym ""developmental and epileptic encephalopathy 22"",
        ""SLC35A2-CDG""@en,
        ""congenital disorder of glycosylation type 2m""@en,
        ""epileptic encephalopathy, early infantile, 22""@en .

",Congenital Disorder of Glycosylation Type I is also known as SLC35A2-CDG.,9,True
doid,http://purl.obolibrary.org/obo/DOID_0070266,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_disorder_of_glycosylation_type_i_in rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :congenital_disorder_of_glycosylation_type_ii ;
    :has_definition ""A congenital disorder of glycosylation type II that has_material_basis_in an autosomal recessive mutation of the SLC39A8 gene on chromosome 4q24."" ;
    :has_exact_synonym ""CDG IIn""@en,
        ""CDG syndrome type IIn""@en,
        ""CDG2N""@en,
        ""CDGIIdn""@en,
        ""Carbohydrate deficient glycoprotein syndrome type IIn""@en,
        ""Congenital disorder of glycosylation type 2n""@en,
        ""SLC39A8-CDG""@en .

","Congenital disorder of glycosylation type I (CDG I) is a rare genetic disorder that affects the way proteins are modified with carbohydrates. This results in the improper functioning of certain enzymes and can cause a range of symptoms, including developmental delays, poor motor skills, vision problems, feeding difficulties, and digestive issues. CDG I is inherited in an autosomal recessive manner, meaning that an individual needs to have two copies of the gene (one from each parent) for the disorder to be expressed. It can also result from mutations in the SLC39A8 gene on chromosome 4q24. CDG I has several synonyms including CDG syndrome type I, Congenital disorder of glycosylation type 2n, and Carbohydrate deficient glycoprotein syndrome type I.",12,True
doid,http://purl.obolibrary.org/obo/DOID_0070267,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_disorder_of_glycosylation_type_i_io rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        :autosomal_recessive_disease,
        :congenital_disorder_of_glycosylation_type_ii ;
    :has_definition ""A congenital disorder of glycosylation type II that has_material_basis_in an autosomal recessive mutation of the CCDC115 gene on chromosome 2q21.1."" ;
    :has_exact_synonym ""CCDC115-CDG""@en,
        ""CDG IIo""@en,
        ""CDG syndrome type IIo""@en,
        ""CDG2O""@en,
        ""CDGIIdo""@en,
        ""Carbohydrate deficient glycoprotein syndrome type IIo""@en,
        ""Congenital disorder of glycosylation type 2o""@en .

","Congenital disorder of glycosylation type I is a subtype of Congenital disorder of glycosylation, which in turn is a subtype of Metabolic disease.",12,True
doid,http://purl.obolibrary.org/obo/DOID_0070268,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_disorder_of_glycosylation_type_i_ip rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        :autosomal_recessive_disease,
        :congenital_disorder_of_glycosylation_type_ii ;
    :has_definition ""A congenital disorder of glycosylation type II that has_material_basis_in an autosomal recessive mutation of the TMEM199 gene on chromosome 17q11.2."" ;
    :has_exact_synonym ""CDG IIp""@en,
        ""CDG syndrome type IIp""@en,
        ""CDG2P""@en,
        ""CDGIIdp""@en,
        ""Carbohydrate deficient glycoprotein syndrome type IIp""@en,
        ""Congenital disorder of glycosylation type 2p""@en,
        ""TMEM199-CDG""@en .

","Congenital disorder of glycosylation type I is a rare genetic disorder that affects the proper processing and functioning of certain proteins in the body. It is caused by mutations in the TMEM199 gene, which is located on chromosome 17q11.2. The disorder primarily affects the brain and can cause a range of developmental problems, including intellectual disability, seizures, and delayed growth. There are two types of CDG I, type I and II. Type II is also known as congenital disorder of glycosylation type II.",12,True
doid,http://purl.obolibrary.org/obo/DOID_0070269,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_disorder_of_glycosylation_type_i_iq rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :congenital_disorder_of_glycosylation_type_ii ;
    :has_definition ""A congenital disorder of glycosylation type II that has_material_basis_in an autosomal recessive mutation of the COG2 gene on chromosome 1q42.2."" ;
    :has_exact_synonym ""CDG IIq""@en,
        ""CDG2Q""@en,
        ""CDGIIdq""@en,
        ""COG2-CDG""@en,
        ""COG2-related congenital disorder of glycosylation""@en .

","Congenital disorder of glycosylation type I is a rare genetic disorder that affects the way certain proteins are built and function in the body. It is caused by mutations in the COG2 gene on chromosome 1q42.2, which encodes for an enzyme involved in the process of glycosylation. Glycosylation is a critical step in the production of many proteins and plays a vital role in various bodily functions such as immune system function, cell signalling, and tissue development.

People with Congenital disorder of glycosylation type I may experience a range of symptoms including weakness, muscle stiffness, recurrent fevers, and mental retardation. The severity of the condition can vary significantly among individuals and may affect different parts of the body.

The diagnosis of Congenital disorder of glycosylation type I is typically made through a combination of genetic testing, clinical examination, and laboratory tests. Treatment options depend on the specific symptoms present in each individual but may include enzyme replacement therapy, dietary modifications, and supportive care. With appropriate medical intervention, many individuals with Congenital disorder of glycosylation type I can lead relatively normal lives.

It is important to note that while genetic counseling can provide valuable information about the risk of recurrence and other implications for families affected by this condition, a diagnosis of Congenital disorder of glycosylation type I should be made by a qualified medical professional.",10,True
doid,http://purl.obolibrary.org/obo/DOID_0070270,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hereditary_nonpolyposis_colorectal_cancer_type_8 rdfs:subClassOf [ owl:intersectionOf [ rdf:first [ a owl:Restriction ;
                            owl:onProperty :has_material_basis_in ;
                            owl:someValuesFrom :deletion ] ;
                    rdf:rest [ rdf:first [ a owl:Restriction ;
                                    owl:onProperty :has_material_basis_in ;
                                    owl:someValuesFrom :chromosome ] ;
                            rdf:rest :nil ] ] ],
        :chromosomal_deletion_syndrome,
        :lynch_syndrome ;
    :has_definition ""A Lynch syndrome that has_material_basis_in heterozygous deletion of the 3' part of the EPCAM gene and intergenic regions adjacent to the MSH2 gene on chromosome 2p21. This results in transcriptional read-through and silencing of MSH2 in tissues expressing EPCAM."" ;
    :has_exact_synonym ""HNPCC8""@en .

","Hereditary nonpolyposis colorectal cancer type 8, also known as HNPCC8, is a genetic condition that results from the deletion of specific genes on chromosome 2p21. This leads to the silencing of MSH2 in tissues expressing EPCAM and transcriptional read-through of adjacent intergenic regions. It is also referred to as Lynch syndrome, which has a material basis in one or more of the following: deletion of DNA mismatch repair genes (MSH2, MLH1, MSH6), microsatellite instability (MSI) and/or constitutional promoter hypermethylation. HNPCC8 can increase the risk of developing colorectal cancer and other types of cancer, such as endometrial cancer and gastric cancer.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070271,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:lynch_syndrome_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :lynch_syndrome ;
    :has_definition ""A Lynch syndrome that has_material_basis_in heterozygous mutations in the MSH2 gene on chromosome 2p21-p16."" ;
    :has_exact_synonym ""FCC1""@en,
        ""HNPCC1""@en,
        ""familial nonpolyposis colon cancer type 1""@en,
        ""hereditary nonpolyposis colorectal cancer type 1""@en .

","Lynch syndrome 1, also known as Hereditary Nonpolyposis Colorectal Cancer (HNPCC) Type 1, is a genetic disorder that is characterized by the development of multiple colorectal cancer (CRC) and/or other types of cancer. It is caused by mutations in the MSH2 gene on chromosome 2p21-p16. These mutations can be inherited from either parent, and can also occur spontaneously during an individual's lifetime. It is important to note that Lynch syndrome 1 is distinct from Lynch Syndrome 2, which is caused by mutations in the MLH1 gene.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0070272,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hereditary_nonpolyposis_colorectal_cancer_type_5 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :lynch_syndrome ;
    :has_definition ""A Lynch syndrome that has_material_basis_in heterozygous mutation in the MSH6 gene on chromosome 2p16."" ;
    :has_exact_synonym ""HNPCC5""@en .

","Hereditary nonpolyposis colorectal cancer type 5 (HNPCC5) is a type of Lynch syndrome, which is characterized by the presence of certain genetic mutations. These mutations can increase the risk of developing certain types of cancer, such as colon and rectum cancer. HNPCC5 specifically has a material basis in heterozygous mutation in the MSH6 gene on chromosome 2p16. It is also known by its exact synonym HNPCC5.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070273,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hereditary_nonpolyposis_colorectal_cancer_type_6 rdfs:subClassOf :lynch_syndrome ;
    :has_definition ""A Lynch syndrome that has_material_basis_in heterozygous mutation in the TGFBR2 gene on chromosome 3p22."" ;
    :has_exact_synonym ""HNPCC6""@en .

","Hereditary nonpolyposis colorectal cancer type 6 (HNPCC6) is a type of Lynch syndrome, which is characterized by the presence of a heterozygous mutation in the TGFBR2 gene on chromosome 3p22. HNPCC6 is also known as Hereditary Nonpolyposis Colorectal Cancer Type 6.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070274,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hereditary_nonpolyposis_colorectal_cancer_type_2 rdfs:subClassOf :lynch_syndrome ;
    :has_definition ""A Lynch syndrome that has_material_basis_in mutations in the MLH1 gene on chromosome 3p22.2."" ;
    :has_exact_synonym ""COCA2""@en,
        ""FCC2""@en,
        ""HNPCC2""@en,
        ""familial nonpolyposis colon cancer type 2""@en .

","Hereditary nonpolyposis colorectal cancer type 2 (HNPCC2) is a Lynch syndrome characterized by mutations in the MLH1 gene on chromosome 3p22.2. HNPCC2 is also known as COCA2, FCC2, and HNPCC2. Additionally, it is referred to as familial nonpolyposis colon cancer type 2.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070275,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hereditary_nonpolyposis_colorectal_cancer_type_4 rdfs:subClassOf :lynch_syndrome ;
    :has_definition ""A Lynch syndrome that has_material_basis_in heterozygous mutation in the PMS2 gene on chromosome 7p22."" ;
    :has_exact_synonym ""HNPCC4""@en .

","That is correct. Hereditary nonpolyposis colorectal cancer type 4, also known as HNPCC4, is a type of Lynch syndrome that is characterized by the presence of a heterozygous mutation in the PMS2 gene on chromosome 7p22. It is one of several types of Lynch syndrome, which are hereditary conditions that increase the risk of developing colorectal cancer and other types of cancer.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070276,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hereditary_nonpolyposis_colorectal_cancer_type_7 rdfs:subClassOf :lynch_syndrome ;
    :has_definition ""A Lynch syndrome that has_material_basis_in mutation in the MLH3 gene on chromosome 14q24.3."" ;
    :has_exact_synonym ""HNPCC7""@en .

","Hereditary nonpolyposis colorectal cancer type 7 (HNPCC7) is a form of Lynch syndrome, which is characterized by the presence of mutations in specific genes. In this case, the mutation occurs in the MLH3 gene on chromosome 14q24.3. This leads to the development of colorectal cancer and other related cancers due to the lack of proper DNA repair mechanisms. HNPCC7 is also known as hereditary nonpolyposis colorectal cancer type 7, which emphasizes its relation to the broader category of Lynch syndrome.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070277,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_autosomal_recessive_microcephaly_15 rdfs:subClassOf :primary_autosomal_recessive_microcephaly ;
    :has_definition ""A primary autosomal recessive microcephaly characterized by impaired intellectual development with poor speech, progressive microcephaly, and appendicular spasticity that has_material_basis_in homozygous or compound heterozygous mutation in the MFSD2A gene on chromosome 1p34."" ;
    :has_exact_synonym ""NEDMISBA"",
        ""neurodevelopmental disorder with progressive microcephaly, spasticity, and brain imaging abnormalities"",
        ""MCPH15""@en .

","primary autosomal recessive microcephaly 15 is a type of primary autosomal recessive microcephaly.
primary autosomal recessive microcephaly 15 has the definition A primary autosomal recessive microcephaly characterized by impaired intellectual development with poor speech, progressive microcephaly, and appendicular spasticity that has_material_basis_in homozygous or compound heterozygous mutation in the MFSD2A gene on chromosome 1p34.
primary autosomal recessive microcephaly 15 has exact synonym MCPH15.
primary autosomal recessive microcephaly 15 has exact synonym NEDMISBA.
primary autosomal recessive microcephaly 15 has exact synonym neurodevelopmental disorder with progressive microcephaly, spasticity, and brain imaging abnormalities.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070278,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_autosomal_recessive_microcephaly_7 rdfs:subClassOf :primary_autosomal_recessive_microcephaly ;
    :has_definition ""A primary autosomal recessive microcephaly that has_material_basis_in homozygous or compound heterozygous mutation in the STIL gene on chromosome 1p33."" ;
    :has_exact_synonym ""MCPH7""@en .

",Primary autosomal recessive microcephaly 7 is a type of primary autosomal recessive microcephaly that is caused by mutations in the STIL gene on chromosome 1p33. It has the same meaning as MCPH7.,3,True
doid,http://purl.obolibrary.org/obo/DOID_0070279,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_autosomal_recessive_microcephaly_14 rdfs:subClassOf :primary_autosomal_recessive_microcephaly ;
    :has_definition ""A primary autosomal recessive microcephaly that has_material_basis_in homozygous or compound heterozygous mutation in the SASS6 gene on chromosome 1p21."" ;
    :has_exact_synonym ""MCPH14""@en .

","primary autosomal recessive microcephaly 14 (MCPH14) is a type of primary autosomal recessive microcephaly. This condition has a genetic basis, specifically in the homozygous or compound heterozygous mutation in the SASS6 gene on chromosome 1p21. It is also known as MCPH14.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070280,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_autosomal_recessive_microcephaly_5 rdfs:subClassOf :primary_autosomal_recessive_microcephaly ;
    :has_definition ""A primary autosomal recessive microcephaly that has_material_basis_in homozygous or compound heterozygous mutation in the ASPM gene on chromosome 1q31."" ;
    :has_exact_synonym ""MCPH5""@en .

","Primary autosomal recessive microcephaly 5 (MCPH5) is a type of primary autosomal recessive microcephaly, which is characterized by abnormally small head size and other developmental defects. It has a genetic basis, with mutations in the ASPM gene on chromosome 1q31 being the cause in most cases.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070281,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_autosomal_recessive_microcephaly_19 rdfs:subClassOf :primary_autosomal_recessive_microcephaly ;
    :has_definition ""A primary autosomal recessive microcephaly that has_material_basis_in homozygous or compound heterozygous mutation in the COPB2 gene on chromosome 3q23."" ;
    :has_exact_synonym ""MCPH19""@en .

","Primary autosomal recessive microcephaly 19 (MCPH19) is a rare genetic disorder characterized by abnormal head development and small head size. It is caused by mutations in the COPB2 gene on chromosome 3q23. The condition can lead to intellectual disability, developmental delays, and other health issues. There is no cure for MCPH19, but early intervention and management can help improve quality of life.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070282,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_autosomal_recessive_microcephaly_8 rdfs:subClassOf :primary_autosomal_recessive_microcephaly ;
    :has_definition ""A primary autosomal recessive microcephaly that has_material_basis_in homozygous or compound heterozygous mutation in the CEP135 gene on chromosome 4q."" ;
    :has_exact_synonym ""MCPH8""@en .

",MCPH8 (primary autosomal recessive microcephaly 8) is a type of primary autosomal recessive microcephaly.,3,True
doid,http://purl.obolibrary.org/obo/DOID_0070283,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_autosomal_recessive_microcephaly_13 rdfs:subClassOf :primary_autosomal_recessive_microcephaly ;
    :has_definition ""A primary autosomal recessive microcephaly that has_material_basis_in homozygous or compound heterozygous mutation in the CENPE gene on chromosome 4q24."" ;
    :has_exact_synonym ""MCPH13""@en .

","primary autosomal recessive microcephaly 13 is a type of primary autosomal recessive microcephaly.
primary autosomal recessive microcephaly 13 has definition A primary autosomal recessive microcephaly that has_material_basis_in homozygous or compound heterozygous mutation in the CENPE gene on chromosome 4q24..
primary autosomal recessive microcephaly 13 has exact synonym MCPH13.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070284,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_autosomal_recessive_microcephaly_12 rdfs:subClassOf :primary_autosomal_recessive_microcephaly ;
    :has_definition ""A primary autosomal recessive microcephaly that has_material_basis_in homozygous or compound heterozygous mutation in the CDK6 gene on chromosome 7q21."" ;
    :has_exact_synonym ""MCPH12""@en .

","primary autosomal recessive microcephaly 12 (MCPH12) is a type of primary autosomal recessive microcephaly. It has a definition as a primary autosomal recessive microcephaly that has a material basis in homozygous or compound heterozygous mutation in the CDK6 gene on chromosome 7q21. Additionally, it has an exact synonym of MCPH12.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070285,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_autosomal_recessive_microcephaly_1 rdfs:subClassOf :primary_autosomal_recessive_microcephaly ;
    :has_definition ""A primary autosomal recessive microcephaly that has_material_basis_in homozygous or compound heterozygous mutation in the MCPH1 gene on chromosome 8p23."" ;
    :has_exact_synonym ""MCPH1""@en .

","User, primary autosomal recessive microcephaly 1 is a type of primary autosomal recessive microcephaly. primary autosomal recessive microcephaly 1 has definition A primary autosomal recessive microcephaly that has_material_basis_in homozygous or compound heterozygous mutation in the MCPH1 gene on chromosome 8p23. primary autosomal recessive microcephaly 1 has exact synonym MCPH1.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070286,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_autosomal_recessive_microcephaly_3 rdfs:subClassOf :primary_autosomal_recessive_microcephaly ;
    :has_definition ""A primary autosomal recessive microcephaly that has_material_basis_in homozygous or compound heterozygous mutation in the CDK5RAP2 gene on chromosome 9q33."" ;
    :has_exact_synonym ""MCPH3""@en .

","Primary autosomal recessive microcephaly 3 (MCPH3) is a type of primary autosomal recessive microcephaly, which refers to a genetic disorder characterized by abnormal head size and development. MCPH3 specifically has a genetic basis in homozygous or compound heterozygous mutations in the CDK5RAP2 gene located on chromosome 9q33. It is considered an example of primary autosomal recessive microcephaly, which means that it is inherited through a person's autosomal genes and affects brain development, resulting in small head size.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070287,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_autosomal_recessive_microcephaly_11 rdfs:subClassOf :primary_autosomal_recessive_microcephaly ;
    :has_definition ""A primary autosomal recessive microcephaly that has_material_basis_in homozygous or compound heterozygous mutation in the PHC1 gene on chromosome 12p13."" ;
    :has_exact_synonym ""MCPH11""@en .

","I understand that you are asking about primary autosomal recessive microcephaly 11, also known as MCPH11. This type of microcephaly is caused by mutations in the PHC1 gene located on chromosome 12p13.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070288,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_autosomal_recessive_microcephaly_17 rdfs:subClassOf :primary_autosomal_recessive_microcephaly ;
    :has_definition ""A primary autosomal recessive microcephaly that has_material_basis_in homozygous or compound heterozygous mutation in the CIT gene on chromosome 12q24."" ;
    :has_exact_synonym ""MCPH17""@en .

","Primary autosomal recessive microcephaly 17 (MCPH17) is a rare genetic disorder characterized by abnormal brain development and small head size. It is caused by mutations in the CIT gene, which is located on chromosome 12q24. MCPH17 is inherited in an autosomal recessive pattern, meaning that to develop the condition, a person must inherit two copies of the mutated gene (one from each parent). Symptoms typically appear during infancy and can include developmental delays, seizures, feeding difficulties, and hearing or vision problems. Treatment may involve therapies aimed at improving cognitive function, behavioral interventions, and surgery in some cases to treat hydrocephalus.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070289,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_autosomal_recessive_microcephaly_16 rdfs:subClassOf :primary_autosomal_recessive_microcephaly ;
    :has_definition ""A primary autosomal recessive microcephaly that has_material_basis_in homozygous or compound heterozygous mutation in the ANKLE2 gene on chromosome 12q24."" ;
    :has_exact_synonym ""MCPH16""@en .

","primary autosomal recessive microcephaly 16 is a type of primary autosomal recessive microcephaly.
primary autosomal recessive microcephaly 16 has definition A primary autosomal recessive microcephaly that has_material_basis_in homozygous or compound heterozygous mutation in the ANKLE2 gene on chromosome 12q24..
primary autosomal recessive microcephaly 16 has exact synonym MCPH16.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070290,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_autosomal_recessive_microcephaly_6 rdfs:subClassOf :primary_autosomal_recessive_microcephaly ;
    :has_definition ""A primary autosomal recessive microcephaly that has_material_basis_in homozygous or compound heterozygous mutation in the CENPJ gene on chromosome 13q12."" ;
    :has_exact_synonym ""MCPH6""@en .

","Primary autosomal recessive microcephaly 6 (MCPH6) is a type of primary autosomal recessive microcephaly, which refers to a condition characterized by abnormal brain development and small head size. MCPH6 specifically has a genetic basis, with mutations in the CENPJ gene on chromosome 13q12 leading to the condition. It is one of several types of primary autosomal recessive microcephaly, which together form a group of disorders characterized by abnormal brain development and small head size.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070291,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_autosomal_recessive_microcephaly_4 rdfs:subClassOf :primary_autosomal_recessive_microcephaly ;
    :has_definition ""A primary autosomal recessive microcephaly that has_material_basis_in homozygous or compound heterozygous mutation in the KNL1 gene on chromosome 15q15."" ;
    :has_exact_synonym ""MCPH4""@en .

","Primary autosomal recessive microcephaly 4 (MCPH4) is a type of primary autosomal recessive microcephaly characterized by abnormally small head size and other developmental abnormalities. It has a genetic basis, with mutations in the KNL1 gene on chromosome 15q15 being the most common cause.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070292,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_autosomal_recessive_microcephaly_9 rdfs:subClassOf :primary_autosomal_recessive_microcephaly ;
    :has_definition ""A primary autosomal recessive microcephaly that has_material_basis_in homozygous or compound heterozygous mutation in the CEP152 gene on chromosome 15q21."" ;
    :has_exact_synonym ""MCPH9""@en .

","MCPH9 stands for Microcephalic Primordial Dwarfism Type 9, which is a type of primary autosomal recessive microcephaly. This condition is characterized by abnormal brain development and small head size (microcephaly) in affected individuals. It is caused by mutations in the CEP152 gene on chromosome 15q21, which provides instructions for making a protein called CEP152, involved in cilia function, cell division, and other essential processes in the brain. Homozygous or compound heterozygous mutations in this gene can lead to MCPH9, resulting in primary autosomal recessive microcephaly 9.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070293,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_autosomal_recessive_microcephaly_2_with_or_without_cortical_malformations rdfs:subClassOf :primary_autosomal_recessive_microcephaly ;
    :has_definition ""A primary autosomal recessive microcephaly that has_material_basis_in homozygous or compound heterozygous mutation in the WDR62 gene on chromosome 19q13."" ;
    :has_exact_synonym ""MCPH2""@en .

","primary autosomal recessive microcephaly 2 with or without cortical malformations is a rare genetic disorder that affects the brain development. It is caused by mutations in the WDR62 gene, which is located on chromosome 19q13. The severity of the condition can vary and may include symptoms such as abnormal head shape, small head size (microcephaly), and cortical malformations or other brain anomalies. It is inherited in an autosomal recessive manner, which means that to develop the disorder, a person must inherit two copies of the mutated gene, one from each parent.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070294,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_autosomal_recessive_microcephaly_10 rdfs:subClassOf :primary_autosomal_recessive_microcephaly ;
    :has_definition ""A primary autosomal recessive microcephaly that has_material_basis_in homozygous or compound heterozygous mutation in the ZNF335 gene on chromosome 20q13."" ;
    :has_exact_synonym ""MCPH10""@en .

","Primary autosomal recessive microcephaly 10 (MCPH10) is a type of primary autosomal recessive microcephaly that is caused by homozygous or compound heterozygous mutations in the ZNF335 gene on chromosome 20q13. It has the same symptoms as primary autosomal recessive microcephaly, which includes a small head size and developmental delays.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070295,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_autosomal_dominant_microcephaly_18 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :primary_microcephaly ;
    :has_definition ""A primary microcephaly that has_material_basis_in heterozygous mutation in the WDFY3 gene on chromosome 4q21."" ;
    :has_exact_synonym ""MCPH18""@en .

","primary autosomal dominant microcephaly 18 is a type of primary microcephaly, which is characterized by the abnormal growth and development of the brain and skull. It is caused by genetic mutations that can be passed down through families. This condition can lead to severe developmental delays and other health issues. There is no cure for primary autosomal dominant microcephaly 18, but early intervention and specialized care can help improve quality of life for those affected.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070296,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_autosomal_recessive_microcephaly rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :primary_microcephaly ;
    :has_definition ""A primary microcephaly characterized by microcephaly present at birth, where the brain is small but has normal architecture, and nonprogressive mental retardation that has_material_basis_in an autosomal recessive mutation."" ;
    :has_exact_synonym ""MCPH""@en .

","Primary autosomal recessive microcephaly (MCPH) is a type of primary microcephaly, which refers to a congenital condition where a baby's head remains small but has normal brain architecture. MCPH is caused by an autosomal recessive genetic mutation and results in nonprogressive mental retardation. The term ""autosomal"" means that the gene responsible for this condition is located on one of the chromosomes other than the sex chromosomes (X and Y). This type of inheritance occurs when an individual inherits two copies of the same abnormal gene from both parents, resulting in a recessive effect. The word ""recessive"" means that the condition will only develop if an individual receives two copies of the gene responsible for it, one from each parent.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070297,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_microcephaly rdfs:subClassOf :microcephaly ;
    :has_definition ""A microcephaly characterized by microcephaly present at birth, where the brain is small but has normal architecture, and nonprogressive mental retardation."" ;
    :has_exact_synonym ""true microcephaly""@en .

","True Microcephaly is a type of microcephaly.
True Microcephaly has definition A severe form of congenital microcephaly in which the brain fails to develop properly, leading to abnormal growth and development, and usually resulting in mental retardation..
True Microcephaly has exact synonym primary microcephaly.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070298,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:multiple_epiphyseal_dysplasia_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :multiple_epiphyseal_dysplasia_due_to_collagen_9_anomaly ;
    :has_definition ""A multiple epiphyseal dysplasia due to collagen 9 anomaly that has_material_basis_in heterozygous mutation in the COL9A2 gene on chromosome 1p34."" ;
    :has_exact_synonym ""EDM2""@en .

","Multiple epiphyseal dysplasia 2, also known as EDM2, is a type of autosomal dominant disorder caused by an anomaly in the collagen 9 gene located on chromosome 1p34.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070299,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:multiple_epiphyseal_dysplasia_5 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :multiple_epiphyseal_dysplasia ;
    :has_definition ""A multiple epiphyseal dysplasia that has_material_basis_in heterozygous mutation in the MATN3 gene on chromosome 2p24."" ;
    :has_exact_synonym ""BHMED""@en,
        ""EDM5""@en,
        ""bilateral hereditary microepiphyseal dysplasia""@en,
        ""multiple epiphyseal dysplasia MATN3-related""@en .

","Multiple epiphyseal dysplasia 5, also known as BHMED or EDM5, is an autosomal dominant disorder characterized by abnormal development of the epiphysis, which are the growth plates located at the ends of long bones in the body. It has a material basis in a heterozygous mutation in the MATN3 gene on chromosome 2p24. The disorder is also known by other names such as bilateral hereditary microepiphyseal dysplasia, multiple epiphyseal dysplasia MATN3-related, and EDM5.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0070300,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:multiple_epiphyseal_dysplasia_4 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :multiple_epiphyseal_dysplasia ;
    :has_definition ""A multiple epiphyseal dysplasia that has_material_basis_in homozygous mutation in the SLC26A2 gene on chromosome 5q32."" ;
    :has_exact_synonym ""EDM4""@en,
        ""MED4""@en,
        ""Polyepiphyseal dysplasia type 4""@en,
        ""multiple epiphyseal dysplasia with bilateral patellae""@en,
        ""multiple epiphyseal dysplasia with clubfoot""@en,
        ""rMED""@en .

","Multiple epiphyseal dysplasia 4 (MED4) is a type of multiple epiphyseal dysplasia, which refers to a group of genetic disorders that affect the development and growth of epiphyses (growth plates) in long bones. MED4 is an autosomal recessive disease, meaning that both copies of the gene must be altered for the condition to develop. The SLC26A2 gene, located on chromosome 5q32, has been identified as the gene responsible for this type of multiple epiphyseal dysplasia.

Clubfoot (also known as talipes equinovarus) is a common birth defect that can occur due to various factors, including genetic and environmental causes. One of the genetic causes is multiple epiphyseal dysplasia 4, which can result in clubfoot when present. Multiple epiphyseal dysplasia with bilateral patellae refers specifically to the presence of bilateral (both sides) kneecaps that are fused together, a characteristic seen in some cases of MED4.

In summary, multiple epiphyseal dysplasia 4 is an autosomal recessive genetic disorder that affects the development and growth of epiphyses in long bones, and can lead to clubfoot when present.",10,True
doid,http://purl.obolibrary.org/obo/DOID_0070301,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:multiple_epiphyseal_dysplasia_6 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :multiple_epiphyseal_dysplasia_due_to_collagen_9_anomaly ;
    :has_definition ""A multiple epiphyseal dysplasia due to collagen 9 anomaly that has_material_basis_in heterozygous mutation in the COL9A1 gene on chromosome 6p13."" ;
    :has_exact_synonym ""EDM6""@en .

","Multiple epiphyseal dysplasia 6 (MED6) is a type of autosomal dominant disorder that is characterized by abnormal development or formation of the joints, specifically affecting the epiphysis. This condition occurs due to a mutation in the COL9A1 gene on chromosome 6p13. The term ""epiphyseal dysplasia"" refers to the abnormal development of the growth plates in the bones, which can lead to short stature and other skeletal problems. MED6 is also known as epicondylopathy, which is a type of epiphyseal dysplasia due to collagen 9 anomaly. It is important to note that while the exact cause of this condition may be genetic, it can also be caused by environmental factors and other external influences.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070302,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:multiple_epiphyseal_dysplasia_7 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :multiple_epiphyseal_dysplasia ;
    :has_definition ""A multiple epiphyseal dysplasia that has_material_basis_in homozygous mutation in the CANT1 gene on chromosome 17q25."" ;
    :has_exact_synonym ""EDM7""@en .

","multiple epiphyseal dysplasia 7 is a type of autosomal recessive disease.
multiple epiphyseal dysplasia 7 is a type of multiple epiphyseal dysplasia that has material basis in some autosomal recessive inheritance.
multiple epiphyseal dysplasia 7 has definition A multiple epiphyseal dysplasia that has_material_basis_in homozygous mutation in the CANT1 gene on chromosome 17q25..
multiple epiphyseal dysplasia 7 is also known as EDM7.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070303,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:multiple_epiphyseal_dysplasia_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :multiple_epiphyseal_dysplasia ;
    :has_definition ""A multiple epiphyseal dysplasia that has_material_basis_in heterozygous mutation in the COMP gene on chromosome 19p13."" ;
    :has_exact_synonym ""EDM1""@en,
        ""MED1""@en,
        ""multiple epiphyseal dysplasia COMP-related""@en,
        ""polyepiphyseal dysplasia type 1""@en .

","Multiple epiphyseal dysplasia 1 (MED1) is a genetic disorder that affects the development of bones, particularly in the hands and feet. It is an autosomal dominant condition, meaning that if one parent has the gene for MED1, there's a 50% chance that their child will inherit the trait. The inheritance is passed down through the mitochondria, not the nucleus.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0070304,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:multiple_epiphyseal_dysplasia_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :multiple_epiphyseal_dysplasia_due_to_collagen_9_anomaly ;
    :has_definition ""A multiple epiphyseal dysplasia due to collagen 9 anomaly that has_material_basis_in heterozygous mutation in the COL9A3 gene on chromosome 20q13."" ;
    :has_exact_synonym ""EDM3""@en,
        ""multiple epiphyseal dysplasia 3 with or without myopathy""@en .

","Multiple epiphyseal dysplasia, also known as EDM3 or Multiple epiphyseal dysplasia 3, is a genetic disorder that affects the growth of bones in the body. It is caused by mutations in the COL9A3 gene on chromosome 20q13. The condition can cause abnormal development and growth of the bones in the extremities, such as the arms and legs, leading to short stature and deformities. In some cases, EDM3 can also be associated with myopathy, a condition that affects muscle function.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070305,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:multiple_epiphyseal_dysplasia_due_to_collagen_9_anomaly rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :gene ],
        :monogenic_disease,
        :multiple_epiphyseal_dysplasia ;
    :has_definition ""A multiple epiphyseal dysplasia that has_material_basis_in mutation in any of the members of the COL9A gene family (COL9A1, COL9A2, COL9A3)."" .

",Multiple epiphyseal dysplasia due to collagen 9 anomaly is a type of monogenic disease.,4,True
doid,http://purl.obolibrary.org/obo/DOID_0070306,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:post_cardiac_arrest_syndrome rdfs:subClassOf :syndrome ;
    :has_definition ""A syndrome that is characterized by four main components: post-cardiac arrest brain injury, post-cardiac arrest myocardial dysfunction, systemic ischemia reperfusion response, and persistent precipitating pathologies."" ;
    :has_exact_synonym ""post cardiac syndrome""@en .

","Post-Cardiac Arrest Syndrome (PCAS) is a complex clinical entity that occurs following cardiac arrest. It is characterized by a combination of factors, including post-cardiac arrest brain injury, post-cardiac arrest myocardial dysfunction, systemic ischemia reperfusion response, and persistent precipitating pathologies.

PCAS can present with a variety of symptoms, ranging from neurological changes such as seizures or coma, to cardiovascular issues like arrhythmias or heart failure. Additionally, systemic manifestations may include fever and acidosis. The management of PCAS involves addressing the underlying cause, providing appropriate supportive care, and implementing evidence-based interventions for each component of the syndrome.

It is important to note that the exact synonym for PCAS is Post Cardiac Syndrome, but it is also referred to as Post Cardiac Arrest Syndrome in clinical practice.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070307,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:craniolenticulosutural_dysplasia rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :syndrome ;
    :has_definition ""A syndrome in neonates that is characterized by facial dysmorphism, late-closing fontanels, cataract, and skeletal defects. It has_material_basis_in the mutation of the SEC23A gene on the 14th chromosome, with the underproduction in the collagen secreting pathway and distension of endoplasmic reticulum leading to bone defects."" ;
    :has_exact_synonym ""Boyadjiev-Jabs Syndrome""@en,
        ""cranio-lenticulo-sutural dysplasia, CLSD""@en .

","Craniolenticulosutural dysplasia is a type of autosomal recessive disease that affects bone development. It is characterized by facial dysmorphism, late-closing fontanels, cataract, and skeletal defects in neonates. The condition has a material basis in the mutation of the SEC23A gene on the 14th chromosome, which leads to underproduction in the collagen secreting pathway and distension of endoplasmic reticulum, resulting in bone defects. It is also known as Boyadjiev-Jabs Syndrome or cranio-lenticulo-sutural dysplasia (CLSD).",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070308,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:rippling_muscle_disease_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :muscle_pain ],
        :muscle_tissue_disease ;
    :has_definition ""A muscle tissue disease characterized by electrically silent contractions of the skeletal muscles in response to mechanical stimuli. It has_material_basis_in mutation in the gene localized to 1q41 at the distal end of the long arm of chromosome 1, has_symptom characteristic lateral rolling movement of muscle, has_symptom muscle cramps, has_symptom muscle pain, has_symptom muscle stiffness during or following exercise."" .

","rippling muscle disease 1 is a type of muscle tissue disease, characterized by electrically silent contractions of the skeletal muscles in response to mechanical stimuli. It has symptoms such as muscle pain and cramps, as well as lateral rolling movement of muscle. It is caused by mutations in the gene localized to 1q41 at the distal end of the long arm of chromosome 1.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070309,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:absence_epilepsy rdfs:subClassOf :electroclinical_syndrome ;
    :has_definition ""An electroclinical syndrome characterized by the occurrence of generalized onset seizures that cause lapses in awareness, begin and end abruptly, typically last only a few seconds and are associated with abnormal spike-wave discharges as seen by electroencephalogram."" .

","Absence epilepsy is a neurological disorder characterized by recurring seizures that cause brief periods of unconsciousness. These seizures, also known as absence seizures, typically last just a few seconds and are accompanied by abnormal electrical activity in the brain, as detected by an electroencephalogram (EEG). Absence epilepsy is one type of epilepsy that affects people's awareness and behavior during the seizure. It can be caused by genetic or environmental factors, and treatment may involve medications to control seizures.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0070310,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:drug_induced_hearing_loss rdfs:subClassOf :nonsyndromic_deafness ;
    :has_definition ""A nonsyndromic deafness that is characterized by cochlear or vestibular dysfunction resulting in loss of hearing caused by drug ototoxicity."" ;
    :has_exact_synonym ""drug induced hearing loss""@en .

","Drug-induced hearing loss, also known as ototoxicity, is a type of nonsyndromic deafness characterized by cochlear or vestibular dysfunction resulting in a loss of hearing due to drug exposure. It is distinct from other types of deafness such as congenital or age-related hearing loss, which are not caused by drugs.
Drug-induced hearing loss can occur at any age and can be permanent or temporary depending on the type and amount of drugs involved. Some common examples include antibiotics (such as gentamicin), chemotherapy drugs (such as cisplatin), and some pain relievers (such as acetaminophen).
It is important to note that not all drugs will cause hearing loss, and the risk of drug-induced hearing loss can vary depending on factors such as the individual's overall health, the type and dose of the drug, and how long the exposure occurs. If you suspect that you or someone you know may have experienced drug-induced hearing loss, it is important to consult with a medical professional to determine the cause and appropriate treatment options.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070311,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:oligoasthenoteratozoospermia rdfs:subClassOf :male_infertility ;
    :has_definition ""A form of male infertility that is characterized by a combination of low number or oligozoospermia, poor motility or asthenozoospermia, and abnormal shape or teratozoospermia of sperms. OAT is the most common cause of male subfertility."" ;
    :has_exact_synonym ""OAT""@en,
        ""oligoasthenoteratospermia""@en .

","Oligoasthenoteratozoospermia (OAT) is a type of male infertility characterized by low sperm count, poor sperm motility, and abnormal sperm shape. It is the most common cause of male subfertility. OAT can be caused by various factors including genetic, environmental, and medical conditions. Treatment options may include lifestyle changes, medications, or assisted reproductive technologies such as in vitro fertilization (IVF).",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070313,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:thiamine_deficiency_disease rdfs:subClassOf :nutritional_deficiency_disease ;
    :has_definition ""A nutritional deficiency disease that is characterized by low levels of thiamine."" .

",Thiamine deficiency disease is a type of nutritional deficiency disease characterized by low levels of thiamine.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0070314,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:obstructive_nephropathy rdfs:subClassOf :kidney_disease ;
    :has_definition ""A kidney disease characterized by kidney damage and dysfunction resulting from urinary tract obstruction."" ;
    :has_exact_synonym ""CON""@en,
        ""congenital obstructive nephropathy""@en .

","Obstructive nephropathy is a type of kidney disease characterized by damage and dysfunction in the kidneys resulting from urinary tract obstruction. It can be caused by various factors, such as congenital abnormalities, stones or tumors in the urinary tract, or other causes of obstruction. In some cases, it may also occur secondary to other types of kidney disease. Treatment for obstructive nephropathy usually involves removing the cause of the obstruction and managing any underlying health conditions that may contribute to the disease.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070315,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hypoplastic_right_heart_syndrome rdfs:subClassOf :congenital_heart_disease ;
    :has_definition ""A congenital heart disease characterized by underdevelopment of the structures on the right side of the heart commonly associated with atrial septal defect."" ;
    :has_exact_synonym ""Right hypoplastic heart syndrome"" .

","Hypoplastic Right Heart Syndrome (HRHS) is a congenital heart disease characterized by the underdevelopment of the structures on the right side of the heart. It is commonly associated with an atrial septal defect, which is a hole in the wall that separates the two upper chambers of the heart. HRHS can lead to problems such as low blood flow and difficulty pumping blood throughout the body, which can result in shortness of breath, fatigue, and swollen legs and feet. Treatment for HRHS typically involves surgery to correct the underlying defects and improve blood flow and circulation.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070316,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:miura_type_epiphyseal_chondrodysplasia rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :bone_development_disease ;
    :has_definition ""A bone developmental disease characterized by tall stature, scoliosis and macrodactyly of the great toes that has_material_basis_in heterozygous mutation in the NPR2 gene on chromosome 9p13."" ;
    :has_exact_synonym ""ECDM""@en,
        ""tall stature-scoliosis-macrodactyly of the great toes syndrome""@en,
        ""tall stature-scoliosis-macrodactyly of the halluces syndrome""@en .

",What is Miura Type Epiphyseal Chondrodysplasia?,7,True
doid,http://purl.obolibrary.org/obo/DOID_0070317,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:wet_beriberi rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :dyspnea ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :tachycardia ],
        :beriberi ;
    :has_definition ""A beriberi that is located_in the cardiovascular system and has_symptom increased heart rate, swelling of lower legs, and shortness of breath."" .

","Wet beriberi is indeed a type of beriberi that is characterized by symptoms such as tachycardia (increased heart rate), dyspnea (shortness of breath), and swelling in the lower legs. It occurs due to a deficiency of thiamine, which is essential for proper functioning of the cardiovascular system.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070318,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:dry_beriberi rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :abnormality_of_gait ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :vomiting ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :confusion ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :dysarthria ],
        :beriberi ;
    :has_definition ""A beriberi that is located_in the nervous system and has_symptom difficulty walking, numbness in extremities, tingling in extremities, paralysis of lower legs, difficulty speaking, confusion, and vomiting."" .

","Dry beriberi is a specific type of beriberi that affects the nervous system and causes symptoms such as difficulty walking, numbness or tingling in the extremities, paralysis of the lower legs, difficulty speaking, confusion, and vomiting. It is important to note that dry beriberi is also known as neurological beriberi, which distinguishes it from other types of beriberi that affect other parts of the body. If you suspect that you or someone you know may be experiencing symptoms of dry beriberi, it is crucial to seek medical attention immediately in order to receive an accurate diagnosis and appropriate treatment.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070319,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:miliaria_pustulosa rdfs:subClassOf :miliaria ;
    :has_definition ""A miliaria that is characterized by pustules resulting from inflammation and bacterial infection."" .

","Miliaria pustulosa is a type of miliaria that is characterized by the presence of small, pus-filled lesions on the skin. These lesions are caused by inflammation and bacterial infection, and can be itchy and uncomfortable for those who have them. It is important to seek medical attention if you suspect you have miliaria pustulosa, as it can be treated with antibiotics and other medications to alleviate the symptoms and prevent further spread of the infection. In some cases, topical creams or ointments may also be prescribed to help reduce inflammation and speed up the healing process.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0070320,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:miliaria_profunda rdfs:subClassOf :miliaria ;
    :has_definition ""A miliaria that is characterized by ductal occlusion of the papillary dermis causing the gland's secretions to leak between the superficial and deep layers of the skin resulting in a rapidly-spreading flesh-colored rash."" .

","Miliaria profunda is a type of miliaria that is characterized by ductal occlusion of the papillary dermis, causing the gland's secretions to leak between the superficial and deep layers of the skin. This results in a rapidly-spreading, flesh-colored rash.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0070321,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:miliaria_crystallina rdfs:subClassOf :miliaria ;
    :has_definition ""A miliaria that is characterized by clear, superficial, noninflammed, subcorneal vesicles that easily rupture when rubbed and is located_in the stratum corneum."" .

","That's correct! Miliaria crystallina is a type of miliaria characterized by clear, superficial, noninflammed, subcorneal vesicles that easily rupture when rubbed and located in the stratum corneum. It is also known as ""crystal miliaria"" due to the presence of these small, clear vesicles on the skin's surface. This type of miliaria is commonly seen in hot and dry environments, and can be caused by prolonged exposure to the sun or other irritants. Is there anything else you would like to know about miliaria crystallina?",2,True
doid,http://purl.obolibrary.org/obo/DOID_0070322,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:childhood_hepatocellular_carcinoma rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :existence_starts_during ;
            owl:someValuesFrom :childhood_onset ],
        :hepatocellular_carcinoma ;
    :has_definition ""A hepatocellular carcinoma that occurs in children and is characterized by a distinct etiological predisposition, biological behavior, and lower frequency of cirrhosis as compared to adult hepatocellular carcinoma."" ;
    :has_exact_synonym ""pediatric hepatocellular carcinoma"" .

","Childhood hepatocellular carcinoma is a type of hepatocellular carcinoma that develops during childhood. It differs from adult hepatocellular carcinoma in terms of etiology, biological behavior, and frequency of cirrhosis. The exact synonym for this condition is pediatric hepatocellular carcinoma.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070323,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:childhood_acute_myeloid_leukemia rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :existence_starts_during ;
            owl:someValuesFrom :childhood_onset ],
        :childhood_leukemia ;
    :has_definition ""A childhood leukemia that is characterized by the rapid growth of abnormal white blood cells that accumulate in the bone marrow and interfere with the production of normal blood cells."" ;
    :has_exact_synonym ""childhood acute myeloid leukaemia""@en,
        ""paediatric acute myeloid leukaemia""@en,
        ""pediatric acute myeloid leukemia""@en .

","Childhood acute myeloid leukemia (CAMLE) is a type of cancer that affects the bone marrow and blood cells in children. It is characterized by the rapid growth of abnormal white blood cells, which interfere with the production of normal blood cells. CAMLE can be treated with chemotherapy, radiation therapy, stem cell transplantation, and targeted therapies.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070324,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:systemic_epstein_barr_virus_positive_t_cell_lymphoma_of_childhood rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :existence_starts_during ;
            owl:someValuesFrom :childhood_onset ],
        :childhood_lymphoma ;
    :has_definition ""A childhood lymphoma that is characterized by monoclonal expansion of Epstein-Barr virus-positive T cells with an activated cytotoxic phenotype in tissues or peripheral blood."" ;
    :has_exact_synonym ""EBV-positive T-cell lymphoproliferative disorder of childhood""@en,
        ""systemic EBV-positive T-cell lymphoma of childhood""@en .

","User, you are correct. Systemic Epstein-Barr virus (EBV) positive T cell lymphoma of childhood is a type of childhood lymphoma that affects the immune system and can cause various symptoms such as fever, fatigue, weight loss, night sweats, pain in the chest or belly area, and swollen lymph nodes. This condition is also known by its medical term ""EBV-positive T-cell lymphoproliferative disorder of childhood"" or simply ""systemic EBV-positive T-cell lymphoma of childhood"". Is there anything else I can help you with?",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070325,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:malignant_childhood_adrenal_gland_pheochromocytoma rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :existence_starts_during ;
            owl:someValuesFrom :childhood_onset ],
        :adrenal_gland_pheochromocytoma ;
    :has_definition ""An adrenal gland pheochromocytoma that is characterized by rare chromaffin cell tumors which secrete catecholamines, and has a higher prevalence of hereditary factors and metastatis in children than adults."" ;
    :has_exact_synonym ""malignant pediatric adrenal gland pheochromocytoma""@en .

","Malignant childhood adrenal gland pheochromocytoma is a type of adrenal gland tumor that typically occurs during childhood. These tumors are characterized by the production of catecholamines, which can cause a variety of symptoms such as high blood pressure, rapid heart rate, and increased sweating. Malignant childhood adrenal gland pheochromocytoma has a higher prevalence of hereditary factors and metastasis in children than in adults. It is also known as malignant pediatric adrenal gland pheochromocytoma.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070326,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spitzoid_melanoma rdfs:subClassOf :skin_melanoma ;
    :has_definition ""A skin melanoma that is characterized by asymmetric shape, diameter greater than 1 cm, a lesion with a deep invasive component, and a high degree of cytologic atypia."" ;
    :has_exact_synonym ""atypical spitz nevus""@en .

","That is correct. Spitzoid melanoma is a subtype of skin melanoma that is characterized by certain unique features such as an asymmetric shape, a diameter greater than 1 cm, a deep invasive component, and high degree of cytologic atypia. It's also known as atypical spitz nevus.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070327,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:melanoma_in_congenital_melanocytic_nevus rdfs:subClassOf :skin_melanoma ;
    :has_definition ""A skin melanoma that arises from a congenital melanocytic nevus."" ;
    :has_exact_synonym ""Malignant melanoma in congenital melanocytic nevus""@en,
        ""melanocytic nevi""@en .

","Congenital melanocytic nevus (CMN) is a type of skin lesion that is present at birth. It is also known as a congenital mole, and it is caused by an overgrowth of melanocytes in the skin's embryonic development. CMN can be genetically passed down through families, and it can increase the risk of developing malignant melanoma, particularly when exposed to sunlight or other UV radiation.
Congenital melanocytic nevus (CMN) is a type of skin lesion that is present at birth. It is also known as a congenital mole, and it is caused by an overgrowth of melanocytes in the skin's embryonic development. CMN can be genetically passed down through families, and it can increase the risk of developing malignant melanoma, particularly when exposed to sunlight or other UV radiation.
Congenital melanocytic nevus (CMN) is a type of skin lesion that is present at birth. It is also known as a congenital mole, and it is caused by an overgrowth of melanocytes in the skin's embryonic development. CMN can be genetically passed down through families, and it can increase the risk of developing malignant melanoma, particularly when exposed to sunlight or other UV radiation.
Congenital melanocytic nevus (CMN) is a type of skin lesion that is present at birth. It is also known as a congenital mole, and it is caused by an overgrowth of melanocytes in the skin's embryonic development. CMN can be genetically passed down through families, and it can increase the risk of developing malignant melanoma, particularly when exposed to sunlight or other UV radiation.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070328,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:adult_hepatocellular_carcinoma rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :abdominal_mass ],
        [ a owl:Restriction ;
            owl:onProperty :existence_starts_during ;
            owl:someValuesFrom :adult_onset ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :liver_inflammation ],
        :hepatocellular_carcinoma ;
    :has_definition ""A hepatocellular carcinoma that is characterized by hepatic mass, abdominal pain and, in advanced stages, jaundice, cachexia and liver failure and often develops in the setting of chronic necro-inflammation."" ;
    :has_exact_synonym ""adult hepatoma""@en,
        ""adult primary hepatocellular carcinoma""@en .

","Adult hepatocellular carcinoma (also known as adult hepatoma or primary liver cancer) is a type of hepatocellular carcinoma that has a specific set of characteristics. These include the existence of a liver mass, abdominal pain, and in advanced stages, jaundice, cachexia, and liver failure. It often develops in the setting of chronic necro-inflammation, such as cirrhosis of the liver. Adult hepatocellular carcinoma is a type of cancer that occurs during adulthood, and its symptoms may include some form of liver inflammation or abdominal mass.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0070329,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:mitochondrial_dna_depletion_syndrome rdfs:subClassOf :mitochondrial_metabolism_disease ;
    :has_definition ""A mitochondrial metabolism disease that is characterized by significant reduction in mitochondrial DNA in affected tissues, resulting in impaired mtDNA-encoded protein synthesis and energy production in the affected tissues and organs."" ;
    :has_exact_synonym ""mtDNA depletion syndrome""@en .

","Mitochondrial DNA Depletion Syndrome (MDDS) is a rare genetic disorder that affects the mitochondria, which are responsible for producing energy in cells. It occurs when there is a significant reduction in the amount of mitochondrial DNA (mtDNA) in affected tissues, leading to impaired function and energy production in those tissues and organs. MDDS can affect various body systems and may cause a wide range of symptoms, including muscle weakness, poor vision, hearing loss, developmental delays, and heart problems. It is typically inherited maternally and affects both males and females equally. There is no cure for MDDS, but treatment options are available to manage the symptoms and improve quality of life.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070330,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:multiple_mitochondrial_dysfunctions_syndrome rdfs:subClassOf :mitochondrial_metabolism_disease ;
    :has_definition ""A mitochondrial metabolism disease that is characterized by reduced function of more than one stage of of energy production resulting from mitochondria impairment."" ;
    :has_exact_synonym ""fatal multiple mitochondrial dysfunction syndrome""@en .

","Multiple mitochondrial dysfunctions syndrome (MMDS) is a type of metabolic disease that occurs due to the impairment of multiple stages of energy production within the mitochondria. It is characterized by reduced function at more than one stage of energy production, leading to a collective decrease in overall energy production within the cells. This condition can be fatal and is often diagnosed in infancy or early childhood.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070331,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:mitochondrial_dna_depletion_syndrome_8b rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_phenotype ;
            owl:someValuesFrom :cachexia ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :ptosis ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :has_phenotype ;
            owl:someValuesFrom :gastrointestinal_dysmotility ],
        :autosomal_recessive_disease,
        :mitochondrial_dna_depletion_syndrome ;
    :has_definition ""A mitochondrial DNA depletion syndrome that is characterized by ophthalmoplegia, ptosis, gastrointestinal dysmotility, cachexia, peripheral neuropathy, and brain MRI changes, known as the MNGIE phenotype, and has_material_basis_in autosomal recessive homozygous or compound heterozygous mutation in the ribonucleotide reductase M2 B gene on chromosome 8q22."" ;
    :has_exact_synonym ""mitochondrial neurogastrointestinal encephalopathy syndrome, RRM2B-related""@en .

","Mitochondrial DNA depletion syndrome 8b is a rare genetic disorder that affects the mitochondria in the body. It is caused by a mutation in the ribonucleotide reductase M2 B gene on chromosome 8q22, which can be passed down through families in an autosomal recessive inheritance pattern. The disorder leads to a combination of symptoms that affect the eyes, muscles, gastrointestinal system, and nervous system. These symptoms may include ophthalmoplegia, ptosis, cachexia, gastrointestinal dysmotility, peripheral neuropathy, and brain MRI changes. The disorder is also known as mitochondrial neurogastrointestinal encephalopathy syndrome or RRM2B-related when caused by a mutation in the ribonucleotide reductase M2 B gene on chromosome 8q22.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0070332,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:multiple_mitochondrial_dysfunctions_syndrome_6 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :multiple_mitochondrial_dysfunctions_syndrome ;
    :has_definition ""A multiple mitochondrial dysfunctions syndrome that is characterized by hypotonia, inability to walk, poor speech, intellectual disability, and motor abnormalities, such as ataxia, dystonia, and spasticity with onset in early childhood and has_material_basis_in autosomal recessive homozygous or compound heterozygous mutation in the PMPCB gene on chromosome 7q22."" .

","Multiple mitochondrial dysfunctions syndrome 6 (MMDS6) is a type of autosomal recessive disease that affects an individual's ability to walk, talk, and perform other motor skills. It is characterized by intellectual disability, hypotonia, ataxia, dystonia, spasticity, and motor abnormalities that begin in early childhood. The condition has a material basis in autosomal recessive inheritance and can be caused by mutations in the PMPCB gene located on chromosome 7q22.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070333,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:breast_implant_associated_anaplastic_large_cell_lymphoma rdfs:subClassOf :peripheral_t_cell_lymphoma ;
    :has_definition ""A periperal T-cell lymphoma characterized by development around textured-surface breast implants confined to the capsule."" .

","Breast Implant Associated Anaplastic Large Cell Lymphoma (BIALCL) is a type of peripheral T-cell lymphoma that specifically affects the tissue surrounding breast implants. This condition is characterized by the presence of abnormal T-cells, which are a type of white blood cell, in the capsule around the breast implant. BIALCL is typically confined to the area around the breast implant and does not spread beyond it.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0070334,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:vegetable_allergy rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_allergic_trigger ;
            owl:someValuesFrom :vegetable_food_product ],
        :food_allergy ;
    :has_definition ""A food allergy triggered by a vegetable food product."" .

","You are correct, vegetable allergy is a type of food allergy triggered by an allergic reaction to one or more vegetables. The definition you provided is accurate and clear. Is there anything else I can help you with?",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070335,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:celery_allergy rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_allergic_trigger ;
            owl:someValuesFrom :leaf_celery_food_product ],
        :vegetable_allergy ;
    :has_definition ""A vegetable allergy triggered by celery (Apium graveolens)."" .

","Celery allergy is a type of vegetable allergy. It occurs when the body's immune system reacts to celery, causing an allergic response. This can lead to symptoms such as itching or swelling of the mouth and throat, difficulty breathing, or even anaphylaxis in severe cases. People with a celery allergy should avoid consuming products that contain celery or ingredients derived from celery, such as modified food starch or maltodextrin. It is important to read labels carefully and ask questions about ingredients when dining out or purchasing prepared foods.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070336,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:arthrogryposis_multiplex_congenita_6 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :existence_starts_during ;
            owl:someValuesFrom :congenital_onset ],
        :arthrogryposis_multiplex_congenita ;
    :has_definition ""An arthrogryposis multiplex congenita characterized by congenital joint contractures, dysmorphic facial features, distal skeletal anomalies with clenched hands and clubfeet, and edema with fetal hydrops and that has_material_basis_in homozygous or compound heterozygous mutation in the NEB gene on chromosome 2q23."" .

","arthrogryposis multiplex congenita 6 is a type of arthrogryposis multiplex congenita, which refers to a condition characterized by congenital joint contractures, dysmorphic facial features, distal skeletal anomalies with clenched hands and clubfeet, and edema with fetal hydrops. It is caused by mutations in the NEB gene on chromosome 2q23.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070337,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:epithelial_recurrent_erosion_dystrophy rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :epithelial_and_subepithelial_dystrophy ;
    :has_definition ""An epithelial and subepithelial dystrophy that is characterized by frequent painful recurrent corneal erosions, small gray anterior stromal flecks associated with larger focal gray-white disc-shaped, circular, or wreath-like lesions with central clarity."" ;
    :has_exact_synonym ""COL17A1"",
        ""ERED"" .

","Epithelial recurrent erosion dystrophy (ERED) is a type of autosomal dominant disease characterized by frequent painful recurrent corneal erosions and small gray anterior stromal flecks associated with larger focal gray-white disc-shaped, circular, or wreath-like lesions with central clarity. It is also referred to as Eroding Keratopathy (EK) and Collagen XVIIa-related dystrophy. The condition is caused by mutations in the COL17A1 gene, which encodes for type XVII collagen, a protein found in the extracellular matrix of the cornea. These mutations lead to abnormalities in the formation and maintenance of the corneal stroma, resulting in the development of erosions and other characteristic features of the disease.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070338,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:cerebellar_hypoplasia rdfs:subClassOf :cerebellar_disease ;
    :has_definition ""A cerebellar disease that is characterized by a cerebellum that is smaller than usual or not completely developed."" ;
    :has_exact_match ""MESH:C562568"" .

","Cerebellar hypoplasia is a condition where the cerebellum, which is responsible for balance and coordination, is underdeveloped or not fully formed. This can result in a range of symptoms such as ataxia (lack of muscle control), tremors, and difficulty with fine motor skills. In some cases, it may also be accompanied by other neurological disorders such as epilepsy. It is typically diagnosed in infancy or early childhood and can be caused by genetic factors, infections, or other environmental influences. Treatment options vary depending on the severity of the condition and may include physical therapy, medication, and supportive care.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070339,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:cerebellar_hyplasia_atrophy_epilepsy_and_global_developmental_delay rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_feature ;
            owl:someValuesFrom :intellectual_disability ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :nystagmus ],
        :syndrome ;
    :has_definition ""A syndrome with a cerebellar malformation as a major feature characterized by cerebellar hypoplasia, bilateral retinal pigmentary changes, intellectual disability that can range from mild to moderate and pronounced language development delay. It presents with early developmental delay, central and peripheral non-progressive visual impairment or asymptomatic retinal changes, hypotonia, non-progressive ataxia and nystagmus."" .

","Cerebellar hyplasia atrophy epilepsy and global developmental delay is a type of syndrome that is characterized by a cerebellar malformation as one of its major features. This condition can cause early developmental delays, central or peripheral visual impairments, hypotonia, non-progressive ataxia, and nystagmus. It may also result in intellectual disability ranging from mild to moderate, and pronounced language development delay.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070340,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:classic_citrullinemia rdfs:subClassOf :citrullinemia ;
    :has_definition ""A citrullinemia that has_material_basis_in homozygous or compound heterozygous mutation in the ASS1 gene, which encodes argininosuccinate synthetase, on chromosome 9q34."" .

","Classic citrullinemia is a rare genetic disorder caused by mutations in the ASS1 gene on chromosome 9q34. These mutations result in a deficiency of argininosuccinate synthetase, which leads to accumulation of citrulline and ornithine in the body. It is considered as one of the most common types of citrullinemia.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0070341,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:neonatal_onset_type_ii_citrullinemia rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :citrullinemia ;
    :has_definition ""A citrullinemia that is characterized by confusion, restlessness, memory loss, abnormal behaviors (such as aggression, irritability, and hyperactivity), seizures and coma, caused by citrin deficiency (NICCD), and has_material_basis_in homozygous or compound heterozygous mutation in the SLC25A13 gene."" ;
    :has_exact_synonym ""neonatal-onset type 2 citrullinemia"" .

","Neonatal Onset Type II Citrullinemia is a type of autosomal recessive disease. It is characterized by confusion, restlessness, memory loss, abnormal behaviors (such as aggression, irritability, and hyperactivity), seizures and coma caused by citrin deficiency (NICCD). This condition has a material basis in homozygous or compound heterozygous mutation in the SLC25A13 gene. It is also known as neonatal-onset type 2 citrullinemia.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070342,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:adult_onset_type_ii_citrullinemia rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :existence_starts_during ;
            owl:someValuesFrom :adult_onset ],
        :citrullinemia ;
    :has_definition ""A citrullinemia that has_material_basis_in homozygous or compound heterozygous mutation in the SLC25A13 gene on chromosome 7q21."" ;
    :has_exact_synonym ""citrin deficiency"" .

","Citrullinemia is a rare metabolic disorder that affects the body's ability to convert an amino acid called citrulline into another amino acid, arginine. There are several types of citrullinemia, including adult-onset type II, which typically presents during adulthood and is caused by mutations in the SLC25A13 gene on chromosome 7q21. Citrin deficiency is a specific type of citrullinemia that results from the lack of function of an enzyme called argininosuccinate synthetase (ASS), which converts citrulline to arginine.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070343,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:csf1r_related_brain_malformation_and_osteopetrosis rdfs:subClassOf :neuroaxonal_dystrophy ;
    :has_definition ""A neuroaxonal dystrophy that has_material_basis_in heterozygous mutations in CSF1R and causes adult-onset leukoencephalopathy with axonal spheroids and pigmented glia, characterized by progressive cognitive and motor impairment and seizures in the fourth to fifth decade of life."" ;
    :has_exact_synonym ""osteoporosis and infantile neuroaxonal dystrophy"" .

","csf1r related brain malformation and osteopetrosis is a type of neuroaxonal dystrophy characterized by adult-onset leukoencephalopathy with axonal spheroids and pigmented glia. It is caused by heterozygous mutations in the CSF1R gene, leading to progressive cognitive and motor impairment and seizures in the fourth to fifth decade of life. The condition has an exact synonym of osteopetrosis and infantile neuroaxonal dystrophy.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070344,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ocular_tuberculosis rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_location ;
            owl:someValuesFrom :eye ],
        :eye_disease,
        :tuberculosis ;
    :has_definition ""A tuberculosis that is located_in some eye, has_material_basis_in Mycobacterium tuberculosis, and has_sypmtom inflamed eyes."" .

","ocular tuberculosis is a type of eye disease that occurs when the Mycobacterium tuberculosis bacteria infects one or more parts of the eye. It can cause inflammation, discharge, and even blindness if left untreated. Symptoms may include pain, itching, redness, or blurriness in the affected eye(s). Early detection and treatment are crucial to prevent further complications and preserve vision.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070345,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:vertebral_anomalies_and_variable_endocrine_and_t_cell_dysfunction rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :syndrome ;
    :has_definition ""A syndrome that has_material_basis_in heterozygous mutation in the TBX2 gene on chromosome 17q23 and is characterized by craniofacial dysmorphisms, cardiac anomalies, skeletal malformations, immune deficiency, endocrine abnormalities and developmental impairments."" ;
    :has_exact_synonym ""heterozygotes for TBX2 variants"" .

",Vertebral anomalies and variable endocrine and T cell dysfunction is a type of autosomal dominant disease.,5,True
doid,http://purl.obolibrary.org/obo/DOID_0070346,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:neurodevelopmental_disorder_with_cataracts_poor_growth_and_dysmorphic_facies rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :abnormality_of_gait ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_feature ;
            owl:someValuesFrom :cataract ],
        [ a owl:Restriction ;
            owl:onProperty :has_phenotype ;
            owl:someValuesFrom :neurodevelopmental_abnormality ],
        :syndrome ;
    :has_definition ""A syndrome that is characterized by impaired intellectual development with absent language and short stature and that has_material_basis_in homozygous mutation in the INTS1 gene on chromosome 7p22."" .

","Neurodevelopmental disorder with cataracts, poor growth, and dysmorphic facies is a type of syndrome.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070347,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:encephalopathy_due_to_defective_mitochondrial_and_peroxisomal_fission_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :delayed_psychomotor_development ],
        :syndrome ;
    :has_definition ""A syndrome that has_material_basis_in heterozygous mutation in the DNM1L gene, and is characterized by delayed psychomotor development and has_symptom hypotonia that may lead to death in childhood."" .

","Encephalopathy due to defective mitochondrial and peroxisomal fission 1 is a type of developmental disorder. Encephalopathy due to defective mitochondrial and peroxisomal fission 1 has the symptom delayed psychomotor development, which can lead to death in childhood if untreated. It is caused by a heterozygous mutation in the DNM1L gene.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070348,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spinal_muscular_atrophy_with_lower_extremity_predominant rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :muscle_weakness ],
        :autosomal_dominant_disease,
        :spinal_muscular_atrophy ;
    :has_definition ""A spinal muscular atrophy that has_material_basis_in autosomal dominant inheritance and is characterized by muscle weakness and wasting in the lower limbs, most affecting the thigh muscles."" ;
    :has_exact_synonym ""spinal muscular atrophy with lower extremity predominance"" .

","Spinal muscular atrophy with lower extremity predominant, also known as Charcot-Marie-Tooth disease type 2, is a genetic disorder that affects the nerve cells in the spinal cord and the peripheral nervous system. It results in muscle weakness and atrophy, particularly in the lower limbs, and can lead to problems with mobility and coordination. The condition is inherited in an autosomal dominant manner, which means that a single copy of the gene is sufficient for the disease to develop. There is no cure for spinal muscular atrophy with lower extremity predominant, but treatment options are available to manage symptoms and improve quality of life.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070349,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spinal_muscular_atrophy_with_lower_extremity_predominant_2a rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :muscle_weakness ],
        :spinal_muscular_atrophy_with_lower_extremity_predominant ;
    :has_definition ""A spinal muscular atrophy with lower extremity predominance that is characterized by early childhood onset of muscle weakness and atrophy predominantly affecting the proximal and distal muscles of the lower extremity, although some patients may show upper extremity involvement and that has_material_basis_in heterozygous mutation in the BICD2 gene on chromosome 9q22."" ;
    :has_exact_synonym ""spinal muscular atrophy with lower extremity predominance 2A"" .

","Spinal muscular atrophy with lower extremity predominant 2a is a type of spinal muscular atrophy that primarily affects the lower extremities. It is caused by mutations in the BICD2 gene and typically presents in early childhood with muscle weakness and atrophy in the proximal and distal muscles of the legs. While some patients may also show involvement in the upper extremities, it predominantly affects the lower body.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070350,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spinal_muscular_atrophy_with_lower_extremity_predominant_2b rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :spinal_muscular_atrophy_with_lower_extremity_predominant ;
    :has_definition ""A spinal muscular atrophy with lower extremity predominance that is characterized by decreased fetal movements and are congenital contractures consistent with arthrogryposis multiplex congenita and that has_material_basis_in heterozygous mutation in the BICD2 gene on chromosome 9q22."" ;
    :has_exact_synonym ""spinal muscular atrophy with lower extremity predominance 2B"" .

","Spinal muscular atrophy with lower extremity predominant 2b, also known as SMA-2B, is a type of spinal muscular atrophy that primarily affects the lower extremities. It is characterized by decreased fetal movements and congenital contractures consistent with arthrogryposis multiplex congenita, which are caused by heterozygous mutations in the BICD2 gene on chromosome 9q22.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070351,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spinal_muscular_atrophy_with_lower_extremity_predominant_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :spinal_muscular_atrophy_with_lower_extremity_predominant ;
    :has_definition ""A spinal muscular atrophy with lower extremity predominance that has_material_basis_in heterozygous mutation in the DYNC1H1 gene on chromosome 14q32."" ;
    :has_exact_synonym ""spinal muscular atrophy with lower extremity predominance 1"" .

","Spinal muscular atrophy with lower extremity predominant 1 (SMA LEP1) is a genetic disorder that affects the nerves in the spine and can lead to weakness and loss of motor function, particularly in the legs. It is caused by mutations in the DYNC1H1 gene on chromosome 14q32. The condition is inherited in an autosomal dominant manner, which means that a single copy of the mutated gene is sufficient to cause the disease. Other forms of SMA, such as SMA type 1 and SMA type 2, are more severe and often lead to death in early childhood. However, with proper treatment and care, individuals with SMA LEP1 can live a relatively normal life expectancy.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070352,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:stress_induced_childhood_onset_neurodegeneration_with_variable_ataxia_and_seizures rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :muscle_weakness ],
        [ a owl:Restriction ;
            owl:onProperty :existence_starts_during ;
            owl:someValuesFrom :childhood_onset ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :ataxia ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :seizure ],
        :autosomal_recessive_disease,
        :neurodegenerative_disease ;
    :has_definition ""A neurodegenerative disease characterized by variable ataxia and seizures, has_material_basis_in homozygous mutation in the ADPRHL2 gene on chromosome 1p34, and has_symptom seizures, muscle weakness, giat ataxia, impaired speach, hearing loss, and cerebellar atrophy."" ;
    :has_exact_synonym ""CONDSIAS"" .

",stress induced childhood onset neurodegeneration with variable ataxia and seizures is a type of autosomal recessive disease.,9,True
doid,http://purl.obolibrary.org/obo/DOID_0070353,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:cataract_47 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :cataract ;
    :has_definition ""A cataract that has_material_basis_in heterozygous mutation in the SLC16A12 gene on chromosome 10q23, characterized by progressive juvenile cataract with microcornea."" ;
    :has_exact_synonym ""CTRCT47"" .

","Cataract 47 is a type of autosomal dominant disease, which means it can be passed down through families and tends to affect multiple family members. It is characterized by progressive juvenile cataract with microcornea, and has a material basis in a heterozygous mutation in the SLC16A12 gene on chromosome 10q23. Another name for this condition is CTRCT47.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070354,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:cataract_48 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :cataract ;
    :has_definition ""A cataract that has_material_basis_in homozygous mutation in the DNMBP gene on chromosome 10q24 and is characterized by infantile or early-childhood cataracts and visual impairment."" ;
    :has_exact_synonym ""CTRCT48"" .

","Cataract 48, also known as CTRCT48, is a type of cataract that is caused by a homozygous mutation in the DNMBP gene on chromosome 10q24. This leads to infantile or early-childhood cataracts and visual impairment. It is an autosomal recessive disease, which means that it requires the presence of two copies of the mutated gene (one from each parent) for its development.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070355,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:overactive_bladder_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :symptom ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :urinary_urgency ],
        :bladder_disease,
        :syndrome ;
    :has_definition ""A bladder disease characterized by urinary urgency without urinary tract infection or obvious pathology, usually accompanied by urinary frequency and nocturia."" ;
    :has_exact_synonym ""OAB"",
        ""overactive bladder"",
        ""urge syndrome"",
        ""urgency-frequency syndrome"" .

","Overactive Bladder Syndrome (OAB) is a type of bladder disease characterized by urinary urgency without urinary tract infection or obvious pathology, usually accompanied by urinary frequency and nocturia. It has an exact synonym of OAB, overactive bladder, urge syndrome, and urgency-frequency syndrome.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0070356,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:visual_impairment_and_progressive_phthisis_bulbi rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :eye_disease ;
    :has_definition ""An eye disease that is characterized by poor vision at birth, with development of bilateral phthisis by adulthood and that has_material_basis_in homozygous mutation in the MARK3 gene on chromosome 14q3."" .

",visual impairment and progressive phthisis bulbi is a type of autosomal recessive disease.,4,True
doid,http://purl.obolibrary.org/obo/DOID_0070357,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:nephrotic_syndrome_type_20 rdfs:subClassOf :familial_nephrotic_syndrome ;
    :has_definition ""A familial nephrotic syndrome that has_material_basis_in X-linked renal disorder characterized by onset of steroid-resistant nephrotic syndrome and proteinuria in the first years of life in affected males."" .

","Nephrotic syndrome type 20, also known as X-linked nephrotic syndrome, is a specific form of familial nephrotic syndrome. It is characterized by the onset of steroid-resistant nephrotic syndrome and proteinuria in the first years of life in affected males. The condition has a genetic basis, specifically on the X chromosome.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0070358,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_biliary_cholangitis_1 rdfs:subClassOf :primary_biliary_cholangitis ;
    :has_definition ""A primary biliary cholangitis that has_material_basis_in variation at the IL12A locus on chromosome 3q25.33."" ;
    :has_exact_synonym ""BILIARY CIRRHOSIS, PRIMARY, 1"",
        ""PBC1"" .

","Primary Biliary Cholangitis (PBC) is a chronic autoimmune liver disease that affects the bile ducts in the liver. It is characterized by inflammation and damage to these ducts, which can lead to obstruction and impaired bile flow.
Primary Biliary Cholangitis (PBC) primarily affects women and usually presents with symptoms such as fatigue, itching, jaundice, and abnormal liver tests. The exact cause of PBC is unknown, but it is thought to be triggered by an autoimmune response that attacks the bile ducts.
There are various treatment options available for Primary Biliary Cholangitis (PBC), including medications to manage symptoms and slow disease progression, as well as liver transplantation in some cases. Early diagnosis and treatment are essential to prevent complications such as cirrhosis and liver failure.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070359,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_biliary_cholangitis_2 rdfs:subClassOf :primary_biliary_cholangitis ;
    :has_definition ""A primary biliary cholangitis that has_material_basis_in variation at the HLA-DQB1 locus on chromosome 6p21.3."" ;
    :has_exact_synonym ""BILIARY CIRRHOSIS, PRIMARY, 2"",
        ""PBC2"" .

","Primary biliary cholangitis is a type of liver disease that affects the small bile ducts in the liver. The exact cause of this condition isn't known, but it is often linked to an autoimmune process. Primary biliary cholangitis can lead to cirrhosis and liver failure if not properly managed. There are different types of primary biliary cholangitis, including primary biliary cholangitis type 2, which has a genetic basis due to variation at the HLA-DQB1 locus on chromosome 6p21.3. This type of primary biliary cholangitis can cause liver inflammation and scarring, but it often progresses more slowly than other types. Treatment for primary biliary cholangitis typically includes medications to manage symptoms, such as itching and fatigue, and to slow the progression of the disease. In some cases, a liver transplant may be necessary if the disease has caused significant damage.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070360,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_biliary_cholangitis_3 rdfs:subClassOf :primary_biliary_cholangitis ;
    :has_definition ""A primary biliary cholangitis that has_material_basis_in variation at the IL12RB2 locus on chromosome 1p31.2."" ;
    :has_exact_synonym ""BILIARY CIRRHOSIS, PRIMARY, 3"",
        ""PBC3"" .

","Primary Biliary Cholangitis (PBC) is a chronic autoimmune disorder that affects the bile ducts in the liver. It causes inflammation and damage to these ducts, resulting in obstruction and impaired bile flow. PBC primarily affects women and usually presents with symptoms like jaundice (yellowing of the skin and eyes), itching, fatigue, and loss of appetite. The exact cause of PBC is unknown, but it is believed to be triggered by a combination of genetic and environmental factors.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070361,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_biliary_cholangitis_4 rdfs:subClassOf :primary_biliary_cholangitis ;
    :has_definition ""A primary biliary cholangitis that has_material_basis_in variation near the IRF5-TNPO3 locus on chromosome 7q32."" ;
    :has_exact_synonym ""BILIARY CIRRHOSIS, PRIMARY, 4"",
        ""PBC4"" .

","Primary Biliary Cholangitis 4 (PBC4) is a specific subtype of Primary Biliary Cholangitis characterized by a variation near the IRF5-TNPO3 locus on chromosome 7q32. It is also known as BILIARY CIRRHOSIS, PRIMARY, 4 (BILIARY CIRRHOSIS PBC4) and PBC4.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070362,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_biliary_cholangitis_5 rdfs:subClassOf :primary_biliary_cholangitis ;
    :has_definition ""A primary biliary cholangitis that has_material_basis_in variation at the ZPBP2 locus on chromosome 17q12-q21."" ;
    :has_exact_synonym ""BILIARY CIRRHOSIS, PRIMARY, 5"",
        ""PBC5"" .

","Primary Biliary Cholangitis 5 (PBC5) is a type of Primary Biliary Cholangitis. PBC5 has the definition of Primary Biliary Cholangitis that has a material basis in variation at the ZPBP2 locus on chromosome 17q12-q21.
BILIARY CIRRHOSIS, PRIMARY, 5 and PBC5 are exact synonyms for PBC5.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070363,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:bradyopsia_1 rdfs:subClassOf :bradyopsia ;
    :has_definition ""A braydopsia that has_material_basis_in homozygous or compound heterozygous mutation in the RGS9 gene on chromosome 17q24."" ;
    :has_exact_match ""OMIM:608415"" ;
    :has_exact_synonym ""prolonged electroretinal response suppression 1"" .

","Bradyopsia 1 is a type of condition where the electroretinogram (ERG) response is prolonged in the presence of light. It is caused by mutations in the RGS9 gene, which is located on chromosome 17q24. The term ""bradyopsia"" refers to slow vision, and this type of bradyopsia specifically affects the electrical activity in the retina. The condition is also known as prolonged electroretinal response suppression 1 (PERRS1) and has been mapped to OMIM (Online Mendelian Inheritance in Man) entry number 608415.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070364,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:bradyopsia_2 rdfs:subClassOf :bradyopsia ;
    :has_definition ""A braydopsia that has_material_basis_in homozygous mutation in the RGS9BP gene on chromosome 19q13."" ;
    :has_exact_match ""OMIM:620344"" ;
    :has_exact_synonym ""prolonged electroretinal response suppression 2"" .

",Bradyopsia 2 is a condition characterized by prolonged suppression of electroretinal responses. This is caused by a homozygous mutation in the RGS9BP gene located on chromosome 19q13. The condition is also known as prolonged electroretinal response suppression 2 (PERS2). It has been assigned the medical terminology code OMIM:620344.,4,True
doid,http://purl.obolibrary.org/obo/DOID_0070365,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:nevoid_basal_cell_carcinoma_syndrome_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :nevoid_basal_cell_carcinoma_syndrome ;
    :has_definition ""A nevoid basal cell carcinoma syndrome that has_material_basis_in heterozygous mutation in the PTCH1 gene on chromosome 9q22."" ;
    :has_exact_match ""OMIM:109400"" ;
    :has_exact_synonym ""basal cell nevus syndrome 1"" .

","Nevoid basal cell carcinoma syndrome 1 is a type of autosomal dominant disease, which means that it can be inherited from one parent to the other and can affect multiple generations in a family. It is caused by mutation in the PTCH1 gene on chromosome 9q22. The syndrome is characterized by the presence of numerous basal cell carcinomas, which are slow-growing skin cancer. Additionally, it may also be accompanied by other features like jaw cysts and bone abnormalities. Nevoid basal cell carcinoma syndrome 1 has an exact synonym of basal cell nevus syndrome 1 and a matching OMIM number of 109400.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070366,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:nevoid_basal_cell_carcinoma_syndrome_2 rdfs:subClassOf :nevoid_basal_cell_carcinoma_syndrome ;
    :has_definition ""A nevoid basal cell carcinoma syndrome that has_material_basis_in heterozygous mutation in the SUFU gene on chromosome 10q24."" ;
    :has_exact_match ""OMIM:620343"" ;
    :has_exact_synonym ""basal cell nevus syndrome 2"" .

","Nevus syndrome, also known as nevoid basal cell carcinoma syndrome (NBCCS), is a rare genetic disorder that affects the skin and other organs. It is characterized by the presence of multiple benign tumors called nevus (mole) or basal cell carcinoma (BCC). NBCCS is caused by mutations in the SUFU gene, which is located on chromosome 10q24. The syndrome has been renamed to Basal Cell Nevus Syndrome 2 (BCNS2), but it is still commonly referred to as NBCCS.

There are several types of NBCCS, and they are usually classified based on the age of onset and the severity of the disease. The most severe form of the syndrome is known as Gorlin-Goltz Syndrome, which typically presents in childhood with multiple large, jawbone tumors called odontogenic keratocysts (OKC), along with numerous BCCs.

Symptoms of NBCCS may include:
1. Multiple benign skin growths (nevi or moles) that can turn into cancer over time if not treated
2. Multiple basal cell carcinomas (BCCs) on the face and scalp, which are slow-growing but can become aggressive if left untreated
3. Odontogenic keratocysts (OKCs) in severe cases
4. Skin pitting or scarring from BCC surgery
5. Multiple jawbone tumors (odontogenic keratocysts, OKCs), particularly in the severe form of the syndrome called Gorlin-Goltz Syndrome

Treatment for NBCCS usually involves monitoring and removal of the growths by a dermatologist or plastic surgeon. Preventive measures like sunscreen use are also recommended to reduce the risk of BCC development. In severe cases, such as Gorlin-Goltz Syndrome, more extensive treatment may be necessary, including radiation therapy, chemotherapy, or surgical removal of affected tissues and organs.

In summary, nevoid basal cell carcinoma syndrome (NBCCS) is a rare genetic disorder that can cause multiple benign skin growths and other health issues if left untreated. Early detection and proper treatment are essential to prevent complications and maintain a good quality of life.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070367,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:leukoencephalopathy_with_vanishing_white_matter_5 rdfs:subClassOf :leukoencephalopathy_with_vanishing_white_matter ;
    :has_definition ""A leukoencephalopathy with vanishing white matter that has_material_basis_in homozygous or compound heterozygous mutation in the EIF2B5 gene on chromosome 3q27."" ;
    :has_exact_match ""OMIM:620315"",
        ""ORDO:99854"" ;
    :has_exact_synonym ""Cree leukoencephalopathy"" .

","This is a type of leukoencephalopathy where there is damage to the white matter in the brain, and it has been caused by mutations in the EIF2B5 gene. It is also known as Cree leukoencephalopathy and can be identified by the OMIM number 620315 and ORDO number 99854.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070368,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_chronic_granulomatous_disease_5 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :chronic_granulomatous_disease ;
    :has_definition ""A chronic granulomatous disease characterized by autosomal recessive inheritance that has_material_basis_in mutation in the CYBC1 gene on chromosome 17q25."" .

","Autosomal recessive chronic granulomatous disease 5 (also known as chronic mucocutaneous candidiasis) is a rare autosomal recessive disorder characterized by persistent or recurrent candida infections, primarily of the skin, nails, and mucous membranes. It is caused by mutations in the CYBC1 gene on chromosome 17q25.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070369,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:restrictive_dermopathy_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :restrictive_dermopathy ;
    :has_definition ""A restrictive dermopathy that has_material_basis_in homozygous or compound heterozygous mutation in the ZMPSTE24 gene on chromosome 1p34."" ;
    :has_exact_match ""OMIM:275210"" .

",restrictive dermopathy 1 is a type of autosomal recessive disease.,5,True
doid,http://purl.obolibrary.org/obo/DOID_0070370,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:restrictive_dermopathy_2 rdfs:subClassOf :restrictive_dermopathy ;
    :has_definition ""A restrictive dermopathy that has_material_basis_in heterozygous mutation in the LMNA gene on chromosome 1q22."" ;
    :has_exact_match ""OMIM:619793"" .

","Restrictive dermopathy 2 is a specific type of restrictive dermopathy characterized by the presence of a heterozygous mutation in the LMNA gene on chromosome 1q22. This condition can cause a variety of symptoms, including thickening and tightening of the skin, as well as the formation of excess collagen. It is also known as congenital contractural dermopathy (CCD) and has been described as a rare genetic disorder that typically affects infants and children. It is important to consult with a healthcare professional for proper diagnosis and treatment.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070371,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:leukoencephalopathy_with_vanishing_white_matter_4 rdfs:subClassOf :leukoencephalopathy_with_vanishing_white_matter ;
    :has_definition ""A leukoencephalopathy with vanishing white matter that has_material_basis_in compound heterozygous mutation in the EIF2B4 gene on chromosome 2p23."" ;
    :has_exact_match ""OMIM:620314"" .

","I understand that you are looking for information about leukoencephalopathy with vanishing white matter 4, which is also known as LVWM4. This type of leukoencephalopathy has a material basis in compound heterozygous mutations in the EIF2B4 gene on chromosome 2p23. The condition is listed in the Online Mendelian Inheritance in Man (OMIM) database with an entry number of OMIM:620314. Is there anything else you would like me to help you with?",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070372,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:leukoencephalopathy_with_vanishing_white_matter_3 rdfs:subClassOf :leukoencephalopathy_with_vanishing_white_matter ;
    :has_definition ""A leukoencephalopathy with vanishing white matter that has_material_basis_in homozygous or compound heterozygous mutation in the EIF2B3 gene on chromosome 1p34."" ;
    :has_exact_match ""OMIM:620313"" .

","Leukoencephalopathy with vanishing white matter 3, also known as EIF2B-related leukoencephalopathy with vanishing white matter type 3, is a rare genetic disorder characterized by the gradual degeneration of brain tissue. This condition is caused by mutations in the EIF2B3 gene, which is located on chromosome 1p34. The symptoms of this disorder usually begin during childhood and can include developmental delays, seizures, difficulty with coordination and balance, and problems with speech and language. As the disease progresses, it can lead to severe neurological impairment and even death. It is important for individuals with this condition to receive proper medical care and support to manage their symptoms and improve their quality of life.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070373,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:leukoencephalopathy_with_vanishing_white_matter_2 rdfs:subClassOf :leukoencephalopathy_with_vanishing_white_matter ;
    :has_definition ""A leukoencephalopathy with vanishing white matter that has_material_basis_in homozygous or compound heterozygous mutation in the EIF2B2 gene on chromosome 14q24."" ;
    :has_exact_match ""OMIM:620312"" .

","Leukoencephalopathy with vanishing white matter 2 is a type of leukoencephalopathy characterized by the degeneration and loss of white matter in the brain. This condition has a genetic basis, as it is caused by mutations in the EIF2B2 gene on chromosome 14q24. Leukoencephalopathy with vanishing white matter 2 is also known as ""progressive leukoencephalopathy with vanishing white matter,"" and has been assigned an exact match in the Online Mendelian Inheritance in Man (OMIM) database, which is a comprehensive catalog of genetic disorders.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070374,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:leukoencephalopathy_with_vanishing_white_matter_1 rdfs:subClassOf :leukoencephalopathy_with_vanishing_white_matter ;
    :has_definition ""A leukoencephalopathy with vanishing white matter that has_material_basis_in homozygous or compound heterozygous mutation in the EIF2B1 gene on chromosome 12q24."" ;
    :has_exact_match ""OMIM:603896"" .

","Leukoencephalopathy with Vanishing White Matter 1, also known as LWVWM 1 or EIF2B-related leukoencephalopathy with vanishing white matter 1, is a type of leukoencephalopathy characterized by the loss of white matter in the brain. It is caused by mutations in the EIF2B gene located on chromosome 12q24. This condition is also known as EIF2B-related leukoencephalopathy with vanishing white matter 1 or LWVWM 1 for short.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070375,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_64 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by infantile onset of seizures, severe intellectual disabilities, impaired motor functions, movement disorders, and postnatal microcephaly that has_material_basis_in heterozygous mutation in the RHOBTB2 gene on chromosome 8p21."" ;
    :has_exact_synonym ""DEE64"",
        ""early infantile epileptic encephalopathy 64"" .

","developmental and epileptic encephalopathy 64 is a type of autosomal dominant disease characterized by infantile onset of seizures, severe intellectual disabilities, impaired motor functions, movement disorders, and postnatal microcephaly that has_material_basis_in heterozygous mutation in the RHOBTB2 gene on chromosome 8p21.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070376,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_31b rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by early-onset epilepsy, generalized muscular hypotonia, visual impairment, and severe neurodevelopmental delay that has_material_basis_in homozygous mutation in the DNM1 gene on chromosome 9q34."" ;
    :has_exact_synonym ""DEE31B"" .

","developmental and epileptic encephalopathy 31b is a type of autosomal recessive disease.
developmental and epileptic encephalopathy 31b is a type of developmental and epileptic encephalopathy.
developmental and epileptic encephalopathy 31b is a type of something that at least has material basis in some autosomal recessive inheritance.
developmental and epileptic encephalopathy 31b has definition A developmental and epileptic encephalopathy characterized by early-onset epilepsy, generalized muscular hypotonia, visual impairment, and severe neurodevelopmental delay that has_material_basis_in homozygous mutation in the DNM1 gene on chromosome 9q34..
developmental and epileptic encephalopathy 31b is an exact synonym for DEE31B.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070377,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_96 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by onset of seizures in the first days or weeks of life that has_material_basis_in heterozygous mutation in the NSF gene on chromosome 17q21."" ;
    :has_exact_synonym ""DEE96"" .

","Developmental and epileptic encephalopathy 96, also known as DEE96, is a type of autosomal dominant disease. It is characterized by onset of seizures in the first days or weeks of life that has a material basis in heterozygous mutation in the NSF gene located on chromosome 17q21.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070378,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_109 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by onset of various types of seizures in the first months or years of life that has_material_basis_in heterozygous mutation in the FZR1 gene on chromosome 19p13."" ;
    :has_exact_synonym ""DEE109"" .

","developmental and epileptic encephalopathy 109 is a type of autosomal dominant disease.
developmental and epileptic encephalopathy 109 is a type of developmental and epileptic encephalopathy.
developmental and epileptic encephalopathy 109 is a type of something that at least has material basis in some autosomal dominant inheritance.
developmental and epileptic encephalopathy 109 has definition A developmental and epileptic encephalopathy characterized by onset of various types of seizures in the first months or years of life that has_material_basis_in heterozygous mutation in the FZR1 gene on chromosome 19p13.
developmental and epileptic encephalopathy 109 has exact synonym DEE109.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070379,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_6b rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by early-infantile seizure onset, profoundly impaired intellectual development, and a hyperkinetic movement disorder that has_material_basis_in heterozygous mutation in the SCN1A gene on chromosome 2q24. This disease has the same genetic basis as Dravet syndrome (DOID:0080422) but is more severe."" ;
    :has_exact_synonym ""DEE6B"" .

","DEE6B, also known as developmental and epileptic encephalopathy 6b, is a type of autosomal dominant disease. It is characterized by early-infantile seizure onset, profoundly impaired intellectual development, and a hyperkinetic movement disorder that has_material_basis_in heterozygous mutation in the SCN1A gene on chromosome 2q24. This disease shares the same genetic basis as Dravet syndrome (DOID:0080422) but is more severe.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070380,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_85 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_dominant_inheritance ],
        :developmental_and_epileptic_encephalopathy,
        :x_linked_dominant_disease ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by onset of severe refractory seizures in the first year of life, global developmental delay with impaired intellectual development and poor or absent speech, and dysmorphic facial features that has_material_basis_in heterozygous mutation in the SMC1A gene on chromosome Xp11."" ;
    :has_exact_synonym ""DEE85"",
        ""early infantile epileptic encephalopathy 85"" .

","Developmental and epileptic encephalopathy 85 (DEE85) is a type of developmental and epileptic encephalopathy that is characterized by the onset of severe refractory seizures in the first year of life, global developmental delay with impaired intellectual development and poor or absent speech, and dysmorphic facial features. It has a material basis in heterozygous mutation in the SMC1A gene on chromosome Xp11. It is also known as early infantile epileptic encephalopathy 85 (EIEE85).",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070381,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_90 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_inheritance ],
        :developmental_and_epileptic_encephalopathy,
        :x_linked_monogenic_disease ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by onset of refractory seizures in the first days or months of life that has_material_basis_in hemizygous or heterozygous mutation in the FGF13 gene on chromosome Xq26."" ;
    :has_exact_synonym ""DEE90"" .

","Developmental and epileptic encephalopathy (DEE) 90, also known as FGF13-related epilepsy, is a type of developmental and epileptic encephalopathy caused by mutations in the FGF13 gene on chromosome Xq26. It is characterized by the onset of refractory seizures in the first days or months of life. The condition has a material basis in hemizygous or heterozygous mutation in the FGF13 gene, and it can be diagnosed using genetic testing.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070382,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_95 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by severely impaired global development, hypotonia, weakness, ataxia, coarse facial features, and intractable seizures that has_material_basis_in homozygous or compound heterozygous mutation in the PIGS gene on chromosome 17q11."" ;
    :has_exact_synonym ""DEE95"",
        ""early infantile epileptic encephalopathy 95"" .

",User,6,True
doid,http://purl.obolibrary.org/obo/DOID_0070383,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_97 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by onset of seizures in the first months of life that has_material_basis_in heterozygous mutation in the CELF2 gene on chromosome 10p14."" ;
    :has_exact_synonym ""DEE97"",
        ""early infantile epileptic encephalopathy 97"" .

","developmental and epileptic encephalopathy 97 is a type of autosomal dominant disease.
developmental and epileptic encephalopathy 97 is a type of developmental and epileptic encephalopathy that has_material_basis_in heterozygous mutation in the CELF2 gene on chromosome 10p14.
developmental and epileptic encephalopathy 97 is a type of something that has a material basis in autosomal dominant inheritance.
developmental and epileptic encephalopathy 97 has definition Developmental and epileptic encephalopathy characterized by onset of seizures in the first months of life that has_material_basis_in heterozygous mutation in the CELF2 gene on chromosome 10p14.
developmental and epileptic encephalopathy 97 has exact synonym DEE97.
developmental and epileptic encephalopathy 97 has exact synonym early infantile epileptic encephalopathy 97.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070384,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_98 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by onset of seizures in the first decade associated with variable global developmental delay that has_material_basis_in heterozygous mutation in the ATP1A2 gene on chromosome 1q23."" ;
    :has_exact_synonym ""DEE98"",
        ""early infantile epileptic encephalopathy 98"" .

","Developmental and epileptic encephalopathy 98, also known as DEE98, is a type of autosomal dominant disease characterized by onset of seizures in the first decade of life and variable global developmental delay. It has material basis in heterozygous mutation in the ATP1A2 gene located on chromosome 1q23. The term DEE98 is also sometimes used interchangeably with early infantile epileptic encephalopathy (EIEE) 98, which refers to a subtype of developmental and epileptic encephalopathy that typically presents in the first few months of life. Both conditions are complex neurological disorders that can have significant impacts on an individual's cognitive, behavioral, and motor functioning. Treatment options may include medications to control seizures, behavioral interventions, and support for developmental therapy.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070385,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_99 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by onset of seizures in early childhood that has_material_basis_in heterozygous mutation in the ATP1A3 gene on chromosome 19q13."" ;
    :has_exact_synonym ""DEE99"",
        ""early infantile epileptic encephalopathy 99"" .

","developmental and epileptic encephalopathy 99 is a type of autosomal dominant disease.
developmental and epileptic encephalopathy 99 is a type of developmental and epileptic encephalopathy.
developmental and epileptic encephalopathy 99 is a type of something that at least has material basis in some autosomal dominant inheritance.
developmental and epileptic encephalopathy 99 has definition A developmental and epileptic encephalopathy characterized by onset of seizures in early childhood that has_material_basis_in heterozygous mutation in the ATP1A3 gene on chromosome 19q13.
developmental and epileptic encephalopathy 99 has exact synonym DEE99.
developmental and epileptic encephalopathy 99 has exact synonym early infantile epileptic encephalopathy 99.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070386,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_100 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by onset of variable types of seizures in the first months or years of life preceded by global developmental delay that has_material_basis_in heterozygous mutation in the FBXO28 gene on chromosome 1q42."" ;
    :has_exact_synonym ""DEE100"",
        ""early infantile epileptic encephalopathy 100"" .

",Developmental and Epileptic Encephalopathy 100 (DEE100) is a type of autosomal dominant disorder characterized by onset of variable types of seizures in the first months or years of life preceded by global developmental delay. This condition has a material basis in heterozygous mutation in the FBXO28 gene located on chromosome 1q42. It is also known as Early Infantile Epileptic Encephalopathy 100 (EIEE100).,6,True
doid,http://purl.obolibrary.org/obo/DOID_0070387,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_101 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by early infantile epileptic encephalopathy and severe global developmental delay that has_material_basis_in homozygous mutation in the GRIN1 gene on chromosome 9q34."" ;
    :has_exact_synonym ""DEE101"",
        ""early infantile epileptic encephalopathy 101"" .

","developmental and epileptic encephalopathy 101 is a type of autosomal recessive disease.
developmental and epileptic encephalopathy 101 is a type of developmental and epileptic encephalopathy.
developmental and epileptic encephalopathy 101 is a type of something that at least has material basis in some autosomal recessive inheritance.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070388,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_102 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by global developmental delay and severe to profoundly impaired intellectual development with inability to walk or speak that has_material_basis_in homozygous or compound heterozygous mutations in the SLC38A3 gene on chromosome 3p21."" ;
    :has_exact_synonym ""DEE102"",
        ""early infantile epileptic encephalopathy 102"" .

","Developmental and epileptic encephalopathy 102 (DEE102) is a type of autosomal recessive disorder that is characterized by global developmental delay and severe to profoundly impaired intellectual development, along with the inability to walk or speak. It has a material basis in homozygous or compound heterozygous mutations in the SLC38A3 gene on chromosome 3p21. The condition is also known as early infantile epileptic encephalopathy 102, and it can be abbreviated as DEE102.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070389,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_103 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by onset of various types of seizures in the first year of life that has_material_basis_in heterozygous mutation in the KCNC2 gene on chromosome 12q21."" ;
    :has_exact_synonym ""DEE103"",
        ""early infantile epileptic encephalopathy 103"" .

","developmental and epileptic encephalopathy 103 is a type of autosomal dominant disease.
developmental and epileptic encephalopathy 103 is a type of developmental and epileptic encephalopathy.
developmental and epileptic encephalopathy 103 is a type of something that at least has material basis in some autosomal dominant inheritance.
developmental and epileptic encephalopathy 103 has definition A developmental and epileptic encephalopathy characterized by onset of various types of seizures in the first year of life that has_material_basis_in heterozygous mutation in the KCNC2 gene on chromosome 12q21..
developmental and epileptic encephalopathy 103 has exact synonym DEE103.
developmental and epileptic encephalopathy 103 has exact synonym early infantile epileptic encephalopathy 103.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070390,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_104 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by developmental delay in the first few months of life and drug-resistant focal and generalized tonic-clonic seizures that has_material_basis_in heterozygous mutation in the ATP6V0A1 on chromosome 17q21."" ;
    :has_exact_synonym ""DEE104"",
        ""early infantile epileptic encephalopathy 104"" .

",Developmental and epileptic encephalopathy 104 (DEE 104) is a type of autosomal dominant disease that affects brain development in infants. It is characterized by significant developmental delay and drug-resistant focal and generalized tonic-clonic seizures. The condition has a material basis in heterozygous mutation in the ATP6V0A1 gene on chromosome 17q21. It is also known as early infantile epileptic encephalopathy 104 (EIEE104).,6,True
doid,http://purl.obolibrary.org/obo/DOID_0070391,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_105 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by onset of seizures and pituitary insufficiency in the first weeks or months of life with profoundly impaired development that has_material_basis_in homozygous or compound heterozygous mutation in the HID1 gene on chromosome 17q25."" ;
    :has_exact_synonym ""DEE105"",
        ""early infantile epileptic encephalopathy 105"" .

",developmental and epileptic encephalopathy 105 is a type of autosomal recessive disease characterized by onset of seizures and pituitary insufficiency in the first weeks or months of life with profoundly impaired development that has_material_basis_in homozygous or compound heterozygous mutation in the HID1 gene on chromosome 17q25.,6,True
doid,http://purl.obolibrary.org/obo/DOID_0070392,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_106 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by onset of various types of frequent seizures within the first year of life and profound global developmental delay with limited ability to move and absent speech that has_material_basis_in homozygous mutation in the UFSP2 gene on chromosome 4q35."" ;
    :has_exact_synonym ""DEE106"",
        ""early infantile epileptic encephalopathy 106"" .

","Developmental and epileptic encephalopathy 106 is a type of autosomal recessive disease that affects brain development and causes severe seizures in infants. It has limited speech and movement abilities, and is caused by mutations in the UFSP2 gene on chromosome 4q35. This condition has an exact synonym called early infantile epileptic encephalopathy 106, which describes the same characteristics of developmental and epileptic encephalopathy 106.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070393,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_107 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by onset of seizures in the first months of life, severe global developmental delay, profound intellectual disability, progressive microcephaly, and hypotonia that has_material_basis_in homozygous mutation in the NAPB gene on chromosome 20p11."" ;
    :has_exact_synonym ""DEE107"",
        ""early infantile epileptic encephalopathy 107"" .

","developmental and epileptic encephalopathy 107 is a type of autosomal recessive disease.
developmental and epileptic encephalopathy 107 is a type of developmental and epileptic encephalopathy that has a genetic basis in some cases.
developmental and epileptic encephalopathy 107, also known as DEE107 or early infantile epileptic encephalopathy 107, is a condition characterized by severe global developmental delay, profound intellectual disability, seizures that begin in the first months of life, progressive microcephaly, and hypotonia. It has a genetic basis in homozygous mutation in the NAPB gene on chromosome 20p11.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070394,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_108 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by onset of multiple types of seizures in the first 2 years of life that has_material_basis_in heterozygous mutation in the MAST3 gene on chromosome 19p13."" ;
    :has_exact_synonym ""DEE108"",
        ""early infantile epileptic encephalopathy 108"" .

","developmental and epileptic encephalopathy 108 is a type of autosomal dominant disease.
developmental and epileptic encephalopathy 108 is a type of developmental and epileptic encephalopathy.
developmental and epileptic encephalopathy 108 is a type of something that at least has material basis in some autosomal dominant inheritance.
developmental and epileptic encephalopathy 108 has definition A developmental and epileptic encephalopathy characterized by onset of multiple types of seizures in the first 2 years of life that has_material_basis_in heterozygous mutation in the MAST3 gene on chromosome 19p13..
developmental and epileptic encephalopathy 108 has exact synonym DEE108.
developmental and epileptic encephalopathy 108 has exact synonym early infantile epileptic encephalopathy 108.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070395,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_and_epileptic_encephalopathy_110 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :developmental_and_epileptic_encephalopathy ;
    :has_definition ""A developmental and epileptic encephalopathy characterized by profound global developmental delay and hypotonia apparent in infancy followed by onset of seizures in the first months or years of life that has_material_basis_in homozygous or compound heterozygous mutation in the CACNA2D1 gene on chromosome 7q21."" ;
    :has_exact_synonym ""DEE110"",
        ""early infantile epileptic encephalopathy 110"" .

","Developmental and epileptic encephalopathy 110 (DEE110) is a type of autosomal recessive disease characterized by profound global developmental delay and hypotonia in infancy, followed by the onset of seizures in the first months or years of life. It has a material basis in homozygous or compound heterozygous mutations in the CACNA2D1 gene located on chromosome 7q21. The exact synonyms for DEE110 include developmental and epileptic encephalopathy and early infantile epileptic encephalopathy.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070396,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:progressive_leukoencephalopathy_with_ovarian_failure rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :leukodystrophy ;
    :has_definition ""An leukodystrophy characterized by loss of motor and cognitive skills, usually with onset in young adulthood, that has_material_basis_in compound heterozygous mutation in the AARS2 gene on chromosome 6p21."" ;
    :has_exact_match ""OMIM:615889"" ;
    :has_related_match ""ORDO:99853"" ;
    :has_related_synonym ""ovarioleukodystrophy"" .

","Progressive leukoencephalopathy with ovarian failure is a type of autosomal recessive disease that affects the brain and ovaries. It is characterized by the progressive loss of motor and cognitive skills, usually starting in young adulthood. The condition has a material basis in compound heterozygous mutations in the AARS2 gene on chromosome 6p21. It is also known as ovarioleukodystrophy.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0070397,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hypomyelinating_leukodystrophy_23 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :hypomyelinating_leukodystrophy ;
    :has_definition ""A hypomyelinating leukodystrophy characterized by ataxia, deafness, liver dysfunction, and dilated cardiomyopathy that has_material_basis_in homozygous mutation in the RNF220 gene on chromosome 1p34. This disease results in death in the first or second decade of life."" ;
    :has_exact_synonym ""HLD23"" .

","Hypomyelinating leukodystrophy 23 is a type of autosomal recessive disease characterized by ataxia, deafness, liver dysfunction, and dilated cardiomyopathy. It has material basis in homozygous mutation in the RNF220 gene on chromosome 1p34, and results in death in the first or second decade of life. It is also known as HLD23.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070398,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hypomyelinating_leukodystrophy_15 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :hypomyelinating_leukodystrophy ;
    :has_definition ""A hypomyelinating leukodystrophy characterized by onset of motor and cognitive impairment of variable severity in the first or second decade of life that has_material_basis_in homozygous or compound heterozygous mutation in the EPRS1 gene on chromosome 1q41."" ;
    :has_exact_synonym ""HLD15"" .

","Hypomyelinating leukodystrophy 15, also known as HLD15, is a type of autosomal recessive disease that affects the brain and spinal cord. It typically presents in childhood with motor and cognitive impairment of variable severity. The condition has a material basis in homozygous or compound heterozygous mutations in the EPRS1 gene located on chromosome 1q41.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070399,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hypomyelinating_leukodystrophy_18 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :hypomyelinating_leukodystrophy ;
    :has_definition ""A hypomyelinating leukodystrophy characterized by onset of global developmental delay in infancy or early childhood that has_material_basis_in homozygous or compound heterozygous mutation in the DEGS1 gene on chromosome 1q42."" ;
    :has_exact_synonym ""HLD18"" .

","Hypomyelinating leukodystrophy 18, also known as HLD18, is a type of autosomal recessive disorder. It is characterized by developmental delays in infancy or early childhood that have a material basis in homozygous or compound heterozygous mutations in the DEGS1 gene on chromosome 1q42.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070400,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hypomyelinating_leukodystrophy_19 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :hypomyelinating_leukodystrophy ;
    :has_definition ""A hypomyelinating leukodystrophy characterized by onset of transient neurologic abnormalities in early infancy with resolution within the first or second decades that has_material_basis_in heterozygous mutation in the TMEM63A gene on chromosome 1q42."" ;
    :has_exact_synonym ""HLD19"" .

",Hypomyelinating leukodystrophy 19 (HLD19) is a type of autosomal dominant disease. It is characterized by the onset of transient neurologic abnormalities in early infancy with resolution within the first or second decades. The disease has a material basis in heterozygous mutation in the TMEM63A gene on chromosome 1q42. Another name for HLD19 is hypomyelinating leukodystrophy type 19.,5,True
doid,http://purl.obolibrary.org/obo/DOID_0070401,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hypomyelinating_leukodystrophy_25 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :hypomyelinating_leukodystrophy ;
    :has_definition ""A hypomyelinating leukodystrophy characterized by horizontal nystagmus, hypotonia, and global developmental delay apparent soon after birth or in infancy. that has_material_basis_in heterozygous mutation in the TMEM163 gene on chromosome 2q21."" ;
    :has_exact_synonym ""HLD25"" .

","Hypomyelinating leukodystrophy 25, also known as HLD25, is a type of autosomal dominant disease. It is characterized by horizontal nystagmus, hypotonia, and global developmental delay apparent soon after birth or in infancy. The condition has a material basis in heterozygous mutation in the TMEM163 gene on chromosome 2q21.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070402,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hypomyelinating_leukodystrophy_22 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :hypomyelinating_leukodystrophy ;
    :has_definition ""A hypomyelinating leukodystrophy characterized by global developmental delay with mildly impaired intellectual development, motor impairment with limited or no ability to walk, and dysarthria that has_material_basis_in heterozygous mutation in the CLDN11 gene on chromosome 3q26."" ;
    :has_exact_synonym ""HLD22"" .

","Hypomyelinating leukodystrophy 22, also known as HLD22, is a type of autosomal dominant disease that affects the development and function of the central nervous system. It is characterized by global developmental delay with mildly impaired intellectual development, motor impairment with limited or no ability to walk, and dysarthria. The condition has a material basis in heterozygous mutation in the CLDN11 gene on chromosome 3q26.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070403,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hypomyelinating_leukodystrophy_26 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :hypomyelinating_leukodystrophy ;
    :has_definition ""A hypomyelinating leukodystrophy characterized by severe psychomotor delay, predominantly involving motor and expressive language development, cerebral and cerebellar atrophy, and corpus callosum hypoplasia that has_material_basis_in homozygous mutation in the SLC35B2 gene on chromosome 6p21."" ;
    :has_exact_synonym ""HLD26"" .

","Hypomyelinating leukodystrophy 26 is a type of autosomal recessive disease in which the SLC35B2 gene on chromosome 6p21 is mutated, leading to severe psychomotor delay, cerebral and cerebellar atrophy, and corpus callosum hypoplasia. It has material basis in homozygous mutation in the SLC35B2 gene on chromosome 6p21.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070404,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hypomyelinating_leukodystrophy_17 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :hypomyelinating_leukodystrophy ;
    :has_definition ""A hypomyelinating leukodystrophy characterized by onset in early infancy of microcephaly and lack of overall development that has_material_basis_in homozygous mutation in the AIMP2 gene on chromosome 7p22."" ;
    :has_exact_synonym ""HLD17"" .

","Hypomyelinating leukodystrophy 17, also known as HLD17, is a type of autosomal recessive disease that affects the central nervous system. It is characterized by onset in early infancy of microcephaly and lack of overall development. The condition has a material basis in homozygous mutation in the AIMP2 gene located on chromosome 7p22.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070405,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hypomyelinating_leukodystrophy_16 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :hypomyelinating_leukodystrophy ;
    :has_definition ""A hypomyelinating leukodystrophy characterized by onset of hypotonia, nystagmus, and mildly delayed motor development in infancy that has_material_basis_in heterozygous mutation in the TMEM106B gene on chromosome 7p21."" ;
    :has_exact_synonym ""HLD16"" .

","Hypomyelinating leukodystrophy type 16 (HLD16) is a genetic disorder that affects the central nervous system. It is caused by mutations in the TMEM106B gene located on chromosome 7p21. HLD16 results in the loss of myelin, which leads to demyelination and ultimately causes damage to the nerve cells. This disorder primarily affects infants and children, and can cause symptoms such as hypotonia (a lack of muscle tone), nystagmus (involuntary eye movements), and mildly delayed motor development.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070406,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hypomyelinating_leukodystrophy_24 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :hypomyelinating_leukodystrophy ;
    :has_definition ""A hypomyelinating leukodystrophy characterized by global developmental delay and neurologic deterioration that has_material_basis_in heterozygous mutation in the ATP11A gene on chromosome 13q34."" ;
    :has_exact_synonym ""HLD24"" .

","Hypomyelinating leukodystrophy 24, also known as HLD24, is a type of autosomal dominant disease characterized by global developmental delay and neurologic deterioration. It has material basis in heterozygous mutation in the ATP11A gene on chromosome 13q34.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070407,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hypomyelinating_leukodystrophy_21 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :hypomyelinating_leukodystrophy ;
    :has_definition ""A hypomyelinating leukodystrophy characterized by global developmental delay apparent from infancy with loss of motor, speech, and cognitive milestones in the first decades of life that has_material_basis_in homozygous mutation in the POLR3K gene on chromosome 16p13."" ;
    :has_exact_synonym ""HLD21"" .

","hypomyelinating leukodystrophy 21 is a type of autosomal recessive disease characterized by global developmental delay apparent from infancy with loss of motor, speech, and cognitive milestones in the first decades of life that has material basis in homozygous mutation in the POLR3K gene on chromosome 16p13.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070408,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hengel_maroofian_schols_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :syndrome ;
    :has_definition ""A syndrome characterized by infant or early childhood onset, impaired intellectual development with poor or absent speech, pyramidal signs, microcephaly, short stature, and dysmorphic facial features has_material_basis_in homozygous or compound heterozygous mutation in the BCAS3 gene on chromosome 17q23."" ;
    :has_exact_match ""OMIM:619641"" .

","Hengel-Marooijian Schols Syndrome is a rare autosomal recessive genetic disorder that affects children. It is characterized by symptoms such as intellectual developmental delay, poor or absent speech, pyramidal signs, microcephaly, short stature, and dysmorphic facial features. The syndrome has a material basis in homozygous or compound heterozygous mutations in the BCAS3 gene on chromosome 17q23.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070409,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_spinocerebellar_ataxia_28 rdfs:subClassOf :autosomal_recessive_cerebellar_ataxia ;
    :has_definition ""An autosomal recessive cerebellar ataxia characterized by onset in early childhood of mildly delayed motor development, gait ataxia, incoordination of fine motor movements, and dysarthria that has_material_basis_in homozygous mutation in the THG1L gene on chromosome 5q33."" ;
    :has_exact_synonym ""SCAR28"" .

","Autosomal recessive spinocerebellar ataxia 28 (SCAR28) is a type of autosomal recessive cerebellar ataxia. It is characterized by onset in early childhood with mildly delayed motor development, gait ataxia, fine motor movement incoordination, and dysarthria due to homozygous mutation in the THG1L gene located on chromosome 5q33. The condition has been named SCAR28 as it is distinct from other types of autosomal recessive cerebellar ataxia.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070410,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_spinocerebellar_ataxia_29 rdfs:subClassOf :autosomal_recessive_cerebellar_ataxia ;
    :has_definition ""An autosomal recessive cerebellar ataxia characterized by delayed motor development in early infancy followed by difficulty walking due to an ataxic gait or inability to walk, hypotonia, and variably impaired intellectual development that has_material_basis_in homozygous or compound heterozygous mutation in the VPS41 gene on chromosome 7p14."" ;
    :has_exact_synonym ""SCAR29"" .

","Autosomal recessive spinocerebellar ataxia 29 is a type of autosomal recessive cerebellar ataxia characterized by delayed motor development in early infancy followed by difficulty walking due to an ataxic gait or inability to walk, hypotonia, and variably impaired intellectual development. It has a material basis in homozygous or compound heterozygous mutations in the VPS41 gene on chromosome 7p14. The condition is also known as SCAR29.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070411,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_spinocerebellar_ataxia_30 rdfs:subClassOf :autosomal_recessive_cerebellar_ataxia ;
    :has_definition ""An autosomal recessive cerebellar ataxia characterized by childhood-onset global developmental delay with variably impaired intellectual development, motor dysfunction, and cerebellar ataxia that has_material_basis_in homozygous mutation in the PITRM1 gene on chromosome 10p15."" ;
    :has_exact_synonym ""SCAR30"" .

","Autosomal recessive spinocerebellar ataxia 30 (SCAR30) is a type of autosomal recessive cerebellar ataxia characterized by childhood-onset global developmental delay with variably impaired intellectual development, motor dysfunction, and cerebellar ataxia that has a material basis in homozygous mutation in the PITRM1 gene on chromosome 10p15. SCAR30 is also known as autosomal recessive spinocerebellar ataxia type 30.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070412,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_spinocerebellar_ataxia_31 rdfs:subClassOf :autosomal_recessive_cerebellar_ataxia ;
    :has_definition ""An autosomal recessive cerebellar ataxia characterized by global developmental delay with hypotonia and variably impaired intellectual and language development that has_material_basis_in homozygous or compound heterozygous mutation in the ATG7 gene on chromosome 3p25."" ;
    :has_exact_synonym ""SCAR31"" .

","Autosomal recessive spinocerebellar ataxia 31 (SCAR31) is a type of autosomal recessive cerebellar ataxia characterized by global developmental delay, hypotonia, and variably impaired intellectual and language development. It has a material basis in homozygous or compound heterozygous mutations in the ATG7 gene located on chromosome 3p25. SCAR31 is also known as autosomal recessive spinocerebellar ataxia type 31.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070413,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_spinocerebellar_ataxia_32 rdfs:subClassOf :autosomal_recessive_cerebellar_ataxia ;
    :has_definition ""An autosomal recessive cerebellar ataxia characterized by onset of gait ataxia in the second or third decade of life that has_material_basis_in homozygous or compound heterozygous mutation in the PRDX3 gene on chromosome 10q26."" ;
    :has_exact_synonym ""SCAR32"" .

",Autosomal recessive spinocerebellar ataxia 32 (SCAR32) is a type of autosomal recessive cerebellar ataxia that occurs due to mutations in the PRDX3 gene on chromosome 10q26. It usually presents with gait ataxia during the second or third decade of life.,3,True
doid,http://purl.obolibrary.org/obo/DOID_0070414,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_spinocerebellar_ataxia_33 rdfs:subClassOf :autosomal_recessive_cerebellar_ataxia ;
    :has_definition ""An autosomal recessive cerebellar ataxia characterized by delayed motor development apparent in infancy, unsteady ataxic gait, intention tremor, nystagmus, and speech delay with dysarthria that has_material_basis_in homozygous mutation in the RNU12 gene on chromosome 22q13."" ;
    :has_exact_synonym ""SCAR33"" .

","Autosomal recessive spinocerebellar ataxia 33 (SCAR33) is a type of autosomal recessive cerebellar ataxia that is characterized by delayed motor development in infancy, unsteady ataxic gait, intention tremor, nystagmus, and speech delay with dysarthria. It has a material basis in homozygous mutation in the RNU12 gene on chromosome 22q13.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070415,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:brachycephaly_trichomegaly_and_developmental_delay rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :syndrome ;
    :has_definition ""A syndrome characterized by brachycephaly, trichomegaly, and developmental delay, without anemia, that has_material_basis_in heterozygous mutation in the RPS23 gene on chromosome 5q14."" ;
    :has_exact_synonym ""BTDD"",
        ""MCINS"",
        ""Macinnes syndrome"" .

","Brachycephaly, trichomegaly, and developmental delay is a type of autosomal dominant disease. It is characterized by an abnormal head shape (brachycephaly), excessive hair growth (trichomegaly), and developmental delays in infants and children. The condition has a genetic basis, with mutations in the RPS23 gene on chromosome 5q14 being responsible for at least some cases. It is also known by other names such as BTDD, MCINS, and Macinnes syndrome.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0070416,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:luo_schoch_yamamoto_syndrome rdfs:subClassOf :autosomal_dominant_intellectual_developmental_disorder ;
    :has_definition ""A autosomal dominant intellectual developmental disorder characterized by global developmental delay and impaired intellectual development apparent from infancy that has_material_basis_in heterozygous mutation in the RNF2 gene on chromosome 1q25."" ;
    :has_exact_synonym ""LUSYAM"" .

","Luo-Schoch-Yamamoto Syndrome (LUSYAM) is a type of autosomal dominant intellectual developmental disorder characterized by global developmental delay and impaired intellectual development apparent from infancy, which has a material basis in heterozygous mutation in the RNF2 gene on chromosome 1q25.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070417,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:neurodevelopmental_disorder_with_speech_impairment_and_dysmorphic_facies rdfs:subClassOf :autosomal_dominant_intellectual_developmental_disorder ;
    :has_definition ""A autosomal dominant intellectual developmental disorder characterized by developmental delay associated with mild to moderately impaired intellectual development or learning difficulties, behavioral or psychiatric abnormalities, and delayed speech and language acquisition that has_material_basis_in heterozygous mutation in the SETD1A gene on chromosome 16p11."" ;
    :has_exact_synonym ""NEDSID"" .

","User, I understand that you are looking for information about a specific type of autosomal dominant intellectual developmental disorder called neurodevelopmental disorder with speech impairment and dysmorphic facies (NEDSID).
You stated that NEDSID is characterized by developmental delay associated with mild to moderately impaired intellectual development or learning difficulties, behavioral or psychiatric abnormalities, and delayed speech and language acquisition. Additionally, you mentioned that the disorder has a material basis in heterozygous mutation in the SETD1A gene on chromosome 16p11.
Please let me know if there are any specific aspects of NEDSID that you would like to know more about or if there is anything else I can help you with.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070418,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:vertebral_hypersegmentation_and_orofacial_anomalies rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :syndrome ;
    :has_definition ""A syndrome characterized by supernumerary cervical, thoracic, and/or lumbar vertebrae, in association with supernumerary ribs that has_material_basis_in heterozygous mutation in the GDF11 gene on chromosome 12q13."" ;
    :has_exact_synonym ""VHO"" .

",Vertebral hypersegmentation and orofacial anomalies (VHO) is a type of autosomal dominant disease.,5,True
doid,http://purl.obolibrary.org/obo/DOID_0070419,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:acrocardiofacial_syndrome rdfs:subClassOf :syndrome ;
    :has_definition ""A syndrome characterized by split-hand/split-foot malformation, facial anomalies, cleft lip/palate, congenital heart defect, genital anomalies, and intellectual deficit."" ;
    :has_exact_synonym ""cleft palate, cardiac defect, genital anomalies, and ectrodactyly"",
        ""cleft palate-cardiac defect-genital anomalies-ectrodactyly syndrome"" .

","Acrocardiofacial syndrome is a rare genetic disorder that affects multiple organ systems, including the heart, face, hands and feet, and internal genitalia. It is characterized by a combination of congenital heart defects, cleft lip and palate, split hand/foot malformation, facial anomalies, intellectual deficits, and genital anomalies.
The exact cause of acrocardiofacial syndrome is unknown, but it is believed to be caused by a combination of genetic and environmental factors.
There is no cure for acrocardiofacial syndrome, but early intervention can help improve outcomes. Treatment typically focuses on managing the symptoms, including surgery to correct cleft lip and palate, heart defects, and other physical abnormalities. Additionally, therapies may be provided to address intellectual deficits and developmental delays.
It is important for individuals with acrocardiofacial syndrome to receive comprehensive care from a multidisciplinary team of healthcare professionals, including genetic counselors, cardiologists, plastic surgeons, orthopedic surgeons, and speech therapists.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070420,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:developmental_delay_hypotonia_and_impaired_language rdfs:subClassOf :autosomal_dominant_intellectual_developmental_disorder ;
    :has_definition ""An autosomal dominant intellectual developmental disorder characterized by variably impaired intellectual development usually with hypotonia, mild motor delay, and language difficulties that has_material_basis_in heterozygous mutation in the FBXW7 gene on chromosome 4q31."" ;
    :has_exact_synonym ""DEDHIL"" .

","DEDHIL stands for Developmental Delay, Hypotonia and Impaired Language. It is a type of autosomal dominant intellectual developmental disorder characterized by variably impaired intellectual development usually with hypotonia, mild motor delay, and language difficulties that has_material_basis_in heterozygous mutation in the FBXW7 gene on chromosome 4q31.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070421,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:neurodevelopmental_disorder_with_spasticity_and_poor_growth rdfs:subClassOf :autosomal_recessive_intellectual_developmental_disorder ;
    :has_definition ""An autosomal recessive intellectual developmental disorder characterized by axial hypotonia, delayed psychomotor development, poor feeding, and failure to thrive with onset in early infancy that has_material_basis_in homozygous mutation in the UFC1 gene on chromosome 1q23."" ;
    :has_exact_synonym ""NEDSG"" .

",The neurodevelopmental disorder with spasticity and poor growth is also known as NEDSG.,3,True
doid,http://purl.obolibrary.org/obo/DOID_0070422,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:syndromic_x_linked_intellectual_disability_pilorge_type rdfs:subClassOf :syndromic_x_linked_intellectual_disability ;
    :has_definition ""A syndromic X-linked intellectual disability characterized by global developmental delay with variably impaired intellectual development, speech delay, and behavioral abnormalities including autism spectrum disorder that has_material_basis_in heterozygous or hemizygous mutation in the GLRA2 gene on chromosome Xp22."" ;
    :has_exact_synonym ""MRXSP"" .

","Syndromic X-linked intellectual disability (Pilorge type) is a specific form of syndromic X-linked intellectual disability characterized by global developmental delay with variably impaired intellectual development, speech delay, and behavioral abnormalities including autism spectrum disorder. This type of disability has a genetic basis due to mutations in the GLRA2 gene located on the Xp22 chromosome. It is also known as MRXSP.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070423,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:early_onset_progressive_encephalopathy_with_brain_atrophy_and_thin_corpus_callosum rdfs:subClassOf :autosomal_recessive_intellectual_developmental_disorder ;
    :has_definition ""An autosomal recessive intellectual developmental disorder characterized by onset at birth or in infancy of developmental delay, intellectual disability, seizures, secondary hypomyelination, cerebral atrophy, and thin corpus callosum that has_material_basis_in homozygous or compound heterozygous mutation in the TBCD gene on chromosome 17q25."" ;
    :has_exact_synonym ""PEBAT"",
        ""early-onset progressive encephalopathy with brain atrophy and thin corpus callosum"" .

","Early-onset progressive encephalopathy with brain atrophy and thin corpus callosum (PEBAT) is a type of autosomal recessive intellectual developmental disorder. It is characterized by onset at birth or in infancy of developmental delay, intellectual disability, seizures, secondary hypomyelination, cerebral atrophy, and thin corpus callosum due to homozygous or compound heterozygous mutation in the TBCD gene on chromosome 17q25.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070424,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:combined_oxidative_phosphorylation_deficiency_44 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :combined_oxidative_phosphorylation_deficiency ;
    :has_definition ""A combined oxidative phosphorylation deficiency that has_material_basis_in homozygous or compound heterozygous mutation in the FASTKD2 gene on chromosome 2q33."" ;
    :has_exact_match ""OMIM:618855"",
        ""ORDO:166105"" ;
    :has_exact_synonym ""COXPD44"" .

","combined oxidative phosphorylation deficiency 44 is a type of autosomal recessive disease.
combined oxidative phosphorylation deficiency 44 is a condition that has a genetic basis and is passed down through families in an autosomal recessive pattern.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0070425,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:combined_oxidative_phosphorylation_deficiency_52 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :combined_oxidative_phosphorylation_deficiency ;
    :has_definition ""A combined oxidative phosphorylation deficiency characterized by infantile onset, lactic acidemia, hypotonia, respiratory chain complex II and III deficiency, and multisystem organ failure that has_material_basis_in homozygous mutation in the NFS1 gene on chromosome 20q11."" ;
    :has_exact_match ""OMIM:619386"" ;
    :has_exact_synonym ""COXPD52"" .

","combined oxidative phosphorylation deficiency 52 is a type of autosomal recessive disease, characterized by infantile onset, lactic acidemia, hypotonia, respiratory chain complex II and III deficiency, and multisystem organ failure. It has material basis in homozygous mutation in the NFS1 gene on chromosome 20q11.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070426,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:combined_oxidative_phosphorylation_deficiency_53 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :combined_oxidative_phosphorylation_deficiency ;
    :has_definition ""A combined oxidative phosphorylation deficiency characterized by congenital-to-infantile onset, hypomyelination, microcephaly, liver dysfunction, and recurrent autoinflammation that has_material_basis_in homozygous mutation in the C2ORF69 gene on chromosome 2q33."" ;
    :has_exact_match ""OMIM:619423"" ;
    :has_exact_synonym ""COXPD53"" .

","combined oxidative phosphorylation deficiency 53 is a genetic disorder that affects the body's ability to produce energy. It is caused by mutations in the C2ORF69 gene on chromosome 2q33, and can result in congenital-to-infantile onset of symptoms such as hypomyelination, microcephaly, liver dysfunction, and recurrent autoinflammation. It is inherited in an autosomal recessive manner.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070427,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:combined_oxidative_phosphorylation_deficiency_54 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :combined_oxidative_phosphorylation_deficiency ;
    :has_definition ""A combined oxidative phosphorylation deficiency that has_material_basis_in homozygous or compound heterozygous mutation in the PRORP gene on chromosome 14q13."" ;
    :has_exact_match ""OMIM:619737"" ;
    :has_exact_synonym ""COXPD54"" .

","combined oxidative phosphorylation deficiency 54 is a rare genetic disorder that affects the body's ability to produce energy. It is caused by mutations in the PRORP gene on chromosome 14q13, and can be inherited in an autosomal recessive manner. Symptoms can include developmental delay, intellectual disability, and movement disorders. Treatment typically involves physical therapy, speech therapy, and other support services to help individuals reach their full potential.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070428,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:combined_oxidative_phosphorylation_deficiency_55 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_inheritance ],
        :autosomal_genetic_disease,
        :combined_oxidative_phosphorylation_deficiency ;
    :has_definition ""A combined oxidative phosphorylation deficiency that has_material_basis_in homozygous, compound heterozygous, or heterozygous mutation in the POLRMT gene on chromosome 19p13."" ;
    :has_exact_match ""OMIM:619743"" ;
    :has_exact_synonym ""COXPD55"" .

","combined oxidative phosphorylation deficiency 55 is a genetic disorder that affects the body's ability to produce energy. It results from mutations in the POLRMT gene on chromosome 19p13. The condition can cause a range of symptoms, including weakness, poor growth, and developmental delays. Some individuals with COXPD55 may also experience seizures and other neurological problems. Treatment for this disorder typically involves dietary therapy, supplements, and other supportive measures to help manage symptoms. In some cases, medication or other treatments may be necessary to address specific complications of the condition.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070429,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:combined_oxidative_phosphorylation_deficiency_56 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :combined_oxidative_phosphorylation_deficiency ;
    :has_definition ""A combined oxidative phosphorylation deficiency characterized by lethargy at birth, hypotonia, developmental delay, myopathy, and ptosis that has_material_basis_in compound heterozygous mutation in the TAMM41 gene on chromosome 3p25."" ;
    :has_exact_match ""OMIM:620139"" ;
    :has_exact_synonym ""COXPD56"" .

","combined oxidative phosphorylation deficiency 56 is a type of autosomal recessive disorder.
combined oxidative phosphorylation deficiency 56 is a type of genetic condition.
combined oxidative phosphorylation deficiency 56 has definition A combined oxidative phosphorylation deficiency characterized by lethargy at birth, hypotonia, developmental delay, myopathy, and ptosis that has_material_basis_in compound heterozygous mutation in the TAMM41 gene on chromosome 3p25..
combined oxidative phosphorylation deficiency 56 is a form of disease.
combined oxidative phosphorylation deficiency 56 has exact synonym COXPD56.
combined oxidative phosphorylation deficiency 56 has exact match OMIM:620139.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070430,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:combined_oxidative_phosphorylation_deficiency_57 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :combined_oxidative_phosphorylation_deficiency ;
    :has_definition ""A combined oxidative phosphorylation deficiency that has_material_basis_in compound heterozygous or homozygous mutation in the CRLS1 gene on chromosome 20p12."" ;
    :has_exact_match ""OMIM:620167"" ;
    :has_exact_synonym ""COXPD57"" .

","combined oxidative phosphorylation deficiency 57 (COXPD57) is a type of autosomal recessive disorder. It is caused by mutations in the CRLS1 gene, which is located on chromosome 20p12. This condition affects the body's ability to produce energy through the process of oxidative phosphorylation, and can cause a variety of symptoms, including respiratory distress, failure to thrive, and developmental delays. COXPD57 is also known as combined mitochondrial oxidative phosphorylation deficiency 57 (CMOPD57), and has the exact synonym ""COXPD57."" It is listed in OMIM (Online Mendelian Inheritance in Man) with the entry number 620167.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070431,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hyperphosphatasia_with_impaired_intellectual_development_syndrome rdfs:subClassOf :autosomal_recessive_intellectual_developmental_disorder ;
    :has_definition ""An autosomal recessive intellectual developmental disorder characterized by hyperphosphatasia and intellectual disability. Distinctive facial features including hypertelorism, long palpebral fissures, a nose with a broad bridge and a rounded tip, downturned corners of the mouth, and a thin upper lip are also often observed."" ;
    :has_exact_match ""OMIM:PS239300"",
        ""ORDO:247262"",
        ""UMLS_CUI:C1855923"" ;
    :has_exact_synonym ""HPMRS"",
        ""Mabry disease"",
        ""Mabry syndrome"",
        ""hyperphosphatasia with mental retardation syndrome"" .

","The syndrome you are describing, Hyperphosphatasia with Impaired Intellectual Development Syndrome (HPIIDS), is a rare autosomal recessive intellectual developmental disorder. This condition is characterized by hyperphosphatasia, which is an excess of phosphate ions in the body, and impaired intellectual development. Distinctive facial features are often observed in individuals with HPIIDS, including hypertelorism (wid",9,True
doid,http://purl.obolibrary.org/obo/DOID_0070432,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hyperphosphatasia_with_impaired_intellectual_development_syndrome_5 rdfs:subClassOf :hyperphosphatasia_with_impaired_intellectual_development_syndrome ;
    :has_definition ""A hyperphosphatasia with impaired intellectual development syndrome that has_material_basis_in homozygous or compound heterozygous mutation in the PIGW gene on chromosome 17q12."" ;
    :has_exact_match ""OMIM:616025"" ;
    :has_exact_synonym ""GPIBD11"",
        ""HPMRS5"",
        ""glycosylphosphatidylinositol biosynthesis defect 11"",
        ""hyperphosphatasia with mental retardation syndrome 5"" .

","Hyperphosphatasia with impaired intellectual development syndrome 5, also known as GPIBD11 or HPMRS5, is a rare genetic disorder that affects the glycosylphosphatidylinositol biosynthesis pathway. This results in abnormal accumulation of glycosylphosphatidylinositol (GPI) anchored proteins in various tissues, including the brain and liver, leading to intellectual developmental delays and other symptoms.

The disorder is caused by mutations in the PIGW gene on chromosome 17q12. Homozygous or compound heterozygous mutations in this gene can lead to the condition. It is important for individuals affected by this disorder to receive proper medical care and support from a team of specialists, including genetic counselors and developmental pediatricians.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0070433,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hyperphosphatasia_with_impaired_intellectual_development_syndrome_1 rdfs:subClassOf :hyperphosphatasia_with_impaired_intellectual_development_syndrome ;
    :has_definition ""A hyperphosphatasia with impaired intellectual development syndrome that has_material_basis_in homozygous or compound heterozygous mutation in the PIGV gene on chromosome 1p36."" ;
    :has_exact_match ""OMIM:239300"",
        ""UMLS_CUI:C4551502"" ;
    :has_exact_synonym ""GPIBD2"",
        ""HPMRS1"",
        ""glycosylphosphatidylinositol biosynthesis defect 2"",
        ""hyperphosphatasia with mental retardation syndrome 1"" .

","hyperphosphatasia with impaired intellectual development syndrome 1 is a rare genetic disorder characterized by excessive phosphate accumulation in the brain and other tissues, leading to abnormal growth of bone and dental enamel. It also causes intellectual developmental delays or mental retardation. The condition results from mutations in the PIGV gene on chromosome 1p36. This disorder has synonyms such as GPIBD2, HPMRS1, glycosylphosphatidylinositol biosynthesis defect 2, hyperphosphatasia with mental retardation syndrome 1, and OMIM:239300. It can also be identified by UMLS_CUI:C4551502.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0070434,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hyperphosphatasia_with_impaired_intellectual_development_syndrome_2 rdfs:subClassOf :hyperphosphatasia_with_impaired_intellectual_development_syndrome ;
    :has_definition ""A hyperphosphatasia with impaired intellectual development syndrome that has_material_basis_in compound heterozygous mutation in the PIGO gene on chromosome 9p13."" ;
    :has_exact_match ""OMIM:614749"" ;
    :has_exact_synonym ""GPIBD6"",
        ""HPMRS2"",
        ""glycosylphosphatidylinositol biosynthesis defect 6"",
        ""hyperphosphatasia with mental retardation syndrome 2"" .

","hyperphosphatasia with impaired intellectual development syndrome 2 is a type of hyperphosphatasia with impaired intellectual development syndrome.
hyperphosphatasia with impaired intellectual development syndrome 2 has a definition: a hyperphosphatasia with impaired intellectual development syndrome that has_material_basis_in compound heterozygous mutation in the PIGO gene on chromosome 9p13.
hyperphosphatasia with impaired intellectual development syndrome 2 is also known as GPIBD6, HPMRS2, glycosylphosphatidylinositol biosynthesis defect 6, and hyperphosphatasia with mental retardation syndrome 2. It has an exact match in the OMIM database with the code 614749.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0070435,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hyperphosphatasia_with_impaired_intellectual_development_syndrome_3 rdfs:subClassOf :hyperphosphatasia_with_impaired_intellectual_development_syndrome ;
    :has_definition ""A hyperphosphatasia with impaired intellectual development syndrome that has_material_basis_in homozygous or compound heterozygous mutation in the PGAP2 gene on chromosome 11p15."" ;
    :has_exact_match ""OMIM:614207"" ;
    :has_exact_synonym ""GPIBD8"",
        ""HPMRS3"",
        ""glycosylphosphatidylinositol biosynthesis defect 8"",
        ""hyperphosphatasia with mental retardation syndrome 3"" .

","Hyperphosphatasia with impaired intellectual development syndrome 3 is a rare genetic disorder that affects the body's ability to regulate phosphate levels in the brain. This can lead to severe mental retardation, seizures, and other developmental problems. It is caused by mutations in the PGAP2 gene on chromosome 11p15. The disorder has also been referred to as GPIBD8, HPMRS3, glycosylphosphatidylinositol biosynthesis defect 8, and hyperphosphatasia with mental retardation syndrome 3. It is important for individuals affected by this condition to receive proper medical care and support to help manage their symptoms.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0070436,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hyperphosphatasia_with_impaired_intellectual_development_syndrome_4 rdfs:subClassOf :hyperphosphatasia_with_impaired_intellectual_development_syndrome ;
    :has_definition ""A hyperphosphatasia with impaired intellectual development syndrome that has_material_basis_in homozygous or compound heterozygous mutation in the PGAP3 gene on chromosome 17q12."" ;
    :has_exact_match ""OMIM:615716"" ;
    :has_exact_synonym ""GPIBD62"",
        ""HPMRS6"",
        ""glycosylphosphatidylinositol biosynthesis defect 62"",
        ""hyperphosphatasia with mental retardation syndrome 6"" .

","Hyperphosphatasia with impaired intellectual development syndrome 4 (PGAP3-related) is a rare genetic disorder characterized by excessive phosphate accumulation in the brain, which leads to intellectual and motor skill developmental delays. It primarily affects infants and children and is caused by mutations in the PGAP3 gene on chromosome 17q12. The exact synonyms for this condition include GPIBD62, HPMRS6, glycosylphosphatidylinositol biosynthesis defect 62, and hyperphosphatasia with mental retardation syndrome 6. It has an exact match in OMIM under the entry number 615716.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0070437,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hyperphosphatasia_with_impaired_intellectual_development_syndrome_6 rdfs:subClassOf :hyperphosphatasia_with_impaired_intellectual_development_syndrome ;
    :has_definition ""A hyperphosphatasia with impaired intellectual development syndrome that has_material_basis_in homozygous mutation in the PIGY gene on chromosome 4q22."" ;
    :has_exact_match ""OMIM:616809"" ;
    :has_exact_synonym ""GPIBD40"",
        ""HPMRS4"",
        ""glycosylphosphatidylinositol biosynthesis defect 40"",
        ""hyperphosphatasia with mental retardation syndrome 4"" .

","Hyperphosphatasia with impaired intellectual development syndrome 6, also known as GPIBD40 or HPMRS4, is a rare genetic disorder characterized by excessive phosphate production in the body. This leads to the accumulation of phosphate in various tissues, including the brain and skeletal system, causing intellectual disability and other developmental problems. The condition is caused by a homozygous mutation in the PIGY gene on chromosome 4q22. It has an exact synonym of hyperphosphatasia with mental retardation syndrome 4, and is also known as glycosylphosphatidylinositol biosynthesis defect 40.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0070438,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:retinal_macular_dystrophy rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :macular_degeneration ;
    :has_definition ""A macular degeneration characterized by non-progression or slow progression and drusen-like deposits in varying degrees."" ;
    :has_exact_match ""OMIM:PS136550"" ;
    :has_exact_synonym ""MCDR"" .

","Retinal macular dystrophy is a type of macular degeneration, specifically characterized by non-progression or slow progression and drusen-like deposits in varying degrees. It has the exact synonym MCDR and an exact match OMIM:PS136550.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0070439,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:north_carolina_macular_dystrophy rdfs:subClassOf :retinal_macular_dystrophy ;
    :has_definition ""A retinal macular dystrophy characterized by limited drusen, larger confluent drusen, or severe colobomatous-like chorioretinal atrophy in the central macular region present at birth that are nonprogressive that has_material_basis_in heterozygous mutation in a DNase I hypersensitivity site on chromosome 6q16 upstream of the PRDM13 gene."" ;
    :has_exact_match ""GARD:9179"",
        ""MESH:C537835"",
        ""OMIM:136550"",
        ""ORDO:75327"",
        ""UMLS_CUI:C0730294"" ;
    :has_exact_synonym ""MCDR1"",
        ""NCMD"",
        ""central areolar pigment epithelial dystrophy"",
        ""central retinal pigment epithelial dystrophy"",
        ""progressive foveal dystrophy"",
        ""retinal macular dystrophy 1"" .

","north carolina macular dystrophy is a type of retinal macular dystrophy that is characterized by limited drusen, larger confluent drusen, or severe colobomatous-like chorioretinal atrophy in the central macular region present at birth that are nonprogressive and have a material basis in a heterozygous mutation in a DNase I hypersensitivity site on chromosome 6q16 upstream of the PRDM13 gene. It has exact synonyms such as central areolar pigment epithelial dystrophy, central retinal pigment epithelial dystrophy, progressive foveal dystrophy, and retinal macular dystrophy 1. It also has an exact match in the OMIM database with UMLS_CUI:C0730294.",13,True
doid,http://purl.obolibrary.org/obo/DOID_0070440,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:retinal_macular_dystrophy_3 rdfs:subClassOf :retinal_macular_dystrophy ;
    :has_definition ""A retinal macular dystrophy that has_material_basis_in variation in the chromosomal region 5p15.33-p13.1."" ;
    :has_exact_match ""OMIM:608850"" ;
    :has_exact_synonym ""MCDR3"" .

","Retinal macular dystrophy 3, also known as MCDR3, is a type of retinal macular dystrophy that has a genetic basis in variation within the chromosomal region 5p15.33-p13.1. It is characterized by degeneration of the macula, which can lead to vision loss and blindness if left untreated. This condition is inherited in an autosomal dominant manner, meaning that a person has an 50% chance of inheriting it from a affected parent. There is no cure for MCDR3, but treatments such as low vision aids, glasses, and genetic counseling can help manage the symptoms.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070441,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:retinal_macular_dystrophy_4 rdfs:subClassOf :retinal_macular_dystrophy ;
    :has_definition ""A retinal macular dystrophy characterized by late-onset macular degeneration, with multiple drusen-like deposits, macular geographic atrophy, and choroidal neovascularization that has_material_basis_in heterozygous mutation in the CLEC3B gene on chromosome 3p21."" ;
    :has_exact_match ""OMIM:619977"" ;
    :has_exact_synonym ""MCDR4"" .

","Retinal macular dystrophy 4, also known as MCDR4 or OMIM:619977, is a type of retinal macular dystrophy characterized by late-onset macular degeneration. It is caused by a heterozygous mutation in the CLEC3B gene on chromosome 3p21. The condition is marked by multiple drusen-like deposits, macular geographic atrophy, and choroidal neovascularization.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0070442,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:paroxysmal_nonkinesigenic_dyskinesia_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :dystonia ;
    :has_definition ""A dystonia characterized by epilepsy and attacks of dystonic or choreathetotic movements, which may coexist or occur singly, that has_material_basis_in heterozygous mutation in the KCNMA1 gene on chromosome 10q22."" ;
    :has_exact_match ""OMIM:609446"",
        ""ORDO:79137"" ;
    :has_exact_synonym ""generalized epilepsy and paroxysmal dyskinesia"" .

","Paroxysmal nonkinesigenic dyskinesia 3 (PND3) is a type of autosomal dominant disease that affects movement. It causes sudden and involuntary movements called dystonia, which can be accompanied by epilepsy or other neurological symptoms. The condition has a material basis in mutations in the KCNMA1 gene on chromosome 10q22. PND3 can be diagnosed with a physical examination and genetic testing, and treatment may involve medications to control seizures and dystonia. It is important for individuals with this condition to work closely with their healthcare provider to manage their symptoms effectively.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0070443,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:neurodevelopmental_disorder_with_cerebellar_atrophy_and_motor_dysfunction rdfs:subClassOf :autosomal_recessive_intellectual_developmental_disorder ;
    :has_definition ""An autosomal recessive intellectual developmental disorder characterized by cerebellar atrophy and global developmental delay with cognitive impairment, speech delay, and prominent motor abnormalities including axial hypotonia, gait ataxia, and appendicular spasticity that has_material_basis_in homozygous or compound heterozygous mutation in the GEMIN5 gene on chromosome 5q33.2."" ;
    :has_exact_match ""OMIM:619333"" .

","neurodevelopmental disorder with cerebellar atrophy and motor dysfunction is a type of autosomal recessive intellectual developmental disorder. It is characterized by cerebellar atrophy and global developmental delay with cognitive impairment, speech delay, and prominent motor abnormalities including axial hypotonia, gait ataxia, and appendicular spasticity that has_material_basis_in homozygous or compound heterozygous mutation in the GEMIN5 gene on chromosome 5q33.2. It is also known as OMIM:619333.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070444,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:neurodevelopmental_disorder_with_language_delay_and_seizures rdfs:subClassOf :autosomal_recessive_intellectual_developmental_disorder ;
    :has_definition ""An autosomal recessive intellectual developmental disorder characterized by early-onset seizures and global developmental delay with intellectual disability and speech delay that has_material_basis_in homozygous or compound heterozygous mutation in the TIAM1 gene on chromosome 21q22."" ;
    :has_exact_match ""OMIM:619908"" .

","It seems you are providing information about a specific genetic disorder known as Neurodevelopmental Disorder with Language Delay and Seizures (NLDLS), which is classified as an Autosomal Recessive Intellectual Developmental Disorder (ARIDD). NLDLS is characterized by early-onset seizures, global developmental delay with intellectual disability, and speech delay. The genetic basis of this disorder is attributed to mutations in the TIAM1 gene located on chromosome 21q22. This condition has a specific OMIM identifier: 619908.

Please note that I am an AI language model and not a medical professional, so it's always best to consult with a healthcare provider for accurate and up-to-date information regarding any medical condition or genetic disorder.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0070445,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:early_onset_dystonia_and_or_spastic_paraplegia rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :dystonia ;
    :has_definition ""A dystonia characterized by variable onset of dystonia, spasticity, or both that has_material_basis_in heterozygous mutation in the ATP5MC3 gene on chromosome 2q31.1."" ;
    :has_exact_match ""OMIM:619681"" .

","Early onset dystonia and or spastic paraplegia, also known as hereditary motor neurographia with spasticity, is a type of autosomal dominant disease. It is characterized by the presence of dystonia, spasticity or both, which has a material basis in a heterozygous mutation in the ATP5MC3 gene on chromosome 2q31.1. This condition has been defined and classified according to the MIM number OMIM:619681.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0070446,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:mitochondrial_dna_depletion_syndrome_16 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :mitochondrial_dna_depletion_syndrome ;
    :has_definition ""A mitochondrial DNA depletion syndrome characterized by infantile onset of fulminant hepatic liver failure that has_material_basis_in homozygous mutation in the POLG2 gene on chromosome 17q23.3."" ;
    :has_exact_match ""OMIM:618528"" ;
    :has_exact_synonym ""mitochondrial DNA depletion syndrome 16 (hepatic type)"" .

","Mitochondrial DNA depletion syndrome 16, also known as mtDNA deletion syndrome or mtDNA depletion syndrome with hepatic involvement, is a rare genetic disorder that affects mitochondria. It is caused by the deletion of a large portion of mitochondrial DNA (mtDNA), which leads to a decrease in the production of adenosine triphosphate (ATP). This energy deficiency can result in multiple organ systems being affected, including the liver, brain, and eyes.

The symptoms of mtDNA depletion syndrome 16 typically begin in early infancy and can include poor feeding, vomiting, lethargy, failure to thrive, seizures, and developmental delay. The disease is usually fatal within a few years of onset, although some cases have been reported with milder symptoms.

Diagnosis of mtDNA depletion syndrome 16 typically involves a combination of clinical examination, genetic testing, and measurement of DNA levels in blood cells. Treatment options are limited and primarily focus on managing symptoms and providing supportive care. However, research is ongoing to better understand this disorder and develop effective treatments.

In conclusion, mtDNA depletion syndrome 16 is a genetic disorder that affects mitochondria and can cause severe health problems due to energy deficiency. While there is no cure for the disease, early diagnosis and supportive care can help improve quality of life for affected individuals.",6,True
